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METHIDATHION
SUMMARY
Methidathion (O,O-dimethyl-phosphorodithioate, S-ester with 4-(mercaptomethyl)-2-
methoxy-Δ-1,3,4-thiadiazolin-5-one) was first registered in 1974 by Ciba Geigy Corporation
(U.S. EPA, 1989).  The Department of Pesticide Regulation (DPR) in the California
Environmental Protection Agency placed methidathion on the high-priority list for risk
assessment based on possible adverse effects identified in chronic toxicity, carcinogenicity and
chromosomal aberrations studies submitted under the Birth Defect Prevention Act (SB 950).   In
1989, the California Assembly passed AB2161 which requires DPR to conduct dietary risk
assessments for all pesticides with food crop uses.  The Department of Pesticide Regulation
(DPR) in the California Environmental Protection Agency completed a Risk Characterization
Document (RCD) for methidathion in 2001 that addressed dietary and drinking water exposure. 
No mitigation was needed for either dietary or drinking water exposure; however, an acute
tolerance assessment suggested that the tolerances for citrus fruit and apples should be reduced
to be health protective. The purpose of this revision to the Risk Characterization Document for
methidathion is to add the occupational and ambient air exposure to dietary and drinking water
exposure, evaluating them separately and in combination.
Toxicity
The pharmacokinetic and toxicology studies were reviewed and presented in the
Toxicology Profile section.  Included in the Toxicology Profile are guideline studies submitted to
the Department of Pesticide Regulation (DPR) and studies from open literature with the greatest
weight generally given to guideline studies that met the Federal Insecticide, Fungicide and
Rodenticide Act (FIFRA) guidelines.  From the treatment-related effects identified in the studies,
the highest dose, which did not cause any toxicological effect, known as No-Observed-Effect
Level (NOEL), was established for each study.  In the Hazard Identification section, the NOELs
and effects at the Lowest-Observed-Effect Level (LOEL) from the available toxicity studies
were then evaluated to determine what would be the most appropriate NOEL, referred to as a
critical NOEL, to evaluate particular exposure scenarios.  The toxicity studies can be categorized
as acute (< 7 days), subchronic (> 7 days to < 6 months), and chronic (1 or more years) in
duration.  For methidathion, critical NOELs were identified for acute, subchronic, and chronic
exposure scenarios.  In addition, a potency factor was estimated for carcinogenicity.  The critical
NOELs were adjusted to absorbed doses because human exposures were expressed as absorbed
doses.  Since all the critical NOELs were derived from oral studies and the oral absorption rate
was assumed to be 100%, no adjustment for oral absorption was necessary. 
Methidathion and its oxygen analog produce their toxic reaction primarily through their
inhibition of cholinesterase (ChE) enzymes, including acetylcholinesterase (AChE).  AChE is
responsible for the termination of nerve impulses across synaptic clefts of certain types of nerves
in the central and peripheral nervous systems.  The effects observed in laboratory animals after
acute exposure to methidathion were various neurological signs typical of ChE inhibitors,
including ataxia, muscle fasciculations, convulsions, excessive salivation and lacrimation,
difficulty in breathing and death.  The most sensitive endpoint in the acute neurotoxicity study in
rats was ChE inhibition in the cerebral cortex of males, but a NOEL was not established in thisMethidathion RCD (Revision 1) February 2007
2
study.   After 2 weeks of exposure in the 90-day neurotoxicity study in rats, a NOEL was
established for the same endpoint.  Therefore, the critical NOEL selected for evaluating the acute
dietary, drinking water, occupational and ambient air exposure to methidathion was 0.18
mg/kg/day based on a significant reduction of ChE activity in the cerebral cortex of male rats
after 2 weeks of exposure in the 90-day neurotoxicity study.  The selection of this 2-week NOEL
for the acute NOEL was supported by the benchmark dose analysis.
  Brain ChE inhibition and cholinergic signs similar to those observed with acute
exposure were also observed in laboratory animals after subchronic exposure.  In addition,
reduced body temperatures, reduced body weights and food consumption, hematological changes
suggestive of anemia, changes in serum enzyme levels suggestive of liver toxicity, and lesions in
the liver, gallbladder, stomach, kidney and heart were seen.  The lowest subchronic NOEL was
0.18 mg/kg/day that was observed in a 90-day neurotoxicity study in rats based reduced ChE
activity in RBCs and various brain regions in both sexes.  ChE inhibition in RBCs was
considered a surrogate for ChE inhibition in the peripheral nervous system which was not
measured in this study.  Dietary and drinking water exposure to methidathion did not vary
significantly with season; however, seasonal occupational and ambient air exposure to
methidathion is anticipated.  Therefore, the subchronic neurotoxicity study in rats was selected
as the definitive study for evaluating seasonal occupational and ambient air exposure to
methidathion.
Several developmental and reproductive effects were seen in studies including reduced
pup weights, signs of maternal neglect, and reduced maternal index.  The NOELs for fetal or pup
effects were equal to or higher than the maternal or parental NOELs, suggesting there is no
increased pre- or post-natal sensitivity to methidathion.  However, in one direct-dosing study
where the LD50 was determined in both weanling and adult rats, the weanling rats appear to be
slightly more sensitive.
The effects observed in laboratory animals with chronic exposure to methidathion were
similar to those observed with subchronic exposure, except that evidence of hepatotoxicity was
more common.  Although both the neurotoxicity and hepatoxicity were seen in most species,
there appeared to be some species differences in the pharmacokinetics of methidathion. 
Cholinesterase inhibition appeared to be the more sensitive endpoint in rats while the
hepatotoxicity was a more sensitive endpoint in dogs.  The lowest NOEL in a chronic study of
acceptable quality was 0.15 mg/kg/day based on elevated liver enzymes in the serum and
microscopic lesions in the liver of dogs exposed to methidathion in the diet for 1 year.
An increase in liver tumors was also observed in male mice in two different
carcinogenicity studies with chronic exposure.  The tumors were only observed at dose levels
that produced significant increases in other non-neoplastic lesions in the livers of mice
suggesting that they maybe secondary to these non-neoplastic lesions.  Most of the genetic
toxicity tests for methidathion were negative.  However, direct DNA interaction could not be
eliminated since its genetic toxicity potential has not been thoroughly tested in well-conducted,
sensitive assays with mammalian cells and a few genetic toxicity tests were positive (a gene
conversion/forward mutation assay with yeast and an in vitro sister chromatid exchange assay
with mammalian cells).   Furthermore, no mechanistic data was submitted to support a threshold
mechanism.  Therefore, it was assumed that a non-threshold mechanism was involved and theMethidathion RCD (Revision 1) February 2007
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carcinogenic potential of methidathion was evaluated using a linear approach based on the
increase in liver tumors in male mice.  The cancer potency was estimated to range from 0.34
(mg/kg/day)
-1 for the maximum likelihood estimate to 0.53 (mg/kg/day)
-1 for the 95% upper
bound estimate. 
The following table summarizes the critical NOELs and cancer potency factor used for
evaluating methidathion exposure along with their respective reference doses and concentrations:
Exposure
Scenario NOEL Effects on LOEL RfD
RfC
Infants Adults
Acute 0.18
mg/kg
Reduced ChE activity in
cerebral cortex of  male
rats
1.8
μg/kg
3.1 μg/m
3
(0.25 ppb)
6.4 μg/m
3
(0.52 ppb)
Seasonal 0.18
mg/kg/day
Reduced ChE activity in
RBCs, cerebral cortex
(M), striatum (F) and
hippocampus (F) of rats
1.8
μg/kg/day
3.1 μg/m
3
(0.25 ppb)
6.4 μg/m
3
(0.52 ppb)
Chronic 0.15
mg/kg/day
Elevated liver enzymes in
serum and liver
histopathology in dogs
1.5
μg/kg/day
2.5 μg/m
3
(0.21 ppb)
5.4 μg/m
3
(0.43 ppb)
Lifetime Potency
0.53 
(mg/kg/day)
-1
Liver tumors in male mice 1.9 
ng/kg/day -----
6.8 ng/m
3
(0.6 ppt)
The oxygen analog or oxon is the presumed active metabolite of methidathion for the
neurological effects, although the pharmacokinetics studies suggest that it may be a minor
metabolite.  There were no toxicity studies for methidaoxon, therefore, it was assumed that the
oxon was equivalent in toxicity to the parent compound for all endpoints.  Most likely the
NOELs for methidaoxon would have been lower since the oxon is usually the active metabolite
for organophosphorothioates, at least for neurological effects.  Consequently, the health risks
from exposure to methidathion are probably underestimated.
  Exposure
Dietary
A tiered approach was used in the dietary exposure analysis.  A tier 3 analysis was
conducted for both acute and chronic exposure using primarily U.S. Department of Agriculture’s
(USDA’s) Pesticide Data Program (PDP) monitoring data from 2000-2003 and adjustments for
percent crop treated.  Dietary consumption of commodities with methidathion residues by
various population subgroups was based on USDA’s Continuing Survey of Food Intakes by
Individuals (CSFII) from 1994 to 1998.  The estimated acute dietary exposure dosages at theMethidathion RCD (Revision 1) February 2007
4
99.9th percentile for users ranged from 0.175 to 0.780 μg/kg/day.  The population subgroup with
the highest acute dietary exposure was children 1 to 2 years old.   The estimated chronic dietary
exposure dosages ranged from 0.001 to 0.019 μg/kg/day.  Non-nursing infants less than 1 year
old had the highest estimated chronic dietary exposure. 
Drinking Water
Methidathion residues have been detected in DPR’s surface water monitoring in
California.  However, it is uncertain if any of the surface water sampled represented drinking
water sources.  No methidathion residues have been detected in well water monitored by DPR. 
In addition, no methidathion residues were detected in the PDP drinking water samples from
2001 to 2003 including California.  Surface water was the source of most of the PDP drinking
water sampled.  Since the PDP data represent finished drinking water, the data from California
was selected for evaluating drinking water exposure to methidathion.  The estimated acute
drinking water exposure to methidathion at the 99.9th percentile for users ranged from 0.002 to
0.012 μg/kg/day.  Non-nursing infants had the highest estimated acute exposure to methidathion
in drinking water.  The estimated chronic drinking water exposure was less than 0.001 μg/kg/day
for all population subgroups, except non-nursing infants less than 1 year old whose chronic
exposure was approximately 0.001 μg/kg/day.
When dietary and drinking water exposure to methidathion were combined, the acute
exposure at the 99.9th percentile for users ranged from 0.172 to 0.777 μg/kg.  Children 1 to 2
years old had the highest combined acute exposure.  Acute estimates for combined dietary and
drinking water exposure at the 99.9th percentile of users were less than dietary exposure alone at
the 99.9th percentile of users, because they represented different populations.  The number of
users increased with the addition of water, but the exposure only increased slightly.  The
combined chronic exposure to methidathion ranged from 0.002 to 0.020 μg/kg/day.  Non-nursing
infants had the highest combined chronic exposure to methidathion.
Occupational
There were no acceptable chemical-specific occupational exposure studies for
methidathion, so handler exposure was estimated using the Pesticide Handler Exposure Database
(PHED).  Daily, seasonal, chronic and lifetime exposure dosages were estimated for 9 handler
exposure scenarios covering aerial, airblast, groundboom, backpack sprayer and low-pressure
handwand application.  The Absorbed Daily Dosage (ADD) represented the upper confidence
limit on the 95th percentile after adjusting for dermal and inhalation absorption using default
values of 50 and 100%, respectively.  The ADDs for handlers ranged from 0.0034 to 5.86
mg/kg/day.  The Seasonal Average Daily Dosage (SADD) was the upper confidence limit on the
mean daily exposure during the high-end use months.  The seasonal and annual exposures for
handlers were estimated to occur over 1 to 2 months.  The SADDs for handlers ranged from
0.044 to 1.55 mg/kg/day.  The Annual Average Daily Dosage (AADD) was calculated by
multiplying the SADD by the annual use months per year and dividing by 12 months.  The
AADDs for handlers ranged from 0.004 to 0.129 mg/kg/day.  The Lifetime Average Daily
Dosage (LADD) was estimated by multiplying the AADD by 40 years of work in a lifetime and
dividing by 75 years in a lifetime.  The LADDs for handlers ranged from 0.002 to 0.069
mg/kg/day.   Mixer/loader/applicators (M/L/As) using low-pressure handwands had the lowestMethidathion RCD (Revision 1) February 2007
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acute exposure dosages while airblast and aerial applicators had the highest acute exposure
dosages.  The M/L/As using backpack sprayers and low-pressure handwands were not
considered to have seasonal and chronic exposures, so the lowest seasonal and chronic exposures
among handlers were for airblast mixer/loaders and groundboom applicators.  Aerial and airblast
applicators continued to have the highest seasonal and chronic exposures.
The exposure dosages were calculated for 3 field worker exposure scenarios using
dislodgeable foliar residues (DFRs) and transfer factors (TFs).  The exposure scenarios for field
workers covered scouting, thinning and harvesting crops treated with methidathion.  The DFRs
for the ADDs and SADDs were those anticipated at the end of the restricted entry interval (REI)
and REI plus 7 days, respectively, for most activities.  The default dermal absorption of 50% was
applied to the field worker exposure calculations.  The ADDs for field workers ranged from
0.007 to 0.093 mg/kg/day.  The SADDs for field workers were between 0.0007 and 0.0045
mg/kg/day.  The seasonal and annual exposures for field workers were estimated to occur over 2
to 4 months.  The AADDs ranged from 0.0001 to 0.0011 mg/kg/day for field workers.  The
LADDs were between 0.00006 and 0.0006 mg/kg/day for field workers.
Ambient Air
Application site and ambient air were monitored in Tulare County during June and July
of 1991.  Tulare County had the highest use of methidathion in 1991, primarily in June and July. 
The air was monitored for both methidathion and methidaoxon.  The application site monitoring
study for methidathion was conducted following an application to an orange grove, but it was not
used because no samplers were downwind due to an unanticipated wind direction.  Instead a
methyl parathion application to a walnut orchard in San Joaquin county in July of 2003 was used
as a surrogate study.  In this study, samplers were placed all around the field and the downwind
samplers were used to estimate exposure.  The methyl parathion study was considered an
appropriate surrogate study for methidathion because of similarities in equipment used, timing of
applications and vapor pressure.  Exposure estimates were adjusted upward to account for
differences in application rate in the methyl parathion study (2 lbs/acre) and the maximum
application rate for methidathion on citrus (5 lbs/acre).  In the methyl parathion study, the air
was monitored for methyl paraoxon in addition to methyl parathion.  The exposure estimates
represent the sum of the parent and oxon exposure.  The 1-hr acute exposure estimates (i.e.,
ADDs) for application site air were 4.62 and 0.832 μg/kg for infants and adults, respectively,
using the highest measured concentration in the surrogate study, assuming heavy activity and
assuming a default inhalation absorption of 100%.  The 24-hr ADDs were 8.04 μg/kg for infants
and 3.82 μg/kg for adults.  Seasonal and chronic exposure estimates were calculated for people
living or working near artichoke fields since up to 8 applications can occur in a year with a
minimum of 2 weeks between applications.  The SADDs for the application site were 0.936 and
0.444 μg/kg/day for infants and adults, respectively, assuming the high use months to be 2
months.  The AADDs were 0.157 μg/kg/day for infants and 0.074 μg/kg/day for adults.  The
exposure estimates for ambient air were initially calculated for the Jefferson Elementary School
in Lindsay since it had the highest daily and average air concentrations.  An acute exposure
estimate was not calculated since it would clearly be less than at the application site.  The
SADDs for ambient air at the Jefferson site were 0.060 μg/kg/day for infants and 0.028
μg/kg/day for adults based on the average air concentration during the monitoring period.  The
AADDs for ambient air at the Jefferson site were 0.045 and 0.021 μg/kg/day for infants andMethidathion RCD (Revision 1) February 2007
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adults, respectively, assuming the season of potential exposure is 9 months per year.  Due to
their higher respiratory rate relative to their body weight, infants consistently had the highest
exposure.
  
Risk Characterization
The risk for non-carcinogenic health effects is expressed as a margin of exposure (MOE)
which is the ratio of the NOEL from the animal study to the human exposure dosage.  Generally,
an MOE of at least 100 is desirable assuming that humans are 10 times more sensitive than
animals and that there is a 10-fold variation in the sensitivity between the lower distribution of
the overall human population and the sensitive subgroup.  The negligible carcinogenic risk level
is generally considered 1 excess cancer case in a million people.  
Dietary
The MOEs for acute dietary exposure to methidathion in the various population
subgroups ranged from 230 to 1,000.  The MOEs for chronic dietary exposure ranged from 8,000
to 110,000.  The MOEs for dietary exposure were sufficiently large (> 100) not to be of concern. 
The estimated cancer risk from dietary exposure to methidathion ranged from 0.7 to 1.1 excess
cancer cases in a million people.  The cancer risks from dietary exposure were also sufficiently
low (~1 excess cancer case in a million people) not to be of concern.  However, the health risks
from dietary exposure were probably underestimated since commodities were not analyzed for
the oxon in either the PDP or DPR monitoring programs. 
Drinking Water
The MOEs for acute drinking water exposure to methidathion ranged from 15,000 to
120,000.   The MOEs from chronic drinking water exposure ranged from 160,000 to 900,000. 
The MOEs from drinking water exposure were large enough that they were not of concern.  The
estimated cancer risk from drinking water exposure to methidathion ranged from 0.9 to 1.4
excess cancers in 10 million people.  The cancer risks from drinking water exposure were also
low enough not to be of concern.
The MOEs for combined acute dietary and drinking water exposure to methidathion
ranged from 230 to 1,000.  The MOEs for combined chronic exposure ranged from 7,700 to
92,000.  The estimated cancer risk from combined dietary and drinking water exposure to
methidathion ranged from 0.8 to 1.2 excess cancer cases in a million people.  Even considering
the combined dietary and drinking water exposure, the health risks from these exposure
scenarios were not of concern.
Occupational
Occupational exposure to methidathion is of particular concern since the MOEs for acute,
seasonal and chronic occupational exposure were less than 100 for all worker exposure
scenarios, except seasonal exposure for thinning of artichokes and chronic exposure for all field
worker scenarios.   The MOEs were less than 10 for most handler scenarios and less than 1 for
some handler scenarios (aerial handlers and airblast applicators), suggesting mitigation is neededMethidathion RCD (Revision 1) February 2007
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especially for handlers.   The cancer risk estimates for occupational exposure to methidathion all
exceeded the negligible risk level, ranging from 2.0 excess cancer cases in 100,000 to 3.7 excess
cancer cases in 100.  The cancer risk estimates from occupational exposure are extremely high
and are of concern, especially for handlers.   Aerial applicators had the highest estimated cancer
risk.
Ambient Air
The MOEs for acute air exposure at the application site were less than 100 for both
infants and adults, not only meeting the criteria for listing methidathion as a toxic air
contaminant, but suggesting mitigation may be needed.  The MOEs for seasonal and chronic air
exposure at the application site were greater than 100 for both infants and adults, but less than
1,000 (except for chronic exposure in adults) which also meets the criteria for identifying
methidathion as a toxic air contaminant.  The cancer risk estimates for the application site air
ranged from 2.5 to 3.9 excess cancer cases in 100,000 which are low enough not only to meet the
criteria for listing, but also to suggest mitigation is needed.  The seasonal and chronic MOEs for
ambient air were greater than 1,000 for infants and adults; however, the cancer risk estimates for
ambient air exceeded the negligible risk level, ranging from 0.71 to 1.1 excess cancer cases in
100,000.  These cancer risk estimates not only meet the criteria for listing methidathion as a
toxic air contaminant, they also suggest mitigation may be needed.
Aggregate
Aggregate exposure for agricultural workers and the general public were evaluated.  The
MOEs for most agricultural workers were already significantly less than 100 from occupational
exposure alone without adding in additional exposure from diet, drinking water and ambient air. 
Therefore, the aggregate MOEs for most agricultural workers was not significantly lower than
their occupational MOEs.  Similarly, the air exposure was a major contributor to the aggregate
exposure for the general population.  Consequently, the aggregate MOEs for the general public
were only slightly lower than the MOEs for air exposure alone. 
Tolerance Assessment
 
A tolerance assessment for methidathion was conducted assuming commodities were
consumed at their tolerance level for acute exposure.  The MOEs for potential acute effects were
less than 100 for one or more population subgroups for citrus fruit and apples.  Based on these
estimates, the tolerances for citrus fruit and apples do not appear to be health protective and DPR
recommends that U.S. EPA reevaluate these tolerances.
Conclusions
The potential health risks from dietary and drinking water exposure to methidathion
appear to be low, although dietary risks may have been underestimated since DPR and PDP
monitoring did analyze commodities for the methidaoxon.  On the other hand, the potential
health risks from occupational exposure to methidathion appear to be quite high for most
exposure scenarios, especially for handlers, suggesting mitigation is needed.  The potential
health risks for bystanders from acute exposure to air at the application site are also high, notMethidathion RCD (Revision 1) February 2007
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only meeting the criteria for listing methidathion as a toxic air contaminant, but suggesting
mitigation is needed.  Cancer risk estimates for both the application site and ambient air were
also high enough to suggest mitigation is needed.   The potential health risks from exposure to
methidathion may be underestimated since methidaoxon was assumed to be equally toxic as
methidathion due to the lack of toxicity data for the oxon.  Furthermore, the health risk estimates
for methidathion were probably underestimated since they did not take into consideration
cumulative exposure from other organophosphates.  Mitigation of the occupational and air
exposures to methidathion is not addressed in this document due to the separation of risk
assessment from risk management.  Mitigation of these exposures will be addressed in a separate
document during the risk management phase.Methidathion RCD (Revision 1) February 2007
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I.  INTRODUCTION
I.A.  REGULATORY BACKGROUND
Methidathion (O,O-dimethyl-phosphorodithioate, S-ester with 4-(mercaptomethyl)-2-
methoxy-Δ-1,3,4-thiadiazolin-5-one) was first registered in 1974 by Ciba Geigy Corporation
(U.S. EPA, 1989).  The Department of Pesticide Regulation (DPR) in the California
Environmental Protection Agency placed methidathion on the high-priority list for risk
assessment based on possible adverse effects identified in chronic toxicity, carcinogenicity and
chromosomal aberrations studies submitted under the Birth Defect Prevention Act (SB 950). 
Methidathion is also a high-priority pesticide for risk assessment under the California Toxic Air
Contaminant Act (AB 1807).  In 1989, the California Assembly passed AB2161 which requires
DPR to conduct dietary risk assessments for all pesticides with food crop uses.   
Methidathion was placed in reevaluation in 1989 along with chlorpyrifos, diazinon, and
ethyl parathion which were used as dormant sprays to control scale and other pests on almond
trees (DPR, 1996).  Reevaluation of these organophosphates was based on a study conducted by
the California Department of Fish and Game (CDFG) which identified possible adverse effects
in resident and migratory red-tailed hawks.  The registrants were then asked to submit additional
data to further evaluate this potential wildlife problem.  During the course of these field studies,
the use of ethyl parathion as a dormant spray was canceled.  Field and laboratory studies
indicated that methidathion had the greatest effect on cholinesterase inhibition of these four
organophosphate pesticides with the exception of ethyl parathion.  The principle route of
exposure to these chemicals for raptors (birds of prey, such as hawks) appears to be the dermal
route from perching on sprayed trees.  DPR concluded that no mitigation was needed because the
elimination of ethyl parathion resulted in a significant reduction in the raptors identified with
lowered cholinesterase levels and, therefore, continued use of the other three organophosphates
did not pose a significant hazard.  CDFG concurred with DPR’s decision.  
In 2001, DPR completed a Risk Characterization Document (RCD) for methidathion
addressing dietary and drinking water exposure.  No mitigation was needed for either the dietary
or drinking water exposure, although the tolerance assessment suggested that the tolerances for
citrus fruit and apples should be reduced to be health protective.  This document has been
revised to include additional occupational and ambient air exposure assessments for
methidathion.  DPR is also updating its use of ChE inhibition data in the risk assessment for ChE
inhibitors.  In anticipation of changes in the use of these endpoints in the risk assessments,
NOELs for both blood and brain ChE inhibition were included in this document.  
I.B.  CHEMICAL IDENTIFICATION
Methidathion is an organophosphate insecticide and acaricide (U.S. EPA, 1988). 
Methidathion and its oxygen analog produce their toxic reaction primarily through their
inhibition of cholinesterase (ChE) enzymes, including acetylcholinesterase (AChE) and butyryl-
cholinesterase (BuChE).  AChE is also called specific or true cholinesterase and is found near
cholinergic synapses, in some organs (e.g., lung, spleen, gray matter) and in hematopoietic cellsMethidathion RCD (Revision 1) February 2007
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(Lefkowitz et al., 1990).  Normally, AChE metabolizes acetylcholine to acetate and choline,
which results in the termination of stimulation to dendritic nerve endings and motor endplates. 
Acetylcholine is the neurochemical transmitter at endings of postganglionic parasympathetic
nerve fibers, somatic motor nerves to skeletal muscle, preganglionic fibers of both
parasympathetic and sympathetic nerves, and certain synapses in the central nervous system
(Murphy, 1986).  The concentration at which methidathion inhibited 50% of the free AChE
activity in electric eel and bovine red blood cells (RBCs) was reported to be 2.3 x 10
-4 M and 4.6
x 10
-4 M, respectively, compared to paraoxon which was 2.8 x 10
-7 M and 9.6 x 10
-8 M,
respectively (Mionetto et al., 1992).  The bimolecular rate constant, Ka (M
-1mm
-1), of
methidathion was 1.9 x 10
2 and 9.3 x 10
1 for the free AChE in electric eel and bovine RBCs,
respectively, compared to paraoxon which was 4 x 10
5 and 0.7 x 10
6.  However, the active
metabolite of methidathion, the oxygen analog, was not used, so the ability of methidathion to
inhibit AChE was underestimated in this experiment. 
The inhibition of AChE results in the accumulation of endogenous acetylcholine in nerve
tissue and effector organs.  In acutely toxic episodes, muscarinic, nicotinic and central nervous
system (CNS) receptors are stimulated with characteristic signs and symptoms occurring
throughout the peripheral and central nervous systems (Ellenhorn and Barceloux, 1988; Murphy,
1986).  Muscarinic effects can include increased intestinal motility, bronchial constriction and
increased bronchial secretions, bladder contraction, miosis, secretory gland stimulation and
bradycardia.  Nicotinic effects include muscle weakness, twitching, cramps and general
fasciculations.  Accumulation of acetylcholine in the CNS can cause headache, restlessness,
insomnia, anxiety and other non-specific symptoms.  Severe poisoning results in slurred speech,
tremors, ataxia, convulsions, depression of respiratory and circulatory centers and, eventually,
coma.
Butyrylcholinesterase (BuChE), sometimes referred to as plasma ChE, pseudo-
cholinesterase, or serum esterase, is also inhibited by methidathion.  Any reference in this
document to "cholinesterase", without specifically indicating that the enzyme is serum or plasma
ChE, should be interpreted as AChE.  BuChE only occurs to a limited extent in neuronal
elements of the central and peripheral nervous systems in adults, but there is compelling
evidence  for a role of BuChE in the developing nervous system and in the co-regulation of
acetylcholine (ACh) levels in the mature nervous system.  The evidence for a role in the co-
regulation of ACh is based on 1) substrate inhibition of AChE, but not BuChE, at high
concentrations of ACh, 2) survival of AChE knockout (AChE
-/-) mice past birth, 3) an increase in
BuChE levels in Alzheimer’s patients while the AChE levels decrease (Giacobini, 2003; Li et
al., 2000; Ballard and Perry, 2003).  Unlike AChE, BuChE occurs primarily in non-neuronal or
non-synaptic sites in adults like the liver, lung, and plasma and has no known physiological
function (Lefkowitz et al., 1990; Brimijoin, 1992; U.S. EPA, 1993; Pantuck, 1993).  An atypical
genetic variant of plasma cholinesterase has been associated with an increased susceptibility to
various drugs, such as succinylcholine and cocaine (Lockridge, 1990; Pantuck, 1993).  However,
it is unclear if this increased susceptibility to certain drugs in people with the atypical plasma
ChE translates to a possible adverse effect when plasma ChE is inhibited by organophosphates. 
There is some evidence suggesting that BuChE does play a role in the metabolism of
organophosphates in that administration of exogenous BuChE provided significant protection
against organophosphate toxicity in several species tested including rats, mice, guinea pigs and
non-human primates (Raveh et al., 1997; Allon et al., 1998).Methidathion RCD (Revision 1) February 2007
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  The physiological role of AChE in RBCs is also unknown.  Due to the expression of
AChE in several types of hematopoietic cell lines, it has been proposed that circulating AChE
may be important in erythropoiesis (Grisaru et al. 1999).   U.S. EPA does not consider RBC ChE
inhibition an adverse effect in itself, but does use RBC ChE inhibition as a surrogate for
peripheral ChE inhibition which is usually not measured (U.S. EPA, 2000a).  Caution is needed
when using RBC ChE as a surrogate since unlike nervous tissue, RBCs lack the ability to
synthesize new AChE (Brimijoin, 1992).   Consequently, the recovery of RBC ChE activity is
much slower than in the central and peripheral nervous system because it is dependent on the
replacement of RBCs. 
I.C.  TECHNICAL AND PRODUCT FORMULATION
Currently, there are two products registered for use in California containing
methidathion: Supracide® 25W and Supracide® 2E.  Supracide® 25W is a wettable powder
containing 25% methidathion.  Supracide® 2E is an emulsifiable concentrate containing 24.4%
methidathion.  The registrant for both products is Gowan Company.
I.D.  USAGE
Supracide® 25 W and 2E may be applied directly to the soil by injection, shank or chisel. 
It may also be applied as a spray by ground or aerial application.  The application rate for most
tree crops was 4 to12 lbs. of product (1 to 3 lbs. methidathion) per acre per application, except
for citrus fruit which may be applied up to 20 lbs of product (5 lbs methidathion) per acre.  For
deciduous fruit and nut trees, the product is usually applied as a dormant spray and diluted in a
minimum of 20 and 50 gallons of water per acre for aerial and ground application, respectively. 
For citrus and olives, the product is diluted in a minimum of 20 and 400 gallons of water per
acre, respectively.  Generally, only one application per season is made to deciduous fruit and nut
trees and nursery stock.  Up to 2 applications per season may be permitted with citrus at anytime,
except during the bloom period or 2 weeks before harvest.  Application rates for row and field
crops ranged from 2 to 4 lbs. of product (0.5 to 1 lbs. methidathion) per acre per application. 
Three to 8 applications maybe applied to artichokes and safflower, respectively.  The pre-harvest
intervals (PHIs) ranged from 7 days for walnuts to 80 days for almonds.  Applications to
artichokes and almonds are prohibited after bud formation.
The use of methidathion has been decreasing since 1998 in which 178,451 lbs of
methidathion were used in California.  In 2004 (the most recent year use data is available), only
61,204 lbs of methidathion were used in California.  The biggest decrease was seen between
1999 and 2000 when use decreased by 45% primarily due to decreased use on almond and citrus
trees.  Despite these reductions, 70% of the total use for methidathion in 2004 was still on tree
crops. Use on nut trees, stone fruit trees, citrus trees, olive trees and pome fruit trees represented
21%, 21%, 19%, 5% and 4% of the total, respectively.Methidathion RCD (Revision 1) February 2007
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I.E.  ILLNESS REPORTS
Dermatitis was associated with exposure to organophosphate insecticides in 202 patients
in Japan either as a solitary compound or as multiple compounds (Matsushita et al., 1985).  None
of the cases of dermatitis associated with a solitary compound involved methidathion.  In another
study, 84 tea growers in Japan were given a patch test for 11 pesticides including methidathion
(Fujita, 1985).  Thirteen percent (4 males and 7 females) had an unequivocal positive response
for methidathion and another 23% (4 males and 15 females) had an equivocal response.  Five
female tea growers had contact dermatitis from occupational exposure, one of which had a
positive patch test for methidathion.  
Eleven greenhouse applicators in Hungary were examined for potential health effects on
two occasions approximately three months apart (Desi et al., 1986).  These workers were
exposed to a variety of pesticides including methidathion.  The examination included urinalysis,
hematology, immunoglobulin levels, whole blood ChE activity, serum γ-glutamyl transferase
activity, lymphocyte chromosome aberrations, and electrocardiography.  No differences in these
measurements were seen, except a slight increase (2.7%) in the numerical chromosome
aberrations rate which was within the reported normal range (4-7%) for the Hungarian
population.
The lymphocytes of 55 male agricultural workers from Hungry were examined for
chromosome aberrations (Nehéz et al., 1988).  These men worked with a variety of pesticides
including methidathion.  Plasma cholinesterase activity was normal in all workers.  Chromosome
aberrations were not observed in any of the 41 men working in closed spaces (green houses or
plastic tents), but there was a significant increase in chromosome aberrations in 14 men working
in open fields.  The investigators suggested that the increased chromosome aberrations in men
working in open fields may be due to exposure to larger volumes of pesticides and/or to a
contaminant in the products.
In a prospective cohort study, 204 farmers in Indonesia  were evaluated for pesticide
exposure and signs and symptoms (Kishi et al., 1995).  Methidathion was one of many pesticides
used by these farmers.  Extensive exposure to pesticides was seen because protective clothing
was too hot or costly, resulting in a significantly higher incidence of signs and symptoms during
the spraying season.  Twenty-one percent of the respondents had 3 or more neurological,
intestinal or respiratory signs or symptoms per spray operation.  There was a dose-response
relationship between the use of multiple organophosphates and the neurobehavioral signs and
symptoms.  
Five case reports of individuals poisoned with methidathion were available.  A 25-year-
old farmer ingested an unknown quantity of a 40% methidathion formulation (Teitelman et al.,
1975).  At admission to the hospital, he was semicomatose, sweating, miotic, and had rales.  The
serum cholinesterase activity was zero a few hours after admission.  He was treated with gastric
lavage, atropine, obidoxime chloride, and cortisol hemisuccinate.  He later developed jaundice, a
high fever and went into a deep coma.  After the first week, there was a gradual improvement. 
He was reevaluated at 2 months and no abnormalities were found, including any evidence of
delayed neurotoxicity.Methidathion RCD (Revision 1) February 2007
13
A 50-year-old Italian man ingested 20 ml of 20% methidathion formulation in a suicide
attempt (Zoppellari et al., 1990).  He exhibited lacrimation, salivation, sweating, miosis,
bradycardia, muscle fasciculations and mental confusion.  He was treated with hemoperfusion,
gastric lavage, atropine and pralidoxime.  The clinical course appeared to vary as methidathion
was redistributed from the fat to the blood.  Methidathion was present in plasma, urine and
gastric juice until the 6th, 7th and 8th day, respectively.  Significant plasma and red blood cell
(RBC) ChE inhibition was seen through day 8.  There was no evidence of delayed neuropathy or
neuropathy target esterase (NTE) inhibition in the lymphocytes.  He was fully recovered 45 days
after exposure.
  Three cases of methidathion poisoning in Crete were reported involving either
intentional or accidental ingestion (Tsatsakis et al., 1996).  A 47-year old man developed miosis,
sialorrhea, cyanosis and diffuse rales initially after ingesting 250 ml of a methidathion
formulation (concentration not reported).  His recovery was protracted and complicated by
tonicoclonic spasms, fasciculations, atelectasis and arrhythmias despite treatment with gastric
lavage, activated carbon, atropine and pralidoxime.  The patient was fully recovered 45 days
after exposure.  A 74-year-old man did not recover after ingesting an unknown quantity of a 40%
methidathion emulsifiable concentrate formulation.  He had acute respiratory failure and was
comatose on admission to the hospital.  Despite treatment with atropine and pralidoxime, he
developed pseudomonas sepsis and multiple organ failure.  Progressively diffuse pulmonary
fibrosis was the main cause of death.  Another 70-year-old man died after ingesting 200 ml of a
40% methidathion emulsifiable concentrate.  Although conscious and breathing normally, the
patient was given gastric lavage, followed by activated carbon and atropine.  He developed an
episode of general seizures 6 hours after admission to the hospital.  A second episode of seizures
28 hours later was fatal.  
Between 1992 and 2003, 39 incidents of illness or injury associated with definite,
probable or possible exposure to methidathion were reported to DPR’s Pesticide Illness
Surveillance Program (PISP) (Beauvais, 2006).  Ten of these incidents were associated with
exposure to methidathion alone while the rest were associated with exposure to methidathion in
combination with other pesticides.  Systemic effects were reported in 28 of the incidents (72% of
the incidents) including nausea, vomiting, abdominal cramps, headache and dizziness.  The other
11 incidents involved irritation or injuries to the eyes, skin or respiratory tract.  Several of the
systemic cases also involved injuries or irritation to the eyes, skin or respiratory tract.  No deaths
were associated with methidathion exposure.  All but one incident were occupational exposures,
mostly involving handlers (19 applicators and 7 mixer/loaders).  The rest of the occupational
exposures were field workers (5) who entered a field treated with methidathion.  The one non-
occupational exposure involved a drift incident of a person doing yard work. 
I.F.  PHYSICAL AND CHEMICAL PROPERTIES
1. Common Name: Methidathion
2. Chemical Name: O,O-dimethyl-phosphorodithioate, S-ester with 4-
(mercaptomethyl)-2-methoxy-Δ-1,3,4-thiadiazolin-
5-one Methidathion RCD (Revision 1) February 2007
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3. Trade Names: Supracide®, Suprathion®, Medacide®, Ultracide®
4. CAS Registry No.: 950-37-8
5. Structural Formula:
6. Empirical Formula: C6H11N2O4PS3
7. Molecular weight: 302.3 g
8. Density: 1.445 g/ml (Newell, 1987)
9. Solubility: Water (22
oC) (Wyler, 1987): 220 mg/L
Solvents (20
OC) (Lail, 1991):
Cyclohexane:   850 g/L
Acetone: 690 g/L
Xylene: 600 g/L
Ethanol: 260 g/L
n-Octanol   53 g/L
10. Vapor pressure: 3.37 x 10
-6 mmHg at 25
oC (Rordorf, 1988)
11. Octanol/water partition coefficient: 166 (log Pow =  2.2) (Daly, 1987)
12. Henry's law constant: 1.95 x 10
-9 atm•m
3/mole at 22
oC (Leffingwell,
1989)
I.G.  ENVIRONMENTAL FATE
Water:  Although the water solubility of methidathion is relatively low, it has been
detected in surface water due to rain run off from fields treated with the winter dormant spray. 
Methidathion residues were detected in 20 of 967 samples collected during surface water
monitoring in 14 counties in California between June 1999 and September 2003 (Starner, 2005). 
DPR collected most of these samples with the Sacramento Watershed Program collecting the
remainder.  The maximum residue level detected was 1.749 ppb.  Methidathion oxon was not
detected in any of the 740 surface water samples analyzed for it.
 
The hydrolysis of methidathion varies with temperature and pH with hydrolysis half-
lives ranging from 0.05 days to 41.3 days (Burkhard, 1978).  The hydrolysis increased primarily
with temperature and to a lesser degree with pH.  Methidathion also underwent photodegradation
in an aqueous environment with photolysis half-lives between 8 and 11 days (Suter, 1983;
Saxena, 1989a).  The primary hydrolytic and photolytic degradate was 2-methoxy-1,3,4-Methidathion RCD (Revision 1) February 2007
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thiadiazole-5(4H)-one, the thiadiazole ring moiety (identified as the RH compound in Figure 1 in
the Pharmacokinetics section). 
Soil:  The soil adsorption coefficients (KOC) for methidathion range from 29 (sandy soil)
to 859 (sandy loam) (Martinson, 1988). Although the adsorption and desorption coefficients for
methidathion vary considerably, the KOC values suggest considerable leaching potential.  DPR
has identified methidathion as a potential groundwater contaminant based on a combination of
its water solubility (> 3 ppm or mg/L), soil adsorption (KOC < 1900 cm
3/g), and hydrolysis half-
life (t1/2 > 14 days) (DPR, 2003a).  However, methidathion has not been detected in 271 wells
monitored in 13 counties in California by DPR from 1986 to 2004 (DPR, 2003b & 2004).   
Soil metabolism studies with methidathion indicate that it is rapidly degraded in soil
under both aerobic and anaerobic conditions (Saxena, 1990).  The estimated half-life under
aerobic conditions was approximately 3 days.  The degradation of methidathion was longer
under anaerobic conditions with a half-life of 30 days.  The field dissipation studies indicate that
methidathion is not likely to migrate below 12" in the soil (Honeycutt, 1986a&b; Silvoy,
1991a&b). 
Methidathion also undergoes photodegradation in soil in a biphasic pattern with a half-
life of approximately 9 days for the first phase and 21 days for the second phase (Saxena,
1989b).  The two metabolites isolated from the irradiated soil samples were the thiadiazole ring
and the sulfoxide.
Air:  The vapor pressure for methidathion is relatively low; however, it has been
detected in air monitoring studies of application sites and ambient air conducted in Tulare
County in 1991 which were contracted by the California Air Resources Board at the request of
the California Department of Pesticide Regulation (Royce et al., 1993).  Aston and Seiber (1997)
also detected methidathion in the ambient air in the Sierra Nevada.   The Henry’s Law Constant
for methidathion is also low indicating that under evaporative conditions it will increase in
concentration on the soil surface and volatilization will increase with time (Spencer, 1987).  The
vapor phase photodegradation of methidathion was very limited under laboratory conditions
when exposed to natural sunlight with an estimated half-life of 1.5 years (Kieatiwong, 1992).  
For more details on the environmental fate of methidathion see Volume III of the Risk
Characterization Document for methidathion (Gurusinghe, 2006).Methidathion RCD (Revision 1) February 2007
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II.  TOXICOLOGY PROFILE
All the available toxicity studies for methidathion are summarized in the Toxicology
Profile including studies from the open literature and studies submitted to the Department of
Pesticide Regulation (DPR) in the California Environmental Protection Agency (Cal/EPA) for
registration of pesticide products in California as required by the Birth Defects Prevention Act
(SB-950).  DPR reviews the studies submitted to fill data requirements for SB-950 and
determines the acceptability of these toxicology studies based on study guidelines as required
under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) (U.S. EPA, 2006).  For
SB-950, literature studies are generally considered supplemental because they do not follow
FIFRA guideline protocols and/or do not provide sufficient detail in their reports to determine if
they were conducted properly.  In the risk assessment, greater weight was given to guideline
studies, especially if they were found acceptable based on FIFRA guidelines.  However,
literature studies are useful in the selection of the critical NOEL in the Hazard Identification
section to support effects seen in the guideline studies and can be used for the critical NOEL if
they evaluate an endpoint not examined in the guideline studies and they appear to be
scientifically valid studies.  Except for the Pharmacokinetics and Acute Toxicity sections, the
studies are generally organized within each section by route and species with the older studies
discussed first.  When mechanistic studies are available they are discussed after the guideline
studies under the appropriate route and species.  The Pharmacokinetics section was organized by
different phases in the disposition of xenobiotics in the body.  The Acute Toxicity section was
separated into data for the technical grade material and the various formulations.
As discussed in the Introduction, cholinesterase (ChE) in nervous tissue is one of the
primary target sites for methidathion.  ChE activity was measured in the brain, red blood cells
(RBCs) and plasma in many of the toxicity studies for methidathion.  ChE inhibition was one of
the more sensitive endpoints with acute, subchronic and chronic exposure, therefore, when
analyzed the ChE data were summarized in a table for each study.  In general, DPR considers
brain ChE inhibition to be indicative of overt toxicity since more subtle functional changes in the
nervous system due to ChE inhibition, such as memory and learning losses, may not be easily
detected in animals unless they are specifically tested for these effects.  The toxicological
significance of plasma and RBC ChE inhibition is less certain because the physiological function
of ChEs in blood have not been clearly established, although several possible physiological
functions have been proposed, which were discussed in the Introduction.   
II.A.  PHARMACOKINETICS
Summary:  There are FIFRA guidelines for metabolism and pharmacokinetic studies,
however, these studies are not required under SB-950 for older pesticides.  However, DPR
requires metabolism studies for newer pesticides when they are first registered for use in
California.  Although methidathion was registered before SB-950 was enacted, the registrants
have submitted some metabolism studies for methidathion, none of which met FIFRA guidelines. 
Even if the studies did not meet guidelines or had non-guideline protocols, the information from
them can be used in evaluating the other toxicity studies.  The most useful information derived
from the pharmacokinetic studies is that related to the amount of radioactive material excreted by
various routes which is then used to estimate absorption rates depending on the route ofMethidathion RCD (Revision 1) February 2007
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administration.  These absorption rates can then be used to adjust NOELs to obtain an internal
dose.  Internal dosages are used when doing route-to-route extrapolation.  
Methidathion is readily absorbed, metabolized and excreted in rats after oral exposure. 
The major routes of excretion were urine and CO2.  Fecal excretion represented a minor route. 
Based on the amount excreted in the urine, CO2 and feces, the oral absorption was assumed to be
100%.  Methidathion was also readily absorbed by the dermal route.  Based on deficiencies in
the available dermal absorption study in mice, a default value of 50% was assumed for dermal
absorption.  The pharmacokinetic studies usually include proposed metabolic pathways based on
the metabolites identified which can help identify the active metabolite(s) and may help explain
some of the toxic effects observed.  Several urinary metabolites of methidathion were identified
in the rat, including the cysteine conjugate, and the sulfide, sulfoxide, sulfone, RH, and
desmonomethyl derivatives (Figure 1).  The presumed active metabolite of methidathion is its
oxygen analog (i.e., oxon).  However, the pharmacokinetics studies suggest that the oxidative
desulfuration of methidathion to the oxon is a minor metabolic pathway.  
The guideline studies for metabolism and pharmacokinetics only recommend testing in
adult male rats and, consequently, do not provide any information regarding differences due to
species, gender, age, and pregnancy.  There was also no information in the literature studies for
methidathion regarding differences in metabolism or pharmacokinetics due to gender, age or
pregnancy.  This information would be useful in identifying subpopulations or life stages where
people may be at greater risk.
II.A.1.  Absorption
Oral:  Groups of 5 rats/sex/dose were administered a single dose of 
14C-methidathion
(labeled on the carbonyl carbon of the thiadiazole ring) by oral gavage at 0.314 or 2.985 mg/kg
(Szolics, 1987).  A third group was administered unlabeled methidathion by oral gavage at 0.25
mg/kg for 14 days and then given single dose of 
14C-methidathion by oral gavage at 0.309 mg/kg
on day 15.  Urine and feces was collected for 7 days following the final application.  The CO2
excretion was estimated in this study based on data from a non-guideline pilot study using 2
rats/sex/dose at 0.295 mg/kg and at 2.949 mg/kg (Simoneaux, 1987a).  In this pilot study, 75-
89% of the administered dose was excreted in the first 24 hours whereas in the main study 63-
73% of the administered dose was excreted in the first 24 hours.  However, there was a
significant difference in the recoveries between the main study (76-93%) and the pilot study (99-
102%).  The author suggested that the low recoveries in the main study were due to losses during
the storage of urine samples for three months prior to analysis.  Since the CO2 excretion was not
actually monitored in the main study, it is uncertain if the recoveries were lower from the losses
in the urinary samples or from the CO2 excretion being higher than estimated from the pilot
study.  A comparison of these two studies is also difficult because different laboratories
conducted these studies and different breeders provided the Sprague-Dawley rats used which
could have slight genetic differences in their metabolism of methidathion.  The main study
conducted by Szolics (1987) did not meet FIFRA guidelines due to incomplete recovery of
radiolabeled compound.  Despite having fewer animals per dose group, the data from the non-
guideline pilot study was used to estimate the percent oral absorption since the recoveries were
better and the CO2 excretion was measured.  The combined urinary, fecal and CO2 excretion in
the pilot study ranged from 98 -102%.  The radioactivity in the feces was assumed to be dueMethidathion RCD (Revision 1) February 2007
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primarily to biliary excretion because of similar fecal excretion rates with dermal application
(Simoneaux and Marco, 1984).  Therefore, the oral absorption rate was assumed to be 100%. 
Dermal:  
14C-Methidathion (labeled on the carbonyl carbon of the thiadiazole ring) was
applied to shaved backs of 4 mice/sex in either an acetone solution or formulated product
containing petroleum hydrocarbon with an emulsifier at 12 mg/kg over an 0.25 sq. inch area
(Simoneaux and Marco, 1984).  Urine, feces, and CO2 excretion were monitored for 72 hours
after application.  With this route of application, CO2 was the main route of excretion ranging
from 51-56% with the formulated product to 61-64% with the acetone solution.  Urinary
excretion was significantly lower ranging from 14-15% with the acetone solution to 16-23%
with the formulated product.  The combined urinary, fecal, and CO2 excretion after 72 hours
ranged from 75.4% for females treated with the formulated product to 82.1% for males treated
with the acetone solution.  It is interesting that while the amount absorbed is not that different
between the two formulations, the pathways by which they are metabolized changed slightly.
Due to the use of organic solvents and the testing of only one dose level, DPR found this study
unacceptable for estimating dermal absorption (Beauvais, 2006).  Therefore, DPR assumed a
default value of 50% for dermal absorption. 
II.A.2.  Distribution
In the pilot study conducted by Simoneaux (1987a), the total amount excreted within the
first 24 hours ranged from 75% in females at 2.949 mg/kg to 89% in males at 0.295 mg/kg.  In
the main study conducted by Szolics (1987), the total amount excreted within the first 24 hours
was estimated to be 63% in males at 0.295 mg/kg to 73% in females at 2.949 mg/kg assuming
similar CO2 excretion rates to the pilot study.  Elimination half-lives were not calculated for the
pilot study, but are obviously less than 24 hours.  Using the CO2 excretion data from the pilot
study, the estimated elimination half-lives for the main rat metabolism study ranged from 7.4
hours in females at 0.295 mg/kg to 9.7 hours in males receiving 0.295 mg/kg/day for 14 days. In
the pilot study, only carcass residue levels were measured 7 days after dosing, ranging from non-
detectable in both sexes at 0.295 mg/kg to 0.93% of administered dose in females at 2.949
mg/kg.  In the main study, tissue residue levels ranged from 0.53% of administered dose in the
females at 2.949 mg/kg to 1.14% in males at 0.295 mg/kg 7 days after the last dose.  The vast
majority of the radioactivity (0.40-0.98% of administered dose) was found in the carcass.  No
other tissue levels exceeded 0.1% of the administered dose.
II.A.3.  Biotransformation
One of the earliest metabolism studies was conducted by Bull (1968) in which male
Wistar rats (number not reported) were administered methidathion (10 mg/kg 
14C- and 1.5 mg
32P-labeled in propylene glycol) intraperitoneally.  With the 
14C-label on the methoxy or carbonyl
carbon of the thiadiazole ring, 22.4 and 25.8% of the dose was expired as radioactive CO2,
respectively, and 57.4 and 52.0% was excreted, respectively, within 48 hrs in the urine and feces. 
When the 
14C-label was on the methylene carbon, 17.7% was expired as CO2 and 59.0% excreted
in the urine and feces.  No metabolites were identified in the urine and feces.  With the 
32P-label,
80% of the applied dose was excreted within 48 hours, with only 7.1% of the applied dose
excreted in the feces.  The urinary metabolites identified dimethyl phosphate (33.6%), dimethylMethidathion RCD (Revision 1) February 2007
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phosphorothioate (24.2%), desmethyl derivative (11.1%), methyl phosphate and phosphoric acid
(both 1.5%).  This was a non-guideline study and was considered supplemental. 
    
Four male rats were administered 0.642 mg 
14C-labeled methidathion by oral gavage in a
non-guideline study conducted by Cassidy et al. (1969).  The 
14C-label was on the carbonyl
carbon of the thiadiazole ring.  Urine samples were collected during the first 24 hours after
dosing and analyzed for metabolites.  Six radioactive urinary metabolites were isolated, but only
three were identified.  The three identified urinary metabolites were the sulfoxide, the sulfone,
and the desmethyl derivative which represented 52%, 13%, and 7% of the radioactivity in the
urine, respectively.  This non-guideline study was considered supplemental.  
Prior to the main study conducted by Szolics (1987), three non-guideline studies were
conducted in which methidathion was administered to rats with the 
14C-label on different carbons
of the thiadiazole ring: the carbonyl carbon, the methoxy group carbon, and the methylene
carbon adjacent to the methoxy group (Simoneaux, 1987a-c).  The amount excreted in the
respiratory gases was lowest with the 
14C-label on the methylene carbon (10-12%).  Significantly
higher amounts of radioactivity were found in the respiratory gases when the 
14C-label was on
the carbonyl carbon (33-44%) or the methoxy group carbon (40-44%).  With the 
14C-label on the
methoxy group carbon, an additional unknown 
14C-labeled material other than CO2 was found in
the trapping solution.  The investigators suggested it might be another volatile gas such as
methane.  Analysis of the urinary metabolites indicated that approximately two-thirds were
organic soluble and one third aqueous soluble, regardless of the position of the 
14C-label.  The
sulfide, sulfoxide, sulfone, and RH derivatives were the major urinary metabolites in the organic
soluble fraction.  The cysteine conjugate and the desmonomethyl derivative were the major
urinary metabolites in the aqueous soluble fraction.  With the 
14C-label on the carbonyl carbon
and the carbon adjacent to the methoxy group, the major urinary metabolite was the sulfide. 
With the 
14C-label on the methoxy carbon, the sulfoxide was the major urinary metabolite.  The
parent compound was found only with the 
14C-label on the carbonyl carbon (0.7%).  The oxygen
analog was found when the 
14C-label was on either the methoxy carbon or adjacent to the
methoxy carbon (0.2-0.8%).  These non-guideline studies were considered supplemental.
A recent study examined the excretion of dialkyl phosphate metabolites after oral and
dermal exposure to methidathion in rats for biomonitoring application (Min et al., 2005).  Five
Sprague-Dawley rats/dose were administered methidathion with a propylene glycol vehicle at
2.16 mg/rat orally or 66.5 mg/rat dermally to a clipped area of 6.25 cm
2 covered with semi-
occlusive dressing for 96 hours.   Urine was collected up to 168 hours after exposure. 
Identification of urinary dialkyl phosphate metabolites was determined by GC/MS.  With oral
exposure, 6.5%, 6.0% and 2.9% of the dose was excreted as O,O-dimethyl phosphate (DMP),
O,O-dimethylphosphorothioate (DMTP) and O,O-dimethylphosphorodithioate (DMDTP),
respectively.  With dermal exposure, 1.1%, 1.0% and 0.7% of the dose was excreted as DMP,
DMTP, and DMDTP, respectively.  All of the DMP and DMDTP and 94% of the DMTP were
excreted within 24 hours after oral administration.  Excretion was slower with dermal application
where 100%, 75% and 87% of DMP, DMTP and DMDTP, respectively, were excreted within 48
hours.  The parent compound was not detected in any of the samples.  More research is needed to
address species differences in excretion and effect of dose level on excretion.  This non-
guideline study from the open literature was also considered supplemental.Methidathion RCD (Revision 1) February 2007
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The in vitro metabolism of 
14C-methidathion (labeled on the carbonyl carbon) was
examined in another non-guideline study using rat and mouse liver subcellular fractions
(Chopade and Dauterman, 1981).  Methidathion underwent O-demethylation via the glutathione
S-transferases forming des(mono)methyl methidathion.  Methidathion also underwent oxidative
desulfuration via the mixed function oxidase system to form the oxygen analog. 
Methoxythiadiazolin (RH compound) was also formed by the mixed function oxidase system,
but the exact mechanism is unknown.  The P-S bond of methidathion and its oxygen analog were
hydrolyzed forming a reactive mercaptomethyl intermediate which underwent S-methylation to
form the sulfide.  The sulfide was then oxidized to the sulfoxide by the FAD-dependent
monooxygenase system; however, the sulfoxide was oxidized to the sulfone by the mixed
function oxidase system.  There did not appear to be any significant species differences in
metabolism between rats and mice.  This non-guideline study from the open literature was
considered supplemental.
The possible metabolic pathways of the isolated urinary metabolites of methidathion is
shown in Figure 1.  These metabolic pathway are based primarily on metabolic pathway
proposed for methidathion by Szolics (1987).  The first step in the major metabolic pathway is
the hydrolysis of the S-P bond to form the reactive mercaptomethyl intermediate which
undergoes S-methylation to form the sulfide.  The sulfide then undergoes oxidation to form the
sulfoxide and sulfone.  Szolics proposed a secondary metabolic pathway in which the
mercaptomethyl intermediate undergoes conjugation with glutathione to form the glutathione
conjugate and its derivatives such as the cysteine conjugate.  Another proposed secondary
metabolic pathway was the O-demethylation to form the des(mono)methyl derivative.  The
oxidative desulfuration of methidathion to the oxygen analog was considered a minor metabolic
pathway.  Szolics suggested that the RH metabolite could be derived from a variety of
intermediates.  The metabolic pathway proposed by Szolics (1987) for methidathion is similar to
one proposed by Chopade and Dauterman (1981), although Chopade and Dauterman considered
the O-demethylation of methidathion to the des(mono)methyl derivative to be the major
pathway.  Not shown in this metabolic pathway is the generation of CO2.  This occurred with the
14C-label in all three locations (methoxy, carbonyl, and methylene) on the thiadiazole ring ,
although the amount was significantly lower with the methylene label.  No intermediate
metabolites were identified in this pathway.  O-demethylation is probably involved in the
generation of CO2 from the methoxy carbon with formaldehyde as a likely intermediate.  The
generation of CO2 from the carbonyl carbon and methylene carbon would involve breaking of
the thiadiazole ring.  In addition to the urinary metabolites identified with 
14C-label, Figure 1
includes the urinary metabolites identified with the 
32P-label (Bull, 1968; Min et al., 2005).   
II.A.4.  Excretion
The two major routes of excretion appear to be the urine and CO2 in both the main study
conducted by Szolics (1987) and the pilot study conducted by Simoneaux (1987a).  In the pilot
study, the mean urinary excretion was essentially identical at both 0.295 and 2.949 mg/kg, but
varied slightly between sexes (M: 57%; F: 54%).  In the main study, the mean urinary excretion
was significantly lower, ranging from 30% in males at 0.295 mg/kg to 42% in males at 2.949
mg/kg, except in females at 2.949 mg/kg which excreted 57%.  As mentioned previously under
the discussion for oral absorption, Szolics suggested the lower recoveries in the main study were Methidathion RCD (Revision 1) February 2007
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Figure 1. Possible Metabolic Pathways for Isolated Urinary Metabolites of Methidathion (Bull,
1968; Cassidy, 1969; Szolics, 1987; Min et al., 2005) 
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due to losses in the urine during a 3-month storage period.  However, another possible
explanation may be slight genetic differences in the metabolism of methidathion due to different
sources of Sprague-Dawley rats used in the two studies.  In the pilot study, the mean CO2
excretion was slightly higher at 0.295 mg/kg (M: 41%; F: 44%) than at 2.949 mg/kg (M: 34%;
F:32%), whereas the mean fecal excretion was lower at 0.295 mg/kg (M: 5%; F: 3%) than at
2.949 mg/kg (M: 8%; F: 12%).  Since the CO2 excretion was not measured in the main study, it
is unknown if the CO2 excretion in this study also varied with dose level or with repeated
exposure.  The mean fecal excretion in the main study was relatively similar between dosing
regimens, but it tended to be slightly higher in the males (0.78-1.14%) than the females (0.53-
0.72%).  
II.B.  ACUTE TOXICITY
Summary:  A battery of six acute toxicity tests (acute oral, dermal and inhalation
LD50/LC50 tests, dermal and eye irritation tests, and a dermal sensitization test) are required for
each pesticide formulation to be registered in California.  Registrants are not required to submit
these guideline acute toxicity studies for the technical material unless it is sold as a product. 
Consequently, only literature studies on the acute oral and dermal toxicity of technical grade
methidathion were available and none of these met FIFRA guidelines.  The clinical signs
observed with the technical material were typical cholinergic signs including tremors, ataxia,
fasciculations, difficulty in breathing, salivation, lacrimation and exophthalmos.  There were
insufficient information in any of these studies for establishing a No-Observed-Effect Level
(NOEL) or Lowest-Observed-Effect Level (LOEL) for the technical grade material.  Based on
the limited data for the technical grade material, it appears to be a Category I pesticide.  One
study found weanling rats were more sensitive to methidathion than adult rats based on their oral
LD50 values.  Several other non-guideline mechanistic studies found evidence of lipid
peroxidation in erythrocyte membranes and liver after a single oral dose of methidathion.  More
acute toxicity data were available for the methidathion formulations since they are required to
register the formulations in California.  Furthermore, these studies were acceptable based on
FIFRA guidelines.  The wettable powder formulation was a Category II pesticide based on its
oral toxicity and inhalation toxicity.  The emulsifiable concentrates were considered a Category I
pesticide based on oral toxicity and severe eye irritation.  Two non-guideline studies evaluated
the relative sensitivity of young and adult turkeys to a single oral or dermal dose of a 25%
wettable powder formulation with the young appearing more sensitive in one study and the
adults more sensitive in the other.  Another non-guideline study reported a synergistic increase in
the toxicity of a 25% wettable powder formulation when administered simultaneously with 6
other organophosphate chemicals.  Other guideline studies with acute or short-term exposure
will be discussed separately under the Developmental Toxicity and Neurotoxicity sections in the
Toxicology Profile.  No acute toxicity data were available on the oxygen analog of methidathion
which could have been used to develop a toxicity equivalency factor.
II.B.1.  Technical Grade Methidathion
Table 1 summarizes the guideline type acute toxicity studies for technical grade
methidathion.  The data available on the technical material are limited to literature studies with
brief summaries of the acute oral and dermal toxicity.  The purity of the technical grade material Methidathion RCD (Revision 1) February 2007
23
Table 1. The Acute Toxicity of Technical Grade Methidathion
Species Sex Results       References
a
Acute Oral LD50
Rat NR 25-48 mg/kg 1
Mouse NR 26-32 mg/kg
Rabbit NR 63-80 mg/kg
Guinea Pig NR 25  mg/kg
Hamster NR 30 mg/kg
Rat, weanling
        adult
M
M
F
21 mg/kg
31 mg/kg
32 mg/kg
2
Pigeon NR 30-40 mg/kg 3
Acute Dermal LD50
Rabbit M/F 140-155 mg/kg 1
Rat M
F
94 mg/kg
85 mg/kg
2
Pigeon NR >59 mg/kg 3
Dermal Sensitization
Guinea Pig F Moderate-Severe 4
a References:  1.  Geigy, 1964; 2.  Gaines and Linder, 1986; 3.  Henderson et al., 1994; 4.  Matsushita and Aoyama, 1981.
was not reported in any of these reports and none of these studies met FIFRA guidelines due to
the limited information provided.  The effects reported included dizziness, ataxia, irregular and
increased respiration, dyspnea, fasciculations, trembling, salivation, exophthalmos, and death.  
Rabbits appear to be less sensitive to methidathion than rats, mice, guinea pigs and hamsters
based on the LD50 values reported for these species by Geigy (1964).  Weanling rats appear to be
more sensitive than adult rats to methidathion based on their oral LD50 values in the study
conducted by Gaines and Linder (1986).  A study was conducted by Henderson et al. (1994)
which compared the acute oral and dermal toxicity in pigeons of several organophosphates used
as dormant sprays in orchards, including ethyl parathion, diazinon and methidathion. 
Methidathion was the least toxic of these three organophosphates based on its lethal oral dose
range (30-40 mg/kg).  The investigators also applied these three organophosphate pesticides to
the feet of pigeons to simulate exposure in hawks from perching in orchards.  With the dermal
exposure, only birds given ethyl parathion at $ 59 mg/kg died.  They found no significant plasma
ChE inhibition at the highest dose tested of methidathion, 37 mg/kg, despite mild signs (not
specified) of organophosphate poisoning.  In another study, a significant reduction in plasma
ChE activity (71% of controls) was seen in pigeons administered a single oral dose of
methidathion at 10 mg/kg (Bartkowiak and Wilson, 1995).  Plasma carboxylesterase activity wasMethidathion RCD (Revision 1) February 2007
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not affected at this dose level.  No other dose levels were tested nor were any other endpoints
evaluated in this study.  Insufficient information was provided in all of these acute toxicity
studies for methidathion to establish a LOEL or NOEL for an acute, single dose exposure 
scenario.   No data were available on the ocular or dermal irritation potential of the technical
grade methidathion.  One dermal sensitization study was available that suggests that
methidathion is a potential sensitizer (Matsushita et al., 1985).  These investigators also
examined if exposure to methidathion during the induction phase causes a cross reaction when
later challenged with benomyl, DDVP, and naled.  There was some evidence of a cross reaction
with DDVP and naled, but no cross reaction with benomyl. 
Several non-guideline studies in the open literature evaluated the mechanism of toxicity
for methidathion with acute exposure.  The effect of methidathion on Na
+/K
+-ATPase,
Ca
2+/Mg
2+-ATPase, cholesterol and phospholipid levels in RBC membranes was evaluated in rats
administered 1, 3, 5 or 7 daily doses at 2 mg/kg (El-Dawy et al., 1995).  There was a significant
reduction in the activity of both ATPases with 1 to 7 doses.  The investigators suggested that this 
reduction in ATPase activity could result in the preservation of cell energy and ions.  The
cholesterol levels in the membranes were also elevated with one or more doses of methidathion. 
By contrast, the phospholipid levels decreased with 3 or more doses.  The investigators
suggested that these changes in cholesterol and phospholipid levels may be an adaptive response
to increase the resistance of the RBCs to osmotic lysis.
Altuntas et al. (2002a) reported that a single oral dose of methidathion (8 mg/kg) to rats
resulted in a significant increase in malondialdehyde (MDA) levels (a biomarker of membrane
lipid peroxidation resulting from the interaction of reactive oxygen species and the cellular
membrane) and a significant decrease in the anti-oxidant enzymes, superoxide dismutase (SOD),
glutathione peroxidase (GSH-Px) and catalase (CAT) activities in erythrocytes compared to
control animals.  Another group of rats was administered methidathion (8 mg/kg) plus vitamin E
(150 mg/kg i.m.) and vitamin C (200 mg/kg i.p.) 30 minutes later.  In this group (MD+Vit), the
MDA levels were comparable to controls.  The SOD and CAT were reduced to a similar degree
as animals treated with methidathion only (MD).  The GSH-Px activity was also reduced in the
MD+Vit group, but less than in the MD group such that the mean activity was significantly
different from the MD group, but not the controls.  
Altuntas et al. (2002b) also examined the effect of methidathion on lipid peroxidation
and liver enzymes in rats.  Rats were assigned to three groups as before: controls, MD and
MD+Vit.  In this experiment, they measured the thiobarbituric acid reactive substances (TBARS,
a endproduct of lipid peroxidation), ChE, alanine aminotransferase (ALT), aspartate
aminotransferase (AST), alkaline phosphatase (ALP), γ-glutamyltransferase (GGT), and lactate
dehydrogenase (LDH) in the serum. The AST, ALP, GGT and LDH levels were all significantly
higher in the MD and MD+Vit groups.  ChE and ALT were significantly lower in the MD and
MD+Vit groups. TBARS were only significantly higher in the MD group.  The addition of
vitamins E and C moderated the effects of methidathion with significant differences between the
MD and MD+Vit groups for TBARS, ChE and AST.  This group also examined the effect of
methidathion on these enzymes in human serum.  They divided serum samples into four
portions: controls, Vit (7.5 μg/ml vitamin E and 10 μg/ml vitamin C), MD (0.4 mg/ml
methidathion) and MD+Vit (0.4 mg/ml methidathion, 7.5 μg/ml vitamin E and 10 μg/ml vitaminMethidathion RCD (Revision 1) February 2007
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C).  Only significant decreases in ChE, ALT and LDH were observed in the MD and MD+Vit
groups.  
In another experiment from this same research group, investigators microscopically
examined the livers of rats approximately 24 hours after a single oral dose of methidathion at 8
mg/kg (MD) or MD+Vit (8 mg/kg methidathion, 150 mg/kg vitamin E i.m., 200 mg/kg vitamin
C i.p.) (Gokalp et al. 2003).  They observed significant increases in mononuclear cells at
parenchymal tissue, sinusoidal dilatation, focal necrotic areas, granular degeneration and
picnotic nuclei in hepatocytes compared to controls in both the MD and MD+Vit groups;
however, the severity of the granular degeneration and sinusoidal dilatation was less in the
MD+Vit group.
II.B.2.  Methidathion Formulations
The acute toxicity of the Supracide®  wettable powder in FIFRA guideline studies is
summarized  in Table 2.  The primary clinical signs observed with inhalation exposure included
hypoactivity, piloerection, tremors, salivation, unsteady gait, exophthalmos, polyuria, nasal
discharge, and lacrimation (Holbert, 1992).  Gross necropsy findings included discoloration of
the contents of the gastrointestinal tract, discoloration of the liver and lungs, lungs swollen, and
small intestine distended with gas.  Similar clinical and gross pathological observations were
observed with oral exposure to the Supracide® wettable powder, except they were less
pronounced (Kuhn, 1992a). With dermal exposure to the Supracide® wettable powder, the only
effect observed was decreased defecation in one of five males (Kuhn, 1992b).  No erythema or
edema was observed  with dermal exposure to the Supracide® wettable powder (Kuhn, 1992c). 
Slight corneal opacity was observed in one of six rabbits exposed to the Supracide® wettable
powder (Kuhn, 1992d). No other ocular effects were seen.  No sensitization response was
observed in guinea pigs after exposure to the Supracide® wettable powder (Kuhn, 1992e). 
Two non-guideline acute studies were conducted in which young (6-8 weeks) and adult
(16-18 weeks) turkeys were administered the 25% wettable powder by the oral or dermal route
(Schlinke and Palmer, 1971; Radeleff and Kunz, 1972).  In the study conducted by Schlinke and
Palmer (1971), 6-week-old turkeys appeared to be more sensitive to methidathion based on a
lower acute oral NOEL (10 mg a.i./kg) for unspecified signs compared to 16-week-old turkeys
(20 mg a.i./kg).  However, in another study conducted by Radeleff and Kunz (1972), 18-week-
old turkeys appeared more sensitive with an acute oral NOEL of 10 mg a.i./kg for unspecified
signs compared to 15 mg a.i./kg in 8-week-old turkeys.  A similar comparison of dermal NOELs
was not possible in either of these studies because of the limited number of dose levels tested
with dermal exposure.  
The acute toxicity of Supracide® emulsifiable concentrate in the guideline studies was
similar to the wettable powder with the exception of the ocular and dermal irritation (Table 3). 
The clinical signs observed with inhalation, oral and dermal exposure to the emulsifiable
concentrate were similar to those observed with the wettable powder with similar LC50/LD50 
values (Holbert, 1989; Kuhn,1989a&b).  Unlike the wettable powder, the Supracide®
emulsifiable concentrate caused moderate dermal irritation including well-defined erythema
lasting up to 21 days and slight edema lasting up to 14 days (Kuhn, 1989c).  The Supracide®
emulsifiable concentration also caused severe eye irritation including complete corneal opacity Methidathion RCD (Revision 1) February 2007
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Table 2. The Acute Toxicity of Methidathion (25%) Wettable Powder
Species Sex Results     References
a
Acute Inhalation LC50
Rat M 0.57 mg/L (4-hr, whole body) 1*
F 0.11 mg/L (4-hr, whole body)
Acute Oral LD 50
Rat M 94 mg/kg 2*
F 53 mg/kg
Acute Dermal LD50
Rabbit M/F > 2,020 mg/kg 3*
Primary Dermal Irritation
Rabbit M/F Non-Irritant 4*
Primary Eye Irritation
Rabbit M/F Moderate Irritant 5*
Dermal Sensitization
Guinea Pig M Non-Sensitizer 6*
a References:  1.  Holbert, 1992; 2.  Kuhn, 1992a; 3.  Kuhn, 1992b; 4.  Kuhn, 1992c; 5.  Kuhn, 1992d; 6. Kuhn, 1992e. 
* Acceptable study based on the FIFRA guidelines.
in some rabbits lasting up to 21 days, iritis that lasted up to 17 days and conjunctivitis that lasted
up to 21 days (Kuhn, 1989d).  Like the wettable powder, there was no evidence of dermal
sensitization in guinea pigs with the Supracide® emulsifiable concentrate (Kuhn, 1989e).
II.B.3.  Synergism
Synergism is sometimes observed when two organophosphate chemicals are given
simultaneously.  In a non-guideline study, the toxicity of a 25% methidathion wettable powder
formulation was evaluated in rats when co-administered with one of 17 compounds
(carbophenothion, demeton, coumaphos, diazinon, azinphos-methyl, dioxathion, EPN, ethion,
malathion, mevinphos, methyl parathion, carbaryl, ethyl parathion, fenchlorphos, schradan, 
disulfoton and S,S,S-tributyl phosphorotrithioite) at 1/8, 1/4 and 1/2 of their LD50 dose (Woodard
Research, 1966a).  A synergistic increase in the toxicity of methidathion was reported with 6
compounds (carbaryl, mevinphos, azinphos-methyl, methyl parathion, fenchlorphos and
disulfoton).  No details were provided on how the toxicity of methidathion was evaluated.Methidathion RCD (Revision 1) February 2007
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Table 3. The Acute Toxicity of Methidathion (22.5%) Emulsifiable Concentrate
Species Sex Results     References
a
Acute Inhalation LC50
Rat M 0.575 mg/L (4-hr, whole body) 1*
F 0.167 mg/L (4-hr, whole body)
Acute Oral LD 50
Rat M 111 mg/kg 2*
F 22 mg/kg
Acute Dermal LD50
Rabbit M > 1,990 mg/kg 3*
F    2,240 mg/kg
Primary Dermal Irritation
Rabbit M/F Moderate Irritant 4*
Primary Eye Irritation
Rabbit M/F Severe Irritant 5*
Dermal Sensitization
Guinea Pig M Non-Sensitizer 6*
a References:  1.  Holbert, 1989; 2.  Kuhn, 1989a; 3.  Kuhn, 1989b; 4.  Kuhn, 1989c; 5.  Kuhn, 1989d; 6. Kuhn, 1989e. 
* Acceptable study based on the FIFRA guidelines.
I.C.  SUBCHRONIC TOXICITY
Summary:  Twelve subchronic toxicity studies were available for methidathion, 6 oral
studies in rats, mice and turkeys and 6 dermal studies in rats, rabbits and turkeys.  Most of the
subchronic studies were non-guideline studies, but did provide useful supplemental information
regarding the adverse effects in different species and/or mechanism of toxicity with subchronic
oral and dermal exposure.  One 21-day dermal study in rabbit came close to meeting FIFRA
guidelines, but was found unacceptable due to an incomplete histopathological examination. 
Clinical signs observed with subchronic exposure to methidathion included lethargy, anorexia,
labored or rapid breathing, hunched posture, ataxia, tremors, soft feces, and low body
temperature.  Reductions in body weights and food consumption were also seen.  Pathological
findings included changes in hematological values suggesting anemia, changes in serum
enzymes suggesting liver toxicity, reduced brain ChE activity, and lesions in the liver,
gallbladder, stomach and heart.  A few mechanistic studies found biochemical evidence of lipid
peroxidation in the heart, aorta and kidneys along with histopathological lesions in these tissues
after subchronic exposure to methidathion.  ChE inhibition was one of the most sensitive
endpoints with subchronic exposure.  The lowest NOEL was 0.18 mg/kg/day based on aMethidathion RCD (Revision 1) February 2007
28
reduction in plasma, RBC and brain ChE activity in rats in several studies of varying length from
the same laboratory.  Other guideline studies that involve short-term or subchronic exposure are
discussed in detail in the Reproductive and Developmental Toxicity sections in the Toxicology
Profile.
II.C.1.  Gavage-Rat
Ten rats/dose (sex and strain not reported) were administered methidathion (purity not
reported) at 0.25, 0.83, 2.5, 8.3, 16.6 or 33.2 mg/kg/day by oral gavage in propylene glycol daily
for 4 weeks (Geigy, 1964).  Five and 10 rats died within the first 4 days of exposure at 16.6 and
33.2 mg/kg/day, respectively.  Consequently, all survivors at these dose levels were sacrificed at
2 weeks.  No changes in body weights were observed at or below 8.3 mg/kg/day.  Rats at 8.3
mg/kg/day and higher were reported to have clinical signs of toxicity, but no details were
provided.  Plasma ChE activity was only reduced at 8.3 mg/kg/day (Table 4).  RBC ChE activity
was reduced at 0.83, 2.5 and 8.3 mg/kg/day.  There was no apparent statistical analysis of the
ChE data.  Based on the limited information provided, the NOEL for this study appears to be
0.25 mg/kg/day based on the reduced RBC ChE activity (62% and 77% of reported normal
values at 2 and 4 weeks, respectively) at 0.83 mg/kg/day.  This study had major deficiencies
based on the FIFRA guidelines for subchronic studies; however, it was conducted before the
guidelines existed.  The deficiencies included no analysis of test article or dosing material, no
control animals, inadequate number of animals per dose level, inadequate exposure duration,
limited clinical chemistry analyses, no hematology or urinalysis, no pathological examination, no
summary of body weights and clinical signs by treatment group, and no individual data. 
Table 4. Blood Cholinesterase Activity Relative to Controls in Rats Administered
Methidathion by Gavage for 4 Weeks
a 
Tissue
Dose Level (mg/kg/day)
0.25 0.83 2.5 8.3
Plasma, 2 wks 112
b 99 94 76
4 wks 93 104 98 73
RBC
c, 2 wks 100 62 51 6
4  w k s 9 07 74 61 6
a Geigy, 1964.   This study did not meet FIFRA guidelines since it predated them.  Not reported, but ChE activity was
presumably measured in all 5 rats/sex/dose.
b Mean activity relative to mean control activity expressed as percentage.  There was no apparent statistical analysis of
these data.
c RBC = Red Blood Cell 
Geigy (1964) conducted a second subchronic study in which groups of 5 rats (strain not
specified)/sex/dose were administered technical grade methidathion (purity not reported) at 2.5,
5, 10 or 20 mg/kg/day by oral gavage in gum arabic on 6 days/week for 4 weeks.  Thirteen
animals died (sex not indicated) during the study, 4 at 10 mg/kg/day and 9 at 20 mg/kg/day. 
Animals at 5 mg/kg/day exhibited signs which were described as typical of cholinesteraseMethidathion RCD (Revision 1) February 2007
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inhibition (no other details provided).  Body weight reductions were seen although the severity
was difficult to estimate from the figures provided.  At 5 mg/kg/day and higher, centro-medio-
lobular fatty deposits in liver cells were seen microscopically.  Based on the limited information
provided, the tentative NOEL for this study appears to be 2.5 mg/kg/day.  This study had
numerous major deficiencies including no analysis of test article or dosing material, no control
animals, inadequate number of animals per dose level, inadequate exposure duration, no clinical
pathology analyses, no summary of body weights, clinical signs, and pathological findings by
treatment group, and no individual data.
The cardiotoxicity and vascular wall damage following subchronic oral exposure to
methidathion was examined in two mechanistic studies (Yavuz et al., 2004a&b).  In both studies,
three groups of approximately 7 male Wistar rats were administered the following by gavage 5
days/week for 4 weeks: corn oil (controls), 5 mg methidathion/kg/day (MD) or 5 mg
methidathion/kg/day plus 50 mg vitamin E/kg (i.m.) and 20 mg vitamin C/kg/day (i.p.)
(MD+Vit).  In both studies, severe fasciculations and fatigue were observed 1-1.5 hours after
dosing in the MD group.  The signs were less severe in the MD+Vit group.  In one study, Yavuz
et al. (2004a) found significantly elevated levels of cardiac troponin I (TnI, a biomarker of
myocardial damage) in the serum and of malondialdehyde (MDA, a biomoarker of membrane
lipid peroxidation) in cardiac homogenates in the MD and MD+Vit groups compared to controls. 
Serum ChE activity was significantly reduced in both the MD (60% of controls) and MD+Vit
groups (81% of controls).  Both the increases in TnI and MDA and the reduction in ChE activity
were moderated by the addition of vitamins E and C to the extent that the levels in MD+Vit
group were significantly different from the MD group.  Histopathological examination of the
heart revealed diffuse loss of striation and myocytoloysis of the cardiomyocytes in the MD and
MD+Vit with the severity much less in the MD+Vit group.  In another study, Yavuz et al.
(2004b) found significantly elevated MDA levels in the thoracic aorta in the MD group, but not
the MD+Vit group.  Histopathological examination revealed irregulation, prominent breaks and
fragmentation of the elastic fibers located in the media of the aortic wall in the MD group.  The
aortic wall also had diffuse vacuolation.  The irregulation and fragmentation were significantly
reduced in the MD+Vit group.  The diameter of the aorta lumen was significantly increased in
the MD and MD+Vit groups compared to controls, but much less in the MD+Vit group to the
extent that it was also significantly different from the MD group.  A NOEL could not be
established in either one of these non-guideline studies.
This same research group also examined the mechanism behind the nephrotoxicity of
methidathion using the same treatment groups (controls, MD, and MD+Vit) and dosing regimen
(5 mg methidathion/kg/day, 50 mg vitamin E/kg/day i.m., 20 mg vitamin C/kg/day i.p.) 5
days/wk for 4 weeks (Sulak et al., 2005).  Serum ChE activity was significantly reduced in both
the MD (67% of controls) and MD+Vit (79% of controls) groups.  The ChE activity in MD+Vit
group was also significantly higher than the MD group.  The MDA levels in the kidney
homogenates was significantly higher in the MD and MD+Vit groups compared to controls, but
significantly lower in the MD+Vit group compared to the MD group.  Histopathological
examination of the kidney revealed glomerular sclerosis, vascular congestion and fibrosis, focal
tubular necrosis, hydropic degeneration of tubular epithelial cells and severe interstitial
mononuclear cell infiltration in the MD group.  MD+Vit group had a similar severity of the
glomerular sclerosis and vascular congestion, but reduced severity of hydropic degeneration of
the tubular epithelial cell, interstitial mononuclear cell infiltration and vascular fibrosisMethidathion RCD (Revision 1) February 2007
1 Estimated assuming for a rat that 1 ppm in the diet is equivalent to 0.05 mg/kg/day (FDA,
1959).
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compared to the MD group.  Focal tubular necrosis was not observed at all in the MD+Vit.  A
NOEL was not establish in this non-guideline study.
II.C.2.  Gavage-Turkey
The oral toxicity of a 25% methidathion wettable powder was evaluated in 5 6-week-old
turkeys (sex not reported)/dose at 0, 2.5, 5, 10 and 20 mg a.i./kg/day for 10 days (Schlinke and
Palmer, 1971).  One bird died at 20 mg/kg/day.  No other effects were reported.  The NOEL in
the 6-week-old turkeys appears to be 10 mg/kg/day.  The 25% wettable powder was also
administered to 5 16-week-old turkeys/dose at 0, 5, 10 and 20 mg a.i./kg/day for 10 days.  Three
deaths and unspecified signs in the other two birds were seen at 20 mg/kg/day.  Signs of toxicity
were also seen in one bird at 10 mg/kg.  The NOEL in 16-week-old turkeys appears to be 5
mg/kg/day.  These data suggest that the adults are more sensitive to methidathion with repeated
exposure.  This is in contrast with the findings of Schlinke and Palmer (1971) after acute
exposure in turkeys which found young turkeys more sensitive, but is consistent with the
findings of another acute study in turkeys by Radeleff and Kunz (1972) which found adult
turkeys more sensitive.  In all cases, the differences in NOELs or LD50 values were small and
may be the result of random chance given the small number of animals tested rather than any real
difference in sensitivity.  This study had major deficiencies based on the FIFRA guidelines for
subchronic studies including no analysis of test article and dosing material, inadequate exposure
period, inadequate number of animals, inadequate summary of clinical signs, no pathological
examination, and no individual data.
II.C.3.  Diet-Rat
Methidathion (purity not reported) was administered to 24 rats (strain not
reported)/sex/dose in the diet at 0, 1, 4, 16 or 64 ppm (0, 0.05, 0.2, 0.8 or 3.2 mg/kg/day,
respectively
1)  for 4 to 22 weeks (Geigy, 1964).  Animals in each group (numbers not reported)
were sacrificed at different times (not specified) during the study for cholinesterase analyses.  In
addition, unspecified blood and urine analyses were performed on rats at 64 ppm during the 14th
week.  There was one death in each of the treatment groups at 4 ppm and higher.  There were no
reported effects on food intake, body weight, hematology, urine analysis, and pathological
findings.  There was no indication if there were any clinical signs.  It was reported that there was
no effect on ChE activity at 4 ppm, a moderate reduction (25-30%) at 16 ppm and strong
reduction (70-80%) at 64 ppm.  However, no details were provided about which ChE was
reduced except that plasma ChE activity was reduced to a lesser extent than RBC or brain ChE
activity.  Based on the limited information provided, the NOEL was tentatively identified as 4
ppm (0.18 mg/kg/day) based on possible plasma, RBC and brain ChE inhibition at 16 ppm.   The
study had numerous major deficiencies including no analysis of test article or dosing material, no
clinical chemistry analyses, no summary of body weights, clinical signs, urinalysis, hematology,
cholinesterase activity and pathological findings by treatment group, and no individual data.Methidathion RCD (Revision 1) February 2007
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I.C.4. Diet-Rat
Twenty rats (strain not reported)/sex/dose were administered methidathion (purity not
reported) dissolved in propylene glycol and mixed in the diet at 0 (two control groups with and
without propylene glycol), 0.5, 2, 10, 50 or 250 ppm (0.05-0.06, 0.2-0.24, 1.1-1.2, 5.5-6.0 or 30
mg/kg/day, respectively) for 6 months (Geigy, 1964).  Several males died during the study
including 2 controls, 1 at 2 ppm, 2 at 20 ppm and 2 at 250 ppm.  These deaths were all attributed
to a severe chronic respiratory disease and was not considered treatment-related.  The only
clinical signs reported was fine fibrillation in the extremities and hyperexcitability at 250 ppm. 
A slight transient reduction in body weights (percentage or mean body weights not reported) was
reported at 250 ppm.  RBC ChE activity was reduced (percentage not reported) at 10 ppm and
higher.  Plasma, brain, muscles, liver and kidney ChE were reduced only at 250 ppm.  No
abnormal pathological lesions were reported, although the histopathological results were not
available at the time of the report.  Based on the limited data provided, the NOEL appears to be 2
ppm (0.18 mg/kg/day) based on the reduced RBC ChE activity (percentage not reported).  The
study had numerous major deficiencies including no analysis of test article or dosing material,
limited clinical chemistry analyses, no hematology or urinalysis, no histopathology, no summary
of body weights, clinical signs, cholinesterase activity, and pathological findings by treatment
group, and no individual data.
II.C.5.  Diet-Mice
Technical grade methidathion (93.8% purity) was administered to 5 Charles River strain
albino mice/sex/dose in the diet at 0, 0.3, 1, 3, 10, 30, 100, 300, 1,000 or 3,000 ppm (M: 0,
0.059, 0.23, 0.60, 2.3, 6.5, 20, 62, 219 or 276 mg/kg/day; F: 0, 0.045, 0.17, 0.54, 1.8, 4.2, 18, 42,
330 or 574 mg/kg/day, respectively) for 28 days (Albanese, 1976).  Five mice (2 males, 3
females) at 1,000 ppm and all the mice at 3,000 ppm died during the first few weeks of the study. 
Generalized weakness was observed in mice at 1,000 ppm and higher.  No other clinical signs
were reported.  Surviving mice at 1,000 ppm had reduced mean body weights (M: 29%; F: 16%)
after 28 days.  Plasma ChE activity was only reduced at 300 ppm (Table 5).  RBC and brain ChE
activity was reduced at 100 and 300 ppm. There was no apparent statistical analysis of the body
weight, food consumption or ChE data.  No gross pathological lesions were seen.  With the
limited information provided, the tentative NOEL appears to be 30 ppm (4.2 mg/kg/day) based
on reduced RBC ChE activity (F: 57% of controls) and brain ChE activity (M: 49%; F: 65% of
controls) at 100 ppm.  This study had major deficiencies including no analysis of dosing
material, inadequate number of animals per treatment group, inadequate clinical chemistry, no
hematology, urinalysis or histopathology, and no individual data.
II.C.6.  Dermal-Rat
Methidathion technical material (purity not reported), 40% wettable powder and 40%
emulsifiable concentrate were each applied in gum arabic to 20 cm
2 shaved dorsal skin of 3 rats
(strain not reported)/sex/formulation at 1.50 mg/kg/day (technical material) or 54 mg/kg/day
(formulations) for 5 successive days (Geigy, 1964).  It does not appear any protective covering
was used since the rats were restrained for 3 hours during exposure and then the skin was wiped
with a damp sponge.  Typical acute clinical signs (not described) were seen, but no mortalities or
dermal irritation were reported.  A NOEL could not be established for this study based on the Methidathion RCD (Revision 1) February 2007
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Table 5.  Cholinesterase Activity Relative to Controls in Mice Fed Methidathion in the Diet for
28 Days
a
Tissue
Dose Level (ppm)
b
0.3 1 3 10 30 100 300
MALES
Plasma 107
c 107 99 114 95 118 73
RBC
d 112 124 97 112 110 100 87
Brain 104 99 92 96 93 51 29
FEMALES
Plasma 97 107 108 110 101 87 79
RBC 78 83 104 98 81 57 66
Brain 109 120 105 104 96 65 34
a Albanese, 1976.  This study did not meet FIFRA guidelines due to major deficiencies.  ChE activity was measured in all
survivors at the study termination.
b Dose level of 0, 0.3, 1, 3, 10, 30, 100 or 300 ppm =  0, 0.059, 0.23, 0.60, 2.3, 6.5, 20, 62, 219 or 276 mg/kg/day,
respectively, in males and  0, 0.045, 0.17, 0.54, 1.8, 4.2, 18, 42, 330 or 574 mg/kg/day, respectively, in females.
c Mean activity relative to mean  control activity expressed as percentage.  There was no apparent statistical analysis of this
data.
d RBC = Red Blood Cell
limited information provided.  The study had numerous major deficiencies including no analysis
of test article or dosing material, inadequate number of animals, inadequate number of treatment
groups, no controls, inadequate exposure duration, no body weight data, no pathology, no
summary of clinical signs by treatment group, and no individual data.
II.C.7.  Dermal-Rat
Technical grade methidathion (purity not reported) in gum arabic was applied to the
shaved skin of 5 rats(strain not specified)/sex/dose at 1.5, 3, 6 or 12 mg/kg/day on 5 days/week
for 4 weeks (Geigy, 1964).  It does not appear any protective covering was used since the rats
were immobilized for 3 hours during exposure after which the skin was wiped with a damp
sponge.  No deaths, clinical signs or dermal irritation was seen.  Body weights were also normal. 
Based on this limited information, the tentative NOEL appears to be 12 mg/kg/day.   The study
had numerous major deficiencies including no analysis of test article or dosing material,
inadequate number of animals, no controls, no pathology, no summary of body weights and
clinical signs by treatment group, and no individual data.Methidathion RCD (Revision 1) February 2007
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II.C.8.  Dermal-Rabbit
Methidathion (purity not reported) was applied topically (non-occlusive exposure) to the
clipped back and flanks of 5 New Zealand white rabbits/sex/dose at 0, 1, 5, or 20 mg/kg/day for
6 hr/day for 22 consecutive days (Folinusz et al., 1986).  A control male and a female at 5
mg/kg/day were injured during the study and were either sacrificed in moribund condition or
died.  Neither of these deaths were considered treatment-related.  Diarrhea or soft feces was
observed on more than one day in several treated animals (1 male at 1 mg/kg/day, 2 males at 5
mg/kg/day, 1 male and 1 female at 20 mg/kg/day).  It is unclear if the diarrhea was treatment-
related, although it is possible.  A male at 20 mg/kg/day also had reduced activity on days 6-19. 
A papular rash was observed in several animals (1 male and 2 females at 1 mg/kg/day, 1 male at
5 mg/kg/day, 1 male and 1 female at 20 mg/kg/day) from days 16 to 24.  Slight reductions in
mean body weights (5%) were observed at 20 mg/kg/day, but were not statistically significant. 
No other treatment-related effect on food consumption, clinical chemistry, hematology or
pathology were noted.  The NOEL appears to be 20 mg/kg/day since the effects seen at this dose
level were minor and not clearly treatment related.  The study had a few deficiencies in that the
purity of the methidathion was not reported and a maximum tolerated dose (MTD) was not
clearly established.   
II.C.9.   Dermal-Rabbit
A range-finding study was conducted in which methidathion (95% purity) was applied to
the clipped backs of 2 New Zealand White rabbits/sex/dose for 6 hours/day for 10 days at 0
(vehicle polyethylene glycol 400), 125, 250, 350, 500 or 740 mg/kg/day (Osherhoff, 1987a). 
The application site was covered with an occlusive binder during the 6-hr exposure period and
then wiped clean after the binder was removed.  The mortality rate was 25%, 50%, 50%, 75%,
100% and 100% of animals at 0, 125, 350, 250, 500, and 750 mg/kg/day, respectively.  The
onset of deaths was usually earlier at the higher dose levels.   Clinical signs were observed at all
dose levels including anorexia, depression, labored or rapid breathing, hunched posture, ataxia,
tremors, and prostration.  A reduction in body weight, body weight gains, and food consumption
were seen in the treatment groups relative to controls.  Plasma, RBC and brain ChE activity were
significantly reduced in survivors at 125 mg/kg/day (M: 16-22%; F: 15-17% of controls), 250
mg/kg/day (M: 9-17%; F: 7-16% of controls) and 350 mg/kg/day (F: 9-14% of controls) after 10
days.  Interpretation of these reductions was difficult because of the small number of animals per
group and the high mortality rate, so the data were not summarized in a table.  No treatment-
related changes in organ weights or gross pathological lesions were seen.  A NOEL was not
established in this study based on the mortalities at the lowest dose, 125 mg/kg/day.  This study
had several major deficiencies including inadequate number of animals per group, inadequate
exposure duration, inadequate clinical chemistry, no hematology, and no histopathology.
II.C.10.   Dermal-Rabbit
Five New Zealand White rabbits/sex/dose were administered methidathion (95% purity)
dermally (rubber dam occlusion) to their clipped backs at 0 (vehicle propylene glycol 400), 1,
10, 40 or 80 mg/kg/day for 6 hours/day for 21 consecutive days (Osherhoff, 1987b).  A dose-
related increase in mortalities was seen in the treatment groups (2 males at 1 mg/kg/day, 2 males
at 10 mg/kg/day, 3 males and 2 females at 40 mg/kg/day, 3 males and 4 females at 80Methidathion RCD (Revision 1) February 2007
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mg/kg/day).  Clinical signs were observed in all of the treatment groups, including anorexia,
lethargy, ataxia, hunch posture, labored respiration, soft feces, thin appearance, low body
temperature and tremors.  There were no significant differences in dermal irritation, body
weights, food consumption, and ophthalmological findings.  The surviving female at 80
mg/kg/day had reduced RBC count, hemoglobin, hematocrit, alkaline phosphatase, and gamma
glutamyl transferase values and increased alanine aminotransferase, aspartate transferase and
blood glucose values.  Males at 80 mg/kg/day only had reduced lymphocyte values.  The plasma,
RBC and brain ChE activity was significantly reduced at 10, 40, and 80 mg/kg/day in one or
both sexes (Table 6). 
Table 6. Cholinesterase Activity Relative to Controls in Rabbits Administered Methidathion
Topically for 21 Consecutive Days
a
Tissue
Dose Level (mg/kg/day)
1 1 04 08 0
MALES
Plasma 93
b 62* 27* 14*
RBC
c 103 60* 22* 22*
Brain 101 58* 20* 12*
FEMALES
Plasma 137 83 42* 25
d
RBC 79 55* 20* 24
d
Brain 109 63* 24* 12
d
a Osherhoff, 1987b.  This study met FIFRA guidelines, except for an incomplete histopathological examination of the
control and high-dose animals.  ChE activity was measured in all survivors on day 22.
b Mean activity relative to mean  control activity expressed as percentage
c RBC = Red Blood Cell
* Significantly different from controls by the Dunnett’s test at p < 0.05.
d Statistical comparison with controls not possible since only one animal in this treatment group survived to the end.
Histological examination revealed lesions in the liver (capsular/subcapsular necrosis with
acute inflammation, hepatocytic clearing, congestion, coagulation necrosis) at 10, 40 or 80
mg/kg/day, in the gallbladder (caseous necrosis, hemorrhage, chronic serosal inflammation,
vasculitis, thrombosis, fibroid necrosis, granulation tissues) at 10, 40 and/or 80 mg/kg/day, in the
stomach (erosion/ulceration, inflammation, hemorrhage, submucosal fibrin) in all groups, in the
kidney (serous atrophy of fat) at 40 and 80 mg/kg and in the heart (degeneration of aortic media,
inflammation of myocardium, myocardial degeneration) at 1, 40 and/or 80 mg/kg/day.  The
investigators considered the liver lesions to be compound-related; however, they suggested the
gall bladder lesions were secondary to reflux of enteric bacteria into the bile duct due to episodes
of hyperperistalsis.  The investigators also suggested that the ulceration and inflammation in the
stomach was stress-related due to the wrapping material and/or neck collar.  Evidence of stressMethidathion RCD (Revision 1) February 2007
2 Estimated assuming for a mouse that 1 ppm in the diet is equivalent to 0.15 mg/kg/day
(FDA, 1959).
35
was seen in all groups, including the controls based on poor weight gains and subnormal food
consumption.  The investigators also attributed the serous atrophy of fat in the kidneys to the
weight loss.   However, the toxicological significance of the lesions in the stomach and heart
were uncertain since only one stomach and no hearts from control animals were examined
microscopically, apparently due to protocol stipulations and the lack of gross lesions. 
Consequently, DPR toxicologists assumed that the lesions in the stomach and heart were
treatment-related.  The NOEL appears to be less than 1 mg/kg/day based on the deaths and
histological lesions in the heart and stomach.  One major deficiency of this study was the
incomplete histopathological examination of control and high dose animals.
II.C.11.  Dermal-Turkey
Ten 8-week-old and 10 18-week-old turkeys (sex not reported) were exposed dermally to
methidathion (purity not reported) by placing them in pens in which the soil had been sprayed at
0 and 64 lb a.i./acre (Radeleff and Kunz, 1972).  The birds were observed for 28 days following
the spraying.  Signs were not observed in any of the birds, although the 8-week-old birds at 64
lb/acre had reduced plasma ChE activity (46% of normal).  This study had major deficiencies
based on the FIFRA guidelines for subchronic studies, including no analysis of test article,
inadequate exposure duration, inadequate number of dose levels, no overt toxicity at highest
dose tested, inadequate summary of clinical signs, no pathological examination, and no
individual data.
II.D.  CHRONIC TOXICITY/CARCINOGENICITY
Summary:  Seven oral chronic toxicity studies were available for methidathion using
four different species, including mice, rats, dogs and monkeys.  Three of the 7 chronic toxicity
studies met FIFRA guidelines and are discussed in more detail.  However, the other older
incomplete studies provide useful supplemental information, especially with regards to ChE
inhibition.  Effects seen with chronic exposure were similar to those observed with subchronic
exposure, although hepatotoxicity was more prevalent.  In addition, focal accumulation of foamy
macrophages in the alveoli and ulceration and inflammation of the skin were seen in one chronic
feeding study in rats.  The lowest NOEL observed in an acceptable study was 0.15 mg/kg/day
based on the elevated liver enzymes in the serum and histological lesions in the liver of dogs. 
There was an increase in hepatocellular adenomas and carcinomas in males in two mouse
studies.  There was no evidence of carcinogenicity in female mice or in either of the rat studies.
II.D.1.  Diet-Mouse
Sixty CD-1 mice/sex/dose were administered methidathion (98.8% purity) in the feed at
0, 1, 10, or 100 ppm (0, 0.15, 1.5 or 15 mg/kg/day, respectively
2) for 18 and 19 months for males
and females, respectively (IBT, 1980).  There was no treatment-related effect on clinical signs or
body weights.  A significant increase in several gross pathological lesions were seen in males at
100 ppm, including liver cysts, liver nodules, and spleen nodules.  HistopathologicalMethidathion RCD (Revision 1) February 2007
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examination revealed an increase in neoplastic lesions (hepatocellular adenomas and
carcinomas) and non-neoplastic lesions (cystic bile ducts, chronic pericholangitis,
intracanalicular pigment, bile duct hyperplasia, and focal necrosis) in the liver of males at 100
ppm (Table 7).  There was no increase in neoplastic or non-neoplastic lesions in the liver of
females.  The NOEL for non-carcinogenic systemic toxicity appears to be 10 ppm (1.5
mg/kg/day) based on the gross and histopathological changes in the liver and spleen.  The study
had numerous major deficiencies including no food consumption data, control group mistakenly
dosed with treated feed in month 14, apparent degradation of test material in the first 8 months,
and no hematology data.
II.D.2.  Diet-Mouse
Groups of 170 CD-1 mice/sex/dose were fed methidathion technical (purity not reported)
in the diet at 0, 3, 10, 50 or 100 ppm (M: 0, 0.4, 1.4, 6.7 or 13.1 mg/kg/day; F: 0, 0.5, 1.6, 8.1 or
15.9 mg/kg/day, respectively) (Goldenthal, 1986).  Fifty mice/sex/dose assigned to the
carcinogenicity study were terminated at 23 months.  The remaining 120 mice/sex/dose were
assigned to the chronic toxicity study which terminated at 18 months with 4 interim sacrifices at
3, 6, 12 and 13 months.  The mice sacrificed at 13 months were removed from treated feed at 12
months and then allowed to recover on the control diet for one month.  An increase in mortality
rate (68% versus 42% in controls) was observed in the males at 100 ppm in the carcinogenicity
study.  Discolored urine (dark yellow, orange or red) was observed in males at 50 and 100 ppm. 
The cause of the discoloration is unclear, although orange or red colored urine is clearly not
normal.  It could be due to blood in the urine or excretion of some orange to red colored product. 
No other treatment-related clinical signs were seen.  There were no treatment-related differences
in body weights, food consumption, water consumption, auditory response, ophthalmological
findings, or hematology.  Significant increases in several liver enzyme activities in the serum
were seen which were suggestive of hepatotoxicity.  The mean serum alkaline phosphatase
(AKP) activity was significantly elevated in males at 100 ppm at 3, 6, 12, 18 and 23 months (12,
4, 10, 19, and 7  fold increase, respectively).  Significant increases in the mean serum alanine
aminotransferase (ALT) activity were observed in males at 50 ppm (200 and 122% at 12 and 23
months, respectively) and 100 ppm (146, 149, 274, 124 and 209% at 3, 6, 12, 18 and 23 months,
respectively).  The mean ALT values were significantly increased in females at 100 ppm (97 and
183% at 6 and 12 months, respectively).  The mean aspartate aminotransferase (AST) activity
was also increased in males at 100 ppm (64, 142 and 108% at 6, 12, and 23 months,
respectively).  The mean plasma ChE activity was increased significantly in males at 100 ppm
(Table 8).  In contrast, the mean RBC ChE activity was significantly reduced in males at 100 
ppm.  The RBC ChE activity in males also appears to be reduced at 50 ppm, but the reductions
were never statistically significant.  In females, the mean RBC ChE activity was reduced at 50
and 100 ppm.  Brain ChE activity was significantly reduced at all time points at 100 ppm for
both males and females.  Brain ChE activity also was reduced at 50 ppm in both sexes, although
the reductions were only significant on a few occasions (M: 6 mos.; F: 24 mos.). 
Numerous gross pathological lesions in the liver were seen, primarily the males,
including enlargement, foci, masses, nodules, cysts, discoloration, mottling, depressions, and
granularity.  Microscopic examination of the liver and gall bladder revealed a significant
increase in numerous non-neoplastic lesions in males at 50 and 100 ppm and in females at 100 Methidathion RCD (Revision 1) February 2007
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Table 7. Non-neoplastic and Neoplastic Lesions in the Liver of Male Mice Fed Methidathion
in the Diet for 18 Months
a
Lesion
Dose Level (ppm)
0 1 10 100
Hepatocellular
adenoma
    0/59
+++
(0%)
0/59
(0%)
0/57
(0%)
     14/59***
(24%)
Hepatocellular
carcinoma
    2/59
+++
(3%)
1/59
(2%)
2/57
(4%)
 10/59*
(17%)
Cystic bile duct     1/59
+++
(2%)
1/59
(2%)
2/57
(4%)
     17/59***
(29%)
Chronic
pericholangitis
    1/59
+++
(2%)
3/59
(5%)
1/57
(2%)
     15/59***
(25%)
Intracanalicular
pigment
    0/59
+++
(0%)
1/59
(2%)
2/57
(4%)
     57/59***
(97%)
Bile duct
hyperplasia
    0/59
+++
(0%)
0/59
(0%)
3/57
(5%)
     34/59***
(58%)
Focal necrosis  1/59
+
(2%)
1/59
(2%)
1/57
(2%)
 6/59
(10%)
a IBT, 1980.
+,+++ Significant trend based on Cochran-Armitage trend test with p < 0.05 and 0.001, respectively.
*,*** Significantly different from controls based on the Fisher exact test with p < 0.05 and 0.001, respectively.
ppm (Table 9).  The non-neoplastic changes included cholecystitis, hyperplasia of the gall
bladder and bile duct, bile stasis, cholangiofibrosis, and chronic hepatitis. 
Neoplastic lesions of the liver were also observed in males which consisted of
hepatocellular adenomas and/or carcinomas (Table 10).  The incidence of hepatocellular
adenomas and carcinomas exhibited a dose-related trend that was highly significant when the
tumors were analyzed separately or combined.  In addition, 3 males at 100 ppm had multiple
liver tumors.  The increase in hepatocellular adenomas was significant by pairwise comparison
to controls at all dose levels.  The incidence of hepatocellular adenomas at 100 ppm exceeded
the historical control range for this tumor type in studies conducted at the test laboratory between
1978 and 1985 with this strain of mice (Table 11) (Quest et al., 1990).  Based on these historical
control means, it appears that the incidence of adenomas in the control group in this study is
unusually low.  The toxicological significance of the apparent increase in adenomas at 3, 10 and
50 ppm is uncertain since the incidences are all greater than the historical control means, but
within the historical control range.  The increase in hepatocellular carcinomas was only
significantly different (p < 0.05) than controls at 100 ppm.  However, the incidence of
carcinomas in the concurrent control group was greater than the historical control range.  When Methidathion RCD (Revision 1) February 2007
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Table 8. Cholinesterase Activity Relative to Controls in Mice Fed Methidathion in the Diet for
24 Months
a
Tissue
Dose Level (ppm)
b
3 10 50 100  
MFMFMFMF
Plasma,   3 mos. 92
c 101   84 97 103   97 118   100  
  6 mos. 106   103   102   103   108   106   127* 90
12 mos.  94 111    99 95 95 106   117* 92
18 mos. 101   97 111   105   172   108   144* 97
24 mos. 107   108   107   105   122   109   154* 91
RBC
d,   3 mos. 104   105   95 105   77   70*     55**     55**
  6 mos. 97 94 88 97 85     64** 67     67**
12 mos. 96 107   91 105   73 81   62*     57**
18 mos. 85 100   91 100   73   73* 91     65**
24 mos. 119   103   95 100   76   74* 81     71**
Brain,  3 mos. 109   102   107   98 85 96     61**     77**
  6 mos. 107   109   98 102     76* 104       66**   76*
12 mos. 104   106   99 98 87 91     51**     74**
18 mos. 100   109   107   103   90 90     66**     78**
24 mos. 109   94 111* 92 85   84*     64**     66**
a Goldenthal, 1986.  This study met FIFRA guidelines.  ChE activity was measured in 8-10 animals/sex/dose at each
time point.
b Dose level of 0, 3, 10, 50 or 100 ppm =  0, 0.4, 1.4, 6.7 or 13.1 mg/kg/day, respectively, in males and 0, 0.5, 1.6, 8.1 or
15.9 mg/kg/day, respectively, in females
c Mean activity relative to mean  control activity expressed as percentage
d RBC = Red Blood Cell
*,** Significantly different from controls by the Dunnett’s Test at p < 0.05 and 0.01, respectively.
combined, the increase in hepatocellular adenomas and carcinomas was statistically significant
(p < 0.05) at 50 and 100 ppm.  The incidence of carcinomas and combined adenomas/carcinomas
exceeded the historical control range at 50 and 100 ppm.
Although there were no treatment-related differences in body weights, an increase in the
mean liver weights was observed in males at 50 (absolute: 35%; relative to body: 36% ; relative Methidathion RCD (Revision 1) February 2007
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Table 9. Non-neoplastic Lesions in the Liver and Gall Bladder of Mice Fed Methidathion in
the Diet for 23 Months
a
Lesion
Dose (ppm)
b
0 3 10 50 100
MALES
Gallbladder
  Cholecystitis 4/49
+++
(8%)
0/46
(0%)
1/47
(2%)
21/48***
(44%)
37/48***
(77%)
  Hyperplasia 0/49
+++
(0%)
0/46
(0%)
0/47
(0%)
15/48***
(31%)
33/48***
(69%)
Liver
  Bile duct hyperplasia 0/50
+++
(0%)
1/47
(2%)
0/47
(0%)
21/49***
(43%)
42/48***
(88%)
  Bile stasis 0/50
+++
(0%)
0/47
(0%)
0/47
(0%)
25/49***
(51%)
47/48***
(98%)
  Cholangiofibrosis 1/50
+++
(2%)
0/47
(0%)
0/47
(0%)
18/49***
(37%)
45/48***
(94%)
  Chronic hepatitis 3/50
+++
(6%)
1/47
(2%)
2/47
(4%)
24/49***
(49%)
47/48***
(98%)
FEMALES
Gallbladder
  Cholecystitis 1/45
+++
(2%)
1/46
(2%)
0/46
(0%)
2/44
(5%)
11/46**
(24%)
  Hyperplasia 0/45
+++
(0%)
0/46
(0%)
0/46
(0%)
0/44
(0%)
5/46*
(11%)
Liver
  Bile duct hyperplasia 0/46
(0%)
1/48
(2%)
2/47
(4%)
0/44
(0%)
3/46
(7%)
  Bile stasis 0/46
+++
(0%)
1/48
(2%)
1/47
(2%)
0/44
(0%)
11/46***
(24%)
  Cholangiofibrosis 0/46
+++
(0%)
0/48
(0%)
1/47
(2%)
0/44
(0%)
7/46**
(15%)
  Chronic hepatitis 3/46
++
(7%)
2/48
(4%)
2/47
(4%)
4/44
(9%)
8/46
(17%)
a Goldenthal, 1986.  This study met FIFRA guidelines.
b Dose level of 0, 3, 10, 50 or 100 ppm =  0, 0.4, 1.4, 6.7 or 13.1 mg/kg/day, respectively, in males and 0, 0.5, 1.6,
8.1 or 15.9 mg/kg/day, respectively, in females
++,+++ Significant trend based on  the Armitage-Cochran trend test at p < 0.01 and 0.001, respectively (Gart et al., 1986).
*,**,*** Significantly different from the control group based on the Fisher’s exact test at p < 0.05, 0.01 and 0.001,
respectively.Methidathion RCD (Revision 1) February 2007
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Table 10. Neoplastic Lesions in the Liver of Male Mice Fed Methidathion in the Diet for 23
Months
a
Lesion
Dose (ppm)
b
0 3 10 50 100
  Hepatocellular adenoma    1/46
c+++
(2%)
   9/45**
(20%)
  7/47*
(15%)
   8/43*
(19%)
  24/45***
(53%)
  Hepatocellular carcinoma   8/46
+++
(17%)
6/45
(13%)
 4/47
(9%)
13/43
(30%)
17/45*  
(38%)
  Combined
d   9/46
+++
(20%)
15/45  
(33%)
11/47
(23%)
  21/43**
(49%)
  38/45***
(84%)
a Goldenthal, 1986.  This study met FIFRA guidelines.
b Dose level of 0, 3, 10, 50 or 100 ppm = 0, 0.4, 1.4, 6.7 or 13.1 mg/kg/day; respectively
c The denominator is the number of animals at risk (excluding those that died before the first tumor was observed on
day 445); the number in parentheses represents the incidence in percentage.
d Animals with both adenomas and carcinomas counted once under combined.  There were 3 animals at 100 ppm
with both adenomas and carcinomas.
+++ Significant trend based on  the Armitage-Cochran trend test at p < 0.001 (Gart et al., 1986).
*,**,*** Significantly different from the control group based on the Fisher’s exact test at p < 0.05, 0.01 and 0.001,
respectively.
Table 11. Historical Control Data on Liver Tumor in Male CD-1 Mice
a
Type of 
Liver Tumor
Studies terminated between
   1978 and 1983 (11 studies)       1984 and 1985 (3 studies)   
Mean (%) Range (%) Mean (%) Range (%)
Adenoma 11 0-26.7 14.8 8.0-24.0
Carcinoma 5.7 0-14.3 6.9 3.3-10.0
Combined 16.7 5.0-26.7 20.0 13.3-32.0
a Data obtained from 11 studies conducted at the test laboratory and terminated between 1978 and 1983, and from 3
studies conducted at the test laboratory and terminated between 1984 and 1985 (Quest et al., 1990).  The carcinogenicity
study of methidathion in CD-1 mice was terminated in 1984.
to brain: 36%) and 100 ppm (absolute: 122%; relative to body: 116%; relative to brain: 120%) at
23 months.  There was also a significant increase in the mean spleen weights (absolute: 67%;
relative to body: 67%; relative to brain: 75%) and a decrease in the mean testes weights 
(absolute: 26%; relative to body: 29%; relative to brain: 26%) in males at 100 ppm that were
sacrificed at 23 months.  The increased spleen weights were associated with macroscopic
changes including enlargement, nodules, adhesions and mottling of the spleen.  An increase in
extramedullary hematopoiesis of the spleen were observed microscopically in males at 100 ppm.
No macroscopic or microscopic changes in the testes were associated with the decrease in testesMethidathion RCD (Revision 1) February 2007
3 Estimated assuming for a rat that 1 ppm in the diet is equivalent to 0.05 mg/kg/day (FDA,
1959).
41
weight.  Significant changes in the kidney (3  ppm), brain (100 ppm) and adrenal gland weights
(100 ppm) observed in females were of uncertain toxicological significance since they were not
associated with pathological changes.  The NOEL established for systemic non-neoplastic effects
was 10 ppm (1.4 mg/kg/day) based on reduced RBC ChE activity (F: 64-74% of controls),
discolored urine, elevated serum ALT values, and histopathological lesions in the liver and gall
bladder of males.  This study was considered acceptable by DPR toxicologists based on FIFRA
guidelines.
II.D.3.  Diet-Rat
Twenty-five albino rats (strain not reported)/sex/dose were fed a 40% methidathion
wettable powder (actual purity not reported) in the diet at 0, 4, 16 or 64 ppm (as active 
ingredient; 0, 0.2, 0.8 or 3.2 mg/kg/day, respectively
3) for 2 years (Johnston, 1967).  The body
weights were reduced (25% at terminal sacrifice) in males at 64 ppm throughout the study. 
There was no apparent statistical analysis of any of the data in this study.  The mean hemoglobin
level was reduced (21%) in males at week 100 due primarily to two males with very low
hemoglobin values.  There were no dose-related reductions in the mean plasma ChE activity,
except for the females at 64 ppm which had consistently reduced activity from week 13 to 100
(Table 12).  The mean RBC ChE activity was reduced primarily at 16 and 64 ppm from week 13 
to 100, but was occasionally reduced at 4 ppm.  A reduction in the mean brain ChE activity was 
seen at 4, 16, and 64 ppm at the terminal sacrifice.  There was no effect on the absolute and
relative organ weights, except for a reduction in the mean weights of the ovary in females at 64
ppm (absolute: 1%; relative: 26%) and of the adrenal glands in females at 16 ppm (absolute: 
18%; relative: 13%) and 64 ppm (absolute: 32%; relative: 28%), respectively.  No treatment-
related differences in gross pathological findings were seen.  A slightly higher incidence of
degenerative changes in the liver were seen in the treatment groups than the controls; however,
the study pathologist indicated that the high incidence of deaths due to pulmonary infections and
subsequent autolysis made interpretation of the hepatic changes difficult.  The NOEL was less
than 4 ppm (0.18 mg/kg/day) based on reduced brain ChE activity (M: 86%; F: 92% of controls). 
The study had major deficiencies including high mortality due to pulmonary infections,
insufficient hematological and clinical chemistry analysis, and incomplete histopathology and
individual data.  
II.D.4.  Diet-Rat
Methidathion (97.3% purity) was administered in the feed to 80 Sprague-Dawley
rats/sex/dose at 0, 4, 40 or 100 ppm (M: 0, 0.17, 1.77 or 4.95 mg/kg/day; F: 0, 0.23, 2.24 or 6.94
mg/kg/day, respectively) for 104 weeks (Yau et al., 1986).  There was no treatment-related effect
on mortality and ophthalmological findings.  An increased incidence of alopecia,
chromorhinorrhea, hyperactivity, hypersensitivity to touch, skin lesions, and tremors were noted
at 40 and 100 ppm.  Most of the neurological signs subsided as the study progressed, suggesting
tolerance since the mean brain ChE activity remained severely reduced at 40 and 100 ppm at theMethidathion RCD (Revision 1) February 2007
42
Table 12. Cholinesterase Activity Relative to Controls in Rats Fed Methidathion in the Diet for
2 Years
a
Tissue
Dose Level (ppm)
41 6 6 4
MFMFMF
Plasma,  13 wks 111
b 87 100 92 135 79
  26 wks 110 98 110 84 110 76
  5 2  w k s 6 09 67 19 66 78 3
  80 wks 100 91 92 98 82 67
100 wks 106 107 86 112 98 87
RBC
c,   13 wks 111 106 81 81 37 25
  2 6  w k s 9 89 26 17 74 12 6
  5 2  w k s 9 09 77 47 63 23 5
  80 wks 110 85 90 81 34 55
100 wks 83 97 49 55 37 11
Brain, 100 wks 86 92 77 90 37 33
a Johnston, 1967.   This study did not meet FIFRA guidelines since it predated them.  Plasma and RBC ChE activity were
measured in 3-5 rats/sex/dose at each time point.  Brain ChE activity was measured in 6-14 rats/sex/dose.
b Dose level of 0, 4, 16 or 64 ppm = 0, 0.2, 0.8 or 3.2 mg/kg/day, respectively.
c Mean activity relative to mean  control activity expressed as percentage.  There was no apparent statistical analysis of this
data.  
d RBC = Red Blood Cell
study termination (Table 13).  Brain ChE activity was also significantly depressed (86% of
controls) in females at 4 ppm at 52 weeks, but not at 93 and 104 weeks.  Reductions in the mean 
RBC ChE activity was seen at 40 and 100 ppm at most time points during the study including the
study termination.  The mean serum ChE activity was also significantly reduced throughout the
study at 40 and 100 ppm, but less frequently than seen with RBC ChE activity.  Significant
reductions in the mean body weight were noted at 40 ppm (M: 3-5% wks 1-5, 7, 9-10; F: 4-6%
wks 1-3) and 100 ppm (M: 4-13% wks 1-16, 72-92; F: 12-21% wks 1-104).  Significant
increases in the mean feed consumption was seen at 40 ppm (M: 5-14% wks 40, 48, 76, 84, 88;
F: 6-16% wks 4-12, 24, 36, 44-52, 64-80, 88) and 100 ppm (M: 5-22% wks 5-7, 16-40, 48-76,
84-100; F: 7-15% wks 24, 48, 68, 84, 88).  The mean water consumption was significantly
reduced at 40 ppm (F: 19-32% wks 28, 44, 84) and 100 ppm (M: 15-16% wks 9, 11; F: 14-54%
wks 2-3, 6, 9, 11, 20, 28-48, 56-72, 84-92).  Methidathion RCD (Revision 1) February 2007
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Table 13. Cholinesterase Activity Relative to Controls in Rats Fed Methidathion in the Diet for
104 Weeks
a
Tissue
Dose Level (ppm)
b
4 40 100
MFMFMF
Serum,   26 wks 77
b 118     59* 81   70*     60**
  52 wks 105   108     74*     78**     72**     65**
  78 wks 93 108   77 76     44**     60**
  93 wks 65 110   56 77 34 98
104 wks 80 99 88 75 72     54**
RBC
c,   26 wks 107   107   92     63**     86**     62**
  52 wks 100   98     86** 97     76**     84**
  78 wks 105   108   94     85**     81**     77**
  93 wks 100   106   106   89 86 98
104 wks 96 102       78**   82*     77**   81*
Brain,   52 wks 113*     86**     58**     34**     45**     31**
  93 wks 97 94     56**     54**     54**     39**
104 wks 92 95     49**     48**     34**     26**
aY a u   et al., 1986.  This study met FIFRA guidelines.  ChE activity was measured in 9-10 rats/sex/dose at each time
point, except at 52  weeks where blood ChE activity was measured in 19-20 rats/sex/dose and at 93 week s where all
ChE activity  was measured in 5 rats/sex/dose.
b Dose level of 0, 4, 40 or 100 ppm = 0, 0.17, 1.77 or 4.95 mg/kg/day, respectively in males and  0, 0.23, 2.24 or 6.94
mg/kg/day, respectively, in females.
c Mean activity relative to mean  control activity expressed as percentage
d RBC = Red Blood Cell
*,** Significantly different from controls by the Dunnett’s Test at p < 0.05 and 0.01, respectively.
Significant reductions in erythrocytic parameters (hemoglobin, red blood cell counts,
hematocrits, mean corpuscular volume, mean corpuscular hemoglobin and mean corpuscular
hemoglobin concentration) were seen primarily in females at 100 ppm, but the reductions were
usually transient and less than 10%.  A significant increase in the percent neutrophils and a
corresponding significant reduction in the percent lymphocytes were seen in both sexes at 100
ppm.  Transient increases in granulocytes, such as neutrophils, have been observed after
administration of some drugs and endotoxins, but are not believed to be of any physiological
consequence (Smith, 1996).  An increase in granulocytes has also been associated with chronic
leukemia; however, the total white blood cell counts were not significantly different at 100 ppm
even though the differential counts were affected.  In addition, a significant increase in theMethidathion RCD (Revision 1) February 2007
4 Estimated assuming for a dog that 1 ppm in the diet is equivalent to 0.025 mg/kg/day
(FDA, 1959).
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platelet counts was seen in both sexes at 100 ppm; however, an increase in platelets has not been
associated with any chemical exposure (Smith, 1996).  Significant differences in various serum
clinical chemistry values (aspartate aminotransferase, lactate dehydrogenase, creatine
phosphokinase, glucose, blood urea nitrogen, total bilirubin, cholesterol, total protein, calcium, 
sodium, potassium, chloride, inorganic phosphorus) were seen in both sexes primarily at 100
ppm, but occasionally at 40 ppm.  These changes were usually transient and often in a direction
opposite of what is normally considered toxicologically significant.  However, a few clinical
chemistry changes of toxicological concern were still present at the study termination in females
at 100 ppm, including an increase in serum aspartate aminotransferase (71%) and serum lactate
dehydrogenase (63%).  Transient reductions in urine volume and increases in urinary specific
gravity were seen during the first year at 40 ppm (females) and 100 ppm (both sexes), and were
not considered toxicologically significant.  A significant reduction in the mean liver weights
were seen in females at 40 ppm (relative to body: 14%) and in both sexes at 100 ppm (males -
relative to body: 17%, relative to brain: 13%; females - absolute: 31%, relative to brain: 34%) at
day 364.  At study termination, only the females still had significantly reduced liver weights at
40 ppm (relative to body: 27%) and 100 ppm (absolute: 18%; relative to brain: 20%).  Although
no histological lesions were seen in the liver, the increase in liver enzymes in the serum and the
reduction in liver weights were assumed to be due to mild hepatotoxicity.  Ulceration and
inflammation of the skin was observed microscopically at 100 ppm which correlated with the
clinical observations of skin lesions.  An increased incidence of focal accumulation of foamy
macrophages in the alveoli was seen at 100 ppm.   No dose-related increase in tumors was seen
in this study.  The systemic NOEL for this study was established at 4 ppm (M: 0.17 mg/kg/day;
F: 0.23 mg/kg/day) based on the clinical signs, reduced body weights and food and water
consumption, reduced RBC and brain ChE activity, reduced liver weights, and skin lesions at 40
ppm.  DPR toxicologists found this study to be acceptable based on FIFRA guidelines.
II.D.5.  Diet-Dog
Three beagle dogs/sex/dose were fed a 40% wettable powder (actual purity not stated) in
their diet at 0, 4, 16 or 64 ppm (as active ingredient; 0, 0.1, 0.4 or 1.6 mg/kg/day, respectively)
4
for 105 weeks (Johnston, 1967).  There was no effect on clinical signs, body weights,
electrocardiograms, heart rates, blood pressure, ophthalmology, and hematology.  The mean
serum AKP activity was increased 1 to 2-fold in dogs at 16 and 64 ppm.  The mean serum AST
activity was not affected, but the mean serum ALT activity was increased in a dose-related
manner at 4, 16 and 64 ppm from approximately 2 to 10 fold.  There was no treatment-related
effect on plasma and brain ChE activity.  The mean RBC ChE activity was reduced throughout
the study in dogs at 64 ppm (M&F: 67-89% of controls).  Dark pigmentation of the liver was
seen microscopically in a few dogs at 4 ppm and all dogs at 16 and 64 ppm.  Increased
pigmentation of the upper nephron tubular cells of the kidney was also noted in dogs at 64 ppm. 
Increased extramedullary hematopoiesis of the spleen was also seen at 16 and 64 ppm.  The
NOEL was 4 ppm (0.1 mg/kg/day) based on the histological changes in the liver and spleen and
the elevated liver enzyme activities in the serum.  This study had several major deficienciesMethidathion RCD (Revision 1) February 2007
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including inadequate number of animals per group, missing electrolyte balance data, inadequate
histopathological examination, and no food consumption data. 
II.D.6.  Diet-Dog
Methidathion (96% purity) was administered in the feed to 4 beagle dogs/sex/dose at 0,
0.5, 2, 4, 40 or 140 ppm (M: 0, 0.02, 0.07, 0.15, 1.33 or 4.51 mg/kg/day; F: 0, 0.02, 0.07, 0.15,
1.39 or 4.90 mg/kg/day, respectively) for 1 year (Chang and Walberg, 1991).  An increased
incidence of salivation and wet coat on forefoot were noted at 2 ppm and higher.  However, the
toxicological significance of these signs is uncertain since there was no clear dose-response
relationship and no significant ChE inhibition except at 140 ppm.  Serum ChE activity was not
affected at any dose level at any time point (Table 14).  The mean RBC activity was significantly
reduced at 140 ppm at 3, 6 and 12 months.  The mean brain ChE activity was also significantly
reduced at 140 ppm in the vermis of the cerebellum and the right hemisphere minus the vermis at
the study termination.  There was no treatment-related effect on body weights or body weight
gains in either sex, but there was a reduction in food consumption (17-37%) in males at 140 ppm
from weeks 7 through 45.  A reduction in the percent neutrophils and a corresponding increase in
the percent lymphocytes was seen at 40 and 140 ppm at 3 months.  In addition, there was a
decrease in mean corpuscular volume at 2 and 40 ppm at the study termination.  These
hematological changes are of uncertain toxicological significance, either because of their
transient nature or lack of dose-response relationship.  Moderate to marked increases in several
serum liver enzyme activities, including AKP, AST, ALT, and sorbitol dehydrogenase, were
seen at 40 and 140 ppm at all time points tested (Table 14).  The mean γ-glutamyl transferase
activity was elevated in females at 40 (40%) and 140 ppm (40-80%) at 3 and 6 months. 
Increases in the mean total bilirubin (100-200%) were seen in both sexes at 40 and 140 ppm at 3
months and in males at 12 months.  Reductions in the mean total serum protein (8% at 6 months)
and serum albumin (9-15% at 3, 6 and 12 months) were seen in females at 40 and 140 ppm. No
treatment-related effects were seen in the urinalysis, fecal analysis, ophthalmological findings or
organ weights.  An increase in livers with generally dark red discoloration were observed
macroscopically in both sexes at 40 and 140 ppm (Table 15).  Moderate to marked cholestasis
was observed microscopically in all dogs of both sexes at 40 and 140 ppm.  Mild chronic
inflammation of the liver was also observed at 40 ppm (M: 1/4; F: 3/4) and 140 ppm (F: 1/4). 
Although the incidence of liver inflammation did not show a dose-response relationship or
correlate with the severity of cholestasis, the investigators considered it a treatment-related
effect.  The NOEL was established at 4 ppm (0.15 mg/kg/day) based on the elevated serum liver
enzymes and liver pathology.  This study was found acceptable by DPR toxicologists based on
FIFRA guidelines.
II.D.7.  Gavage-Monkey
Five to 7 rhesus monkeys/sex/dose were administered methidathion (purity not reported)
by oral gavage at 0, 0.25 and 1 mg/kg/day 6 days/week for 23 months (Coulston and Golberg,
1971).  There was no effect on clinical signs, body weights or food consumption, although there
was no apparent statistical analysis of any of the data in the study.  Hematological and clinical 
chemistry values were normal, except for an elevated alanine aminotransferase activity level in
one male in the 1 mg/kg/day group at 22 months.  A reduction in the mean plasma ChE activity
was seen in the 1 mg/kg/day group at 22 months (Table 16).  The mean RBC ChE activity was Methidathion RCD (Revision 1) February 2007
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Table 14. Cholinesterase Activity Relative to Controls in Dogs Fed Methidathion in the Diet for
1 Year
a
Tissue
Dose Level (ppm)
b
0.5 2 4 40 140
MALES
Serum,   3 mos. 103
c  95 99 102   101  
  6 mos. 90 76 83 87 79
12 mos. 102   92 100   103   99
RBC
d,   3 mos. 111   85 109   70     13**
  6 mos. 107   91 106   73     18**
12 mos. 116   95 113   80     23**
Brain
e, 12 mos. 89 109   97 95     73**
Brain
f, 12 mos. 98 103   105   99 84
FEMALES
Serum,   3 mos. 119   111   121   126   120  
  6 mos. 134   120   129   135   136  
12 mos. 121   109   130   129   138  
RBC,   3 mos. 105   114   131   86     17**
  6 mos. 118   126   137   96   24*
12 mos. 109   125   133   95     24**
Brain, 12 mos. 101   100   107   96   78*
Brain, 12 mos. 99 101   103   101   83
a Chang and Walberg, 1991.  This study met FIFRA guidelines.  ChE activity was measured in 4 dogs/sex/dose at each
time point.
b Dose level of 0, 0.5, 2, 4, 40 or 140 ppm = 0, 0.02, 0.07, 0.15, 1.33 or 4.51 mg/kg/day, respectively, in males and 0,
0.02, 0.07, 0.15, 1.39 or 4.90 mg/kg/day, respectively, in females 
c Mean activity relative to mean  control activity expressed as percentage
d RBC = Red Blood Cell
e ChE activity in the vermis of the cerebellulm
f ChE activity in the right hemisphere minus vermis
*,** Significantly different from controls by the Dunnett’s Test at p < 0.05 and 0.01, respectively.Methidathion RCD (Revision 1) February 2007
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Table 15. Dose-Related Effects on Serum Liver Enzyme Activity and Liver Pathology in Dogs
Fed Methidathion for One Year
a
Dose Level (ppm)
b
0 0.5 2 4 40 140
MALES
Alkaline Phosphatase
(U/L)
126
± 46 
122
± 101   
103
± 41 
  99
± 34 
 297*
± 38 
  371**
± 152    
Asp. Aminotransferase
 (U/L)
  23
 ± 3
  23
 ± 3
  21
 ± 2
  23
 ± 3
  29
 ± 7
  32*
± 4
Ala.  Aminotransferase
(U/L)
  15
 ± 4
  21
 ± 3
  21
 ± 4
   40
± 16
  134**
± 37  
  140**
± 70  
Sorbitol Dehydrogenase
(U/L)
    4
 ± 1
    6
 ± 1
    3
 ± 1
    6
 ± 3
    11**
± 3
    13**
± 5
Liver Discoloration   0/4
++ 0/4 0/4 0/4 1/4 2/4
Cholestasis    0/4
+++ 0/4 0/4 0/4  4/4*  4/4*
FEMALES
Alkaline Phosphatase
(U/L)
152
± 81 
133
± 66 
114
± 60 
190
± 40 
353
± 120   
 623*
± 467   
Asp. Aminotransferase
(U/L)
  24
 ± 2
  25
 ± 6
  21
 ± 3
  22
 ± 3
  28
 ± 6
   35*
± 7
Ala. Aminotransferase
(U/L)
  17
 ± 5
  15
 ± 1
  15
 ± 4
  26
 ± 7
  126**
± 42  
  134**
± 58  
Sorbitol Dehydrogenase
(U/L)
    5
 ± 1
    6
 ± 2
    6
 ± 1
    6
 ± 1
    13**
± 4
   10*
± 3
Liver Discoloration    0/4
+++ 0/4 0/4 0/4 2/4 3/4
Cholestasis    0/4
+++ 0/4 0/4 0/4  4/4*  4/4*
a Chang and Walberg, 1991.   This study met FIFRA guidelines.
b Dose level of 0, 0.5, 2, 4, 40 or 140 ppm = 0, 0.02, 0.07, 0.15, 1.33 or 4.51 mg/kg/day, respectively, in males and 0,
0.02, 0.07, 0.15, 1.39 or 4.90 mg/kg/day, respectively, in females 
*,** Significantly different from controls based on the Fisher’s exact test at p < 0.05 and 0.01, respectively.
++,+++ Significant trend based on the Cochran-Armitage trend test at p < 0.01 and 0.001, respectively.Methidathion RCD (Revision 1) February 2007
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Table 16. Cholinesterase Activity Relative to Controls in Monkeys Administered Methidathion
by Oral Gavage for 23 Months
a 
Tissue
Dose Level (mg/kg/day)
0.25 1.0
Plasma, 18 months 107
b 105   
22 months 84 39
RBC
c,   6 months 81 76
12 months 73 60
18 months 83 63
22 months 91 74
Brain, 12 months 112   98
22 months 101   108  
a Coulston and Golberg, 1971.  This study did not meet FIFRA guidelines since it predated them.  Plasma and RBC ChE
activity were measured in 4-8 monkeys (M&F combined)/dose at each time point.  Brain ChE activity was measured in 2-
9 monkeys (M&F combined)/dose at each time point.
b Mean activity relative to mean  control activity expressed as percentage.  There was no apparent statistical analysis of this
data. 
c RBC = Red Blood Cell
reduced at 1 mg/kg/day from 6 to 22 months.  There was no effect on brain ChE activity, or
gross and histopathological findings.  The NOEL was 0.25 mg/kg/day based on the reduction in 
plasma and RBC ChE activity.  The study had major deficiencies including insufficient number
of dose levels tested, lack of overt toxicity at the highest dose level, inadequate histopathological
examination and no individual data.
II.E.  GENOTOXICITY
Summary:  Nine gene mutation studies for methidathion (5 reverse-mutation assays with
Salmonella typhimurium, 1 reverse-mutation assay with Escherichia coli, and 3 host-mediated
assays) were negative.  Reverse mutation assays with S. typhimurium for 3 metabolites of
methidathion were also negative.   Positive responses were reported in a gene
conversion/forward mutation assay with Saccharomyces cerevisiae; however, this assay is
considered a poor predictor of gene mutation in mammalian systems.  None of the gene mutation
studies met FIFRA guidelines; however, the negative results were reproduced in the reverse-
mutation assays from several different laboratories over a range of doses with and without
metabolic activation, presenting consistent and compelling evidence of the lack of mutagenicity. 
An in vivo micronucleus assay in Chinese hamster and a dominant lethal assay in mice were
negative.  The dominant lethal assay met FIFRA guidelines, but that assay is considered
relatively insensitive.  There was an equivocal response in an in vivo sister chromatid exchangeMethidathion RCD (Revision 1) February 2007
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(SCE) assay with Chinese hamsters with an increase in SCEs at the mid-dose only and an
unequivocal positive response in an in vitro SCE assay with Chinese hamster cell line V79. 
Neither of these studies met FIFRA guidelines; however, even if these findings had been in
acceptable studies, the biological significance of SCEs has not been demonstrated.  A
chromosomal aberrations assay was not conducted for methidathion either in vitro or in vivo.  An
in vivo micronucleus assay for a metabolite of methidathion was negative.  Based on the limited
data, DPR concluded methidathion-induced chromosomal damage could not be ruled out.  Six
assays for DNA damage were available for methidathion, including 5 unscheduled DNA
synthesis (UDS) assays and 1 rec assay.  These studies were all negative.  Two of the UDS
assays met FIFRA guidelines; however, the UDS assay is not considered very sensitive.  Overall,
the evidence that methidathion is genotoxic is limited, but its potential to induce chromosomal
damage cannot be ruled out.
II.E.1.  Gene Mutation
Five reverse mutation assays for methidathion using Salmonella typhimurium strains
TA98, TA100, TA1535, TA1537, and TA1538 were submitted by the registrant.  All five assays
were negative, but none of the studies met FIFRA guidelines.  The results for one assay were
only presented in abstract form with no information about the levels tested, purity of test article
or number of replicates (Lippens et al., 1983).  Two assays were conducted using methidathion
(purity not stated) at 0, 25, 75, 225, 675 and 2025 μg/0.1 ml with and without metabolic
activation in triplicate (Arni, 1980a&b).  Both studies had major deficiencies including
inadequate positive controls, no individual plate data, and inadequate test article
characterization. Two other assays tested methidathion (99.95% purity in one study; purity not
reported in other) at 0, 10, 50, 100, 500, 1000 and 5000 μg/plate with and without metabolic
activation (Simon and Poole, 1977; Satou et al., 1979).  The study conducted by Simon and
Poole (1977) had several major deficiencies including questionable positive controls for two
strains, inadequate number of replicates and no individual plate data in the report.  The Satou et
al. (1979) study also had major deficiencies including no indication of the number of replicates,
no statistics, no individual plate data, inadequate test article characterization, and inadequate
positive controls for several strains.  There was no evidence of mutagenicity in a reverse
mutation assay using Escherichia coli  strain WP2 Hcr- where methidathion (99.95% purity) was
tested at 0, 10, 50, 100, 500, 1000 and 5000 μg/plate with and without activation (Satou et al.,
1979).  This study also had several deficiencies including no confirmatory assay, inadequate
number of replicates, and no individual plate data.  
Positive results were reported in a gene conversion/forward mutation assay where
Saccharomyces cerevisiae MP-1 were exposed to methidathion (93.4% purity) at 675, 1250,
2500, 5000 or 10,000 μg/ml (Arni and Muller, 1981).  It was not possible to assess the quality of
the study based on the limited information that was available.
No evidence of mutagenicity was found in several host-mediated assays.  In a study
conducted by Simmon and Poole (1977), 6-10 male Swiss Webster mice/dose were given
methidathion (purity not reported) by oral gavage either in a single dose at 0, 10, 20 or 40
mg/kg/day or in five daily doses at 0, 5, 10, or 20 mg/kg/day.  S. typhimurium strains TA1535
and 1538 were injected intraperitoneally at the time of dosing and then recovered from the
peritoneal cavity four hours later.  The study had several major deficiencies including noMethidathion RCD (Revision 1) February 2007
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evidence of actual exposure of bacteria to test material, no individual plate data, and insufficient
test article characterization.  In a study conducted by Arni (1980c), 6 male albino mice/dose
were administered methidathion (purity not reported) by oral gavage at 0, 5, 10, or 20
mg/kg/hour at 2 hours, 1 hour and immediately before injection of S. typhimurium strains TA98,
TA100 or TA1537 into the tail vein.  One hour later the animals were sacrificed and the
homogenized liver assayed for mutants.  This study also had major deficiencies including no
evidence for actual exposure of bacteria to test material, no positive controls, no testing with
TA1535, excessive mortality, no individual plate data and insufficient test article
characterization.  In a third study conducted by Strasser (1980), methidathion (purity not stated)
was administered to 4 DBA/Bom/SPF mice/dose at 0 or 15 mg/kg by oral gavage after
intraperitoneal injection of mouse lymphoma cells.  The cells were harvested from the peritoneal
cavity 3 days later.  This study had major deficiencies including no evidence of actual exposure
of cells to the test material, no positive controls, inadequate detail on cell viability or replicates,
and inadequate test article characterization.  
Reverse mutation assays using S. typhimurium for 3 metabolites of methidathion were all
negative.  The RH metabolite of methidathion, GS 12956 (purity not stated), was tested at 0, 10,
30, 90, 270 and 810 mg/0.1 ml with and without metabolic activation using strains TA98,
TA100, TA 1535 and TA1537 (Arni, 1980d).  The sulfoxide of methidathion, GS 28370 (purity
not stated), was tested at 0, 25, 225, 675,  and 2025 μg/0.1 ml with and without metabolic
activation using strains TA98, TA100, TA1535 and TA1537 (Arni, 1980e).  The sulfone of
methidathion, GS 28369 (purity not stated), was also tested at 0, 15, 30, 60, 120, 240, 480, and
960 μg/0.1 ml with and without metabolic activation with strains TA98 and TA100 (Arni,
1980f).
II.E.2.  Chromosome Mutation
No evidence of a dominant lethal effect was seen in a study conducted by Fritz (1976a) in
which 20 male NMRI mice/dose were administered methidathion (98.4% purity) by oral gavage
at 0, 15 or 45 mg/kg and subsequently mated over 6 weekly periods with 2 females per week. 
Signs of toxicity (deaths, ataxia, diarrhea, somnolence, and convulsions) were seen at the high
dose.  DPR toxicologists found this study acceptable based on FIFRA guidelines.  An increase in
sister chromatid exchanges was observed at 34 mg/kg in a study conducted by Hool (1980a) in
which 4 Chinese hamsters/sex/dose were given methidathion (93.4% purity) by oral gavage at 0,
17, 34 or 68 mg/kg and sacrificed 24 hours later.  The toxicological significance of this finding is
unclear since an increase in sister chromatid exchanges was not seen at 68 mg/kg.  This study
had an inadequate number of animals/cells scored.  In another study using the Chinese hamster
cell line V79, an increase in sister chromatid exchanges and cell cycle delay was seen at the
highest dose levels, 40 and 80 μg/ml (Chen et al., 1981).  This study was only available as a
published report and as a result it is unclear if the study met FIFRA guidelines.  No increase in
micronuclei formation were seen when methidathion (96.9% purity) was administered to 6
Chinese hamsters/sex/dose at 0, 17, 34 or 68 mg/kg twice 24 hours apart (Hool, 1980b).  The
hamsters were sacrificed 24 hours after the second dose.  The slides from only 3
animals/sex/dose were scored.  This study was also unacceptable to DPR toxicologists based on
an inadequate number of animals examined and no data supporting the sacrifice time.Methidathion RCD (Revision 1) February 2007
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Hool (1980c) also conducted a micronucleus assay with the methidathion RH metabolite,
GS 12956 (purity not stated), in which 3 Chinese hamsters/sex/dose were administered the test
compound by oral gavage at 0, 121, 242, or 484 mg/kg/day twice 24 hours apart.  The hamsters
were sacrificed 24 hours after the second dose.  No increase in micronuclei was found; however,
DPR toxicologists found the study unacceptable due to insufficient information.
II.E.3.  Other Genotoxic Effects
There was no evidence of genotoxicity in a rec assay in which Bacillus subtilis strains
H17 and M45 were exposed to methidathion (99.95% purity) at 0, 250, 500, 1250, 2500, 5000 or
10000 μg/well without activation (Satou et al., 1979).  This study was unacceptable to DPR
toxicologists based on no metabolic activation and insufficient information.  Two acceptable
autoradiographic DNA repair tests using primary hepatocytes from adult male Tif.FAIf(SPF) rats
were negative for methidathion.  In one test, cells were exposed to methidathion (97.2% purity)
at 0, 0.128, 0.64, 3.2, and 16 mg/ml for 5 hours (Hertner, 1988).  In the second test, cells were
exposed to methidathion (96.0% purity) at 0, 1.85, 5.56, 16.67, 50, 100, and 200 mg/ml for 16-
18 hours (Hertner, 1990).  An autoradiographic DNA repair test was also conducted using
human fibroblasts (Ciba-Geigy, 1982).  Cells were exposed to methidathion (purity not stated) at
0, 1.024, 5.12, 25.6 or 128 μg/ml for 5 hours.  No significant difference in the number of silver
grains per nucleus were seen.  This study had major deficiencies including no metabolic
activation, no background grain counts, inadequate protocol information, inadequate test
material information, and inadequate data summary.  Two unscheduled DNA synthesis (UDS)
assays were also negative for methidathion (purity not stated) using mouse and rat primary
hepatocytes (Tong, 1982a&b).  Hepatocytes were exposed at concentrations from 5 x 10
-7% to
1% (mouse) and 5 x 10
-9% to 1% (rat).  Both were unacceptable based on insufficient
information regarding the purity of the test article and number of cells examined.
Two in vivo studies were available in which liver DNA damage was evaluated in rats
exposed to pesticide mixtures containing methidathion.  In one study, the pesticide mixture
induced free radical DNA damage based on an increase in the levels of 8-OH-2-deoxyguanosine
in liver DNA at low doses, but not at high doses (Lodovici et al., 1994).  The investigators
suggested the lack of free radical damage at high doses was due to a depression of cellular
metabolism based on reductions in benzo(a)pyrene hydroxylase, N-demethylase activities,
glutathione peroxidase, glutathione reductase, glutathione S-transferase and thiol transferase
activities.  In a medium-term liver bioassay, a significant increase in placental glutathione S-
transferase (GST-P) positive foci was seen in the liver of rats fed a pesticide mixture containing
20 pesticides after an initial induction of hepatic carcinogenesis with diethylnitrosamine (Ito et
al., 1995).  It is unclear if the effects seen in these studies are due to a single chemical or
multiple chemicals acting either additively or synergistically.  Methidathion has been shown to
induce liver tumors in male mice, but not in rats.
II.F.  REPRODUCTIVE TOXICITY
Summary:  Four reproductive toxicity studies in rats were available for methidathion. 
More weight was given to the more recent two-generation study which met FIFRA guidelines;
however, the two pre-FIFRA studies and one pilot study did provide useful supplementalMethidathion RCD (Revision 1) February 2007
5 Estimated assuming for a rat that 1 ppm in the diet is equivalent to 0.05 mg/kg/day (FDA,
1959).
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information.  The purpose of the guideline reproductive toxicity studies is to provide information
on the effects of a chemical on the integrity and performance of the male and female
reproductive systems and preliminary information on pre- and postnatal developmental toxicity. 
The effects in the parental generations can also be used for identifying critical NOELs to
evaluate subchronic exposure to methidathion.  The effects observed in the parents included
tremors, alopecia, reductions in food consumption and body weights, reduced mating index and
poor maternal care.  Some of these maternal effects, like the tremors, were only observed in
lactating females and were probably due to their higher food consumption during this period. 
The effects observed in pups included tremors, signs of maternal neglect (cool to touch, starving,
weak or lethargic), reduced pup weights and reduced survival.  Pregnant females, fetuses and 
developing animals may be more susceptible to the toxicity of methidathion due to differences in
their pharmacokinetics during these life stages; however, there was also no information available
for methidathion regarding differences in metabolism or pharmacokinetics due to age or
pregnancy.  In the one acceptable study, the parental NOEL of 5 ppm (0.4 mg/kg/day) was based
on alopecia and tremors (females), reduced mating index, and poor maternal care.  The
reproductive NOEL in this study was also 5 ppm (0.4 mg/kg/day) based on reduced pup weights
and signs of maternal neglect.  There was no evidence of increased postnatal sensitivity since the
parental and reproductive NOELs were the same in the two studies where both were established. 
II.F.1.  Diet-Rat
Methidathion (purity not reported) was fed to 8 male and 4 female rats (strain not
reported) per dose in the diet at 0 or 50 ppm (mg/kg/day) for 3 months and then mated (FPCL,
1965).  The mean litter size was smaller in the treated group, but the difference was not
statistically significant.  The RBC ChE activity was reduced to about 20-40% of normal.  It was
unclear if plasma or brain ChE activity had been measured.  A NOEL could not be established
for this study based on this limited information.  This study was unacceptable to DPR
toxicologists since it did not follow standard FIFRA protocol for this type of study and the
information provided was only a summary of findings; however, it was conducted before the
FIFRA guidelines existed.
II.F.2.  Diet-Rat
A 40% wettable powder methidathion formulation was fed to 10 male and 20 female rats
in the diet at 0, 4 or 32 ppm (0, 0.2 or 1.6 mg/kg/day, respectively
5) for 3 generations (Woodard
Research, 1966b).  The parental generation was maintained on their assigned diet for 27-28
weeks during which time the females were mated twice to different males within their treatment
group.  A reduction in survival of pups at 32 ppm was the only effect reported.  A tentative
reproductive NOEL of 4 ppm (0.2 mg/kg/day) was identified based on the reduced survival of
pups.  A parental NOEL could not be identified based on insufficient information.  This study
had major deficiencies including no analysis of test article and diet, inadequate number of dose
levels tested, inadequate number of animals per dose level, no summary of clinical signs, bodyMethidathion RCD (Revision 1) February 2007
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weights, and food consumption, inadequate summary of reproductive parameters, inadequate
pathological examination, and no individual data.   
II.F.3.  Diet-Rat
As a pilot study, a one-generation, two-litter reproductive toxicity study was conducted
in which methidathion technical (purity not reported) was fed to 15 male and 30 female Charles
River CD® Sprague-Dawley rats/dose at 0, 5, 50 or 100 ppm (M: 0, 0.4, 4.4 or 9.1 mg/kg/day; F:
0, 0.5, 4.9 or 10.6 mg/kg/day, respectively) for 12 weeks prior to mating (Salamon, 1986).  After
weaning the first litter, the females were rested two weeks and then mated again.  No deaths or
clinical signs were observed during the premating period.  During F1a lactation, dams at 50 and
100 ppm exhibited muscle tremors possibly due to their higher compound intake (0, 0.6, 5.9 or
11.4 mg/kg/day) during this period.  In general, the tremors occurred early in the lactation period
at 100 ppm and later in the lactation period at 50 ppm.  There was a significant reduction in the
mean body weights at 100 ppm in both sexes during premating (M: 8-9%; F: 8-14%) and in
females during F1a gestation (11-12%) and lactation (10-18%).  The mean food consumption was
also significantly reduced at 100 ppm in males during premating week 2 and 3 (12%) and in
females during premating week 2 (12%) and F1a lactation weeks 1 and 2 (26-34%).  There was a
significant reduction in the mean food consumption in females at 50 ppm during lactation week 2
(20%).  The F1a mating index was significantly reduced at 100 ppm (25%).  A significant
reduction was seen in the percentage of F1a pups surviving to days 4, 7, 14 and 21 (20.8-42.6%)
at 100 ppm.  The mean body weights of F1a pups were significantly reduced at 50 ppm (5-25%)
and 100 ppm (11-41%).  Muscle tremors were also observed in 3 different litters of F1a pups at
100 ppm.  No structural anomalies or gross pathological lesions were seen in pups at the end of
lactation.  Based on the tremors and poor survival of pups at 100 ppm, this dose level was
reduced to 25 ppm after the F1a pups were weaned.  However, because the reproductive
performance of the animals at 25 ppm was significantly depressed during the F1b mating period
(14 of 22 mated with only 10 pregnancies; only 6 of the 10 delivered litters), the study was
terminated.  The parental NOEL appears to be 5 ppm (0.5 mg/kg/day) based on the tremors in
dams at 50 ppm during lactation.  The reproductive NOEL was also 5 ppm (0.5 mg/kg/day)
based on the reduced pup weights.  This study had several deficiencies, including no analysis of
test article, changes in dose levels and only one generation was exposed due to early termination
of study.
II.F.4.  Diet-Rat
In the main reproductive toxicity study, 15 male and 30 female CR1:CD BR rats/dose
were fed methidathion (95% purity) in the diet at 0, 5, 25 or 50 ppm (M: 0, 0.4, 2.2 or 4.3
mg/kg/day; F: 0, 0.5, 2.5 or 5.0 mg/kg/day, respectively) for two generations (Salamon, 1987). 
F1 males at 50 ppm had significantly reduced mean body weights (15%) during weeks 1-8 of the
premating period.  The mean body weights for the F0 and F1 dams were significantly reduced (8-
12%) at 50 ppm on lactation days 14 and 21.  The mean food consumption was reduced in F1
males at 25 ppm during week 2 (10%) and at 50 ppm during week 1-3 (11-14%).  Significant
reductions in the mean food consumption were also seen in F0 dams at 50 ppm on lactation day
14 (15%) and F1 dams at 50 ppm on lactation days 7 and 14 (19-28%).   Significant increases in
food consumption were also noted in F0 dams at 50 ppm on gestation day 7 (23%) and at 25 ppm
on gestation days 7 and 14 (14-19%) and lactation day 21 (42%).  Tremors were observed inMethidathion RCD (Revision 1) February 2007
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dams during lactation, usually the second or third week, in both generations at 25 and 50 ppm.  It
is not surprising that signs of maternal toxicity were only seen during lactation since feed intake
was higher during this period.  The average compound consumption of methidathion was nearly
doubled during lactation (0, 0.75, 3.84 and 7.16 mg/kg/day) compared to the average compound
consumption during premating and gestation (0, 0.45, 2.22 and 4.62 mg/kg/day, respectively). 
There was also evidence in the pups suggesting poor maternal care, including being cool to the
touch, starving, weak or lethargic.  It is also possible these effects are due to consumption of
methidathion in the milk by the pups rather than neglect by the dams.  However, without cross-
fostering studies it is uncertain if the effects are from maternal neglect or direct consumption of
the methidathion in the diet.  Other effects were seen in the pups including a significant
reduction in the mean number of viable pups per litter (F2: 30%) at 50 ppm, a significant
reduction in the mean pup body weights at 25 ppm (F1: 8-15%; F2: 3-20%) and 50 ppm (F1: 9-
30%; F2: 3-40%) during lactation, a significant reduction in survival of pups to day 21 at 50 ppm
(F2: 34%), and a reduction in the mean absolute brain (F2: 7-8%) and liver weights (F2: 23-27%)
at 50 ppm.  Adult males had reduced mating indices at 25 ppm (F1: 18.9%) and 50 ppm (F1:
22%).  Adult females had an increased incidence of alopecia at 25 and 50 ppm (F0) and reduced
mean relative liver weight (F1: 9%) at 50 ppm and reduced mean absolute and relative ovary
weights (F0&F1: 20-22%) at 50 ppm.  The parental NOEL was established at 5 ppm (0.4
mg/kg/day) based on a reduction in the mating index in males and alopecia, poor maternal care
and tremors in females.  The reproductive NOEL was also 5 ppm (0.4 mg/kg/day) based on
reduced pup weights and signs of maternal neglect in pups (cool to touch, starving, weak or
lethargic).  This study had some minor deviations from FIFRA guidelines (age at start of
treatment, number of animals/sex/dose, time intervals for body weights, males sacrificed at the
same time as females), but none invalidated the study.  Therefore, DPR toxicologists found this
study acceptable for fulfilling the data requirement for reproductive toxicity.
II.G.  DEVELOPMENTAL TOXICITY
Summary:  Five developmental toxicity studies were available for methidathion (3 rat
studies and 2 rabbit studies).  Although more weight was given to the studies that met FIFRA
guidelines, the 3 studies (2 rat and 1 rabbit) that did not meet FIFRA guidelines provided useful
supplemental information.  The purpose of the guideline developmental toxicity studies is to
provide general information regarding the effects of exposure of the pregnant test animals on the
developing organism.  The signs observed in pregnant females in the first few days of exposure
and most of the effects observed in the fetuses could be due to a single exposure and were
considered in selecting a critical NOEL for evaluating acute exposure to methidathion.  Some of
the maternal signs that were not observed until the latter part of gestation are probably the result
of repeated exposure and were considered in selecting a NOEL for evaluating subchronic
exposure to methidathion.  Systemic maternal effects included death, tremors, salivation,
lacrimation, convulsions, ataxia, labored or raspy respiration, exophthalmia, miosis,
chromodacryorrhea, crust around eyes, vaginal bleeding, unthriftiness, lethargy, stool alterations,
loss of righting reflex, reduced food consumption and body weights.  Pregnant females and
fetuses may be more susceptible to the toxicity of methidathion due to differences in their
pharmacokinetics during these life stages; however, there was also no information available for
methidathion regarding differences in metabolism or pharmacokinetics during development or
pregnancy.  The lowest maternal NOEL in an acceptable study was 1.0 mg/kg/day based on theMethidathion RCD (Revision 1) February 2007
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mortality, clinical signs, and a reduction in food consumption and body weights in pregnant rats. 
Fetal effects included reduced ossification of the sternabrae and reduced body weights. The
lowest developmental NOEL in an acceptable study was equal to or greater than 2.5 mg/kg/day,
the highest dose tested in rats.  There was no evidence of increased prenatal sensitivity in any of
these studies, based on the developmental NOEL being equal to or greater than the maternal
NOEL. 
II.G.1.  Gavage-Rat
Methidathion (technical, purity not reported) was administered by gavage in an aqueous
solution of 2% carboxymethylcellulose to 24, 28, 23 and 21 pregnant female Sprague-Dawley
rats at 0, 1, 2.5, and 5.0, respectively, on gestation days 6-15 (Fritz, 1976b).  Dams at 5.0
mg/kg/day had tremors after each dosing beginning on treatment day 4.   A reduction in food
intake and body weights were observed in dams at 2.5 and 5.0 mg/kg/day (no means or
individual data provided).  Incompletely ossified 5th sternabrae were observed at 5.0 mg/kg/day. 
The maternal NOEL was 1 mg/kg/day based on the reduction in body weights and food
consumption.  The developmental NOEL was 2.5 mg/kg/day based on the reduced ossification of
the sternabrae.  This study had major deficiencies including no analysis of test material or dosing
solution, no summary tables for body weights, food consumption, uterine weights, fetal sex, and
number of corpora lutea, no gross pathological examination of dams, and no individual data.
II.G.2.  Gavage-Rat
In a range-finding study, 24 pregnant female Crl:COBS CD (SD) BR rats/dose were
administered methidathion (technical, purity not reported) by oral gavage at 0 (vehicle = 3%
cornstarch with 0.5% Tween 80), 0.1, 1.0 or 7.5 mg/kg/day on gestation days 6-15 (Marcsinsin
et al., 1986).  Eighteen animals at 7.5 mg/kg/day died before the end of the study.  Numerous
clinical signs were seen at 7.5 mg/kg/day including ataxia, chromodacryorrhea, crust around
eyes, labored respiration, lacrimation, salivation, tremors, convulsions, vaginal bleeding and
unthriftiness.  The onset of most of these signs (except ataxia, crust around eyes, vaginal
bleeding and unthriftiness) was between gestation days 6 and 9 (treatment days 1 and 4) and,
therefore, these signs were considered acute effects.  Significant reductions in the mean food
consumption (18-70%) and body weights (15-23%) were seen in females at 7.5 mg/kg/day
during treatment.  There was no significant effect on reproductive parameters including the
number of corpora lutea, implantation sites, resorptions or dead fetuses.  A significant reduction
in the mean fetal weights was seen (M:18%; F: 19%).  No significant increase in gross (external)
malformations was observed in the fetuses.  The maternal NOEL for this study was established
at 1.0 mg/kg/day based on the mortalities, clinical signs and reduction in food consumption and
body weights.  The developmental NOEL was also 1.0 mg/kg/day based on the reduced fetal
body weights.  This study had several major deficiencies including no analysis of test article or
dosing material, and no microscopic examination of fetuses for skeletal or visceral
malformations.
II.G.3.  Gavage-Rat
Methidathion (95% purity) was administered by oral gavage to 25 pregnant female
Crl:COBS CD (SD) BR rats/dose at 0 (vehicle = 3% cornstarch with 0.5% Tween 80), 0.25, 1.0Methidathion RCD (Revision 1) February 2007
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or 2.5 mg/kg/day on gestation days 6-15 (Mainiero et al., 1987).  One animal at 2.5 mg/kg/day
died on gestation day 12.  Clinical signs were observed in dams at 2.5 mg/kg including lethargy,
tremors, salivation, lacrimation, exophthalmia, raspy respiration, vaginal bleeding, and
chromodacryorrhea.  The onset of some of these signs (lethargy, tremors, salivation and raspy
respiration) was between gestation days 6 and 9 (treatment days 1 and 4) and, therefore, the signs
were considered acute effects.  Significant reductions in the mean food consumption (9-16%)
and body weights (5%) were seen at 2.5 mg/kg/day.  There was no treatment-related effect on
pregnancy rate, number of corpora lutea, resorptions, or stillbirths, sex ratio, fetal weights or
fetal malformations (gross, visceral or skeletal).  The maternal NOEL was established at 1.0
mg/kg/day based on the mortality, clinical signs, and reduction in food consumption and body
weights.  The developmental NOEL was equal to or greater than 2.5 mg/kg/day, the highest dose
tested.  DPR toxicologists found this study acceptable based on FIFRA guidelines.  
II.G.4.  Gavage-Rabbit
In a range-finding study, 6 pregnant New Zealand White were administered methidathion
(purity not reported) by oral gavage at 0 (vehicle = 3% cornstarch solution with 0.5% Tween
80), 10, 30 and 50 mg/kg/day on gestation days 7-19 (Wallace, 1986).  All animals at 30 and 50
mg/kg/day died during the treatment period.  One doe died at 10 mg/kg/day on gestation day 15. 
Prior to dying, the females exhibited various signs including tremors, ataxia, salivation, miosis,
lethargy, stool alterations (decreased/no/soft stools), loss of righting reflex, rales and
convulsions.  The only clinical sign exhibited in females at 10 mg/kg/day was decreased or soft
stools.  There was insufficient information on the onset of any of these signs to determine if they
could be considered an acute effect.  The food consumption was unaffected in animals at 10
mg/kg/day, but their mean body weight gains were reduced (38%) compared to controls.  There
was no treatment related effect on reproductive parameters (pregnancy rate, number of corpora
lutea, implantations, resorptions or still births) or fetal weights.  The maternal NOEL was less
than 10 mg/kg/day based on the death, reduced body weight gains, and decreased or soft stools. 
The developmental NOEL could not be established since fetuses were not examined for
malformations (gross, visceral or skeletal).  This study had major deficiencies primarily due to it
being a dose range-finding study and, consequently, there was limited data collected and/or
reported.  
II.G.5.  Gavage-Rabbit
Methidathion (95% purity) was administered by oral gavage to 19 pregnant New Zealand
White rabbits/dose at 0 (vehicle = 3% cornstarch with 0.5% Tween 80), 2, 6 or 12 mg/kg/day on
gestation days 7 to 19 (Hummel et al., 1987).  One animal at 6 mg/kg/day died on day 17 after a
mis-dosing and another animal at 12 mg/kg/day was sacrificed after a back injury.  Three other
does (one each at 2, 6 and 12 mg/kg/day) were sacrificed early because they aborted (on
gestation days 20, 23 and 26, respectively).  Clinical signs were observed at 12 mg/kg/day
including ataxia, salivation, tremors, miosis, and blood in the cage pan.  The onset for all of the
neurological signs was gestation day 15 (exposure day 8) and for the blood in the cage pan was
gestation day 26 (post exposure).  These signs occurred after at least 8 consecutive daily doses
and, therefore, were not considered acute signs.  There were no treatment-related changes in the
maternal food consumption, maternal body weights, pregnancy rate, number of corpora lutea,
implantation sites or resorptions, sex ratio of fetuses, fetal body weights or fetal malformationsMethidathion RCD (Revision 1) February 2007
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(gross, visceral or skeletal).  The maternal NOEL was established at 6 mg/kg/day based on the
neurological signs.  The developmental NOEL was equal to or greater than 12 mg/kg/day, the
highest dose tested.  This study was acceptable based on FIFRA guidelines.
II.H.  NEUROTOXICITY
Summary:  Eight neurotoxicity studies were available for methidathion (5 acute studies
in hens, 2 acute studies in rats and a  90-day study in rats).  Although only 3 of these studies met
FIFRA guidelines, including 1 hen study, 1 acute study in rats, and the 90-day study in rats, the
other studies (4 pre-FIFRA hen studies and one pilot rat study) provided useful supplemental
information.  The purpose of the guideline neurotoxicity studies in hens was to evaluate the
potential of organophosphate (OP) chemicals to induce delayed neuropathy.  Design of these
studies is generally not useful for deriving a NOEL.  The hen is used instead of the rat for this
type of study since rats are less sensitive to OP-induced delayed neuropathy (OPIDN).  There
was no evidence of delayed neuropathy in any of the hen studies.  The purpose of the acute and
subchronic neurotoxicity studies in rats is as a screen for gross neurological functional deficits
and histopathological changes in the central and peripheral nervous system and are not intended
to be a complete evaluation of the neurotoxic potential of a chemical.  NOELs from these studies
were considered in selecting critical NOELs for evaluating acute and subchronic exposure to
methidathion.  In the acute and subchronic neurotoxicity studies in rats, signs of neurotoxicity
were observed in the functional observational battery, including changes in autonomic signs,
CNS signs, sensorimotor effects, impaired neuromuscular functions and reduced body
temperature.  A reduction in maze activity was also observed.  A reduction in ChE activity in
four different regions of the brain (cerebellum, cerebral cortex, hippocampus, and striatum) and
the spinal cord were seen.  The acute NOEL was less than 1 mg/kg based on reduced ChE
activity in the cerebral cortex of males (59% of controls) at the time of peak effect.  The
subchronic NOEL was 3 ppm (M: 0.182 mg/kg/day; F: 0.198 mg/kg/day) based on the reduced
ChE activity in RBCs (M: 74-81%: F: 56-75% of controls - wks 4-13), cerebral cortex (M: 74%
of controls - wks 2-4) and striatum (F: 63% of controls - wk 13).  
II.H.1.  Acute
II.H.1.a.  Gavage-Hen
Methidathion (technical, purity not reported) was administered by gavage in 2%
carboxymethylcellulose at 0 mg/kg to 10 hens (White Leghorn), 43.75 mg/kg to 15 hens, 87.5
mg/kg to 15 hens, 175 mg/kg to 30 hens and 350 mg/kg to 30 hens twice with a 21 day interval
between dosing (Ullman, no date).  Hens at 350 mg/kg were pretreated with atropine before
dosing.  Deaths occurred primarily at 175 and 350 mg/kg, but one death occurred at  both 43.75
and 87.5 mg/kg.  Clinical signs were seen at all treatment levels during the 42-day observation
period including ataxia, convulsions, curved position, and sedation.  There was no evidence of
delayed neuropathy when the spinal cord and peripheral nerve were examined microscopically. 
This study had several major deficiencies including no forced motor activity, no body weight
data, and no histopathological examination of the thoracic spinal cord or medulla oblongata.Methidathion RCD (Revision 1) February 2007
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II.H.1.b.  Gavage-Hen
Four hens (Rhode Island/Light Sussex and White Leghorn/Light Sussex hybrids) were
administered 4 weekly subcutaneous injections of methidathion (purity not reported) in glycerol
formal at 50 mg/kg (Geigy, 1964).  Signs of acute toxicity (no details provided) were seen, but
no evidence of delayed neurotoxicity (ataxia, paralysis, loss of weight) was observed.  This study
had numerous major deficiencies including inadequate description of methods, no analysis of test
article, inadequate number of animals, no dose justification, no positive or negative control
groups, no data summaries or individual data.
II.H.1.c.  Gavage-Hen
Four hens (strain not reported) were given four weekly subcutaneous injections of
methidathion (technical, purity not reported) in glycerol formal at 0 or 50 mg/kg (FPCL, 1965). 
No hens developed signs of delayed neuropathy during the 8 weeks of observation.  This study
had numerous major deficiencies including inadequate description of methods, no analysis of test
article, inadequate number of animals, no dose justification, no positive or negative control
groups, no data summaries or individual data.
II.H.1.d.  Gavage-Hen
Sixty production red breed hens were administered methidathion (96.5% purity) in corn
oil by gavage at 145 mg/kg twice with a 21-day interval between doses (Kuhn, 1989f).  The hens
were given atropine at 5, 20.5, 25.5 and 29 hours after dosing.  A negative control group
containing 10 hens received corn oil only.  A positive control group containing 8 hens was given
tri-O-tolyl phosphate (TOTP) at 500 mg/ml once.  Twenty-eight hens receiving methidathion
died, 22 after the first dose and 6 after the second dose.  Eight hens receiving methidathion
exhibited signs of unsteadiness after the first dose, but only one was persistent.  No signs of
delayed neurotoxicity were seen after the second dose.  Histopathological examination of the
nervous tissue did not reveal any lesions in hens receiving methidathion that were consistent
with organophosphate-induced delayed neuropathy.  All hens receiving TOTP exhibited ataxia
by day 16 and had some degree of degeneration and swelling of the axons of some portion of the
nervous tissue examined microscopically.  DPR toxicologists found this study acceptable based
on FIFRA guidelines.
II.H.1.e.  Diet-Hen
Methidathion in a 40% wettable powder was fed in the diet to 10 hens/dose at 0, 16, 52,
or 160 ppm (as active ingredient) for 45 days (Woodard Research, 1965).  Hens at 160 ppm had
reduced food consumption (no data provided).  Discolored livers were noted in all hens receiving
methidathion with a higher frequency at 160 ppm.  Two hens at 160 ppm had equivocal
histopathological lesion in the nerves (no details provided).  This study had major deficiencies
including  inadequate description of methods, no analysis of test article, no data summaries or
individual data.Methidathion RCD (Revision 1) February 2007
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II.H.1.f.  Gavage-Rat
In a range-finding study, 3 male Sprague-Dawley Crl:CD® BR rats/dose were
administered a single dose of methidathion (94.3% purity) by oral gavage at 0, 4, 8, 12, 16 or 20
mg/kg (Leahy, 1993).  Three females/dose were administered methidathion at 0, 4, 16, 20 (6
females) or 30 mg/kg.  An additional 5 males and 6 females were also administered methidathion
at 25 mg/kg and observed for mortality for 2 days.  Animals were evaluated in an abbreviated
functional observational battery (FOB) at 1, 2, 3, 4, 6, and 8 hours.  The effects seen included
cholinergic signs (lacrimation, salivation, diarrhea, tremors, ataxia, and muscle fasciculations),
central nervous system (CNS) signs, autonomic signs, neuromuscular signs, and disturbances in
equilibrium at $ 8 mg/kg in males and $ 16 mg/kg in females.  The onset of signs was as early as
1 hour after dosing.  Deaths occurred at $ 20 mg/kg in males and $ 25 mg/kg in females.  The
NOEL was 4 mg/kg in both sexes based on the effects seen in the FOB.  As a range finding
study, this study was not designed to meet FIFRA guidelines and, therefore, it had several
deficiencies including an inadequate number of animals per dose level, inadequate FOB and no
pathological examination of rats.
II.H.1.g.  Gavage-Rat
Methidathion (93.2%) was administered to 20 Crl:CD® Sprague-Dawley rats/sex/dose at
0, 1, 4, 8 and 16 mg/kg after an 18-hour fast (Chang and Richter, 1994).  The first 10
rat/sex/dose were subjected to a battery of tests to evaluate neurological function while the
remaining animals were divided into two satellite groups of 5 animals/sex/dose for
cholinesterase measurements at the time of peak effect (1.5 hours after dosing) and the study
termination (2 weeks).  A positive control group of 10 rats/sex was administered carbaryl at 30
mg/kg by gavage.  No deaths occurred; however, clinical signs (muscle fasciculations, pallor,
reduced activity, salivation and tremors) were observed at 8 and 16 mg/kg on the day of dosing. 
One female at 1 mg/kg also exhibited clinical signs, but was considered improperly dosed. 
There was a significant reduction in the mean cumulative body weight gain (15%) in males at 16
mg/kg.  The mean food consumption was also reduced at 16 mg/kg (M: 15%; F: 11%) the first
week after dosing.  Significant differences were observed in both sexes in the functional
observational battery (FOB) at 8 and/or 16 mg/kg (Table 17) at the time of peak effect (1.5 hours
after exposure).  These differences included changes in autonomic signs, CNS signs,
sensorimotor effects, impaired neuromuscular functions and reduced body temperature.  Some
CNS signs and impaired neuromuscular function were seen in females at 1 and 4 mg/kg, but the
incidence was not statistically significant.  There was a significant reduction in the mean total
session activity for both sexes in the figure-8 maze at 8 mg/kg (M: 62%; F: 63%) and 16 mg/kg
(M: 84%; F: 83%) at the time of peak effect.  There was also a significant reduction in the mean
activity for females at 4 mg/kg during the first 5 minutes of measurement which the investigators
considered treatment-related.
The mean serum ChE activity was reduced in males at 8 mg/kg and 16 mg/kg at the time
of peak effect, but had returned to control levels two weeks after dosing (Table 18).  Reductions
in the mean serum ChE activity between 71% and 77% of control activity was seen in the
females at all dose levels at the time of peak effect, but the reductions were not statistically
significant.  The mean RBC ChE activity was significantly reduced at 4, 8, and 16 mg/kg at the Methidathion RCD (Revision 1) February 2007
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Table 17. Neurological Effects in Rats Administered a Single Oral Dose of Methidathion
a
Functional Domain/
Observations
Dose Level (mg/kg)
MALES  FEMALES
0 1 4 81 6 014 8 1 6
Autonomic
  Respiration 0
b 0 0 2     7** 0 0 0     4**    10**
  L a c r i m a t i o n 0001 30001  3
  S a l i v a t i o n 0001 20000    4 *
CNS Excitability
  Tremors  (Home Cage)
(Open Field)
0
0
0
0
0
0
3
    7**
    7**
    7**
0
0
0
0
0
0
    6**
    7**
   10**
   10**
  Tonic Convulsions (Home Cage)
  Clonic Convulsions (Open Field)
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
 0
 3
  Ease of Handling (In Hand)
  Ease of Removal (From Cage)
0
0
0
0
0
0
0
0
3
0
0
0
0
1
0
1
1
1
 3
   5*
  Lowered Arousal 0 0 0 4     7** 0 1 0 3    10**
  Bizarre Behavior (Home Cage)
                              (Open Field)
0
0
0
0
0
0
  4*
    7**
    7**
    7**
0
0
1
1
1
2
  5*
    6**
   10**
   10**
CNS Activity
  Home Cage Posture 0002 40001  5
  Mean No. Rears/2 minutes  9   7 11       2**     2** 12   10   8     5**      1**
Sensorimotor
  Touch Response 0 0 0 0     4** 0 0 0 2      5**
  Pupil Response 0 0 1 2 1 0 0 1 0  3
  Tail Pinch Response 0 0 0 2 3 0 0 0 1      5**
Neuromuscular
  Ataxic Gait 0 0 0     8**     5** 0 2 1     8**    10**
  Abnormal Gait 0 0 0     8**     7** 1 2 2     7**    10**
  Righting Reflex 0 0 0     5**     6** 0 2 3 4      9**
  Hindlimb Extensor Strength 0 0 0 1 2 0 1 1 2      7**
  Hindlimb Position 0 0 0 2   4* 0 0 1 3      8**
  Hindlimb Splay (% Control) 100 105 112 118   125* 100 119 121 128 124
  Forelimb Grip Strength (% Control) 100   98   97     74*      37** 100   85   87      53**     21**
  Hindlimb Grip Strength (% Control) 100 115 101   95   78 100   93   95   81   70
Physiological
  Temperature (% Control) 100 100 100      96**     96** 100   99   99      94**     92**
a Chang and Richter, 1994.  This study met FIFRA guidelines.
b Behavioral effects observed at peak time to effect, 1.5 hours after dosing.   Ten animals/sex/dose at all doses except
at 16 mg/kg (8 males, 9 females).
*, **  Significantly different at p < 0.05 & 0.01, respectively, when compared to control based on Fisher’s exact test
(categorical or incidence data) or Dunnett’s test (quantitative or ranked data).Methidathion RCD (Revision 1) February 2007
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Table 18. Cholinesterase Activity Relative to Controls in Blood and Nervous Tissue of Rats
Administered a Single Dose of Methidathion by Oral Gavage
a
Tissue Time
Dose Level (mg/kg)
148 1 6
MALES
Serum 1.5 hrs 101
b   81      70**      59**
 2 wks 116 111 129 110
Red Blood Cell 1.5 hrs   97      42**      26**      16**
2 wks 102    65*   82   73
Cerebellum 1.5 hrs   88      47**      32**      22**
2 wks   97   98   93   84
Cerebral Cortex
 w/ Hippocampus
1.5 hrs     59**      32**      12**        6**
2 wks 129 130 104   95
Striatum 1.5 hrs 107      28**      16**        9**
2 wks 110 135   68   64
FEMALES
Serum 1.5 hrs   77   76   77   71
2 wks   92 101 112 108
Red Blood Cell 1.5 hrs   91      33**      18**      14**
2 wks   94   93   78   81
Cerebellum 1.5 hrs   87      39**      25**      17**
2 wks   95   95   92   91
Cerebral Cortex
 w/ Hippocampus
1.5 hrs   87      29**      11**        6**
2 wks   98 102   91   85
Striatum 1.5 hrs   92      27**        8**        5**
2 wks 233 117 187 140
a Chang and Richter, 1994.  This study met FIFRA guidelines.
b Percent of control activity.  Five different animals/sex/dose tested at each time point.
*, ** The mean activity was significantly different from controls by Dunnett’s test at p < 0.05 and 0.01, respectively.
time of peak effect.  Two weeks later, only the males at 4 mg/kg had a significant reduction in
RBC ChE activity.  ChE activity was measured in three different regions of the brain:
cerebellum, cerebral cortex with hippocampus, and striatum.  The mean ChE activity in the
cerebellum was significantly reduced at 4, 8, and 16 mg/kg.  Significant reductions in the mean
ChE activity in the cerebral cortex were seen at 1.5 hours after dosing at 1 (males only), 4, 8 and
16 mg/kg.  The mean ChE activity in the striatum was also significantly reduced at the time to
peak effect at 4, 8, and 16 mg/kg.  The mean ChE activity in all three brain regions had returnedMethidathion RCD (Revision 1) February 2007
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to control levels by two weeks, except for the striatum where reductions in the mean activity
were still present in males at 8 and 16 mg/kg.  However, the reductions in the ChE activity in the
striatum at 2 weeks were not statistically significant.  There is some uncertainty about the
toxicological significance of the ChE inhibition in the cerebral cortex of males at 1 mg/kg since
the females appear to be more sensitive to methidathion based on the higher incidence of effects
in the FOB and the more severe reduction in ChE activity in all three regions of the brain at
higher dose levels.  Furthermore, the cerebral cortex does not appear to be uniquely sensitive to
ChE inhibition when compared to the striatum at 4 mg/kg and higher.  It is also unusual to see
significant brain ChE inhibition without either serum or RBC ChE inhibition.  However, the
reduction in cortex ChE activity at 1 mg/kg does not appear to be a statistical aberration based on
similar reduction in ChE activity in this brain region of males at 10 ppm (0.6 mg/kg/day) in a 90-
day neurotoxicity study (Chow and Turnier, 1995).  Therefore, DPR toxicologists made a health
protective assumption that the ChE inhibition in the cerebral cortex of males at 1 mg/kg was of
toxicological significance.  No treatment-related gross or histopathological lesions were found. 
The study LOEL was 1 mg/kg/day based on the reduced ChE activity (59% of controls) in the
cerebral cortex of males at 1.5 hours after exposure and, therefore, the NOEL was less than 1
mg/kg/day.  DPR toxicologists found this study acceptable based on FIFRA guidelines.
II.H.2.  Subchronic
II.H.2.a.  Diet-Rat
Groups of 30 Crl:CD® Sprague-Dawley rats/sex/dose were fed methidathion (94.9%
purity) at 0, 3, 10, 30 or 100 ppm (M: 0, 0.182, 0.608, 1.86 or 6.36 mg/kg/day; F: 0, 0.198,
0.659, 2.01 or 7.19 mg/kg/day, respectively) for 90 days (Chow and Turnier, 1995).  The first 10
rats/sex/dose were subjected to a battery of tests to evaluate neurological function while the
remaining animals served as four satellite groups of 5 rats/sex/dose for cholinesterase
measurements at weeks 2, 4, 8 and 13.  Ten additional rats/sex were administered acrylamide at
16 mg/kg by oral gavage as a positive control group.  Two males at 10 ppm and 1 male at 30
ppm died during the study; however, the investigators did not consider any of these deaths to be
treatment-related.  Treatment-related clinical signs were seen in females at 100 ppm, including
infrequent stools, transient tremors, and chromorhinorrhea.  Females at 100 ppm had a dramatic
reduction in body weight gains during the first two weeks of the study (67% and 36%,
respectively) which resulted in the mean cumulative body weight gain to be significantly
reduced until the near end of the study (16% at week 12).  There was no significant reduction in
the food consumption in females to account for the dramatic reduction in body weights during
the first two weeks.  The only treatment-related effects seen in the FOB were in females at 100
ppm.  These effects included neuromuscular effects (abnormal gait and reduced forelimb and
hindlimb grip strength), CNS signs (tremors, stereotypy, bizarre behavior), and sensorimotor
effects (increased response to touch, sound and tail pinch).  There was no significant difference
in the figure-8 maze activity in either sex at any dose level.  
The mean serum ChE activity was significantly reduced at 30 (females only) and 100
ppm (Tables 19 and 20).  Significant reductions in the mean RBC ChE activity were seen at 10,
30, and 100 ppm.  ChE activity was measured in the spinal cord and four regions of the brain:
cerebellum, cerebral cortex, striatum, and hippocampus.  The mean ChE activity in the
cerebellum was significantly reduced at 30 and 100 ppm.  In the cerebral cortex, significant Methidathion RCD (Revision 1) February 2007
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Table 19. Cholinesterase Activity Relative to Controls in Blood and Nervous Tissue of Male
Rats Fed Methidathion in the Diet for 90 Days
a
Tissue Time
Dose Level (ppm)
3 10 30 100
Serum 2 wks  89
b 76 84   65*
4 wks 94 105   95 66
8  w k s 9 27 99 57 0
 13 wks 92 90 106     68*
Red Blood Cell 2 wks 99 86    66**    19**
4 wks  93    81*    40**    10**
8 wks 85    74**    37**    17**
13 wks 89   80*    41**    12**
Cerebellum 2 wks 93 93 90    58**
4 wks 96 96    87**    47**
8 wks 102   100   88    49**
13 wks 99 86 86    48**
Cerebral Cortex 2 wks 89   74* 78    32**
4 wks 86    74**    56**    15**
8 wks 115   74 66    23**
13 wks 81 75   59*    19**
Striatum 2 wks 104   113   91    35**
4 wks 89 98 84    16**
8 wks 114   90    61**    17**
13 wks 93 90    59**    13**
Hippocampus 2 wks 97 101   108      41**
4 wks 96 97    81**    23**
8 wks 89 97    68**    21**
13 wks 105   96    76**    26**
Spinal Cord 2 wks 103   90 88    48**
4 wks 123   116   98    36**
8 wks 104   94 80    35**
13 wks 86 87   77*    23**
a Chow and Turnier, 1995.  This study met FIFRA guidelines.
b  Dose level of 0, 3, 10, 30 or 100 ppm = 0, 0.182, 0.608, 1.86 or 6.36 mg/kg/day, respectively 
c Percent of control activity.  Five different animals/sex/dose tested at each time point.
*, ** The mean activity was significantly different from controls by Dunnett’s test at p < 0.05 and 0.01, respectively.Methidathion RCD (Revision 1) February 2007
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Table 20. Cholinesterase Activity Relative to Controls in Blood and Nervous Tissue of Female
Rats Fed Methidathion in the Diet for 90 Days
a
Tissue Time
Dose Level (ppm)
b
3 10 30 100
Serum 2 wks 138*
c 103   136* 77
4 wks 87 75    59**    44**
8 wks 99 141   87 71
 13 wks 76 93 91  55*
Red Blood Cell 2 wks 95 92    54**    15**
4 wks 87    75**    24**      9**
8 wks 106      56**    20**    14**
13 wks 98    68**    28**      9**
Cerebellum 2 wks 98 94    79**    41**
4 wks 103   100      68**    34**
8 wks 102   82 80    20**
13 wks 92 81    64**    32**
Cerebral Cortex 2 wks 97 99    60**    18**
4 wks 88 86    41**    11**
8 wks 104   102      37**    11**
13 wks 95 85    34**      8**
Striatum 2 wks 92 91    56**      9**
4 wks 105   96    34**      6**
8 wks 100   88    31**      3**
13 wks 95    63**    34**      4**
Hippocampus 2 wks 97 89    60**    17**
4 wks 105   97    71**    13**
8 wks 102   83    32**      7**
13 wks 103      76**    44**      9**
Spinal Cord 2 wks 102   103      72**    30**
4 wks 116   93    52**    19**
8 wks 102   86    47**    18**
13 wks 108   99   64**     17**
a Chow and Turnier, 1995.  This study met FIFRA guidelines.
b Dose Level of 0, 3, 10, 30 or 100 ppm =  0, 0.198, 0.659, 2.01 or 7.19 mg/kg/day, respectively
c Percent of control activity.  Five different animals/sex/dose tested at each time point.
*, ** The mean activity was significantly different from controls by Dunnett’s test at p < 0.05 and 0.01, respectively.Methidathion RCD (Revision 1) February 2007
65
reductions in the mean ChE activity were observed at 10 (males only), 30 and 100 ppm.  There
was some uncertainty about the toxicological significance of the reduced ChE activity in the
cerebral cortex of males at 10 ppm because females had more pronounced inhibition of ChE in
this region at higher doses.  Furthermore, males did not exhibit any abnormal behavior in the
FOB or maze even at 100 ppm.  However, the cortex ChE activity in males at 10 ppm was
consistently reduced to about 75% of control activity throughout the study (although it was not
always statistically significant).  Therefore, DPR toxicologists made the health protective
assumption that the ChE inhibition in males at 10 ppm was of toxicological significance.  The
mean ChE activity in the striatum was reduced at 10 (females only), 30, and 100 ppm. 
Significant reductions in the mean ChE activity were seen in the hippocampus at 30 and 100
ppm.  The mean ChE activity in the spinal cord was also significantly reduced at 30 and 100
ppm.  No treatment-related gross or histopathological lesions were found.  The NOEL for this
study was established at 3 ppm (M: 0.182 mg/kg/day; F: 0.198 mg/kg/day) based on the reduced
ChE activity in RBCs (M: 74-81%; F: 56-75% of controls - wks 4-13), cerebral cortex (M: 74%
of controls - wks 2-4), striatum (F: 63% of controls - wk 13), and hippocampus (F: 76% of
controls - wk 13).  DPR toxicologists found this study acceptable based on FIFRA guidelines.Methidathion RCD (Revision 1) February 2007
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III.     RISK ASSESSMENT
III.A. HAZARD IDENTIFICATION
III.A.1.  Acute Toxicity
The NOELs and LOELs observed in the acute studies for methidathion are summarized
in Table 21.  The studies included in the table were all studies that have sufficient information to
establish an acute NOEL or LOEL, regardless of whether they met FIFRA guidelines.  This
included LD50/LC50 studies, mechanistic studies, acute neurotoxicity studies, and developmental
toxicity studies.  Table 21 also includes the acute effects that were observed at the LOEL.  With
acute, subchronic and chronic exposure, the effects that are generally considered adverse include
clinical signs, reductions in body weight and food consumption greater than 10%, and increases
in gross and histopathological lesions.  Minimal changes in clinical chemistry and hematology
values and organ weights without accompanying functional or structural changes are generally
not considered adverse.  The effects observed in the LD50/LC50 studies included dizziness, ataxia,
irregular and increased respiration, dyspnea, fasciculations, trembling, salivation, exophthalmos,
and death.  There was insufficient information available from the LD50/LC50 studies to establish
NOELs for these effects. 
In general, DPR considers brain ChE inhibition to be indicative of overt toxicity since it
is one of the primary functional target sites and more subtle central neurological signs, such as
memory and learning losses, may not be easily detected in animals unless they are specifically
tested for these effects.  The toxicological significance of plasma and RBC ChE inhibition is less
certain because the physiological function of ChEs in blood have not been clearly established,
although several possible physiological functions have been proposed.  Plasma ChE, or more
specifically butyrylcholinesterase (BuChE), may be involved in the binding/metabolism of
certain drugs, such as succinylcholine, which suggests that its inhibition may compromise an
organism’s ability to defend against subsequent toxic insults (Lockridge and Masson, 2000). 
BuChE is also the predominant form of ChE in the developing nervous system of birds and
mammals (Brimijoin and Koenigsberger, 1999).  Other evidence suggests that BuChE may also
play a role in the co-regulation of ACh levels in the adult nervous system including 1) substrate
inhibition of acetylcholinesterase (AChE) at high ACh concentrations, 2) the survival of AChE
knockout mice, and 3) the increase in BuChE levels with Alzheimer’s disease as AChE levels
decrease (Giacobini, 2003; Li et al., 2000; Ballard and Perry, 2003).  Due to the expression of
AChE in several types of hematopoietic cell lines, it has been proposed that circulating AChE
may be important in erythropoiesis (Grisaru et al. 1999).   U.S. EPA does not consider plasma or
RBC ChE inhibition an adverse effect in itself, but does use RBC ChE inhibition as a surrogate
for peripheral ChE inhibition (U.S. EPA, 2000a).  The Joint Meeting on Pesticide Residues of
the FAO/WHO concluded that RBC ChE activity should only be used as a surrogate for
peripheral ChE activity at the time of peak effect with acute exposure (JMPR, 1999) since RBCs
lack the ability to synthesize new AChE (Brimijoin, 1992).  Consequently, the recovery of RBC
ChE activity is much slower than in neurological and neuromuscular tissue because it is
dependent on the replacement of RBCs.  DPR is reevaluating the use of ChE inhibition data in its
risk assessments.  In anticipation of changes in the use of these endpoints in the risk assessments,
NOELs for blood and brain inhibition were identified in this document based on statistical
significance.  Methidathion RCD (Revision 1) February 2007
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Table 21. Acute Effects of Methidathion and Their Respective NOELs and LOELs
Species Exposure Effect
NOEL LOEL
Ref.
a
(mg/kg/day)
Oral
Rat
b Single, gavage 9 ChE
c activity in the
 cerebral cortex (M: 59%)
d
--- 1.0   1*
Rat Single, gavage 8MDA
e, 9antioxidant enzymes
 in erythrocytes
--- 8.0 2
Rat Single, gavage 8TBARS
f & liver enzymes in
 serum
--- 8.0 3
Rat Single, gavage Histopathological lesions in
 liver
--- 8.0 4
Rat
g 9 Days, gavage Maternal: Tremors
 (onset day 4)
Fetal: 9Ossification
2.5
2.5
5.0
5.0
5
Rat
g 9 Days, gavage Maternal: Tremors, salivation,
 lacrimation, convulsions,
 labored respiration,
 chromodacryorrhea 
 (onset days 1-4)
Fetal: 9Birth weight
1.0
1.0
7.5
7.5
6
Rat
g 9 Days, gavage Maternal: Lethargy, tremors,
 salivation, raspy respiration
 (onset days 1-4)
1.0 2.5 7*
Rat
b 14 Days, diet 9 ChE activity in cerebral
cortex (M: 74%)
0.18 0.61 8*
a References: 1. Chang and Richter, 1994; 2. Altuntas et al., 2002a; 3. Altuntas et al., 2002b; 4. Gokalp et al., 2003; 5. Fritz,
1976b; 6. Marcsinsin et al. 1986; 7. Mainiero et al., 1987; 8. Chow and Turnier, 1995.
b Neurotoxicity study
c ChE = Cholinesterase
d Percent of control activity
e MDA = malondialdehyde, a biomarker of membrane lipid peroxidation
f TBARS - thiobarbituric acid reactive substances, a endproduct of lipid peroxidation
g Developmental toxicity study: All fetal effects were considered acute effects; however, only maternal effects observed
within the first few days of exposure were considered acute exposure.
* Acceptable study based on FIFRA guidelines
In two mechanistic studies, evidence of lipid peroxidation was observed in rats after a
single oral dose at 8 mg/kg, including increased malondialdehyde (MDA) levels and reduced
antioxidant enzyme levels (superoxide dismutase, glutathione peroxidase and catalase) in
erythrocytes and increased thiobarbituric acid reactive substances (TBARS) in serum (Altuntas
et al., 2002a&b).  The increase serum TBARS were also associated with an increase in liver
enzymes (alanine aminotransferase, alkaline phosphatase, γ-glutamyltransferase, and lactate
dehydrogenase) in the serum which were indicative of hepatotoxicity (Altuntas et al., 2002b).  In
a subsequent study from the same research group, they found an increase in histopathologicalMethidathion RCD (Revision 1) February 2007
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lesions in the liver (mononuclear cells at parenchymal tissue, sinusoidal dilatation, focal necrotic
areas, granular degeneration and picnotic nuclei in hepatocytes) in rats after a single oral dose at
8 mg/kg (Gokalp et al., 2003).  A NOEL was not established in any of these studies since only
one dose level was tested.
Some effects observed in the developmental toxicity studies were considered acute
including maternal signs observed within the first few days of exposure and any fetal effects
assuming they were the result of a single exposure.  Cholinergic signs (tremors, salivation,
lacrimation, labored or raspy respiration, convulsions) were seen in dams in several rat
developmental toxicity studies during the first few days of treatment.  The NOELs in these
studies ranged from 1 to 2.5 mg/kg/day.  A NOEL of 1 mg/kg/day was established in an
acceptable study conducted by Mainiero et al. (1986) where lethargy, tremors, salivation, and
raspy respiration were observed in pregnant rats at 2.5 mg/kg/day on days 1 to 4 of treatment. 
Fetal effects were also observed in two of these developmental toxicity studies in rats, including
reduced ossification and reduced body weights (Fritz, 1976b; Marcsinsin et al. 1986).  The
NOELs for the fetal effects were same as the maternal NOELs, 1 to 2.5 mg/kg/day.  The onset of
the neurological signs in the one rabbit developmental toxicity study which had sufficient
information to determine this was after at least 8 consecutive daily doses and, therefore, was
considered a subacute or subchronic effect rather than an acute effect (Hummel et al., 1987). 
However, even if it had been considered an acute effect, the NOEL for these cholinergic signs in
rabbits was higher (6 mg/kg/day) than the NOELs for similar signs in rats.  No fetal effects were
observed in the rabbit developmental toxicity studies.
 In an acute neurotoxicity study in rats, treatment-related differences in clinical signs
(muscle fasciculations, pallor, reduced activity, salivation and tremors), the functional
observational battery (FOB) parameters and figure-8 maze activity were seen in both sexes at 8
and 16 mg/kg at the time of peak effect (Chang and Richter, 1994).  The effects seen in the FOB
included autonomic signs (impaired respiration, lacrimation, salivation), CNS signs (tremors,
reduced arousal, decreased activity, convulsions, muscle fasciculations, repeated opening and
closing of mouth), sensorimotor effects (reduced touch and tail pinch responses), impaired
neuromuscular function (ataxic and/or abnormal gait, impaired righting reflex, reduced hind limb
extensor strength, reduced forelimb and hindlimb grip strength) and reduced body temperature. 
Some signs indicative of CNS excitability and impaired neuromuscular function were seen in
females at 1 and 4 mg/kg, but the incidence was not statistically significant.  The toxicological
significance of the low incidence of these signs at these lower dose levels is uncertain given that
there was no significant ChE inhibition in the plasma, RBCs or brain of females at 1 mg/kg. 
Furthermore, the incidence of these signs were not significantly greater at 4 mg/kg where there
was a marked reduction in brain and RBC ChE activity (25-40% of control activity).   There was
a significant reduction in the mean ChE activity in the cerebral cortex of males (59% of controls)
at 1 mg/kg at 1.5 hours after dosing even though there were no neurological signs observed in
males at 1 or 4 mg/kg (except one male at 4 mg/kg with impaired pupil response).   The
toxicological significance of the ChE inhibition in the cortex of males at 1 mg/kg is uncertain for
several reasons.  First, the females appear to be more sensitive to methidathion based on the ChE
activity in all three regions of the brain at higher dose levels and the higher incidence of effects
seen in the FOB.  Second, the cerebral cortex does not appear to be uniquely sensitive to ChE
inhibition when compared to the striatum at 4 mg/kg and higher dose levels.  Third, it is unusual Methidathion RCD (Revision 1) February 2007
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to see significant brain ChE inhibition without either significant plasma or RBC ChE inhibition.
However, the reduction in cortex ChE activity in males at 1 mg/kg does not appear to be a
statistical aberration since a similar reduction in cortex ChE activity was seen in males at 10 ppm
(0.61 mg/kg/day) at 2 weeks in an acceptable 90-day neurotoxicity study for methidathion
(Chow and Turnier, 1995).  Unlike the acute neurotoxicity study, a NOEL was observed for this
endpoint at 2 weeks in the 90-day neurotoxicity study.  It was assumed the NOEL with a single
exposure would be equal to or greater than the NOEL after 2 weeks of repeated daily exposure. 
Therefore, the critical NOEL selected for evaluating acute dietary, drinking water, occupational
and ambient air exposure to methidathion was 3 ppm (0.18 mg/kg/day) based on significantly
reduced ChE activity in the cortex of males that was observed after 2 weeks in the 90-day
neurotoxicity study.  The use of the 2-week NOEL as a surrogate for the acute NOEL is
supported by the benchmark dose analysis which showed that the dose response was the same for
the ChE inhibition in cortex of males at 1.5 hrs in the acute study and at 2 weeks in the 90-day 
(see the Risk Appraisal section of this document for a detailed discussion).  The 2-week NOEL
of 0.18 mg/kg/day corresponded to the BMDL at 15%.
The methidathion oxon is the presumed active metabolite for the neurological effects,
although the pharmacokinetics studies suggest that the oxidative desulfuration to the oxon is a
minor metabolic pathway.  Typically, the oxon is more toxic than the parent compound for
organophosphorothioates.  However, there were no acute toxicity studies for the oxon, not even
an LD50 study, to derive a toxicity equivalency factor for the oxon.  The registrant has cited the
conclusion by U.S. EPA that the oxon was only a minor metabolite whose toxicity was
accounted for in the toxicity studies for the parent as the reason why they never conducted any
toxicity studies for oxon (U.S. EPA, 1995).  In the 2006 update of the cumulative risk
assessment for OPs, U.S. EPA became concerned about the contribution of methidaoxon to the
drinking water cumulative risk assuming it was 10X or 100X as toxic as methidathion. 
Consequently, they have requested the registrant submit toxicity data for the oxon.  In the
absence of these data, DPR has assumed the acute toxicity of the oxon was equivalent to the
parent compound.  However, theoretical estimates of the risks from drinking water and air
exposure have been calculated in the Risk Appraisal section of this document assuming the oxon
was 10X or 100X as toxic as the parent.  This exercise was not conducted for dietary and
occupational exposure since the oxon was not included in these exposure estimates for different
reasons.
III.A.2. Subchronic Toxicity
The NOELs and LOELs observed in laboratory animals after subacute (< 28 days) or
subchronic (3 - 6 months) exposure to methidathion are summarized in Table 22.  The studies
included in the table were all studies with subacute or subchronic exposure that have sufficient
information to establish a subchronic NOEL or LOEL, regardless of whether they met FIFRA
guidelines.  These include standard oral and dermal subchronic toxicity studies, subchronic
neurotoxicity studies, developmental and reproductive toxicity studies, and mechanistic studies. 
Table 22 also includes the effects that are observed at the LOEL.  Clinical signs observed in oral
and dermal subchronic toxicity studies of varying length included lethargy, anorexia, labored or
rapid breathing, hunched posture, ataxia, tremors, soft feces, and low body temperature. 
Reductions in body weights and food consumption were also seen.  Pathological findings Methidathion RCD (Revision 1) February 2007
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Table 22. Subacute/Subchronic Effects of Methidathion and Their Respective NOELs and
LOELs
Species Exposure Effect
NOEL LOEL
Ref.
a
(mg/kg/day) 
Oral
Rat
b 9 days, gavage Maternal: 9 Body weights & food
 consumption
    1.0     2.5     1
Rat
b 9 days, gavage Maternal: Death, cholinergic
 signs, 9 body weights & food
 consumption
    1.0     7.5     2
Rat
b 9 days, gavage Maternal: Death, cholinergic
 signs, 9 body weights & food
 consumption
    1.0     2.5     3*
Rabbit
b 13 days, gavage Maternal: Decreased or soft stools,
 9 body weights
   -----   10.0     4
Rabbit
b 13 days, gavage Maternal: Cholinergic signs     6.0   12.0     5*
Mouse 28 days, diet 9 ChE
c activity in RBCs (M&F:
 57%
d) & brain (M: 49%; F: 65%)
    4.2    18.0     6
Rat 4 weeks, diet 9 RBC ChE activity (M&F: 62%-
 77%)
    0.25    0.83     7
Rat 4 weeks, diet Unspecified cholinergic signs,
 fatty deposits in liver
    2.5     5.0     7
Rat 4 week, 5 days/wk,
 gavage
8 Cardiac TnI
e in serum, 8 MDA
f
 & histopathological lesions in
 the heart
-----     5.0     8
Rat 4 week, 5 days/wk,
 gavage
8 MDA & histopathological
 lesions in aorta, 9 serum ChE
 activity (60%) 
-----     5.0     9
Rat 4 week, 5 days/wk,
gavage
8 MDA & histopathological
 lesions in kidneys, 9 serum ChE
 activity (67%)
-----     5.0   10
Rat
g 2-gen., 10 wks
 premating, diet
Parental: Reduced mating
 index (M), alopecia (F), poor
 maternal care, tremor (F)
Fetal: Reduced pup weights
 and signs of maternal neglect
    0.4
    0.4
    2.2
    2.2
  11*
Rat
h 90-days, diet 9 ChE activity in RBCs (M: 74-
 81%; F: 56-75%), cerebral
 cortex (M: 74%), striatum
 (F: 63%), and hippocampus
 ( F: 76%)
    0.18     0.61   12*
Rat 22 weeks, diet 9 ChE activity (70-75%, unclear if
 blood or brain)
    0.2     0.8     7
Rat 6 months, diet 9 RBC ChE activity
 (% not reported)
    0.2     1.1      7Methidathion RCD (Revision 1) February 2007
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Table 22 (cont.). Subacute/Subchronic Effects of Methidathion and Their Respective NOELs
and LOELs
Dermal
Rat 3 hrs/day, 5
 days/wk, 4 wks
None   12.0    -----     7
Rabbit 6 hrs/day, 22 days None   20.0    -----    13
Rabbit 6 hrs/day, 21 days Death, lesions in stomach and heart    -----     1.0   14
a References: 1. Fritz, 1976b; 2. Marcsinsin et al., 1986; 3. Mainiero et al., 1987; 4. Wallace, 1986; 5. Hummel, 1987; 6.
Albanese, 1976; 7. Geigy, 1964; 8. Yavuz et al., 2004a; 9. Yavuz et al., 2004b; 10. Sulak et al., 2005; 11. Salamon,
1987; 12. Chow and Turnier, 1995; 13. Folinusz et al., 1986; 14. Osherhoff, 1987b.
b Developmental toxicity study: Only maternal effects observed after the first few days were included.
c ChE = Cholinesterase
d Percent of control activity
e TnI = troponin I, a biomarker of myocardial damage
f MDA = malondialdehyde, a biomarker of membrane lipid peroxidation
g Reproductive toxicity study
h Neurotoxicity study
* Acceptable study based on FIFRA guidelines
included changes in hematological values suggesting anemia, changes in serum enzyme levels
suggesting liver toxicity, reduced brain ChE activity, increased levels of a biomarker for lipid
peroxidation in the heart, aorta and kidney, and histopathological lesions in the liver, gallbladder,
stomach, kidney, aorta and heart.  The lowest LOEL in a standard subchronic toxicity study was
1 mg/kg/day based on deaths and histological lesions in the stomach and heart in rabbits after a
21-day dermal exposure (Osherhoff, 1987).  This study had one major deficiency in that there
was an incomplete histopathological examination of the control and high-dose animals. 
In addition to the standard subchronic toxicity studies, Table 22 includes several
developmental toxicity studies where maternal effects were observed after subacute exposure for
1 to 2 weeks.  Maternal signs observed after subacute exposure to methidathion included
tremors, ataxia, salivation, lacrimation and other ocular discharge, exophthalmia, miosis, vaginal
bleeding and unthriftiness.  Reductions in food consumption and maternal body weights were
also seen.  The lowest maternal NOEL in an acceptable developmental toxicity study was 1
mg/kg/day based on death, lethargy, tremors, salivation, lacrimation, exophthalmia, raspy
respiration, vaginal bleeding, chromodacryorrhea, and reduced food consumption and body
weights in pregnant rats (Mainiero et al., 1987).  This study met FIFRA guidelines.
Any effects observed in reproductive toxicity studies were also included in Table 22. 
The effects observed in the parental generations of the reproductive toxicity studies for
methidathion included tremors, alopecia, reductions in food consumption and body weights,
reduced mating index and poor maternal care.  The effects observed in pups included tremors,
signs of maternal neglect (cool to touch, starving, weak or lethargic), reduced pup weights and
reduced survival.  In the one acceptable study, the parental NOEL of 5 ppm (0.4 mg/kg/day) was
based on alopecia and tremors (females), reduced mating index, and poor maternal care
(Salamon, 1987).  The reproductive NOEL in this study was also 5 ppm (0.4 mg/kg/day) based
on reduced pup weights and signs of maternal neglect. Methidathion RCD (Revision 1) February 2007
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In the acceptable 90-day neurotoxicity study in rats, females exhibited clinical signs
(infrequent stools, transient tremors, chromorhinorrhea), changes in FOB parameters, and
reductions in body weights at 100 ppm (Chow and Turnier, 1995).  The changes in FOB
parameters included neuromuscular effects (abnormal gait, reduced forelimb and hindlimb grip
strength), CNS signs (tremors, stereotypy, bizarre behavior) and sensorimotor effects (increased
response to touch, sound and tail pinch).  Significant reductions in ChE activity in the cerebral
cortex, cerebellum, hippocampus and striatum were also seen in both sexes.  The NOEL for this
study was 3 ppm (M: 0.18 mg/kg/day; F: 0.20 mg/kg/day) based on the reduced ChE activity in
RBCs (M: 74-81%; F: 56-75% of controls - wks 4-13), cerebral cortex (M: 74% of controls -
wks 2-4), striatum (F: 63% of controls - wk 13) and hippocampus (F: 76% of controls - wk 13). 
There was some uncertainty about the toxicological significance of the ChE inhibition in the
cerebral cortex of males since females had more pronounced ChE inhibition in this region at
higher dose levels and males did not exhibit any clinical signs, changes in FOB parameters or
changes in maze activity at any dose level.  However, the cortex ChE activity in males at 10 ppm
was consistently reduced to about 75% of control activity throughout the study (although it was
not always statistically significant).  Therefore, DPR toxicologists made the health protective
assumption that the reduced ChE activity in the cerebral cortex of males at 10 ppm (0.61
mg/kg/day) was of toxicological significance. 
Reduced RBC and brain ChE activity appear to be the most sensitive endpoints with
subchronic exposure to methidathion.  ChE activity was not measured in any of the
developmental or reproductive toxicity studies, so the NOELs for these studies might have been
lower if ChE activity had been measured.  There does not appear to be any significant seasonal
variation in dietary or drinking water exposure to methidathion; however, the occupational and
ambient air exposure to methidathion were seasonal.  Therefore, the 90-day neurotoxicity study
was selected as the definitive study for evaluating seasonal occupational and ambient air
exposure to methidathion because it had the lowest subchronic NOEL and it met FIFRA
guidelines.  The critical NOEL was 0.18 mg/kg/day based on the reduced ChE activity in the
RBCs of both sexes (56-81% of controls), in the cerebral cortex of male rats (74%) and in the
striatum (63% of controls) and hippocampus (76% of controls) of female rats. 
As with acute toxicity, there were no subchronic toxicity studies, including
developmental and reproductive toxicity studies, for the methidathion oxon, the presumed active
metabolite for the neurological effects.  Therefore, it was assumed that the subchronic toxicity of
the oxon was equivalent to the parent compound.  
III.A.3.  Chronic Toxicity
The NOELs and LOELs observed in laboratory animals with chronic exposure (> 1 year)
to methidathion are summarized in Table 23.  The studies included in the table were all studies
that have sufficient information to establish a chronic NOEL or LOEL studies, regardless of
whether they met FIFRA guidelines.  This included the typical 1- to 2-year chronic feeding
studies in mice, rats and dogs as well as an unusual 2-year gavage study in monkeys.  Table 23
also includes the effects that are observed at the chronic LOEL.  Effects seen in laboratory
animals with chronic exposure to methidathion were similar to those seen with subchronic
exposure, except hepatotoxicity was more common.  In addition, ulceration and inflammation of
the skin and focal accumulation of foamy macrophages in the alveoli were seen in a chronic Methidathion RCD (Revision 1) February 2007
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Table 23. Chronic Effects of Methidathion and Their Respective NOELs and LOELs
Species Exposure Effect
NOEL LOEL
Ref.
a
(mg/kg/day)
Mouse 18-19 months,
 diet
Histological lesions in the liver of
 males
   1.5  15.0    1
Mouse 18-23 months,
 diet
Discolored urine, 9 RBC ChE
 activity (F: 64-74%
c), 8 serum
 ALT levels, histological lesions
 in liver and gall bladder (M)
   1.4    6.7    2*
Rat 2 years, diet  9 Brain ChE activity
 (M: 86%; F: 92%)
   -----    0.2    3
Rat 104 weeks, diet Clinical signs, 9 body weights,
 food & water consumption,
 9 ChE activity in RBCs (M: 78%;
 F: 82%) & brain (M: 49%; F:
 48%), 9liver weights, skin lesions
   0.17    1.77    4*
Dog 105 weeks, diet 8 Liver enzymes in serum,
 histological lesions in liver
 and spleen
  0.12    0.48    3
Dog 1 year, diet 8 Liver enzymes in serum,
 histological lesions in the liver
  0.15    1.33    5*
Monkey 23 months,
 gavage
9ChE activity in plasma (M&F:
 39%) and RBCs (M&F: 60-76%) 
 0.25    1.0    6
a References: 1.  IBT, 1980; 2.  Goldenthal, 1986; 3.  Johnston, 1967; 4.  Yau et al., 1984; 5.  Chang and Walberg, 1991; 6. 
Coulston and Goldberg, 1971.
b ChE = cholinesterase
c Percent of control activity
* Acceptable study based on FIFRA guidelines
feeding study with rats (Yau et al., 1986).   Hepatotoxicity and brain ChE inhibition were the
most common effects seen.  Mice appear to be significantly less sensitive to the hepatotoxicity
and brain ChE inhibition since the NOELs in mice were nearly an order of magnitude higher
than in rats and dogs.  The lowest LOEL (0.2 mg/kg/day) was observed in a 2-year rat chronic
toxicity study based on slightly reduced brain ChE activity (M: 86%; F: 92%) (Johnston, 1967). 
There were multiple deficiencies in this older rat study including a high mortality rate due to
pulmonary infections, no analysis of test compound or feed to verify purity or concentration,
insufficient hematological and clinical chemistry analysis, incomplete histopathology and 
incomplete individual data.  The findings from this older study were superceded by those from a
more recent study conducted by Yau et al. (1985) which met FIFRA guidelines and established a
NOEL of 0.17 mg/kg/day based on clinical signs, reduced body weights, reduced food and water
consumption, reduced ChE activity in RBCs (M: 78%; F: 82% of controls) and brain (M: 49%;Methidathion RCD (Revision 1) February 2007
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F: 48% of controls), reduced liver weights, and skin lesions.  A similar NOEL, 0.15 mg/kg/day,
was seen in dogs based on elevated liver enzymes in the serum and histological lesions in the
liver (Chang and Walberg, 1991).  The rats appear to be slightly more sensitive to the
neurotoxicity of methidathion whereas the dogs appear more sensitive to the hepatotoxicity.  The
different responses could be due to differences in metabolism (either in the rate or the major
pathways) between dogs and rats.  However, there are no metabolism or pharmacokinetic data to
explain the apparent differences in sensitivity in the dog.  Primates do not appear to be any more
sensitive than rats to ChE inhibition in blood, although since the brain ChE activity was not
analyzed in this study, it is unknown if this is also true for that endpoint.  The monkey is a more
relevant animal model for evaluating the risk for human health effects from methidathion;
however, due to major deficiencies with this older study (including an insufficient number of 
dose levels tested, lack of overt toxicity at the highest dose level, inadequate histopathological
examination and no individual data) less weight was given to this study.  Instead, the dog study
conducted by Chang and Walberg (1991) was selected as the definitive study for evaluating
chronic exposure to methidathion since it had a slightly lower NOEL and it met FIFRA
guidelines.  The critical NOEL for chronic exposure was 0.15 mg/kg/day based on elevated liver
enzymes in the serum and histological lesions in the liver.
As with acute and subchronic toxicity, there were no chronic toxicity studies for the
methidathion oxon, the presumed active metabolite for the neurological effects.  However, it is
uncertain if the oxon is the active metabolite for the hepatotoxicity observed with chronic
exposure to methidathion.  Therefore, it was assumed that the chronic toxicity of the oxon was
equivalent to the parent compound.  
III.A.4.  Carcinogenicity - Weight of Evidence
There is evidence that methidathion is carcinogenic based on a significant increase in the
incidence of hepatocellular adenomas and carcinomas in male mice in two different
carcinogenicity studies (IBT, 1980; Goldenthal, 1986).  In one mouse study, an increase in
hepatocellular adenomas and carcinomas was seen in males at 100 ppm (IBT, 1980).  However,
this study had numerous major deficiencies including no food consumption data, control group
mistakenly dosed with treated feed in month 14, apparent degradation of the test material in the
first 8 months, and no hematology data.  In an acceptable mouse carcinogenicity study, there was
also a significant increase in the incidence of hepatocellular adenomas and carcinomas at 50 and
100 ppm (Goldenthal, 1986).  The incidence of both tumor types exhibited a dose-related trend
that was highly significant when analyzed separately or combined (Table 10).  In addition, 3
animals at 100 ppm had multiple liver tumors.  The increase in hepatocellular adenomas was
significant by pairwise comparison to controls at all dose levels.  However, the incidence in the
controls was unusually low and only the incidence at 100 ppm was clearly outside the historical
control range for this laboratory (0-27%) (Table 11) (Quest et al., 1990).  The increase in
hepatocellular carcinomas was also significantly different than controls at 100 ppm.  When
combined, the increase in hepatocellular adenomas and carcinomas was significant at 50 and 100
ppm.  The incidence of carcinomas and combined adenomas/carcinomas exceeded the historical
control range (carcinomas: 0-10%; combined: 5-32%) at 50 and 100 ppm.  The proportion of
malignant tumors at 50 and 100 ppm (62 and 45%, respectively) was greater than historical
controls (mean 34%), but not concurrent controls (89%).Methidathion RCD (Revision 1) February 2007
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There appeared to be a reduction in the time to tumor in males at 100 ppm since the
proportion of tumor-bearing animals that died early was higher (76%) when compared to
concurrent controls (33%).  In fact, the shortest time to tumor (445 days) was seen in a male at
100 ppm.  However, if the time to death of the liver tumor-bearing males that died early is
compared, the means are similar for controls (618 days) and males at 100 ppm (608 days).   If
only the males where liver tumors were considered the cause of death were included, the mean
time to death was actually higher at 100 ppm (645 days) than controls (618 days).  The liver
tumors were considered the cause of death for only 11 of 29 male mice (38%) at 100 ppm that
died early with liver tumors compared to 3 of 3 male mice (100%) in the control group.
It is noteworthy that the significant increases in neoplastic liver lesions in male mice
occurred at dose levels that also caused significant increases in non-neoplastic liver lesions
(Table 9).  There was no increase in neoplastic liver lesions in females despite a slight increase
in non-neoplastic lesions at 100 ppm.  However, the incidence of non-neoplastic liver lesions in
females at 100 ppm (bile stasis 24%, chronic hepatitis 17%) was considerably lower than in
males at 50 ppm (bile stasis 51%, chronic hepatitis 49%).  There was also no significant increase
in neoplastic or non-neoplastic liver lesions in either sex of rats up to the highest dose level, 100
ppm (~ 5 mg/kg/day).  The apparent association of the hepatotoxicity with the liver tumors
suggests that an increase in cell proliferation or turnover may be responsible for the increase in
tumors.  The mechanism behind the liver toxicity is unknown, although research by Altuntas et
al. (2002b) suggests the liver toxicity may be related to lipid peroxidation based on an increase
in thiobarbituric acid reactive substances (TBARS, an end-product of lipid peroxidation) that
was seen in the serum of rats along with increases in several liver enzymes after a single oral
dose of methidathion at 8 mg/kg.  The levels of TBARS and liver enzymes were reduced in rats
treated with both methidathion and vitamins E and C.  In a subsequent study, this same research
group also observed histopathological lesions in the liver of rats after a single oral dose of
methidathion at 8 mg/kg that was ameliorated by administration of vitamins E and C (Gokalp et
al., 2003).  However, if this mechanism is involved, there must be some species and gender
differences in the formation or detoxification of the active metabolites, since the incidence of
liver tumors and hepatotoxicity was much higher in male mice compared to female mice and rats
of both sexes.  
An argument could be made that the increase in mortalities (68% versus 42% in controls)
and the high incidence of non-neoplastic lesions in the liver (bile stasis and chronic hepatitis -
98%) in male mice at 100 ppm indicate that this dose level was excessively toxic and the tumor
response at this dose level should be disregarded in the evaluation of the carcinogenic potency of
methidathion.  It is less clear if the severity of hepatotoxicity at 50 ppm was sufficient to
disregard the increase in tumors at this dose level.  Furthermore, there is inadequate mechanistic
data to demonstrate that the excessive toxicity at the high dose was solely responsible for the
increase in tumors.
The evidence that methidathion is genotoxic is limited.  All the gene mutation studies
were negative (4 reverse-mutation assays with Salmonella typhimurium, 1 reverse-mutation
assay with Escherichia coli, and 3 host-mediated assays with mice), except for a gene
conversion/forward mutation assay with Saccharomyces cerevisiae (Simon and Poole, 1977;
Satou et al., 1979; Arni, 1980a,b&c; Strasser, 1980; Arni and Muller, 1981; Lippens et al.,
1983).  None of the gene mutation tests met FIFRA guidelines, however, the negative resultsMethidathion RCD (Revision 1) February 2007
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were reproduced in the reverse-mutation assays from several different laboratories over a range
of doses with and without metabolic activation, presenting consistent and compelling evidence
of the lack of mutagenicity.  The reverse-mutation assay is considered a relatively sensitive test
for evaluating mutagenic potential.  The gene conversion/forward mutation assay is conducted in
yeast and, therefore, is considered a poor indicator of mammalian genotoxicity.  Furthermore,
this positive finding was only available in summary form in a published report so there was
insufficient information to evaluate the quality of the study.  Two assays for chromosome
damage (a dominant lethal assay in mice and an in vivo micronucleus assay in Chinese hamster)
were negative (Fritz, 1976a and Hool, 1980b).  Although the dominant lethal assay met FIFRA
guidelines, this assay is considered relatively insensitive.  The micronucleus assay is a useful test
for evaluating the potential of chemicals to induce chromosomal anomalies.  There is a high
correlation between agents that induce chromosomal aberrations and micronuclei, however, this
study was not of acceptable quality due to an inadequate number of animals scored and no data
supporting the sacrifice time.  The results were positive in an in vitro sister chromatid exchange
(SCE) assay with Chinese hamster V79 cell line and equivocal in an in vivo SCE assay with
Chinese hamsters (Chen et al., 1981; Hool, 1980a).  However, neither of these studies were of
acceptable quality since the in vitro study had limited information provided in this published
report and the in vivo study had an inadequate number of animals/cells scored.  Even if these
SCE studies had been of acceptable quality, the toxicological significance of SCEs has not been
demonstrated.  The six available assays for DNA damage/repair (5 unscheduled DNA synthesis
(UDS) assays and 1 rec assay) were all negative (Lippens et al., 1983; Arni, 1980a,b&c; Simmon
and Poole, 1977; Satou et al., 1979; Strasser, 1980; Fritz, 1976a; Hool, 1980b; Hertner, 1988 &
1990; Ciba-Geigy, 1982; Tong 1982a&b).   Two of the UDS assays met FIFRA guidelines.  The
UDS assay, however, is not considered a very sensitive assay.  Overall, the evidence that
methidathion is genotoxic is limited, but its potential to induce chromosomal damage cannot be
ruled out.  It is noteworthy that chromosomal aberrations were observed in 14 out of 55
agricultural workers examined in Hungry who worked with various pesticides including
methidathion (Nehéz et al., 1988).  
A few genotoxicity tests were available for several metabolites of methidathion including
reverse-mutation assays for 3 metabolites and an in vivo micronucleus assay for one metabolite
(Arni, 1980d-f; Hool, 1980c).  These tests were all negative, but none of these were of
acceptable quality.  It is possible that there are some genotoxic metabolites of methidathion that
have either not been isolated or not been tested thoroughly for genotoxicity.  One example may
be formaldehyde which is a likely intermediate in the metabolism of the methoxy carbon of the
thiadiazole ring to CO2.  Formaldehyde is non-mutagenic to Salmonella, although mutagenic to
Drosophila (Ashby et al., 1985).  Formaldehyde is thought to be a locally active carcinogen
which could explain the liver tumors if methidathion is metabolized to formaldehyde in the liver
(Ashby and Lefevre, 1982).  If a genotoxic metabolite is responsible for the carcinogenicity of
methidathion then there must be species and gender differences in the metabolism to explain
why the liver tumors were only increased in male mice.  
U.S. EPA performed a structure-activity relationship search for chemicals with structural
similarity to methidathion (Quest et al., 1990).  Only two pesticides were identified as
structurally similar, prothidathion and lythidathion.  No toxicity data were available for these
pesticides since they are not registered in the United States.  Methidathion RCD (Revision 1) February 2007
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III.A.5.  Quantitative Assessment of Carcinogenic Effects
There is little doubt that the increase in liver tumors in male mice is treatment-related. 
There was a clear dose-response relationship and an increase in these tumors was seen in male
mice in two studies, although one study had major deficiencies (IBT, 1980; Goldenthal, 1986).  
Furthermore, in the study that met FIFRA guidelines, there was an increase in the multiplicity of
tumors at the highest dose level, a possible increase in the proportion of malignant tumors, and a
possible reduction in the time to tumor.  On the other hand, the weight of evidence for
carcinogenicity was limited because it involved a common tumor type in only one tissue site in
only one sex of one species.  There was no evidence of carcinogenicity in female mice or in two
chronic rat studies for methidathion (IBT, 1980; Goldenthal, 1986; Johnston, 1967; Yau et al.,
1986).  Moreover, there is only evidence of genotoxicity in two tests whose biological
significance is uncertain.  In addition, there appears to be an association between the incidence
of hepatotoxicity and liver tumors.   The U.S. EPA has classified methidathion as a Group C
carcinogen (i.e., possible human carcinogen), but did not consider the evidence sufficient to
quantitate a carcinogenic potency factor (Quest et al., 1990).  The FAO/WHO Joint Meeting on
Pesticide Residues (JMPR) also did not consider the evidence sufficient to warrant calculating a
carcinogenic potency factor (Caris, 1992).  Although DPR toxicologists agree that the weight of
evidence is limited, the mode of action is uncertain.  Direct DNA interaction could not be ruled
out since its genotoxicity potential has not been thoroughly tested in well-conducted, sensitive
assays with mammalian cells.   The association between the hepatotoxicity and the liver tumors
suggests secondary DNA effects from a possible increase in cell proliferation; however, there
were no mechanistic studies to support this possibility.  An increase in lipid peroxidation may be
another possible mechanism, but there were no studies demonstrating a connection between the
lipid peroxidation and the liver tumors.  The U.S. EPA Guidelines for Carcinogen Risk
Assessment recommends that, when there is insufficient data on the mode of action, a linear
approach be used as a default (U.S. EPA, 2005).  Consequently, a linear approach was used to
evaluate the carcinogenic potential of methidathion.  
The combined incidence of  hepatocellular adenomas and carcinomas in male mice in the
carcinogenicity study conducted by Goldenthal (1986) was used to estimate carcinogenic
potency.  Due to the reduced survival of male mice at the highest dose tested, 100 ppm, the
multistage-Weibull time-to-tumor model, MULTI-WEIB, was used to estimate the
carcinogenicity potency.  The dosages for male mice (0, 0.4, 1.4, 6.7 or 13.1 mg/kg/day) were
first converted to human equivalent dosages (0, 0.06, 0.20, 0.97 or 1.90 mg/kg/day, respectively)
by multiplying by an interspecies scaling factor of body weight to the 3/4 power
[(BWtA/BWtH)
0.25 = (0.030 kg/70 kg)
0.25 = 0.144] (U.S. EPA, 2005).   The estimated carcinogenic
potency for methidathion ranged from 0.34 (mg/kg/day)
-1 (maximum likelihood estimate or
MLE) to 0.53 (mg/kg/day)
-1 (95% upper bound or 95% UB). 
The estimated carcinogenic potency for methidathion expressed as unit risk is shown in
Table 24 relative to other chemicals for which there are carcinogenic potency estimates that have
been approved by the Scientific Review Panel (SRP) for Toxic Air Contaminants (TACs).  The
unit risk estimate for methidathion was 1.5 x 10
-4 (μg/m
3)
-1  at the 95% UB. 
As with chronic toxicity, there were no carcinogenicity studies for the methidathion oxon,
the presumed active metabolite for the neurological effects.  However, it is uncertain if the oxon Methidathion RCD (Revision 1) February 2007
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Table 24.  Carcinogenic Potency for Methidathion Relative to Other Carcinogenic
Potencies Approved by the Scientific Review Panel for Toxic Air Contaminants
a 
Compound
Unit Risk
(μg/m
3)
-1
Potency
 (mg/kg/day)
-1
Dioxins 3.8 x 10
1 to 3.8 x 10
0  1.3 x 10
4 to 1.3 x 10
5
Chromium IV 1.5 x 10
-1 5.1 x 10
2
Asbestos 6.3 x 10
-2  2.2 x 10
2
Dibenzo[a,h]pyrene 1.1 x 10
-2 3.9 x 10
1
1,6-Dinitropyrene 1.1 x 10
-2 3.9 x 10
1
6-Nitrochrysene 1.1 x 10
-2 3.9 x 10
1
Cadmium 4.2 x 10
-3 1.5 x 10
1
Inorganic Arsenic 3.3 x 10
-3 1.2 x 10
1
Benzo[a]pyrene 1.1 x 10
-3 3.9 x 10
0
Dibenzo[a,e]pyrene 1.1 x 10
-3 3.9 x 10
0
7H-Dibenzo[c,g]carbazole 1.1 x 10
-3 3.9 x 10
0
1,8-Dinitropyrene 1.1 x 10
-3 3.9 x 10
0
5-Methylchrysene 1.1 x 10
-3 3.9 x 10
0
Diesel Exhaust 3 x 10
-4 1.1 x 10
0
Nickel 2.6 x 10
-4 9.1 x 10
-1
1,3-Butadiene 1.7 x 10
-4 6.0 x 10
-1
Methidathion 1.5 x 10
-4 5.3 x 10
-1
Benz[a]anthracene 1.1 x 10
-4 3.9 x 10
-1
Benz[b]fluoranthrene 1.1 x 10
-4 3.9 x 10
-1
Indeno[1,2,3-cd]pyrene 1.1 x 10
-4 3.9 x 10
-1
Dibenzo[a,h]acridine 1.1 x 10
-4 3.9 x 10
-1
1-Nitropyrene 1.1 x 10
-4 3.9 x 10
-1
4-Nitropyrene 1.1 x 10
-4 3.9 x 10
-1
Ethylene Oxide 8.8 x 10
-5 3.1 x 10
-1
Vinyl Chloride 7.8 x 10
-5 2.7 x 10
-1
Ethylene Dibromide 7.1 x 10
-5 2.5 x 10
-1
Carbon Tetrachloride 4.2 x 10
-5 1.5 x 10
-1
Naphthalene 3.4 x 10
-5 1.2 x 10
-1
Benzene 2.9 x 10
-5 1.0 x 10
-1
Ethylene Dichloride 2.1 x 10
-5 7.2x 10
-2
DEF 1.6 x 10
-5 5.9x 10
-2
Inorganic Lead 1.2 x 10
-5 4.2 x 10
-2
Chrysene 1.1 x 10
-5 3.9 x 10
-2
2-Ntirofluorene 1.1 x 10
-5 3.9 x 10
-2
Perchloroethylene 5.9 x 10
-6 2.1 x 10
-2
Formaldehyde 6.0 x 10
-6 2.1 x 10
-2
Chloroform 5.3 x 10
-6 1.9 x 10
-2
Acetaldehyde 2.7 x 10
-6 1.0 x 10
-2
Trichloroethylene 2.0 x 10
-6 7.0 x 10
-3
Methylene Chloride 1.0 x 10
-6 3.5 x 10
-3
Methyl tert-butyl ether (MTBE) 2.6 x 10
-7 1.8 x 10
-3
a Unit risk values from OEHHA (2005).  Methidathion RCD (Revision 1) February 2007
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is the active metabolite for the carcinogenicity observed with chronic exposure to methidathion. 
Therefore, it was assumed that the carcinogenic potency of the oxon was equivalent to the parent
compound.  
III.B.  EXPOSURE ASSESSMENT
III.B.1.  Dietary Exposure
III.B.1.a.  Introduction
The Department of Pesticide Regulation conducts acute and chronic dietary exposure
assessments to evaluate the risk of human exposure to a pesticide in food (Bronzan and Jones,
1989).  Two separate approaches are used to estimate the risk: (1) risk is determined for the total
dietary exposure based on measured residue levels on all label-approved commodities and (2)
risk is estimated for exposure to an individual commodity at the tolerance level (see Tolerance
Assessment section).
Dietary exposure is a product of the amount of food that is consumed and the
concentration of the pesticide residue in that food.  The total exposure in an individual’s diet
during a defined period of time (e.g., a day) is the sum of exposure from all foods (in various
forms and as ingredients in food items) consumed within that period:
() Exposure  =  residue  x consumption  of foods
i1
n
ii =
where n is the number of food items in the diet.
Accordingly, two distinct pieces of information are required to assess the dietary
exposure: (1) the amount of the pesticide residue on food and (2) the food consumption.  For
estimating the acute exposure, the highest residue values at or below the tolerance, or the
distribution of residues are considered.  In contrast, for chronic exposure, the mean residue
values are appropriate.  Finally, acute dietary exposure is calculated on a per-user basis (i.e.,
including in the distribution of exposure only the days of survey that at least one commodity
with potential pesticide residues is consumed).  Chronic dietary exposure to pesticides is
generally calculated using per-capita mean consumption estimates to include the entire
population.
III.B.1.b.  Dietary Exposure
The acute and chronic dietary exposure analyses were conducted using the Dietary
Exposure Evaluation Model- Food Commodity Ingredient Database (DEEM-FCID™, version  
2.03) software developed by Exponent, Inc., in which the food translations are based on
EPA/USDA FCID recipe set as of August 2002.  DEEM-FCID™ calculates acute and chronic
exposure estimates for 33 different population subgroups, including nursing or non-nursing
infants less than 1 year old, children ages 1-2, 3-5 or 6-12 years old, youth 13-19 years old,
pregnant or nursing women, and adults 50 years and older.  The Acute Analysis module also
allows for calculation of exposure for custom populations, such as workers, ages 16 years and
older.  The Acute Analysis module estimates the distribution of exposure per user-day (i.e., theMethidathion RCD (Revision 1) February 2007
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percentile exposure for only individuals that consume at least one commodity of concern on the
day of survey). The Acute Analysis estimates exposure either using a deterministic approach
(i.e., a single residue value or point estimate for each commodity) or a probabilistic approach
(i.e., Monte Carlo method where residue and consumption values are randomly selected from
different distribution curves for each commodity).  In the deterministic approach, the distribution
of exposure is calculated by multiplying the single residue value and the consumption
distribution.  In the probabilistic approach, the distribution of exposure is calculated by
multiplying the distribution of residue and the distribution of consumption (Petersen et al.,
2001).  Since the probabilistic approach is more time consuming, it is only used if the margins of
exposure are inadequate using the deterministic approach and/or if there is sufficient residue data
to describe the distributions.  The Chronic Analysis estimates the annual average exposure per
capita using point estimates that represent the average residue values. The chronic analysis
estimates the average exposure of all surveyed individuals in a population subgroup at the
average pesticide residue.  The residue values for both acute and chronic exposure can be
adjusted by percent crop treated; however, DPR generally only adjusts the acute residue values
for percent crop treated when a probabilistic approach is used. 
In the Acute Analysis, the Critical Exposure Commodity (CEC) analysis provides
consumption records for individuals at the high end of dietary exposure (in the top 5% or less). 
The CEC analysis also identifies the commodities contributing to the high end of the dietary
exposure.  The records include the amount of food(s) consumed, body weight, age, residue
values and the exposure estimate by food.  The CEC analysis provides the means to identify high
contributing commodities and any apparent error in the consumption database (e.g.,
unreasonable body weight at a given age).  A detailed description on the CEC analysis is
provided in the DEEM™ manual (Kidwell et al., 2001).  In the Chronic Analysis, the Critical
Commodity Contribution (CCC) analysis performs a similar analysis; however, with chronic
exposure the contributing commodities identified are based on the average consumption of the
population not the consumption at the high end.
III.B.1.c.  Consumption Data
The United States Department of Agriculture (USDA) directs the Continuing Survey of
Food Intakes by Individuals (CSFII), which analyzes the food intake and adequacy of the diets of
various population subgroups.   The purpose of the CSFII is to analyze food intake every few
years to provide up-to-date information on the adequacy of the diets of various population
groups and early indications of dietary changes.  Individual intake data are collected using both a
1-day recall and a 2-day record protocol.  The surveys were conducted in all months of the year. 
In each year, approximately 5,500 participants in 62 geographical areas were surveyed.  The
consumption data used in this risk assessment were the CSFII 1994-98 data  which were
collected from January 1994 to February 1997 (referred to as 1994-96) and from December 1997
to December 1998 (referred to as 1998).  This is the preferred consumption data since it is the
most recent and representative consumption data.  These data provide information on 2-day food
intake by 20,607 individuals of all ages from 62 geographical areas.  The 1994-96 data included
4,253 children, ages 0 to 9 years old.  The 1998 CSFII data included an additional 5,559 children
of the same age to increase the database for dietary patterns of infants and children in response to
the Food Quality Protection Act of 1996.Methidathion RCD (Revision 1) February 2007
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III.B.1.d.  Residue Data
The federal and state monitoring programs analyze food samples at produce markets and
chain store distribution centers close to the consumer level.  Recent, multi-year (3-5 years)
residue data are preferred.  The USDA Pesticide Data Program (PDP) is the most representative
monitoring residue data because it is designed to obtain residue data for risk assessments.  The
PDP samples are collected in ten states, including California.  When a sufficient number of
samples (e.g., 30 or more) is analyzed in California, the California only data can be used instead
of the nationwide data.  Often the limit of detection (LOD) for the California laboratory is lower
than the other USDA national contract laboratories.
DPR has two major sampling programs: priority pesticide and marketplace surveillance.  
DPR monitoring programs may not be representative because they focus on commodities with
known violations (DPR, 1994-2002).  In addition, the residue LOD may be high.  However, data
from the DPR monitoring programs may be useful when PDP data are not available.
The U.S. Food and Drug Administration (FDA) Regulatory Residue Monitoring Program
analyzes domestic and imported foods for pesticide residue to enforce the tolerances set by U.S.
EPA.  Thus, the residue data may not be representative.  In addition, residue information may be
incomplete for conducting a distribution (e.g., only a range of pesticide concentrations on a
particular food is provided; LOD is not indicated, etc.).  FDA data may be useful when PDP and
DPR data are not available.
The monitoring studies may also be conducted by manufacturers or task force groups of a
particular pesticide(s).  In most cases, these food surveys are designed to determine the residues
on specified commodities in response to the U.S. EPA Data Call-In Notices.  Samples are
usually collected at the produce markets, chain store distribution centers and/or at the farm gates. 
The task force studies most closely approximates the PDP sampling and may be representative in
that they analyze a large number of samples of high consumption commodities and generally
have a low LOD.  However, the duration of task force studies is generally short (e.g., 1 year)
unlike the multi-year analysis by the PDP.
Other sources for residue data include use of surrogate commodities, field trial studies,
and tolerances.  When residue data are not available from monitoring studies, residues reported
for similar foods can be used as surrogates.  The choice of the most appropriate surrogate
commodity should be based on the classification or grouping of related raw agricultural
commodities (RAC) into crop groups, established in 40 CFR 180.40, and according to the
agricultural practices specified in the product label.  The field trial studies are submitted to DPR
by pesticide manufacturers for support in the setting of tolerances (U.S. EPA, 1982).  These
studies are usually conducted under the highest application rate permitted by the label conditions
and, as a result, the residue data may likely consist entirely of upper-end pesticide
concentrations.  The residue levels are set at the tolerance level when no monitoring or field trial
data are available and there is no suitable surrogate commodity.  The tolerance is the legal
maximum residue concentration of a pesticide on a RAC or processed food.  The tolerances are
established by the U.S. EPA at levels necessary to allow for the maximum application rate and
frequency which most likely do not reflect the actual pesticide use pattern.  Therefore, use of the
tolerances for residue levels will most likely overestimate the residue levels.Methidathion RCD (Revision 1) February 2007
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  Since dietary exposure assessments can be very labor intensive, DPR toxicologists use a
tiered approach to the dietary exposure assessment with additional refinements when the risk for
adverse health effects in humans is considered too high based on grossly overestimated exposure
levels from a simplified approach.  Some of the more common refinements to the dietary
exposure estimate are: 1) use of residue monitoring data where commodities are analyzed closer
to the point of consumption, 2) use of residue monitoring data with a lower LOD (which is
important when no residues are detected), and 3) accounting for the percent of a crop that is
treated with a pesticide.  The initial dietary analysis for methidathion using the tolerances was
considered as Tier 1.  The tiered approach for acute dietary exposure begins with the point
estimates, which are generally less time-consuming.  Since the estimated acute and chronic
dietary exposure appeared too high based on overestimated exposure (see criteria described in
the Risk Characterization and Risk Appraisal sections), the dietary exposure was further refined. 
In the Tier 2 analysis, the residue values from DPR’s and PDP’s market basket surveys
were considered.  PDP data were given preference over DPR data, when available, for the
following reasons: 1) the commodities were analyzed closer to the point of consumption than
DPR, 2) the commodities are usually washed and peeled if normally consumed that way, and 3)  
the LODs were usually lower.  When sufficient data were available (i.e., > 100 samples), PDP
data from California were used exclusively.  The PDP data were limited in that most
commodities were analyzed for only 1-3 years.  The acute and chronic residue values used from
the PDP data are summarized in Table 25.  The acute residue value was the highest detected
residue value if a point estimate was used.  In 1995, U.S. EPA reviewed the metabolites of 
Table 25. Methidathion Residues in Raw Agricultural Commodities from USDA’s PDP
Monitoring Programs
Raw
Agricultural
Commodity
N
Acute
Value
a
(ppm)
Chronic
Value
b
(ppm)
Years & Percent Crop Treated
Apple, whole 127 0.007 0.00035 2002, CA only, LOD = 0.007,
 PCT = 15% (acute), 10% (chronic)
Cherries 118 0.004 0.0001 2000 & 2001, CA only, LOD = 0.004,
 PCT = 10% (acute), 5% (chronic)
Nectarine 153 0.004 0.0001 2000 & 2001, CA only, LOD = 0.004,
 PCT = 10% (acute), 5% (chronic)
Orange, whole 333 0.007 0.000168 2000 & 2001, CA only, LOD = 0.004,
 PCT = 10% (acute), 5% (chronic) 
Peach 254 0.004 0.000065 2001 & 2002, CA only, LOD = 0.001-2,
 PCT = 15% (acute), 10% (chronic)
Pear 187 0.004 0.0001 2003, National, LOD = 0.004,
 PCT = 10% (acute), 5% (chronic)
a The acute value represents the highest residue level detected in any sample.  When no residues were detected the acute
value is the LOD.  When a Monte Carlo analysis was done for a commodity, the PCT was used to set some of the non-
detects to zero.  The remaining non-detects were set at ½ of the LOD.
b When no residue was detected, ½ of the LOD was used in calculating the chronic value for a commodity.
LOD Limit of detection
PCT Percent crop treatedMethidathion RCD (Revision 1) February 2007
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methidathion that were identified in plant and livestock metabolism studies and found that the
oxon was present in considerably lower concentrations than the parent (U.S. EPA, 1995). 
Furthermore, the toxicity of the metabolite could be accounted for in the toxicity studies with the
parent.  Therefore, the tolerance for methidathion included only the parent compound.  The PDP
data did not include the methidathion oxon in the analysis of these commodities for residues,
presumably because it was not included in the tolerance. 
Due to unacceptable exposures from the Tier 2 analysis, the acute exposure was further
refined in a Tier 3 analysis by performing a Monte Carlo analysis on the commodities with high
consumption.   This included all the commodities with PDP data and two commodities (apricots
and plum) with DPR data.  Instead of assuming that all commodities were 100% treated, the
percent crop treated (PCT) was taken into consideration in the residue files for the Monte Carlo
analysis by setting some of the samples with non-detectable residues to zero rather than ½ of
LOD.  The PCT estimates were calculated from data available from various state and federal
regulatory agencies.  The acreage treated in California with methidathion was obtained from
DPR’s Pesticide Use Report (DPR, 2000, 2002 & 2005).  The acreage bearing or harvested in
California was obtained from agricultural statistics available from the California Department of
Food and Agriculture (CDFA) or U.S. Department of Agriculture (USDA) (CDFA, 2004 and
USDA, 2000, 2002 & 2004).  Generally, the years covered were 1999, 2001 and 2003 since
reports for these crops were usually only generated every other year.  The highest PCT in these 3
years was used for acute exposure while the average PCT for these 3 years was used for chronic
exposure (see Table 25 for specific values used).  PCT estimates were rounded up to the nearest
5% due to the uncertainty in these estimates.
Generally, PDP data were not available for processed commodities.  There was one
exception: pear juice.  However, these data were not used because generally DPR does not adjust
blended commodities like juice for PCT.  Since there were no detections in either the whole
pears or pear juice and their LODs were the same, using the pear juice data would result in a
higher exposure estimate for pear juice since it is being determined entirely by the LOD. 
Therefore, the whole pear data was used to estimate exposure for pear juice.  When no residue
data were available for processed commodities, residues were estimated from the fresh
commodity by multiplying by the adjustment factors that account for the loss of water.  The
following default adjustment factors from DEEM™ (version 7.87) were used in DEEM™-FCID
(version 2.03): apple, dried - 8; apple, juice - 1.3; apricot, dried - 6; cherry, juice - 1.5; grapefruit
- 2.1; lemon, juice - 2.0; lime, juice - 2.0; orange, juice - 1.8; peach, dried - 7; pear, dried - 6.25;
plum/prune, dried - 5; plum/prune, juice - 1.4; tangerine, juice - 2.3.  If the residues in processed
commodities were higher than the tolerance for the RAC, they would be considered illegal since
no tolerances were established for these commodities.   Therefore, if the resultant residue in the
processed commodity was greater than the tolerance, the residue was set to the tolerance and the
adjustment factor was set to 1.
There were several crops for which there were DPR monitoring data, but no PDP
monitoring data.  The residues for these commodities (apricots, artichokes, kiwifruit, mangos
and plums) are summarized in Table 26.  No residues were detected in any of the samples tested
for all five commodities.  The LODs for these five commodities were all 0.05 ppm which is an
order of magnitude higher than the LODs for the PDP data.  DPR also did not analyze these
commodities for the methidathion oxon.Methidathion RCD (Revision 1) February 2007
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Table 26. Methidathion Residues in Raw Agricultural Commodities from DPR’s Monitoring
Programs
a
Raw
Agricultural
Commodity
N
Acute
Value
b
(ppm)
Chronic
Value
c
(ppm)
Years & Percent Crop Treated
Apricot 151 0.05 0.025 2000-2004, LOD = 0.05
 PCT = 5% (acute and chronic)
Artichoke 131 0.05 0.025 2000-2004, LOD = 0.05
 PCT = 100% (chronic only)
Kiwi fruit 108 0.05 0.025 2000-2004, LOD = 0.05
 PCT = 10% (chronic only)
Mango 184 0.05 0.025 2000-2204, LOD = 0.05
 PCT = 100% (chronic only)
Plum 329 0.05 0.025 2000-2004, LOD = 0.05
PCT = 15% plum (acute and chronic)     
        =   5% prune (acute and chronic)
a Residues from DPR's monitoring sampling programs 1 (priority pesticide) and 4 (marketplace surveillance).
b The acutevalue represents the highest residue level detected in any sample.  When no residues were detected the acute
value was set at the LOD.
c When no residue was detected, ½ of the LOD was used in calculating the chronic value for a commodity.
For some commodities where there was no PDP monitoring data (grapefruit, lemons,
limes, pummelos and tangerines), a surrogate crop (oranges) was used instead.  The PCT for
oranges (10% acute, 5% chronic) was used for these commodities.  Apple data was used as
surrogate for crabapple, quince and loquat data since they were also pome fruits.  The PCT for
apples (15% acute and 10% chronic) was also used for these other pome fruits.
For a few commodities where there was no monitoring data and no good surrogate crop,
field trial data was used when available.  This was done with safflower and sunflower residues
because when ½ of the tolerance was used for the chronic residue value, the carcinogenic risk
estimates were unacceptable.  A commodity contribution analysis indicated that these
commodities contributed to more than 75% of the chronic exposure estimate in the U.S.
population when the residue was set at ½ of the tolerance.  Field trial data for these commodities
had been submitted to DPR.  The residue for methidathion in safflower was less than the LOD,
0.01 ppm, in several studies where it was applied at the maximum label-approved application
rate (0.5 lb/acre) and sampled after the minimum pre-harvest interval (28 days) (Ciba-Geigy,
1977).  For sunflower, the average residue in the five residue studies was 0.11 ppm with a high
value of 0.22 ppm at the maximum label-approved application rate (0.5 lb/acre) and sampled
after the minimum pre-harvest interval (50 days) (Mattson and Kahrs, 1974).  Processing data
indicated that 55%, 20% and 20% of the residues were in the hulls, meal and oil of sunflower
seeds. Assuming that the hulls are not normally consumed by humans, the residue in whole seeds
was multiplied by a processing factor of 45%.  A processing factor of 20% was multiplied by the
residue in whole seeds to get the residue in oil.  The residue in these crops could have been
further refined by the PCT, but it was not possible to get an accurate estimate of the acres
harvested in CA from CDFA’s or USDA’s agricultural statistics due to the small number of acresMethidathion RCD (Revision 1) February 2007
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planted.  Consequently, the acres harvested in California were combined with other states or with
other seed oil crops in California.  It appears the PCT for sunflower is quite low since there was
no reported use of methidathion on sunflowers in California in 4 of 5 years between 1999 and
2003.  However, since there was insufficient information available to calculate a PCT for
safflowers and sunflowers the PCT for these crops was assumed to be 100%.
  
If there were no monitoring data, appropriate surrogate data or field trial data, the residue
levels were assumed to be at the tolerance level for acute exposure and 2 of the tolerance level
for chronic exposure (CFR, 2004).  The tolerance levels were used for the following
commodities: nuts (0.05 ppm), cottonseed (0.2 ppm), olive (0.05 ppm), starfruit (0.1 ppm), sugar
apple (0.2 ppm).   The PCT assumed for these commodities was 100% except for the following
commodities with chronic exposure: almonds ( 5%), cottonseed (1%), olive (5%), pecan (10%),
pistachio (10%), and walnut (5%) based on data from CDFA’s agricultural statistics and DPR’s
PUR for these crops.  
A Tier 3 analysis was performed for the chronic dietary exposure due to the unacceptable
carcinogenic risk with a Tier 2 analysis.  Point estimates are still used in the Tier 3 analysis with
the chronic exposure analysis, but residues are refined by taking PCT into consideration as well
as additional processing factors.  Unlike acute exposure analysis, the point estimate in the
chronic exposure analysis represents the average residue rather than the highest.  The PCT is
taken into consideration in the chronic residue values accordingly:
a. When a default value was used (e.g., ½ tolerance or LOD) either due to no residue data or
no detectable residues in all the samples, the default value was multiplied by the average
PCT.
b. When residues were detected, some of the non-detectable residues were replaced by zeros
based on the average PCT according to the following formula:
() ( ) ( ) [ ]
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where, AR = average residue, LOD=  detection limit, RN1 = residue for the number of
samples (N1) in which residues were detected, N2= the number of samples theoretically
can contain residues with N2=N x PCT – N1 and residues assumed at ½ LOD, N3=
number of samples theoretically contain no residues with N3=N x (1-PCT) and residue
assumed at zero. 
III.B.1.e.  Acute Dietary Exposure Estimates
As mentioned, a tiered approach was used in the dietary exposure assessment.  The
results of the Tier 3 analysis are shown in Table 27.   The 99.9
th percentile of the user-day
exposure for all specific population subgroups is presented.  A user-day is any day in which at
least one food form from the label-approved commodities is consumed.  Based on the 99.9
th
percentile, the potential acute dietary ingestion of methidathion from all labeled uses rangedMethidathion RCD (Revision 1) February 2007
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from 0.175 μg/kg/day in adults 50 years and older to 0.780 μg/kg/day in children 1-2 years old
(Table 27, Appendix B).   
III.B.1.f.  Chronic Dietary Exposure Estimates
A Tier 3 analysis was also performed for chronic dietary exposure assessment taking into
consideration the PCT and processing factors in addition to the residue monitoring data.   A Tier
3 analysis was necessary with methidathion due to the carcinogenicity concern.  The mean
potential chronic dietary exposure ranged from 0.001 μg/kg/day for adults 20 years and older to
0.019 μg/kg/day for non-nursing infants less than 1 year old (Table 27, Appendix B).  For
estimating the lifetime exposure, these age-based exposures should be amortized over a lifetime
of 70 years.  With DEEM™-FCID, the amortized lifetime exposure was assumed to be the same
as the chronic exposure output for the "U.S. population" which contains all the age-based
population subgroups.  
Table 27. Potential Acute and Chronic Dietary Exposures to Methidathion Residues
Population Subgroup
Exposure Dosage (μg/kg/day)
Acute
a Chronic
b
U.S. Population 0.329 0.002
Western Region 0.351 0.003
Nursing Infants (< 1 yr) 0.275 0.005
Non-nursing Infants (< 1  yr) 0.504 0.019
Children (1-2 yrs) 0.780 0.007
Children (3-5 yrs) 0.603 0.005
Children (6-12 yrs) 0.474 0.003
Youth (13-19 yrs) 0.334 0.002
Adults (20-49) 0.214 0.001
Adults (50+ yrs) 0.175 0.001
Females (13-49 yrs) 0.215 0.002
Females (13+ yrs, pregnant/not nursing) 0.294 0.005
Females (13+ yrs, nursing) 0.298 0.004
Workers (16+ yrs) 0.196 NA
a Based on 99.9
th exposure percentile for each user-day population subgroups.
b Based on the annual average daily dosage for each population subgroups.
III.B.2.  Drinking Water Exposure
III.B.2.a.  Drinking Water Residues
Although methidathion has been detected in 2% of surface water samples collected by
DPR between June 1999 and September 2003 (Starner, 2005), it has not been detected by DPR
in any wells tested between 1986 and 2004 (DPR, 2003b & 2004).  It has also not been detected
in drinking water sampled by PDP from 2001 to 2003 (USDA, 2003-2005).  PDP did not begin
testing drinking water until 2001.  The PDP drinking water samples were collected at water
treatment facilities.  In 2001, samples were taken from 10 sites in California and 11 sites in New
York representing major metropolitan areas, agricultural regions and highly protectedMethidathion RCD (Revision 1) February 2007
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watersheds.  In 2001, the LODs for methidathion and its oxon were 10 and 25 ppt, respectively,
for the California sites.  In 2002, 6 new sites (Kansas  - 2, Colorado - 2, Texas - 1, California - 1)
were added to the sites in New York and California tested in 2001.  These same sites were tested
again in 2003.  Source waters for the PDP finished drinking water were primarily surface water.  
Although the range of the LODs for methidathion and its oxon increased with the addition of the
new sites in 2002, the California LODs decreased to 0.009 ppb for the parent and 0.012 ppb for
the oxon.  Since PDP had the lowest LODs and the drinking water was from a mixture of
sources, the California PDP data were selected to evaluate drinking water exposure to
methidathion over DPR’s surface water monitoring data which does not necessarily represent
drinking water sources. 
III.B.2.b.  Drinking Water Exposure Estimates
A Tier 2 analysis was done for both the acute and chronic drinking water exposure
assessment using point estimates.   In the absence of any toxicity data for the oxon, it was
assumed that the oxon was equivalent to the parent in toxicity.  Since there were no detectable
residues in any of the PDP drinking water samples, the California LODs for the parent (0.009
ppb) and the oxon (0.012 ppb) from the more recent years were added together for a combined
worse case residue estimate of 0.021 ppb to evaluate acute drinking water exposure.  To evaluate
chronic drinking water exposure ½ of this LOD (0.011 ppb) was used.  At the 99.9th percentile
of user-day exposure, the potential acute exposure to methidathion and its oxon in drinking water
ranged from 0.002 to 0.012 μg/kg/day with the highest exposure estimate for non-nursing infants
less than 1 year old (Table 28).  The mean potential chronic drinking water exposure for all
population subgroups was less than 0.001 μg/kg/day for all population subgroups except non-
nursing infants less than 1 year whose exposure estimate was 0.001 μg/kg/day (Table 28). 
Table 28. Potential Acute and Chronic Drinking Water Exposure to Methidathion for Selected
Population Subgroups
Population Subgroup
Exposure Dosage (μg/kg/day)
Acute
a Chronic
a
U.S. Population 0.004 < 0.001
Western Region 0.005 < 0.001
Nursing Infants (< 1 yr) 0.008 < 0.001
Non-nursing Infants (< 1  yr) 0.012     0.001
Children (1-2 yrs) 0.004 < 0.001
Children (3-5 yrs) 0.004 < 0.001
Children (6-12 yrs) 0.002 < 0.001
Youth (13-19 yrs) 0.003 < 0.001
Adults (20-49 yrs) 0.003 < 0.001
Adults (50+ yrs) 0.002 < 0.001
Females (13-49 yrs) 0.003 < 0.001
Females (13+ yrs/pregnant/not nursing) 0.002 < 0.001
Females (13+ yrs/nursing) 0.002 < 0.001
Workers (16+ yrs) 0.003 NA
a Based on 99.9th exposure percentile for each user-day population subgroups.
b Based on the annual average daily dosage for each population subgroups.Methidathion RCD (Revision 1) February 2007
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III.B.c.  Combined Dietary and Drinking Water Exposure
The same dietary and drinking water residues used for the separate dietary and drinking
water assessments were used for the combined assessment for acute and chronic exposures.  The
combined drinking water and dietary exposure estimates are summarized in Table 29.  The
combined exposure to methidathion in drinking water and food is not equal to the sum of the
dietary and drinking water exposures because each of these estimates is based on a distribution
among consumers which changes as commodities or water are added or removed.   In fact, the
combined exposure estimates at the 99.9th percentile were lower than for food alone at the same
percentile primarily because the drinking water component of the total exposure was very small
and the number of users increased when drinking water was added.  Based on the combined
acute exposure to methidathion in drinking water and food ranged from 0.172 to 0.777
μg/kg/day.  Children ages 1 to 2 years old had the highest potential combined acute exposure. 
The mean potential combined chronic exposure for all population subgroups ranged from 0.002
to 0.020 μg/kg/day.  The population subgroup with the highest potential combined chronic
exposure was non-nursing infants less than 1 year old.
Table 29. Potential Combined Acute and Chronic Dietary and Drinking Exposure to
Methidathion for Selected Population Subgroups
Population Subgroup
Exposure Dosage (μg/kg/day)
Acute
a Chronic
b
U.S. Population 0.321 0.002
Western Region 0.339 0.003
Nursing Infants (< 1 yr) 0.253 0.006
Non-nursing Infants (< 1  yr) 0.503 0.020
Children (1-2 yrs) 0.777 0.008
Children (3-5 yrs) 0.589 0.006
Children (6-12 yrs) 0.478 0.003
Youth (13-19 yrs) 0.335 0.002
Adults (20-49 yrs) 0.214 0.002
Adults (50+ yrs) 0.172 0.002
Females (13-49 yrs) 0.214 0.002
Females (13+ yrs/pregnant/not nursing) 0.295 0.006
Females (13+ yrs/nursing) 0.299 0.005
Workers (16+ yrs) 0.190 NA
a Based on 99.9th exposure percentile for each user-day population subgroups.
b Based on the annual average daily dosage for each population subgroups.
III.B.4.  Occupational Exposure
There are no residential, industrial or institutional uses of methidathion.  A number of
studies were available in which agricultural worker exposure to methidathion was evaluated; 
however, none of these studies were acceptable for reasons explained in the Exposure
Assessment Document (EAD) for methidathion (Beauvais, 2006).  Therefore, exposure estimatesMethidathion RCD (Revision 1) February 2007
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for handlers were derived using the Pesticide Handler Exposure Database (PHED) developed by
U.S. EPA, Health Canada and the American Crop Protection Association.  PHED provides mean
exposure estimates, but does not provide sufficient information to allow calculation of an upper
bound estimate.  A method for approximating the upper bound from PHED data was developed
by the Worker Health and Safety Branch which multiplied the mean by constants that increased
as the number of observations decreased (Powell, 2002).  The 95th percentile is used for acute
exposure to estimate the highest exposure an individual may realistically experience while
performing label-approved activities.  When the acute exposure estimate is based on surrogate
data (i.e., PHED), the 90% upper confidence limit on the 95th percentile is used to account for
some added uncertainty with using surrogate data.  The acute exposure estimate is referred to as
the Absorbed Daily Dosage (ADD).  Default assumptions of 50% dermal absorption, 100%
inhalation absorption and 70 kg body weight were used in the calculation of the ADD.  The
default dermal absorption value is based on a review of dermal absorption of several chemicals
(Donahue, 1996).  The default inhalation absorption was used in the absence of any chemical
specific data.  The ADDs for handlers ranged from 0.0034 mg/kg/day for mixer/loader/-
applicators (M/L/As) using low-pressure handwands to 5.86 mg/kg/day for airblast applicators
(Table 30). 
For seasonal and chronic exposure estimates, the 90% upper confidence limit on the
arithmetic mean estimate was used to account for the uncertainty due to using surrogate data. 
The seasonal exposure estimate is referred to as the Seasonal Absorbed Daily Dosage (SADD). 
The SADD represents the mean daily exposure during the high-use season.   The seasonal and
annual exposures are estimated to occur over 1, 1 and 2 months for aerial, airblast and
groundboom activities, respectively.  No seasonal or annual exposures were anticipated for
backpack sprayer and low-pressure handwand activities.  The SADDs for handlers ranged from
0.044 mg/kg/day for groundboom applicators to 1.55 mg/kg/day for aerial applicators (Table 30). 
The chronic exposure estimate or Annual Average Daily Dosage (AADD) is the SADD
multiplied by the annual use months per year divided by the number of months per year.  The
AADDs for handlers ranged from 0.004 mg/kg/day for airblast mixer/loaders (M/Ls) to 0.129
mg/kg/day for aerial applicators.   The Lifetime Average Daily Dosage (LADD) was calculated
to estimate carcinogenic risk for workers.  The LADD is calculated by multiplying the AADD by
40 years of work in a lifetime and dividing it by 75 years in a lifetime.  The LADDs for handlers
ranged from 0.002 mg/kg/day for airblast M/Ls to 0.069 mg/kg/day for aerial applicators.   
The ADDs for field workers were calculated from dislodgeable foliar residues (DFRs)
and transfer factors (TFs) using Equation 3 described in the EAD for methidathion (Beauvais,
2006).  The default assumptions of 50% dermal absorption, an 8 hr workday and a 70 kg body
weight were used in this equation.  The ADDs were calculated using DFRs that corresponded to
the expiration of the REIs (REI = 48 hrs, except for harvesting and thinning of citrus which was
30 days).  The ADDs ranged from 0.0007 mg/kg/day for harvesting/thinning of citrus to 0.093
mg/kg/day for scouting in cotton and safflower fields (Table 30).   The DFRs used in calculating
the SADDs corresponded to the REI plus 7 days for most activities (i.e., DFRs for 9 days),
except for thinning and harvesting of citrus in which the DFRs corresponded to the REI plus 10
days (i.e, DFRs for 40 days).   The SADDs for field workers ranged from 0.0007 mg/kg/day for
thinning of artichokes to 0.0045 mg/kg/day for scouting in cotton and safflower fields.  The
AADDs for field workers were calculated as they were for handlers by amortizing the SADDs Methidathion RCD (Revision 1) February 2007
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Table 30. Estimated Exposure Dosages for Methidathion in Agricultural Workers
a 
Exposure Scenarios
Acute ADD
b SADD
c AADD
d LADD
e
mg/kg/day mg/kg/day mg/kg/day mg/kg/day
Handlers
f
Aerial
M/L
g 1.15 0.460 0.038 0.020
Applicator 4.65 1.55 0.129 0.069
Flagger 1.90 0.475 0.040 0.021
Airblast
M/L 0.131 0.053 0.004 0.002
Applicator 5.86 1.46 0.122 0.065
Groundboom
M/L 0.158 0.063 0.011 0.006
Applicator 0.177 0.044 0.007 0.004
Backpack sprayer
M/L/A
h 0.191 NA NA NA
Low-pressure handwand
M/L/A 0.0034 NA NA NA
Field Workers
i
Scouting in cotton/safflower 0.093 0.0045 0.0011 0.0006
Harvesting/thinning citrus 0.007 0.0024 0.0008 0.0004
Thinning artichokes 0.014 0.0007 0.0001 0.00006
a Exposure estimates from Table 10-12 in the Exposure Assessment Document (EAD) for methidathion by Beauvais (2006).
b ADD = Acute Absorbed Daily Dosage. For handlers, acute ADD = [(short-term exposure) x (acres/day) x (rate lb
AI/acre)] / (70 kg body weight) fro handlers.  The short-term exposure is derived from Pesticide Handlers Exposure
Database (PHED, 1995) using the 90% upper confidence limit on the 95
th percentile.  Acres treated per day assumptions
differed  for each application method.  The acres applied per day were 350, 40 and 80 for aerial, airblast and groundboom
scenarios, respectively.  The application rates were 5, 5 and 3 lbs/acre for aerial, airblast and groundboom scenarios,
respectively.   The application rate and acres applied are not applicable to backpack sprayer and low-pressure handwand
scenarios.  For field workers, acute ADD (μg/kg/day) = [dermal absorption x  dislodgeable foliar residues (μg/cm
2) x
transfer factor (cm
2/hr) x exposure duration (hrs/day)]/body weight (kg).     
c SADD = Seasonal Absorbed Daily Dosage which is the 90% upper confidence limit on the mean estimate of the total
absorbed dosage from PHED during high-end use season for handlers.  For field workers, the SADDs were calculated
using DFRs from corresponded to the REI plus 7 days for most activities (i.e., DFRs for 9 days), except for thinning and
harvesting of citrus in which the DFRs corresponded to the REI plus 10 days (i.e, DFRs for 40 days)
d AADD = Annual Average Daily Dosage which is the SADD x (annual use months per year) / 12 months.
e LADD = Lifetime Average Daily Dosage which is the AADD x (40 years of work in a lifetime) / (75 years in a lifetime).   
f The seasonal and annual exposures are estimated to occur over 1, 1, and 2 months for aerial, airblast, and groundboom
activities, respectively.  Seasonal and annual exposures were not anticipated for backpack sprayer and low-pressure
handwand activities.  
g M/L = Mixer/Loader
h M/L/A = Mixer/Loader/Applicator
i The estimated seasonal exposure for field workers was assumed to be 3, 3 and 2 months for scouting in cotton/safflower,
harvesting/thinning citrus, and thinning artichokes, respectively.  The estimated annual exposure for field workers was
assumed to be 3, 4 and 2 months for scouting in cotton/safflower, harvesting/thinning citrus, and thinning artichokes,
respectively. Methidathion RCD (Revision 1) February 2007
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over a year (i.e., multiplying the SADD by the annual use months per year and dividing by 12
months).  The estimated seasonal exposure for field workers was assumed to be 3, 3 and 2
months for scouting in cotton/safflower, harvesting/thinning citrus, and thinning artichokes,
respectively.  The estimated annual exposure for field workers was assumed to be 3, 4 and 2
months for scouting in cotton/safflower, harvesting/thinning citrus, and thinning artichokes, 
respectively.  The AADDs for field workers were between 0.0001 and 0.0011 mg/kg/day.   The
LADDs for field workers ranged from 0.00006 to 0.0006 mg/kg/day.
III.B.5.  Application Site and Ambient Air Exposure
III.B.5.a.  Application Site Air Exposure
Individuals might be exposed to methidathion if they are working or standing adjacent to
fields that are being treated or have recently been treated (i.e., bystander exposure).  Air
monitoring for methidathion was conducted following an application to an orange grove in
Tulare County in July 1991 (Royce et al., 1993).  Only three monitoring stations were setup
based on the prevailing wind direction (from the northwest), but during the application the winds
were primarily from the southwest.  Consequently, no samplers were located downwind where
the highest air concentrations were expected.  Therefore, surrogate data from an application site
monitoring study for methyl parathion were used to estimate exposure to methidathion
(Beauvais, 2006).  The methyl parathion application monitoring study was conducted in July of
2003 following a walnut orchard application in San Joaquin county.  The air was monitored for 5
days following application.  A downwind sampler with the highest peak and daily concentrations
was selected to evaluate bystander exposure.  The methyl parathion study was considered an
appropriate surrogate for methidathion due to similarity in equipment used, timing of
applications and vapor pressure.  Both studies had summer, nighttime applications to tree crops
using airblast applicators with low wind and little vertical mixing resulting in likely higher off-
site concentrations.  In addition, neither methidathion or methyl parathion were very volatile
with vapor pressures less than 10
-4 mmHg.  The vapor pressure for methyl parathion (1.7 × 10
-5
mmHg at 25°C; Spencer et al., 1979) was slightly higher than that for methidathion (3.37 × 10
-6
mmHg at 25°C; Rordorf, 1988) suggesting the air concentrations in this study might be higher
than they would be with methidathion.  The exposure estimates were not adjusted downward
based on the difference in vapor pressures because of the uncertainties associated with the other
factors affecting air concentrations.  However, the exposure estimates were adjusted upward
since the application rate in the methyl parathion study (2 lbs/acre) was less than the maximum
application rate for methidathion on citrus (5 lbs/acre).  Although the methyl paraoxon was
monitored in this study, it was only detected in a few samples during the first few sampling
intervals.  For all the samples in which no methyl paraoxon residues were detected, the air
concentration was assumed to be at the reporting limit or (0.077 μg/m
3 - 24 hours; 0.155 μg/m
3 -
11 hours) for acute exposure and ½ of reporting limit for seasonal and chronic exposure.  The
exposure estimates below represent the sum of the methidathion and methidaoxon exposure. 
The maximum concentration detected was used to calculate 1-hour exposures, while the 21-hour
time-weighted average (TWA) was used to estimate 24-hour exposure.  
Table 31 summarizes the exposure estimates for methidathion at the application site.  The
1-hr acute exposure estimates (ADDs) were 4.62 μg/kg for infants and 0.832 μg/kg for adults. 
The 24-hr ADDs at the application site were 8.04 and 3.82 for infants and adults, respectively.  Methidathion RCD (Revision 1) February 2007
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Table 31. Estimated Exposure for the General Public to Methidathion in Application Site and
Ambient Air 
Exposure Dosages Infants Adults
Application Site
a
ADD
b - 1 hr (μg/kg) 4.62 0.832
ADD - 24 hr (μg/kg) 8.04 3.82
SADD
d (μg/kg/day) 0.936 0.444
AADD
e (μg/kg/day) 0.157 0.074
Ambient
c
SADD
d (μg/kg/day) 0.060 0.028
AADD
e (μg/kg/day) 0.045 0.021
a Application site exposure dosages based on surrogate data from an application site monitoring study for methyl parathion
conducted in a walnut orchard in San Joaquin county during July  of 2003.  The exposure estimates represent the sum of
the methidathion and methidaoxon exposure after adjusting for the application rate.
b ADD = Absorbed Daily Dosage.  The 1-hr exposure is based on the maximum 11-hr TWA concentration.  The 24-hr
exposure was based on the highest 21-hr TWA concentration.  A default inhalation absorption of 100%  was used.  For
more explanation of the calculations, see the exposure assessment document for methidathion prepared by Beauvais
(2006).  
c  Ambient exposure dosages based on air concentrations at the Jefferson site in a study in Tulare County conducted by
ARB.
d SADD = Seasonal Average Daily Dosage using on the mean air concentration during the monitoring period.  No
adjustment was made for application rate with application site air.
e AADD = Annual Average Daily Dosage = SADD x annual use months/12 months.  Annual use months were assumed to
be 2 months per year for application site air and 9 months per year for ambient air.
Although seasonal and chronic exposure is unlikely around tree crops due to the limited number
of applications (1-2) allowed per year, seasonal and chronic exposure could occur near artichoke
fields since up to 8 applications per year are allowed with a minimum 2-week interval between
applications.  Therefore, seasonal and chronic exposure estimates were calculated for application
site air assuming the high-use season for artichokes to be 2-months.  The SADDs at the 
application site were 0.936 μg/kg/day for infants and 0.444 μg/kg/day for adults.  The AADDs
were 0.157 and 0.074 μg/kg/day for infants and adults, respectively.
III.B.5.b.  Ambient Air Exposure
Ambient air monitoring data of methidathion and the oxon was also conducted in Tulare
County at four sites all within 0.25 mile of citrus groves (Sunnyside Union Elementary School in
Strathmore, Jefferson Elementary School in Lindsay, Exeter Union High School in Exeter and
the University of California Lindcove Field Station in Exeter) (Royce et al., 1993).   The
background site was the ARB Ambient Air Monitoring Station in Visalia.   Samples were
collected during a 4-week interval between June 27 and July 25 of 1991.   In 1991, Tulare 
County had the highest use of methidathion in California (75,582 lbs.) which occurred primarily
in June and July.   The Jefferson Elementary School in Lindsay had the highest daily and average
air concentration.  Therefore, the risk estimates were initially calculated using the exposure
estimates from this site, assuming that if they were acceptable at this location, they would be
acceptable at the other three locations in Tulare County where the air concentrations were lower. 
As with application site monitoring the air concentrations of methidathion and its oxon were
added together to derive the exposure dosages, assuming they were equally toxic.  The exposureMethidathion RCD (Revision 1) February 2007
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estimates for ambient air are also summarized in Table 31.   The SADDs were estimated to be
0.060 and 0.028 μg/kg/day for infants and adults, respectively, using the mean ambient air
concentration at the Jefferson site during the 4-week monitoring period.  The AADD is the
average air concentration for a year assuming the season of potential exposure is 9 months per
year for methidathion.  The AADDs for the Jefferson site were 0.045 and 0.021 μg/kg/day for
infants and adults, respectively.
III.B.6.  Aggregate Exposure
III.B.6.a.  Agricultural Workers
The exposure to methidathion through the diet, drinking water and residential (ambient)
air was also considered in the potential exposure for agricultural workers (Table 32).  The acute
dietary and drinking water exposure to methidathion for workers (males and females 16 years
and older) was estimated to be 0.190 μg/kg/day based on the 95th percentile of user-day
exposure.   The chronic dietary and drinking water exposure for workers was estimated to be
0.002 μg/kg/day based on the average exposure for the U.S. population (custom subpopulations 
Table 32.  Estimated Aggregate Exposure Dosages for Methidathion in Agricultural Workers
a 
Exposure Scenarios
Acute Seasonal Chronic Lifetime
mg/kg/day mg/kg/day mg/kg/day mg/kg/day
Handlers
Aerial
M/L
b 1.15 0.460 0.038 0.020
Applicator 4.65 1.55 0.129 0.069
Flagger 1.90 0.475 0.040 0.021
Airblast
M/L 0.134 0.053 0.004 0.002
Applicator 5.86 1.46 0.122 0.065
Groundboom
M/L 0.161 0.063 0.011 0.006
Applicator 0.180 0.044 0.007 0.004
Backpack sprayer
M/L/A
c 0.194 NA NA NA
Low-pressure handwand
M/L/A 0.006 NA NA NA
Field Workers
Scouting in cotton/safflower 0.096 0.0048 0.0012 0.0007
Harvesting/thinning citrus 0.010 0.0027 0.0009 0.0005
Thinning artichokes 0.017 0.0010 0.00015 0.00011
a Aggregate exposure estimates are the sum of the occupational exposure estimates from Table 30 and the dietary and
drinking water estimates from Table 29 and ambient air estimates from Table 31.  The acute dietary and drinking water
estimates for workers was 0.190 μg/kg.  The seasonal and chronic dietary and drinking water estimates for workers were
0.002 μg/kg/day based on the U.S. population.  The ambient air exposure estimates were adjusted to 2.56, 0.297 and 0.050
μg/kg/day for acute, seasonal and chronic assuming workers are exposed to application site air for a maximum of 16 hours
per day at home which was adjacent to the treated fields.
b M/L = Mixer/Loader
c M/L/A = Mixer/Loader/ApplicatorMethidathion RCD (Revision 1) February 2007
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could not be calculated for chronic exposure).   The application site air exposure estimates for
adults were used to estimate aggregate exposure assuming workers lived adjacent to treated
fields.   The application site air exposure estimates were adjusted to 2.56, 0.297 and 0.050
μg/kg/day for acute, seasonal and chronic exposure, respectively, assuming a maximum exposure
of 16 hours per day to residential air for agricultural workers.  The acute aggregate exposures for 
workers ranged from 0.006 mg/kg/day to 5.86 mg/kg/day.  The seasonal aggregate exposure for
ranged from 0.0010 mg/kg/day to 1.55 mg/kg/day  The chronic aggregate exposure for workers
ranged from 0.00015 mg/kg/day to 0.129 mg/kg/day.  The lifetime aggregate exposure for
workers ranged from 0.00011 mg/kg/day to 0.069 mg/kg/day.   The dietary, drinking water and
ambient air exposure was less than 5% of the aggregate exposure for most workers. 
Consequently, its addition had little impact on the aggregate exposure.  Only for work activities
where the occupational exposure was low (M/L/As using low-pressure handwands, field workers
harvesting/thinning citrus, thinning artichokes) did the dietary, drinking water and ambient air
represent a significant contribution.  For these activities, the dietary, drinking water and ambient
air exposure combined represented 6%-46% of the aggregate exposure. 
III.B.6.b.  General Public
The aggregate exposure to methidathion through the diet, drinking water and residential
(ambient) air was considered in the potential exposure for the general public (Table 33).  The
estimated acute combined dietary and drinking water exposure to methidathion was assumed to
be 0.503 and 0.321 μg/kg/day for infants (non-nursing, less than 1 year old) and adults (U.S.
population), respectively.  Since no seasonal exposure was estimated for dietary and drinking 
 
Table 33. Estimated Aggregate Exposure Dosages for Methidathion in the General Public 
Exposure Dosages Infants Adults
Application Site
a
ADD
b - 1 hr (μg/kg) 5.12 1.15
ADD - 24 hr (μg/kg) 8.54 4.14
SADD
d (μg/kg/day) 0.956 0.446
AADD
e (μg/kg/day) 0.177 0.076
Ambient
c
SADD
d (μg/kg/day) 0.080 0.030
AADD
e (μg/kg/day) 0.065 0.023
a The aggregate exposure estimates are the sum of the combined dietary and drinking water exposure (Table 29) and the
ambient air exposure (Table 31).  The combined acute dietary and drinking water exposure was assumed to be 0.503
μg/kg/day for infants based on non-nursing infants less than 1 years old and 0.321 μg/kg/day for adults based on the U.S.
population.  The combined chronic dietary and drinking water exposure was assumed to be 0.020 μg/kg/day for infants
(non-nursing infants less than 1 year old) and 0.002 μg/kg/day for adults (U.S. population).
b ADD = Absorbed Daily Dosage.  The 1-hr exposure is based on the maximum 11-hr TWA concentration.  The 24-hr
exposure was based on the highest 21-hr TWA concentration.  A default inhalation absorption of 100%  was used.  For
more explanation of the calculations, see the exposure assessment document for methidathion prepared by Beauvais
(2006).  
c  Ambient exposure dosages based on air concentrations at the Jefferson site in a study in Tulare County conducted by
ARB.
d SADD = Seasonal Average Daily Dosage using on the mean air concentration at the Jefferson site during the monitoring
period. 
e AADD = Annual Average Daily Dosage = SADD x annual use months/12 months.  Annual use months were assumed to
be 2 months per year for application site air and 9 months per year for ambient air.Methidathion RCD (Revision 1) February 2007
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water exposure, the chronic dietary and drinking water exposures were used estimating seasonal
aggregate exposure.  The estimated chronic dietary and drinking water exposure was assumed to
be 0.020 μg/kg/day for infants (non-nursing, less than 1 year old) and 0.002 μg/kg/day for adults
(U.S. population), respectively.  The application site air exposure from Table 31 was used for the
residential air exposure in the acute aggregate exposure for infants and adults.  The ambient air 
exposure from Table 31 was used for the residential air exposure in the seasonal and chronic
aggregate exposure estimates.  The 1-hr acute aggregate exposure at the application site for
infants and adults was 5.12 and 1.15 μg/kg, respectively.  The 24-hr acute aggregate exposure
estimates increased to 8.54 and 4.14 μg/kg for infants and adults, respectively.  The seasonal
aggregate exposure at the application site for infants and adults was 0.956 and 0.446 μg/kg/day,
respectively.  The chronic aggregate exposure was 0.177 and 0.076 μg/kg/day for infants and
adults , respectively.  The seasonal and chronic exposure estimates for ambient air at the
Jefferson school site were more than an order of magnitude lower.  The seasonal aggregate
exposure estimates to ambient air for infants and adults was 0.080 and 0.030 μg/kg/day,
respectively.  The chronic aggregate exposure to ambient air was 0.065 and 0.023 μg/kg/day for
infants and adults , respectively.
III.C.  RISK CHARACTERIZATION
The risk for non-carcinogenic human health effects is expressed as a margin of exposure
(MOE).  The MOE is the ratio of the NOEL from experimental animal studies to the human
exposure dosage.
Marginof Exposure
NOEL
ExposureDosage
=
The risk for carcinogenic effects was calculated by multiplying the carcinogenic potency
by the exposure dosage.
CarcinogenicRisk Carcinogenic Potency x ExposureDosage =
III.C.1.  Dietary Exposure
The MOEs for dietary exposure to methidathion were calculated for the various
population subgroups using the NOEL for acute toxicity (0.18 mg/kg/day) and the acute dietary
exposure dosages from Table 27.   With the Tier 3 analysis, the MOEs for acute toxicity ranged
from 230 for children 1-2 years old to 1,000 for adults 50 years and older (Table 34).  The MOEs
for chronic dietary exposure to methidathion were calculated for the various population
subgroups using the NOEL for chronic toxicity (0.15 mg/kg/day) and the Tier 3 chronic dietary
exposure dosages in Table 27.  The chronic MOEs ranged from 8,000 for non-nursing infants 
less than 1 year old to 110,000 for adults 20 to 49 years old.  The estimated carcinogenic risk
from dietary exposure was calculated using the Tier 3 chronic exposure estimate for the U.S. 
population and the carcinogenic potency.   The estimated carcinogenic potency of methidathion
based on the incidence of  liver hepatocellular adenomas and carcinomas in male mice ranged
from 0.34 (mg/kg/day)
-1 for the maximum likelihood estimate (MLE) to 0.53 (mg/kg/day)
-1 for Methidathion RCD (Revision 1) February 2007
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Table 34. Estimated Margins of Exposure for Potential Dietary Exposure to Methidathion  for
Selected Population Subgroups
Population Subgroup
Margins of Exposure
a
Acute Chronic
U.S. Population 550 69,000
Western Region 510 52,000
Nursing Infants (< 1 yr) 650 29,000
Non-nursing Infants (< 1  yr) 360 8,000
Children (1-2 yrs) 230 20,000
Children (3-5 yrs) 300 29,000
Children (6-12 yrs) 380 51,000
Youth (13-19 yrs) 540 90,000
Adults (20-49) 840 110,000
Adults (50+ yrs) 1,000 100,000
Females (13-49 yrs) 840 98,000
Females (13+ yrs, pregnant/not nursing) 610 28,000
Females (13+ yrs, nursing) 600 35,000
Workers (16+ yrs) 920 NA
a Margin of Exposure = NOEL / Exposure Dosage.  Acute NOEL = 0.18 mg/kg (male rats, reduced ChE activity in
cerebral cortex).  Chronic NOEL = 0.15 mg/kg/day (dogs, elevated liver enzymes in serum and histological lesions in
the liver).  Exposure dosages from Table 27.  Values rounded to two significant figures.
the 95%  upper bound (95% UB).  The carcinogenic risk estimates ranged from 7.3 x 10
-7 (MLE)
to 1.1 x 10
-6 (UB). 
III.C.2.  Drinking Water Exposure
The MOEs for exposure to methidathion in drinking water were calculated for the
various population subgroups using the NOEL for acute toxicity (0.18 mg/kg/day) and the acute
drinking water exposure dosages in Table 28.   The MOEs for drinking water exposure to
methidathion are summarized in Table 35.  The acute MOEs ranged from 15,000 for non-nursing
infants less than one year old to 120,000 for pregnant, non-nursing females 19 years and older. 
The chronic MOEs for drinking water ranged from 160,000 for non-nursing infants less than one
year old to 900,000 for youth between 13 and 19 years old.  The estimated carcinogenic risk 
from exposure to methidathion in drinking water was calculated using the chronic water
exposure for the U.S. population and the carcinogenic potency.  The estimated carcinogenic risk
for drinking water exposure alone ranged from 7.9 x 10
-8 (MLE) to 1.2 x 10
-7 (95% UB).  
III.C.3.  Combined Dietary and Drinking Water Exposure
The MOEs for combined exposure to methidathion in the diet and drinking water were
calculated for the various population subgroups using the NOEL for acute toxicity (0.18
mg/kg/day) and the combined exposure estimates in Table 29.   The MOEs for combined dietary
and drinking water exposure are summarized in Table 36.  The acute MOEs for combined
exposure ranged from 230 for children 1 to 2 years old to 1,000 for adults 50 years and older. Methidathion RCD (Revision 1) February 2007
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Table 35. Estimated Margins of Exposure for Potential Drinking Water Exposure to
Methidathion for Selected Population Subgroups
Population Subgroup
Margins of Exposure
a
Acute Chronic
U.S. Population 43,000 650,000
Western Region 39,000 560,000
Nursing Infants (< 1 yr) 24,000 530,000
Non-nursing Infants (< 1  yr) 15,000    160,000
Children (1-2 yrs) 41,000 440,000
Children (3-5 yrs) 42,000 470,000
Children (6-12 yrs) 72,000 670,000
Youth (13-19 yrs) 67,000 900,000
Adults (20-49 yrs) 58,000 690,000
Adults (50+ yrs) 85,000 660,000
Females (13-49 yrs) 62,000 700,000
Females (13+ yrs/pregnant/not nursing) 120,000 670,000
Females (13+ yrs/nursing) 83,000 470,000
Workers (16+ yrs) 62,000 NA    
a Margin of Exposure = NOEL / Exposure Dosage.  Acute NOEL = 0.18 mg/kg (male rats, reduced ChE activity in
cerebral cortex).  Chronic NOEL = 0.15 mg/kg/day (dogs, elevated liver enzymes in serum and histological lesions in
the liver).  Exposure dosages from Table 28.  Values rounded to two significant figures.
The chronic MOEs for combined exposure ranged from 7,700 for non-nursing infants less than
one year old to 92,000 for adults 20 to 49 years old.  When drinking water exposure was
combined with the dietary exposure, the estimated carcinogenic risk increased slightly ranging
from 8.2 x 10
-7 (MLE) to 1.3 x 10
-6 (95% UB). 
III.C.4.  Occupational Exposure
The acute MOEs for occupational exposure to methidathion were calculated using the
NOEL for acute toxicity (0.18 mg/kg/day) and the ADDs in Table 30.   The MOEs for acute
exposure ranged from < 1 for aerial M/Ls to 53 for M/L/As using low-pressure hand wands
(Table 37).  The seasonal MOEs for occupational exposure to methidathion were calculated
using the subchronic NOEL (0.18 mg/kg/day) and the SADDs in Table 30.  The MOEs for
seasonal exposure ranged from < 1 for aerial M/Ls to 260 for thinning of artichokes (Table 37). 
The MOEs for chronic occupational exposure to methidathion were calculated for the various
exposure scenarios using the NOEL for chronic toxicity (0.15 mg/kg/day) and the AADDs in
Table 30.  The chronic MOEs ranged from 1 for aerial and airblast applicators to 1500 for
thinning of artichokes (Table 37).
The carcinogenic risk for agricultural workers exposed to methidathion was calculated
using the LADDs in Table 30.  The estimated carcinogenic risk for agricultural workers using
the MLE for carcinogenic potency ranged 2.0 x 10
-5 to 2.3 x 10
-2 (Table 38).  When the 95% UB
for carcinogenic potency was used, the estimated carcinogenic risk for workers ranged from 3.2
x 10
-5 to 3.7 x 10
-2.Methidathion RCD (Revision 1) February 2007
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Table 36.  Estimated Margins of Exposure for Potential Combined Dietary and Drinking Water
Exposure to Methidathion for Selected Population Subgroups
Population Subgroup
Margins of Exposure
a
Acute Chronic
U.S. Population 560 63,000
Western Region 530 47,000
Nursing Infants (< 1 yr) 710 27,000
Non-nursing Infants (< 1  yr) 360 7,700
Children (1-2 yrs) 230 19,000
Children (3-5 yrs) 300 27,000
Children (6-12 yrs) 380 48,000
Youth (13-19 yrs) 540 82,000
Adults (20-49 yrs) 840 92,000
Adults (50+ yrs) 1,000 90,000
Females (13-49 yrs) 840 86,000
Females (13+ yrs/pregnant/not nursing) 610 27,000
Females (13+ yrs/nursing) 600 33,000
Workers (16+ yrs) 940 NA   
a Margin of Exposure = NOEL / Exposure Dosage.  Acute NOEL = 0.18 mg/kg (male rats, reduced ChE activity in
cerebral cortex).  Chronic NOEL = 0.15 mg/kg/day (dogs, elevated liver enzymes in serum and histological lesions
in the liver).  Exposure dosages from Table 29. Values rounded to two significant figures.
III.C.5.  Application Site and Ambient Air Exposure
The MOEs for acute exposure to methidathion were calculated using the acute NOEL
(0.18 mg/kg/day) and the ADDs for application site and ambient air in Table 31.  The 1-hr acute
MOEs for the application site were 39 for infants and 220 for adults (Table 39).  The 24-hr acute
MOEs for the application site ranged from 22 for infants to 47 for adults.  The MOEs for
seasonal exposure to methidathion were calculated using the NOEL from the 90-day
neurotoxicity study in rats (0.18 mg/kg/day) and the SADDs from Table 31.  The seasonal MOEs
for the application site were 190 for infants and 400 for adults (Table 39).   The seasonal MOEs
for ambient air at the Jefferson school site ranged from 3,000 for infants to 6,400 for adults
(Table 39).  The MOEs for chronic exposure to methidathion were calculated using the chronic
NOEL of 0.15 mg/kg/day and the AADDs from Table 31.  The chronic MOEs for the application
site were 950 for infants and 2,000 for adults (Table 39).  The MOEs for chronic exposure to
methidathion in ambient air ranged from 3,300 for infants to 7,100 for adults.  The carcinogenic
risk was calculated using the AADDs for adults (Table 31) and the estimated carcinogenic
potency based on liver hepatocellular adenomas and carcinomas in male mice (0.34 
(mg/kg/day)
-1 for MLE or 0.53 (mg/kg/day)
-1 for 95% UB).  For the application site, the
carcinogenic risk estimates were between 2.5 x 10
-5 (MLE) and 3.9 x 10
-5 (95% UB).  The
estimated carcinogenic risk from lifetime exposure to ambient air at the Jefferson site ranged
from 7.1 x 10
-6 (MLE) to 1.1 x 10
-5 (95% UB). Methidathion RCD (Revision 1) February 2007
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Table 37. Estimated Margins of Exposure for Agricultural Workers Exposed to Methidathion
a
Exposure Scenarios Acute Seasonal Chronic
Handlers
Aerial
M/L
a < 1 < 1 4
Applicator < 1 < 1 1
Flagger < 1 < 1 4
Airblast
M/L 1 3 38
Applicator < 1 < 1  1
Groundboom
M/L 1 3 14
Applicator 1 4 21
Backpack sprayer
M/L/A
c 1N A N A
Low-pressure handwand
M/L/A 53 NA NA
Field Workers
Scouting in cotton/safflower 2 40 140
Harvesting/thinning citrus 26 75 190
Thinning artichokes 13 260 1500
a Margin of Exposure = NOEL / Exposure Dosage.  Acute  NOEL = 0.18 mg/kg (male rats, cortex ChE inhibition). 
Seasonal NOEL = 0.18 mg/kg/day (rats, RBCs and regional brain ChE inhibition).  Chronic NOEL = 0.15 mg/kg/day
(dogs, elevated liver enzymes in serum and histological lesions in the lever).  Exposure dosages from Table 30.  Values
rounded to two significant figures or the nearest whole number if less than 10.
b M/L = Mixer/Loader
c M/L/A = Mixer/Loader/Applicator
III.C.6.  Aggregate Exposure
The acute aggregate MOEs for agricultural workers were calculated using the acute
aggregate exposure estimates in Table 32 and the NOEL at 2-weeks in the 90-day neurotoxicity
study in rats (0.18 mg/kg/day for ChE inhibition in cortex (M)).  Since dietary, drinking water
and residential air exposure contributed less than 5% to the aggregate exposure for most
agricultural workers, the aggregate MOEs were not significantly different from the occupational
MOEs for most workers (Table 40).  The exceptions were MLAs using low-pressure handwands
and field workers doing harvesting and thinning of citrus and thinning of artichokes.  The acute
aggregate MOEs were 30 for MLAs using low-pressure handwands, 18 for field workers
harvesting/thinning citrus, and 11 for field workers thinning artichokes.   The MOEs for seasonal
aggregate exposure were calculated using the aggregate seasonal exposure estimates in Table 32
and the subchronic NOEL from the subchronic neurotoxicity study in rats (0.18 mg/kg/day). 
Only the seasonal aggregate MOEs for field workers were quantitatively different from the
MOEs for occupational exposure alone (Table 40).  The MOEs for chronic aggregate exposure
were calculated using the chronic exposure estimates in Table 32 and the chronic NOEL from
the 1-year dog study (0.15 mg/kg/day).  There was also no quantitative impact on the chronic
MOEs when occupational exposure was aggregated with dietary, drinking water and ambient air
exposure, except for field workers (Table 40).Methidathion RCD (Revision 1) February 2007
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 Table 38. Estimated Carcinogenic Risk for Agricultural workers for Potential Lifetime
Exposure to Methidathion
a
Exposure Scenarios
Maximum Likelihood
Estimate
95% Upper Bound
Handlers
Aerial
M/L 6.8 x 10
-3 1.1 x 10
-2
Applicator 2.3 x 10
-2 3.7 x 10
-2
Flagger 7.1 x 10
-3 1.1 x 10
-2
Airblast
M/L 6.8 x 10
-4 1.1 x 10
-3
Applicator 2.2 x 10
-2 3.4 x 10
-2
Groundboom
M/L 2.0 x 10
-3 3.2 x 10
-3
Applicator 1.4 x 10
-3 2.1 x 10
-3
Backpack sprayer
M/L/A NA NA
Low-pressure handwand
M/L/A NA NA
Field Workers
Scouting in cotton/safflower 2.0 x 10
-4 3.2 x 10
-4
Harvesting/thinning citrus 1.4 x 10
-4 2.1 x 10
-4
Thinning of artichokes 2.0 x 10
-5 3.2 x 10
-5
a Carcinogenic Risk = Carcinogenic Potency x Exposure Dosage.  The exposure dosage was the LADD in Table 30. The
maximum likelihood estimate for carcinogenic potency was 0.34 (mg/kg/day)
-1.  The 95% upper bound estimate for
carcinogenic potency was 0.53 (mg/kg/day)
-1.
Table 39. Estimated Margins of Exposure for Potential Application Site and Ambient Air
Exposure to Methidathion for the General Public
a
Exposure Scenarios Infants Adults
MOE
b % RfC
c MOE % RfC
Application Site
Acute - 1 hr 39 250 220 46
Acute - 24 hr 22 440 47 210
Seasonal 190 51 400 25
Chronic 950 11 2,000 5
Ambient
Seasonal 3,000 3 6,400 2
Chronic 3,300 3 7,100 1
a Margin of Exposure = NOEL / Exposure Dosage.  Acute NOEL = 0.18 mg/kg (male rats, cortex ChE inhibition).  Seasonal NOEL = 0.18
mg/kg/day (rats, RBCs and regional  brain ChE inhibition).  Chronic NOEL = 0.15 mg/kg/day (dogs, elevated liver enzymes in serum and
histological lesions in the lever).  Exposure dosages from Table 31.  Values rounded to two significant figures.
b MOE = Margin of Exposure
c % RfC = Percentage of Reference Concentration.  The acute, seasonal and chronic reference concentration for methidathion are 3.1 μg/m
3
(0.25 ppb), 3.1 μg/m
3 (0.25 ppb) and 2.5 μg/m
3 (0.21 ppb).  See section VI. Reference Doses/Concentrations for explanation of
calculations. Values rounded to two significant figures.Methidathion RCD (Revision 1) February 2007
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Table 40. Estimated Margins of Exposure for Aggregate Exposure to Methidathion in
Agricultural Workers
a
Exposure Scenarios Acute Seasonal Chronic
Handlers
Aerial
M/L
a < 1 < 1 4
Applicator < 1 < 1 1
Flagger < 1 < 1 4
Airblast
M/L 1 3 38
Applicator < 1 < 1 1
Groundboom
M/L 1 3 14
Applicator 1 4 21
Backpack sprayer
M/L/A
c 1N A N A
Low-pressure handwand
M/L/A 30 NA NA
Field Workers
Scouting in cotton/safflower 2 38 120
Harvesting/thinning citrus 18 67 170
Thinning artichokes 11 180 1000
a Margin of Exposure = NOEL / Exposure Dosage.  Acute  NOEL = 0.18 mg/kg (male rats, cortex ChE inhibition).  Seasonal NOEL = 0.18
mg/kg/day (rats, RBC and regional brain ChE inhibition).  Chronic NOEL = 0.15 mg/kg/day (dogs, elevated liver enzymes in serum and
histological lesions in the lever).  Exposure dosages from Table 32.  Values rounded to two significant figures or the nearest whole
number if less than 10.
b M/L = Mixer/Loader
c M/L/A = Mixer/Loader/Applicator
The aggregate carcinogenic risk for agricultural workers exposed to methidathion was
calculated using the lifetime exposure estimates in Table 32.  The estimated carcinogenic
potency of methidathion based on the incidence of  liver hepatocellular adenomas and
carcinomas in male mice ranged from 0.34 (MLE) to 0.53 (95% UB) (mg/kg/day)
-1.  The
estimated aggregate carcinogenic risk for agricultural workers were not significantly different
from the estimated carcinogenic risk from occupational exposure alone, except for field workers
(Table 41).
The aggregate MOEs for the general public were calculated using the aggregate exposure
estimates in Table 33 and the corresponding NOELs for acute, subchronic and chronic toxicity
(0.18, 0.18 and 0.15 mg/kg/day, respectively).  The 1-hr acute aggregate MOEs at the application
site for infants and adults were 35 and 160, respectively (Table 42).  The 24-hr acute aggregate
MOEs were 21 for infants and 43 for adults.  The seasonal aggregate MOEs at the application
site were 190 for infants and 400 for adults.  The chronic aggregate MOEs at the application site
were 850 and 2,000 for infants and adults, respectively.   The seasonal aggregate MOEs for
ambient air at the Jefferson site were 2,200 for infants and 6,000 for adults.  The chronic
aggregate MOEs for ambient air at the Jefferson site were 2,300 and 6,500 for infants and adults,Methidathion RCD (Revision 1) February 2007
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Table 41. Estimated Aggregate Carcinogenic Risk for Agricultural Workers for Potential
Lifetime Exposure to Methidathion
a
Exposure Scenarios
Maximum Likelihood
Estimate
95% Upper Bound
Handlers
Aerial
M/L 6.8 x 10
-3 1.1 x 10
-2
Applicator 2.3 x 10
-2 3.7 x 10
-2
Flagger 7.1 x 10
-3 1.1 x 10
-2
Airblast
M/L 6.8 x 10
-4 1.1 x 10
-3
Applicator 2.2 x 10
-2 3.4 x 10
-2
Groundboom
M/L 2.0 x 10
-3 3.2 x 10
-3
Applicator 1.4 x 10
-3 2.1 x 10
-3
Backpack sprayer
M/L/A NA NA
Low-pressure handwand
M/L/A NA NA
Field Workers
Scouting in cotton/safflower 2.4 x 10
-4 3.7 x 10
-4
Harvesting/thinning citrus 1.7 x 10
-4 2.6 x 10
-4
Thinning of artichokes 3.7 x 10
-5 5.8 x 10
-5
a Carcinogenic Risk = Carcinogenic Potency x Exposure Dosage.  The exposure dosage was the LADD in Table 32. The
maximum likelihood estimate for carcinogenic potency was 0.34 (mg/kg/day)
-1.  The 95% upper bound estimate for
carcinogenic potency was 0.53 (mg/kg/day)
-1.
Table 42. Estimated Margins of Exposure for Aggregate Exposure to Methidathion for the
General Public
a
Exposure Scenarios Infants Adults
MOE
b % RfC
c MOE % RfC
Application Site
Acute - 1 hr 35 280 160 64
Acute - 24 hr 21 470 43 230
Seasonal 190 52 400 25
Chronic 850 12 2,000 5
Ambient
Seasonal 2,200 4 6,000 2
Chronic 2,300 4 6,500 2
a Margin of Exposure = NOEL / Exposure Dosage.  Acute NOEL = 0.18 mg/kg (male rats, cortex ChE inhibition).  Seasonal NOEL = 0.18
mg/kg/day (rats, RBCs and regional  brain ChE inhibition).  Chronic NOEL = 0.15 mg/kg/day (dogs, elevated liver enzymes in serum and
histological lesions in the lever).  Exposure dosages from Table 33.  Values rounded to two significant figures.
b MOE = Margin of Exposure
c % RfC = Percentage of Reference Concentration.  The acute, seasonal and chronic reference concentration for methidathion are 3.1 μg/m
3
(0.25 ppb), 3.1 μg/m
3 (0.25 ppb) and 2.5 μg/m
3 (0.21 ppb).  See section VI. Reference Doses/Concentrations for explanation of
calculations. Values rounded to two significant figures.Methidathion RCD (Revision 1) February 2007
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respectively.   The aggregate carcinogenic risk for the general public was calculated using the
chronic aggregate exposure estimate for adults and the estimated carcinogenic potency based on
liver hepatocellular adenomas and carcinomas in male mice (0.34 (mg/kg/day)
-1 for MLE or 0.53
(mg/kg/day)
-1 for 95% UB).  The aggregate carcinogenic risk at the application site ranged from
2.6 x 10
-5 (MLE) to 4.0 x 10
-5 (95% UB).  For ambient air, the aggregate carcinogenic risk was
estimated to be between 7.8 x 10
-6 (MLE) and 1.2 x 10
-5 (95% UB).Methidathion RCD (Revision 1) February 2007
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IV.  RISK APPRAISAL
Risk assessment is the process used to evaluate the potential for human exposure and the
likelihood that the adverse effects observed in toxicity studies with laboratory animals will occur
in humans under the specific exposure conditions.  Every risk assessment has inherent
limitations on the application of existing data to estimate the potential risk to human health. 
Therefore, certain assumptions and extrapolations are incorporated into the hazard identification,
dose-response assessment, and exposure assessment processes.  These, in turn, result in
uncertainty in the risk characterization which integrates all the information from the previous
three processes.  Qualitatively, risk assessments for all chemicals have similar uncertainties. 
However, the degree or magnitude of the uncertainty can vary depending on the availability and
quality of the data, and the types of exposure scenarios being assessed.  Specific areas of
uncertainty associated with this risk assessment for methidathion are delineated in the following
discussion.
Following the discussion of the uncertainties related to the different components of
DPR’s risk assessment is a comparison with the endpoints and exposure estimates used in U.S.
EPA’s risk assessment for methidathion.  In addition, there is a discussion of the information
available for methidathion related to Food Quality Protection Act including potential increased
pre- and post-natal sensitivity in infants and children, endocrine effects, cumulative toxicity and
aggregate exposure.  Both the uncertainties in the risk estimates and the information related to
FQPA can be used in determining the adequacy of the MOEs for methidathion.
IV.A.  HAZARD IDENTIFICATION
All the available toxicity studies for methidathion were summarized in the Toxicology
Profile including studies from the open literature and studies submitted to DPR for registration of
pesticide products in California.  DPR determines the acceptability of the toxicology studies
submitted for registration based on FIFRA study guidelines.  DPR generally considers literature
studies supplemental because they often do not follow FIFRA guideline protocols and/or do not
provide sufficient detail in their reports to determine if they were conducted properly.  In the risk
assessment, DPR gives greater weight to guideline studies, especially if they were found
acceptable.  However, literature studies are useful in the selection of the critical NOEL in the
Hazard Identification section for support of effects seen in the guideline studies and can be used
for the critical NOEL if they evaluate an endpoint not examined in the guideline studies and they
appear to be scientifically valid studies. 
The studies considered in the selection of the NOELs for acute, subchronic and chronic
exposure were any studies, regardless of whether they met FIFRA guidelines, that have
sufficient information to establish an acute NOEL or LOEL.  For the acute exposure, this
included LD50/LC50 studies, mechanistic studies, acute neurotoxicity studies, and developmental
toxicity studies.  The effects observed in the developmental toxicity studies which were
considered acute included maternal signs observed within the first few days of exposure and any
fetal effects assuming they were the result of a single exposure.  For subchronic exposure, the
studies considered included standard oral and dermal subchronic toxicity studies (> 7 days, but <
6 months), subchronic neurotoxicity studies, developmental and reproductive toxicity studies,
and mechanistic studies.  For chronic exposure, the studies included the typical chronic feedingMethidathion RCD (Revision 1) February 2007
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studies in mice, rats and dogs which lasted 1-2 years as well as an unusual 2-year gavage study
in monkeys.  The effects that are generally considered adverse with acute, subchronic and
chronic exposure, include clinical signs, reductions in body weight and food consumption greater
than 10%, and increases in gross and histopathological lesions.  Minimal changes in clinical
chemistry and hematology values and organ weights without accompanying functional or
structural changes are generally not considered adverse.  
The primary mechanism of toxicity for methidathion is the inhibition of AChE in the
nervous system.  In general, DPR considers brain ChE inhibition to be indicative of overt
toxicity since more subtle functional changes in the nervous system due to ChE inhibition, such
as memory and learning losses, may not be easily detected in animals unless they are specifically
tested for these effects.  The toxicological significance of plasma and RBC ChE inhibition is less
certain because the physiological function of ChEs in blood have not been clearly established,
although several possible physiological functions have been proposed, which were discussed in
the Introduction.  In an acute neurotoxicity study, reduced ChE activity was seen in the cerebral
cortex of male rats (59% of control activity) at the time to peak effect at the lowest dose tested, 1
mg/kg (Chang and Richter, 1994).  However, no clinical signs or changes in behavior were seen
in the FOB until 8 mg/kg.  At 8 mg/kg, clinical signs and behavioral signs were seen in both
sexes, although they were more pronounced in females.  The reduction in ChE activity in the
different regions of the brain were also more pronounced in females (8-25% of controls) than
males (16-32% of controls) at 8 mg/kg.  A NOEL could have been estimated for this study by
dividing the LOEL by a default uncertainty factor of 10.  However, this would result in an
estimated acute NOEL of 0.1 mg/kg which would be less than the observed NOEL of 0.18
mg/kg/day in 90-day neurotoxicity for the same endpoint.  Consequently, the observed NOEL
from the 90-day study was used for the acute NOEL.  
An alternative to estimating a NOEL for the acute neurotoxicity study by dividing by an
uncertainty factor was to estimate a benchmark dose (BMD).  U.S. EPA’s Benchmark Dose
Software (BMDS, version 1.3.2) offers several models for estimating BMD values with
continuous data; however, they all require that you select a benchmark response (BMR) level
that is meaningful.  The response level selected should depend on the normal variability found in
the data.  U.S. EPA used a BMR of 10% brain ChE inhibition in female rats when doing their
evaluation of the cumulative toxicity of OPs (U.S. EPA, 2001).  U.S. EPA selected this response
level because it was at or near the limit of sensitivity for detecting a statistically significant
decrease in ChE activity in blood or brain and is a response level close to background.  Based on
DPR’s review of  the coefficients of variation (CVs) for brain ChE activity in control animals in
registrant data for OPs, a 10%  response level appears to be a reasonable point of departure for
whole brain data which had CVs usually between 5-10% (Lewis et al., 2006).  However, the
normal variability in regional brain ChE activity was much greater with CVs usually between 10
and 20%.  One contributing factor to this greater variability may be the difficulty in precisely
excising various brain regions.  Another possibility is that there may be an inherent variability in
where the cholinergic neurons run through the different regions of the brain despite a small
variability in the total number of cholinergic neurons in the whole brain.  In the BMD analysis of
the methidathion data presented here, the lower limit on the BMD (BMDL) was estimated for
various brain regions in the acute and subchronic neurotoxicity where there was an apparent
reduction in the mean activity at the lowest dose level, even if it was not statistically significant. 
The BMDL was estimated at the 10%, 15% and 20% response level.  The results of this analysisMethidathion RCD (Revision 1) February 2007
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are shown in Table 43.  Only the results from the Hill model are shown since it generally gave
the best fit.  It is interesting to note that the BMDLs at 10, 15 and 20% response levels were
identical for ChE inhibition in the cortex of males in the acute study and at 2 weeks in the
subchronic study, supporting that use of the 2-week NOEL from the subchronic neurotoxicity
study as a surrogate for an acute NOEL.  It also should be noted that the BMDL15 for ChE
inhibition in the cerebral cortex of males at 2 weeks was equivalent to the NOEL (0.18
mg/kg/day) that was established for this same endpoint and time based on statistical significance. 
The NOEL from the 90-day study is also similar to a BMDL10 of 0.17 mg/kg/day for whole brain
ChE inhibition in female rats in the chronic toxicity study that U.S. EPA used for methidathion
in its cumulative risk assessment for OPs (U.S. EPA, 2006).  However, if the BMDL at 10% or
20% response levels for the cortex in males had been used instead of the 2-week NOEL, the
MOEs would be approximately 40% lower or higher than estimated, respectively.
The study selected for evaluating chronic dietary exposure to methidathion was a 1-year
dog study (Chang and Walberg, 1991).  The NOEL for this study was 4 ppm (0.15 mg/kg/day) , 
Table 43.  Benchmark Dose Analysis of Regional Brain ChE Data in the Acute and Subchronic
Neurotoxicity Studies for Methidathion
a
BMDL10
b
(mg/kg/day)
BMDL15
(mg/kg/day)
BMDL20
(mg/kg/day)
ACUTE
Males
Cortex – 1.5 hrs 0.11 0.18 0.26
Cerebellum – 1.5 hrs 0.48 0.72 0.97
Females
Cortex – 1.5 hrs 0.34 0.50 0.67
Cerebellum – 1.5 hrs 0.49 0.70 0.90
SUBCHRONIC
Males
Cortex –   2 wks
c 0.11 0.18 0.26
  4 wks 0.18 0.29 0.41
13 wks 0.12 0.20 0.28
Striatum –   4 wks
d 0.63 0.95 1.28
13 wks 0.29 0.46 0.63
Hippocampus –   8 wks 0.60 0.89 1.18
13 wks 0.52 0.80 1.10
Spinal cord – 13 wks 0.75 1.12 1.50
Females
Cortex –   4 wks 0.21 0.33 0.46
13 wks 0.29 0.40 0.51
Striatum – 13 wks 0.10 0.16 0.22
Hippocampus – 13 wks 0.21 0.32 0.43
a Chang and Richter, 1994; Chow and Turnier, 1995.  
bB M D L 10, BMDL15 BMDL20 = Lower limit of the benchmark dose at the 10, 15 and 20% response level.  The Hill model
from the U.S. EPA’s Benchmark Dose Software (version 1.3.2) was used for the analysis.
b Omitted 30 ppm (1.86 mg/kg/day) dose level due to poor fit when all dose levels included
c Omitted 10 ppm (0.608 mg/kg/day) dose level due to poor fit when all dose levels includedMethidathion RCD (Revision 1) February 2007
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based on elevated levels of liver enzymes (alkaline phosphatase, aspartate aminotransferase,
alanine aminotransferase, sorbitol dehydrogenase) in the serum, dark red liver discoloration
cholestasis and mild chronic inflammation of the liver in both sexes at 40 ppm (M: 1.33
mg/kg/day; F: 1.39 mg/kg/day).  A similar NOEL (0.17 mg/kg/day) was observed in a rat study
based on clinical signs (alopecia, chromorhinorrhea, hyperactivity, hypersensitivity to touch, and
tremors), reduced body weights, reduced food and water consumption, reduced ChE activity in
RBCs (M: 78%; F: 82% of controls) and brain (F: 49%; M: 48% of controls), reduced liver
weights, and skin lesions.  Both studies were of acceptable quality, so this could not be used as
the basis for selecting one study over the other.  Differences in species sensitivity was also not
clear.  Rats were more sensitive to the neurotoxicity than dogs, but less sensitive to the
hepatotoxicity.  Therefore, the study with the lower NOEL was selected.  However, the
difference in the NOELs was minor and if the NOEL from the rat study had been used, the
chronic MOEs would only be 13% higher than estimated.  U.S. EPA also used the same dog
study and NOEL for calculating the RfD for methidathion in their risk assessment for
methidathion, although they included RBC ChE inhibition along with hepatotoxicity as the
endpoints of concern (Travaglini, 1999).  FAO/WHO JMPR identified a NOEL of 0.1 mg/kg/day
in estimating the acceptable daily intake (ADI) for methidathion based on a one-year study in
dogs (Caris, 1992).
The U.S. EPA Guidelines for Carcinogen Risk Assessment recommends using a linear
approach when the mode of action is not known (U.S. EPA, 2005).  They also recommend using
a benchmark dose as a point of departure from the observed data to do a linear extrapolation to
the origin.   If DPR had used this approach, the potency estimates would be similar to those
obtained with the MULTI-WEIB model.  The ED10 (benchmark dose with an estimated excess
lifetime tumor incidence of 10%) and LED10 (lower limit on ED10) were estimated to be 0.48 and
0.16 mg/kg/day, respectively, using Multi-stage model in the U.S. EPA’s Benchmark Dose
Software (BMDS, version 1.3.2).  The slope or potency factors corresponding to the ED10 and
LED10 were estimated to be 0.21 and 0.63 (mg/kg/day)
-1, respectively, by dividing the risk at
these dose levels (10% or 0.1) by the dose.   If there had been sufficient evidence to support a
threshold mechanism, a non-linear approach could have been used.  In this case, the U.S. EPA
guidelines recommend dividing the LED10 by the exposure dosage to calculate a margin of
exposure for carcinogenicity.  It is interesting to note that the LED10, 0.16 mg/kg/day, is similar
to chronic NOEL that was used to calculate the chronic MOEs, although the LED10 is based on
the human equivalent dose.  Consequently, the MOEs for carcinogenicity would be similar to
chronic MOEs calculated based on hepatotoxicity.  One problem with using the nonlinear
approach for threshold mechanisms, as suggested by U.S. EPA’s cancer guidelines, is that they
have not suggested how large the MOE for carcinogenicity should be to be considered adequate. 
However, Gaylor et al. (1999) have proposed that the LED10/10,000 or an MOE of 10,000 would
be adequate for irreversible adverse health effects, including nongenotoxic carcinogenic effects. 
This proposal assumes the LED10 is equivalent to a LOAEL, so that an uncertainty factor of 10 is
needed to extrapolate to a NOAEL.  An additional uncertainty factor of 1,000 is recommended
for interspecies extrapolation, intraspecies variation in susceptibility, and increased susceptibility
for children.  It should be noted that the chronic MOE for methidathion from combined dietary
and drinking water exposure was greater than 7,000.  The chronic MOEs for occupational
exposure ranged from <1 to 1,500 with most less than 100.  The chronic MOEs for air exposure
ranged from 950 (infants, application site) to 7,100 (adults, ambient).Methidathion RCD (Revision 1) February 2007
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The methidathion oxon is the presumed active metabolite for the neurological effects,
although the pharmacokinetics studies suggest that the oxidative desulfuration to the oxon may
be a minor metabolic pathway.  Typically, the oxon is more toxic than the parent compound for
organophosphorothioates.  However, there is no toxicity data for the oxon, not even an LD50
study, to derive a toxicity equivalency factor for the oxon.  Therefore, the assumption was made
that it was equivalent in toxicity to the parent.  This assumption most likely underestimates the
neurotoxicity of the oxon and, therefore, the risk for neurological effects.  It is uncertain if the
oxon is the active metabolite with regards to the hepatotoxicity and carcinogenicity of
methidathion.  Therefore, the risk for these endpoints may not have been underestimated.  
In their recent update to the cumulative risk assessment for organophosphates, U.S. EPA
calculated risks from drinking water exposure to methidathion and other OPs assuming the oxon
was 10 times or 100 times as toxic as the parent for most OPs including methidathion (U.S. EPA,
2002a).  If DPR made similar assumptions about the toxicity of methidaoxon, a combined MOE
could have been calculated using the following calculation:
Hazard Index
ExposureDosage
NOEL
=
Marginof Exposure MOE
Hazard Index Hazard Index
combined
parent oxon
() =
+
1
Some exposure estimates did not include the oxon for various reasons.  With dietary exposure,
the oxon was not monitored in food since the tolerance did not include the oxon. With
occupational exposure, the oxon was not included in the exposure estimates since they were all
theoretical estimates for the parent based on PHED database for handlers and DFRs and transfer
factors for field workers.  The methidaoxon was monitored in PDP drinking water samples;
therefore, combined MOEs were calculated for drinking water assuming the oxon was 10X and
100X as toxic as methidathion (Table 44).   As might be expected, the MOEs decreased an order
of magnitude as the toxicity of the methidaoxon was increased by 10-fold.  However, these
toxicity estimates for the oxon are only theoretical and, therefore, these combined MOEs
presented here are highly speculative.  It should be noted that for the two OPs that U.S. EPA had
toxicity data for the oxon (chlorpyrifos and methyl parathion), the toxicity of the oxon was less
than 10X as toxic as the parent compound. 
Methidaoxon was also monitored in the air monitoring studies for methidathion;
however, because of problems with location of samplers in relation to the wind direction
surrogate data from a methyl parathion application site monitoring study were used to evaluate
methidathion application site exposure.  Using the formula above, the combined MOEs for air
exposure were calculated assuming the methidaoxon is 10X or 100X more toxic than
methidathion (Table 45).  As with the drinking water MOEs, the MOEs for air exposure
decreased nearly an order of magnitude for every 10-fold the toxicity of the oxon was increased. 
These MOEs are also highly speculative since the toxicity of the oxon is unknown.Methidathion RCD (Revision 1) February 2007
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Table 44. Estimated Combined Margins of Exposure for Potential Drinking Water Exposure
Assuming Methidaoxon Is 10 or 100 Times as Toxic as Methidathion
Population Subgroup
Combined Margins of Exposure
a
Acute Chronic
10X
b 100X
c 10X 100X
U.S. Population   7,100   750 110,000 12,000
Western Region   6,300   680   96,000 10,000
Nursing Infants (< 1 yr)   3,800   410   90,000   9,700
Non-nursing Infants (< 1  yr)   2,500   260   27,000   2,900
Children (1-2 yrs)   6,700   710   74,000   7,900
Children (3-5 yrs)   6,900   730   79,000   8,500
Children (6-12 yrs) 12,000 1,300 110,000 12,000
Youth (13-19 yrs) 11,000 1,200 150,000 16,000
Adults (20-49 yrs)   9,500 1,000 120,000 13,000
Adults (50+ yrs) 14,000 1,500 110,000 12,000
Females (13-49 yrs) 10,000 1,100 120,000 13,000
Females (13+ yrs/pregnant/not nursing) 19,000 2,000 110,000 12,000
Females (13+ yrs/nursing) 14,000 1,400   79,000   8,500
Workers (16+ yrs) 10,000 1,100 NA     NA
a Combined Margin of Exposure = 1/(Hazard Indexmethidathion + Hazard Indexmethidaoxon) where the Hazard Index = Exposure
Dosage/NOEL.  The NOELs for methidathion were 0.18 and 0.15  mg/kg/day for acute and chronic exposure,
respectively.  Values rounded to two significant figures.
b The NOELs for the methidaoxon were estimated by dividing the NOELs for methidathion by an uncertainty factor  of
10X.  
c The NOELs for the methidaoxon were estimated by dividing the NOELs for methidathion by an uncertainty factor of
100X. 
Table 45. Estimated Combined Margins of Exposure for Air Exposure Assuming Methidaoxon
is 10 or 100 Times More Toxic Than Methidathion
a
Exposure Scenarios Infants Adults
10X
b 100X
c 10X 100X
Application Site
Acute - 1 hr 33 13 180 69
Acute - 24 hr 17 5 35 10
Seasonal 130 30 270 64
Chronic 750 140 1600 320
Ambient
Seasonal  780  93 1,700 200
Chronic 920 100 1,900 210
a Combined Margin of Exposure = 1/(Hazard Indexmethidathion + Hazard Indexmethidaoxon) where the Hazard Index = Exposure
Dosage/NOEL.  The NOELs for the methidathion were 0.18, 0.18, 0.15 mg/kg/day for acute, seasonal and chronic
exposure, respectively.  Values are rounded to two significant figures.
b The NOELs for the methidaoxon were estimated by dividing the NOELs for methidathion by 10.  
c The NOELs for the methidaoxon were estimated by dividing the NOELs for methidathion by 100. Methidathion RCD (Revision 1) February 2007
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IV.B.  EXPOSURE ASSESSMENT
The dietary exposure assessment was based primarily on PDP and DPR monitoring data . 
PDP monitoring data is more representative of the actual exposure because commodities are 
washed and peeled if normally consumed that way whereas DPR monitoring measures residue in
the whole commodity, regardless of how it is normally consumed.  Since the peel is not normally 
consumed for most citrus fruit, except for small quantities, the PDP orange data were used as
surrogate for other citrus commodities even though there were some DPR data for some of these
commodities.  PDP apple data were used as a surrogate for several other pome fruits (crabapple,
quinces and loquats) for which there were no monitoring data.  Preference was also given to the
PDP monitoring data since it tends to have lower LODs than the DPR monitoring program,
which is important especially with chronic exposure where the mean residue value is used and
there are a significant number of samples with non-detectable residues.  When no residues are
detected, ½ of the LOD is used.  Even with these refinements, the dietary exposure was still
probably overestimated since tolerance values were used for all the nut commodities because no
monitoring data were available.  Some other high contributing commodities such as safflower
and sunflower were not adjusted for PCT, since agricultural statistics were not available for these
crops.  It seems very unlikely that 100% of sunflower seeds were treated, in particular, since
there was no registered use in California on sunflowers for several of the more recent years for
which use data are available.  The acute dietary exposure assessment may have also been
overestimated since probabilistic estimates were only used for the most highly consumed
commodities (most citrus, pome and stone fruits).   Point estimates, including tolerance levels for
most nut commodities, were used for the rest of the commodities.  However, these conservative
assumptions for acute exposure are counterbalanced to some degree by the fact that residues
were monitored on composite samples which tends to eliminate the extreme values that might be
found on single serving pieces of fruit or vegetables.  The dietary exposure to methidathion was
also probably underestimated since only the parent compound and not the oxon were analyzed in
the PDP and DPR monitoring data.  According to U.S. EPA’s Human Health Risk Assessment,
the HED Metabolism Assessment Review Committee (MARC) determined that the residue of
concern in plants was the parent compound only (U.S. EPA, 1999).  However, Simoneux (1991
& 1993) found that the oxygen analog was a major plant metabolite in cotton and artichokes. 
The metabolism in other rotational crops and citrus trees appears to be the same.  
The revised drinking water exposure estimates for methidathion were considered fairly
realistic since they were taken from the finished water at water treatment facilities in California
from the three most recent years available from PDP (2001-2003).  The previous estimate for
drinking water exposure to methidathion by DPR was based entirely on surface water monitoring
data which probably exaggerated the exposure since it is uncertain if the samples were collected
from sites that were used for drinking water and if the residues would persist after standard water
treatment.  Furthermore, no methidathion residues have been found in DPR’s well water
monitoring.  More recent surface water monitoring data by DPR indicates that the frequency and
magnitude of the residues have dropped in surface water, probably due to significant reductions
in the use of methidathion.  DPR recognized in its previous drinking water exposure estimates
that using DPR’s surface water monitoring data probably overestimated the actual exposure, but
at the time that risk assessment was conducted, there was only one year of PDP drinking water
data available.Methidathion RCD (Revision 1) February 2007
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The uncertainties in the occupational exposure assessment are discussed in more detail in
the Exposure Appraisal section of the EAD (Beauvais, 2006).  In this assessment, PHED data
were used to estimate exposure which results in more uncertainty in the estimates than if
chemical-specific data were used.  To compensate for this uncertainty, the 90% upper confidence
limit on the mean and 95th percentile were used to estimate seasonal and acute exposure,
respectively.  This is a new approach used by DPR and one of the main reasons DPR’s
occupational exposure estimates were significantly higher than U.S. EPA’s for the same
scenarios.  
Uncertainties associated with the ambient and application site air exposure estimates 
were also discussed in the Exposure Appraisal section of the EAD (Beauvais, 2006).  The
greatest uncertainties were in the estimates for the application site air exposure due to the use of
surrogate data from a methyl parathion application to a walnut orchard in July of 2003 in San
Joaquin Valley.  There are also uncertainties associated with the ambient air monitoring that was
conducted in Tulare County during June and July of 1991.  These sites and time were selected
based on their high use in this county during this time of year.  It is unclear, however, how
representative these sites were since applications of methidathion around these sites was not
confirmed. 
IV.C. RISK CHARACTERIZATION
Generally, an MOE of at least 100 is considered sufficiently protective of human health
when the NOEL for an adverse effect is derived from an animal study.  The MOE of 100 allows
for humans being 10 times more sensitive than animals and for a 10-fold variation in sensitivity
between the lower range of the normal distribution in the overall population and the sensitive 
subgroup (Dourson et al., 2002).  A carcinogenic risk level less than 10
-6 is generally considered
negligible.  
The potential health risks from dietary exposure appear low. The acute MOEs for dietary
exposure even at the 99.9
th percentile were greater than 200 for all population subgroups.  The
chronic MOEs for dietary exposure were equal to or greater than 8,000 for all population
subgroups.  The upper bound estimate of carcinogenic risk from dietary exposure to
methidathion in the U.S. population was just slightly greater than the negligible risk level at 1.1
x 10
-6.  This risk level is probably acceptable given the limited evidence of a genotoxic
mechanism for the carcinogenicity.
The potential health risks from drinking water exposure also appear low.  The acute
MOEs for drinking water at the 99.9
th percentile were equal to or greater than 15,000 for all
population subgroups.  The chronic MOEs from drinking water exposure were greater than
150,000 for all population subgroups.  The acute MOEs for combined dietary and drinking water
exposure were still greater than 200 for all populations subgroups.  The chronic MOEs for
combined dietary and drinking water exposure were greater than 7,000.  The estimated
carcinogenic risk from exposure to methidathion in drinking water is clearly less than the
negligible risk level at both the maximum likelihood estimate and the 95% upper bound estimate. 
 The upper bound cancer risk estimate for combined dietary and drinking water exposure was
slightly greater than the negligible risk level, but is probably acceptable given the limitedMethidathion RCD (Revision 1) February 2007
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evidence of a genotoxic mechanism for carcinogenicity.   A maximum contaminant level (MCL)
has not been established for methidathion in water (U.S. EPA, 1999).  
In contrast, the potential health risks from occupational exposure appear to be quite high
for most exposure scenarios, suggesting mitigation is needed.  The acute, seasonal and chronic
MOEs were less than 100 for all scenarios, except seasonal MOEs for thinning artichokes and
chronic MOEs for all field worker scenarios.  The MOEs were less than 10 for most exposure
scenarios and less than 1 for some scenarios (aerial handlers and airblast applicators).  In
addition, the carcinogenic risk estimates for occupational exposure to methidathion all exceeded
the negligible risk level.  The estimated carcinogenic risk based on the maximum likelihood
estimate ranged from 2.0 x 10
-5 to 2.3 x 10
-2.  The upper bound estimates of carcinogenic risk
were between 3.2 x 10
-5 and 3.7 x 10
-2.  Airblast applicators had the highest carcinogenic risk
estimates.  
Acute exposure to methidathion in application site air is of also concern since the MOEs
were less than 100 for both infants and adults, suggesting mitigation is needed.  The seasonal and
chronic MOEs for application site air were greater than 100, but less than 1,000, still meeting the
criteria for identifying methidathion as a toxic air contaminant since the MOEs are not 10-fold
greater than the benchmark that is considered adequately protective of human health (California
Code of Regulations, Title 3, Division 6, Section 6890).   The MOEs for seasonal and chronic
exposure to methidathion in ambient air were greater than 1,000 for both infants and adults.  The
carcinogenic risk estimates for both the application site air (2.5 x 10
-5 to 3.9 x 10
-5) and ambient
air (7.1 x 10
-6 to 1.1x 10
-5) were greater than the negligible risk level, also suggesting mitigation
is needed.
The MOEs for most agricultural workers were already significantly less than 100 from
occupational exposure alone, consequently, their aggregate MOEs were not significantly lower
with the addition of dietary, drinking water and ambient air exposure.  Similarly, air exposure
was a major contributor to the aggregate exposure for the general population, so that their
aggregate MOEs were only slightly lower than their MOEs for air exposure alone.
The health risks for methidathion were probably underestimated due to the lack of
toxicity data for the oxygen analog which is the presumed active metabolite.  In the absence of
these toxicity data, the oxon was assumed to have equivalent in toxicity to the parent compound. 
Most likely the NOELs for the oxon would have been lower since the oxon is usually more toxic
than the parent compound for organophosphorothioates, at least for neurological effects.  In
addition, the dietary exposure was probably underestimated since the oxon was not analyzed in
either the PDP or DPR monitoring data. 
IV.D. U.S. EPA’S REREGISTRATION ELIGIBILITY DOCUMENT FOR
METHIDATHION
U.S. EPA completed a Human Health Risk Assessment for methidathion in December
1999 (Travaglini, 1999).  U.S. EPA evaluated dietary, drinking water and occupational exposure
to methidathion using route-specific NOELs whenever possible.  U.S. EPA estimated acute
dietary exposure to methidathion using PDP data and a Monte Carlo analysis in their recent
Human Health Risk Assessment for methidathion (Travaglini, 1999).  At the 99.9th percentile,Methidathion RCD (Revision 1) February 2007
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U.S. EPA’s acute dietary estimates ranged from 0.281 μg/kg/day for females 13 years and older
to 1.280 μg/kg/day for nursing infants less than 1 year old.  These estimates were similar or
slightly higher than the estimates DPR obtained for acute exposure with the Tier 3 analysis using
the 99.9th percentile and PDP monitoring data.  U.S. EPA estimated the chronic dietary exposure
to range from 0.040 μg/kg/day for females 13 years and older to 0.338 μg/kg/day for children 1
to 6 years old with adjustment for percent crop treated.  Unlike acute exposure, U.S. EPA’s
chronic dietary estimates are higher than DPR’s chronic exposure estimates although it appears
they only did a Tier 2 analysis whereas DPR did a Tier 3 analysis for chronic dietary exposure
because of the carcinogenicity concern.
For  acute dietary and drinking water exposure, U.S. EPA used a NOEL of 0.2 mg/kg/day
from the 90-day neurotoxicity study based on brain ChE inhibition observed at 2 weeks (Chow
and Turnier, 1995).  DPR used the same study and NOEL for evaluating acute exposure.  Using
this acute NOEL, both U.S. EPA and DPR found the acute dietary MOEs did not exceed their
level of concern even at the 99.9th percentile.  For chronic dietary and drinking water exposure,
U.S. EPA use a NOEL of 0.15 mg/kg/day from a 1-year chronic toxicity study in dogs based on
RBC ChE inhibition, elevated liver enzymes and liver lesions (Chang and Walberg, 1991).  DPR
also used the same dog study and NOEL for evaluating chronic exposure to methidathion.  Using
this chronic NOEL, the MOEs for chronic dietary exposure also did not exceed the level of
concern for either U.S. EPA or DPR, although the chronic MOEs from DPR’s analysis were
higher due to their more refined chronic dietary exposure analysis (Tier 3) compared to U.S.
EPA’s (Tier 2).
U.S. EPA calculated  Estimated Environmental Concentrations (EECs) for methidathion
in drinking water using the SCI-GROW model for ground water and the PRIZM-EXAMS model
for surface water (Travaglini, 1999).   The ground and surface water EECs were 0.4 and 6 ppb,
respectively, for acute exposure.  For chronic exposure, the EECs were 0.4 and 0.6 ppb for
ground and surface water, respectively.   Although DPR considers methidathion a potential
groundwater contaminant based on environmental fate studies submitted, no methidathion
residues have been detected in well water monitored by DPR between 1989 and 1996. 
Methidathion residues were detected in surface water monitoring by DPR and U.S. Geological
Survey; however, no residues were detected in the PDP drinking water samples from California
between 2001 and 2003 whose source waters were primarily surface water.   Since it was
uncertain if the surface water analyzed by DPR was used for drinking water or if the
methidathion residues would remain after normal water treatment, the DPR used the PDP data in
its drinking water exposure estimates.  U.S. EPA’s EECs were significantly higher than the
residues used by DPR which were the LOD (0.021 ppb) and ½ of the LOD (0.011 ppb) for acute
and chronic exposure, respectively.
U.S EPA used Drinking Water Levels of Comparison  (DWLOCs) to evaluate risk for
drinking water.  A DWLOC is the concentration of pesticide that is acceptable as an upper limit
taking into consideration the aggregate exposure from food, water and residential uses.  A
DWLOC may vary between population subgroups depending on water consumption patterns and
body weights.  They estimated the acute DWLOCs to vary from 7.2 to 59 ppb for various
sensitive population subgroups.  The estimated chronic DWLOCs ranged from 13 to 48 ppb for
the sensitive population subgroups.  In all subgroups, the EECs did not exceed the DWLOCs. 
DPR evaluated drinking water exposure by using PDP drinking water data from CaliforniaMethidathion RCD (Revision 1) February 2007
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between 2001 and 2003.  The acute and chronic drinking water exposure were evaluated
separately and in combination with the dietary exposure for all population subgroups.  The
MOEs for drinking water exposure were all greater than 100, even when combined with dietary
exposure.  
U.S. EPA evaluated short-term dermal exposure in workers using a 21-day dermal
toxicity study in rabbits conducted by Folinusz et al. (1986) with a NOEL of 20 mg/kg/day. 
DPR used the acute NOEL of 0.18 mg/kg/day based on ChE inhibition in the cerebral cortex of
male rats at 2 weeks in the 90-day neurotoxicity study to evaluate acute dermal and inhalation
occupational exposure to methidathion (Chow and Turnier, 1995).  U.S. EPA selected the 90-day
neurotoxicity study for evaluating intermediate-term dermal and short and intermediate-term
inhalation exposure to methidathion in workers with an estimated NOEL of 0.2 mg/kg/day based
on plasma, RBC and brain ChE inhibition.  Because a route-specific NOEL was not used, U.S.
EPA applied a dermal absorption factor of 30%  or an inhalation absorption factor of 100% to
the exposure dosage before calculating the MOEs.  The dermal absorption was estimated by
taking the ratio of the NOAELs from the oral developmental toxicity study in rabbits (6
mg/kg/day) and the 21-day dermal toxicity study in rabbits (20 mg/kg/day).  DPR also used the
same NOEL from the 90-day neurotoxicity study in rats for evaluating subchronic dermal and
inhalation occupational exposure to methidathion.  However, DPR assumed a default of 50%
dermal absorption and 100% inhalation absorption.   U.S. EPA concluded that the current use
pattern (1-2 applications/year) did not indicate a concern for potential long-term occupational
exposure and, therefore, did not calculate any chronic MOEs.  DPR concluded there was
sufficient use throughout the year to calculate chronic MOEs for occupational exposure.  U.S.
EPA classified methidathion as a group C carcinogen (possible human carcinogen) based on the
liver tumors in male mice, but did not consider the evidence strong enough to warrant a
quantitative estimation of human risk.  DPR did calculate carcinogenic risk estimates for
occupational exposure.
U.S. EPA calculated the occupational exposure for handlers using their Pesticide
Handlers Exposure Database (PHED).  DPR also used PHED to calculate exposure dosages for
handlers.  The same assumptions were made regarding the application rates, average body
weight, average workday, acres applied per day.  Despite using the same general method for
calculating exposure, the ADDs calculated by U.S. EPA were lower than those calculated by
DPR, primarily because DPR used the 90th upper confidence limit on the 95th percentile for the
ADD, and the 90th upper confidence limit on the arithmetic mean for the SADD.  U.S. EPA used
only the geometric mean estimates for their ADDs to evaluate both short-term and intermediate-
term exposure.  For post-application occupational exposure, U.S. EPA used a similar formula to
DPR’s for calculating dermal exposure dosages from dislodgeable foliar residues (DFRs) and
transfer factors (TFs); however, different DFRs were used.  The DFRs varied depending on the
REI used and the data from which the DFRs were derived.   DPR preferred to use California-
specific data whenever available due to the effect of weather on DFR dissipation.  
Consequently, different estimated dermal doses were calculated.  U.S. EPA incorporated
mitigation in their exposure assessment when MOEs were less than the target MOE of 100. 
However, in their 1999 risk assessment, U.S. EPA estimated the dermal MOEs were less than
their target of 100 after mitigation for mixing/loading of the liquid formulation for aerial
application.  The combined dermal and inhalation MOEs were less than 100 for mixing and
loading of water soluble packets (WSPs) for aerial application and liquid aerial application withMethidathion RCD (Revision 1) February 2007
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fixed-wing aircraft.  U.S. EPA only considered changes in REIs in the mitigation for post-
application exposure.  The required REI that would result in an MOE greater than 100 varied
from 1 day for early scouting in cotton fields to 24 days for citrus harvesting.  DPR’s exposure
assessment only incorporated the protective equipment, engineering controls and REIs that are
recommended in the current labels. 
As part of the Food Quality Protection Act (FQPA), U.S. EPA evaluated the
developmental and reproductive toxicity studies for methidathion and recommended the 10X
uncertainty factor be reduced to 1X based on 1) completeness of the database, 2) no evidence of
increased susceptibility in the developmental toxicity studies, 3) no evidence of increased
susceptibility in the reproductive toxicity study, 4) no evidence for requiring a developmental
neurotoxicity study in rats, 5) adequate residue data for evaluating dietary and drinking water
exposure and 6) no residential use.  DPR also concluded there was no evidence of increased pre-
or post-natal sensitivity from the developmental and reproductive toxicity studies in rats and
rabbits.
U.S. EPA completed an Interim Reregistration Eligibility Document (IRED) in March
2002 (U.S. EPA, 2002b).  There were no changes in the dietary and drinking water assessment
from the 1999 risk assessment.  The toxicity studies selected for evaluating short-term and
intermediate-term occupational exposure also did not change.  There were some slight changes
in the exposure estimates based on different MOEs reported for the same tasks compared to their
risk assessment from 1999.  It is unclear what the basis was for these changes in the exposure
estimates since the discussion of the exposure estimates was more brief than in the 1999 risk
assessment and the exposure estimates were not reported.  Regardless, U.S. EPA remained
concerned about mixing and loading of WSPs for aerial application and liquid aerial application
by fixed-wing aircraft.  U.S. EPA proposed mitigating these risks by limiting the use of WSPs to
non-aerial application, addition of PPE, use of closed systems and the application of minimum of
500 gallons of water per acre to dilute methidathion products.  U.S. EPA recognizes these
measures will not increase the MOEs to above 100 in all cases, but considers the remaining risks
reasonable given protective assumptions in the risk assessment and considering the benefits of
methidathion use.
IV.E. ISSUES RELATED TO THE FOOD QUALITY PROTECTION ACT
The Food Quality Protection Act of 1996 mandated U.S. EPA to “upgrade its risk
assessment process as part of the tolerance setting procedures” (U.S. EPA, 1997a and b).  The
improvements to risk assessment were based on the recommendations from the 1993 National
Academy of Sciences report, “Pesticides in the Diets of Infants and Children” (NAS, 1993).  
The Act required an explicit finding that tolerances are safe for children.  U.S. EPA was required
to use an extra 10-fold safety factor to take into account potential pre- and post-natal
developmental toxicity and the completeness of the data unless U.S. EPA determined, based on
reliable data, that a different margin would be safe.  In addition, U.S. EPA must consider
available information on: 1) aggregate exposure from all non-occupational sources; 2) effects of
cumulative exposure to the pesticide and other substances with common mechanisms of toxicity;
3) the effects of in utero exposure; and 4) the potential for endocrine disrupting effects.Methidathion RCD (Revision 1) February 2007
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IV.E.1.  Prenatal and Postnatal Sensitivity
Five developmental toxicity studies (3 with rats and 2 with rabbits) were available for
methidathion.  One rat and one rabbit study were acceptable based on FIFRA guidelines.  Fetal
effects included reduced ossification of the sternabrae and reduced body weights. The lowest
developmental NOEL in an acceptable study was equal to or greater than 2.5 mg/kg/day, the
highest dose tested in rats. There was no evidence of increased prenatal sensitivity to
methidathion in any of these studies since  the developmental NOELs were equal to or greater
than the maternal NOELs.  However, brain ChE activity was not measured in either adults or
pups in any of the developmental toxicity studies.
Four reproductive toxicity studies in rats were available for methidathion with exposure
ranging from one to three generations.  Only one of these studies was found acceptable to DPR
based on FIFRA guidelines.  The effects observed in pups included tremors, signs of maternal
neglect (cool to touch, starving, weak or lethargic), reduced pup weights and reduced survival. 
In the one acceptable study, the pup NOEL was the same as parental NOEL, 5 ppm (0.4
mg/kg/day).  A comparison of the acute toxicity of methidathion in adult (> 90 days of age) and
weanling (4-6 weeks of age) rats found weanling rats were slightly more sensitive to
methidathion based on a slightly lower oral LD50 value (M: 21 mg/kg) than adults (M: 31 mg/kg;
F: 32 mg/kg) (Gaines and Linder, 1986).  Based on this evidence, there may be an increased
postnatal sensitivity to methidathion.  None of the reproductive toxicity studies nor the acute
toxicity study conducted by Gaines and Linder (1986) measured brain ChE activity in either
adults or pups.
IV.E.2.  Endocrine Effects
The Food Quality Protection Act (FQPA) of 1996 required U.S. EPA to develop a
screening program to determine the endocrine disruption potential of pesticides.  In 1997, the
Risk Assessment Forum of the U.S. EPA published a report that reviewed the current state of
science relative to environmental endocrine disruption (U.S. EPA, 1997c).  U.S. EPA formed the
Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) to develop a
strategy for screening and testing of pesticides for their potential to produce endocrine
disruption.  The EDSTAC members include various stakeholders and scientific experts.  This
screening and testing process was to be implemented by August of 1999 as required by FQPA.
Environmental chemicals can interact with the endocrine system, resulting in cancer,
reproductive and/or developmental anomalies (EDSTAC, 1998).  It may produce these effects by
affecting hormonal production and synthesis, binding directly to hormone receptors or
interfering with the breakdown of hormones (U.S. EPA, 1997c).   The interim science policy
stated in U.S. EPA’s 1997 report is that “the Agency does not consider endocrine disruption to
be an adverse endpoint per se, but rather to be a mode or mechanism of action leading to other
outcomes.”  The only possible endocrine related effects in the available animal studies for
methidathion were reduced mating index and poor maternal care (Salamon 1986 & 1987). 
However, it is unclear from these data if either of these effects are mediated through endocrine
disruption, ChE inhibition or some other mechanism. Methidathion RCD (Revision 1) February 2007
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IV.E.3.  Cumulative Toxicity
There is a potential for cumulative toxicity between methidathion and other
organophosphates (OPs) because they have a common mechanism of toxicity, inhibition of ChE. 
In fact, there is evidence that methidathion acted synergistically with at least 6 (carbaryl,
mevinphos, azinphos-methyl, methyl parathion, fenchlorphos and disulfoton) out of 15
organophosphate compounds tested (Woodard Research, 1966a).  Exposure to methidathion in
the induction phase also resulted in a cross reaction when later challenged with DDVP and naled,
but not benomyl (Matsushita et al., 1985).  However, until recently, a scientifically defensible
approach to quantitatively evaluate the potential for cumulative toxicity was not available.  An
elaborate methodology was recently developed by U.S. EPA to assess the exposure to multiple
chemicals with a common mechanism of action (U.S. EPA, 2002c).  Because the OPs were
assigned priority for tolerance reassessment, they were the first to be considered as a “common
mechanism group” for cumulative risk assessments.  In 2001, U.S. EPA completed a preliminary
cumulative risk assessment for the OPs (U.S. EPA, 2001).  The assessment estimated the
potential risk from exposure to multiple OPs by multiple pathways.  A total of 31 OP pesticides
were included in the risk assessment. These OPs were selected based on their detection in the
USDA’s PDP, as well as their potential for human exposure through residential, non-
occupational uses and drinking water.  The assessment utilized data from three exposure
pathways: food, drinking water and residential/non-occupational exposure to OPs (air, soil,
grass, indoor surfaces).  Methidathion was one of the evaluated OPs in the food and drinking
water exposure pathways.
U.S. EPA employed the relative potency factor (RPF) method to determine the combined
exposure to the OPs.  RPF was defined as the ratio of the toxic potency of a compound to that of
an index chemical.  Methamidophos was selected as the index chemical, because of the quality
and extensive availability of its dose-response data for all routes of exposure.  The toxic
potencies for the OPs were based on the common endpoint of the inhibition of the brain ChE
activity in female rats for 21 days or longer.  Both the point of comparison among the chemicals
and the point of departure (POD) for the index chemical was based on the BMD10, the
benchmark response of 10% reduction of the ChE activity. In this analysis, U.S. EPA considered
the exposure to OP residues in foods as uniform across the U.S. Twelve regional assessments
were conducted for drinking water and residential exposures. The uniform food exposure
estimate was combined with region-specific exposures from residential uses and drinking water. 
In Region 7, which included California, the use of methidathion on apples, pears, peaches,
apricots, nectarines, plums, almonds, walnuts, oranges, tomatoes and alfalfa was considered in
the drinking water exposure modeling for the north and/or south central valley.
The conclusions from the preliminary OP cumulative risk assessment were that the
drinking water was not a major contributor to the total risk.  The exposures from OPs in food at
percentiles above the 95
th percentile for all population subgroups were at least one order of
magnitude higher than water.  U.S. EPA indicated that additional sensitivity analysis is needed
on the upper percentiles of the food exposure assessments before any risk management decisions
can be made.  Following this preliminary assessment, U.S. EPA began developing guidelines for
the application of the FQPA factor for pre and post-natal sensitivity in the cumulative risk
assessments for chemicals with a common mechanism of toxicity (U.S. EPA, 2002d).Methidathion RCD (Revision 1) February 2007
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U.S. EPA revised the preliminary cumulative risk assessment for OPs after considering
public comment and additional scientific review (U.S. EPA, 2002a).  One of the major additions
was assignment of different FQPA factors to various OPs based on the available information
regarding increased sensitivity in infants and children.  They assigned an FQPA factor of 3X to
most OPS including methidathion.  This is in contrast to the FQPA factor that U.S. EPA has
recommended in the separate risk assessments for methidathion conducted in 1999 and 2002
(U.S. EPA, 1999 & 2002b).  This decision was based on missing comparative ChE inhibition
data in young animals.  They also included over-tolerance values into the dietary exposure
assessment and added a 7-day rolling average exposure estimate.  They reduced the number of
regions for drinking water analysis down from 13 to 7.  A sensitivity analysis was conducted to
look at individual animal data, extreme outliers in the CSFII data (no outliers identified), use of
14- and 21-day rolling averages in dietary exposure, use of additional subpopulations in dietary
and drinking water exposure assessments.  They also identified pesticide/crop combinations that
had significant roles in the risk estimates.  Ranges of risks were identified at various percentiles
of exposure.  For most portions of the ranges, the MOEs did not represent levels of potential
concern for dietary exposure.  Drinking water still was not considered a significant source of
exposure, even considering periods of high-volume runoff.
In 2006, U.S. EPA updated the cumulative risk assessment for OPs (U.S. EPA, 2006). 
This risk assessment took into consideration mitigation taken by the agency affecting food,
drinking water and residential risk estimates for the various OPs.  More OP-specific FQPA
factors were used which were applied to RPF factor for each OP.  However, a standard 10X
FQPA factor was used for most OPs including methidathion which lacked two critical studies, a
developmental neurotoxicity study and a comparative ChE study in juveniles and adults.  In
addition, inter- and intra-species extrapolation was evaluated, although a target MOE of 100 was
still used.  The MOEs for single-day dietary exposures were greater than 100 for all population
subgroups at the 99th percentile, but not the 99.9th.  The MOEs for 21-day dietary exposure
were all greater than 100 at the 99.9th percentile, except for children 3-5 yrs old whose MOE
was 99.  The other change to the 2006 update was an evaluation of the drinking water risk
estimates assuming the oxons of OPs that form them are 10X or 100X more toxic than the
parent.  When the oxon was assumed to be 10X as toxic methidathion became a major
contributor to the risk for Region C (southwest and California central valley).  Region C
included the use of a number of oxon formers.  When the oxon was assumed to be 100X as toxic,
methidathion became the dominant contributor in Region C.  However, the cumulative OP
exposures from drinking water were generally orders of magnitude lower than exposures from
food sources.  
IV.E.4.  Aggregate Exposure
The combined dietary, drinking water, occupational, and residential air exposure for
agricultural workers has been addressed in this document.   The dietary, drinking water and
residential air exposure was less than 5% of the aggregate exposure for most workers. 
Consequently, its addition did not significantly impact the aggregate exposure.  Only for work
activities where the occupational exposure was low (e.g., M/L/As for low-pressure handwand,
harvesting/thinning of citrus, and thinning of artichokes), did the dietary, drinking water and
residential air represent a significant contribution.  Even for these activities, the dietary, drinking
water and residential air exposure represented 6-46% of the aggregate exposure.Methidathion RCD (Revision 1) February 2007
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The combined dietary, drinking water and ambient air exposure for the general public
was also addressed in this document.  The aggregate acute MOEs for the general public at the
application site were all less than 100, except for the 1-hr MOE for adults.  The aggregate
carcinogenic risk estimates for the general public were higher than the negligible risk level for
both the application site air (2.5 x 10
-5 to 3.9 x 10
-5) and ambient air (7.1 x 10
-6 to 1.1 x 10
-5). 
The air exposure appears to be the primary contributor since the carcinogenic risk estimates from 
air exposure alone were also significantly greater than negligible risk level.  Dietary exposure
was also a significant contributor since the carcinogenic risk estimates from dietary exposure
alone were slightly greater than the negligible risk level.  The drinking water exposure
contributed the least to the aggregate exposure for the general population since drinking water
exposure alone were slightly less than the negligible risk level.Methidathion RCD (Revision 1) February 2007
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V.  TOLERANCE ASSESSMENT
V.A.  INTRODUCTION
V.A.1.  U.S. EPA
U.S. EPA is responsible under the Federal Food, Drug, and Cosmetic Act (FFDCA) for
setting tolerances for pesticide residues in RACs (Section 408 of FFDCA) and processed
commodities (Section 409 of FFDCA).  A tolerance is the legal maximum residue concentration
of a pesticide which is allowed on a raw agricultural commodity or processed food.  The
tolerances are established at levels necessary for the maximum application rate and frequency,
and not expected to produce deleterious health effects in humans from chronic dietary exposure
(U.S. EPA, 1991).  The data requirements for tolerances include:  (1) residue chemistry, (2)
environmental fate, (3) toxicology, (4) product performance such as efficacy, and (5) product
chemistry (Code of Federal Regulations, 1996).  The field studies must reflect the proposed use
with respect to the rate and mode of application, number and timing of applications and
formulations proposed (U.S. EPA, 1982).
In 1996, the Food Quality Protection Act (FQPA) amended the overall regulation of
pesticide residues under FIFRA and FFDCA (U.S. EPA, 1997a and b).  One major change was
the removal of the Delaney Clause that prohibited residues of cancer-causing pesticides in
processed foods.  The tolerances must be health-based and the same standards are used to
establish tolerances for both the RACs and their processed forms.  FQPA required an explicit
finding that tolerances are safe for children.  U.S. EPA was required to use an extra 10-fold
safety factor to take into account potential pre- and post-natal developmental toxicity and the
completeness of the data unless U.S. EPA determined, based on reliable data, that a different
margin would be safe.  In addition, the evaluations of the tolerance must take into account: (1)
aggregate exposure from all non-occupational sources, (2) effects from cumulative exposure to
the pesticide and other substances with common mechanisms of toxicity, (3) effects of in utero
exposure; and (4) potential for endocrine disrupting effects.
Under FQPA, U.S. EPA is also required to reassess all existing tolerances and
exemptions from tolerances for both active and inert ingredients by 2006 (U.S. EPA, 1997d). 
Previously, U.S. EPA reassessed tolerances as part of its reregistration and Special Review
processes.  In the evaluation of tolerances, the U.S. EPA uses a tiered approach and the
assessment includes all label-use commodities.
V.A.2. California
In California, U.S. EPA established tolerances are evaluated under the mandate of
Assembly Bill 2161, generally referred to as the Food Safety Act (Bronzan and Jones, 1989). 
The Act requires DPR to conduct an assessment of dietary risks associated with the consumption
of produce and processed food treated with pesticides.  In these assessments, the tolerance for
each specific commodity is evaluated individually and is discussed in the following sections. 
For a pesticide registered for use on a large number of commodities, tolerance assessments are
conducted for only a group of selected fruits and vegetables.  Generally, commodities are
selected from all the uses based on the potential for high levels of exposure.  For a number ofMethidathion RCD (Revision 1) February 2007
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RACs, only the tolerances for the commodities on FDA's list of the 20 most frequently
consumed fruits and vegetables were examined.  These commodities were selected because of
either their high consumption (oranges, apples, pears, peaches, plums, apricots, cherries,
almonds, walnuts, sunflower seeds) and/or high tolerance (oranges, grapefruit, lemons,
tangerines).  For methidathion, the tolerances for the following commodities were evaluated:
oranges (2.0 ppm), lemons (2.0 ppm), grapefruit (2.0 ppm), tangerines (6.0 ppm), apples (0.05
ppm), pears (0.05 ppm), peaches (0.05 ppm), apricots (0.05 ppm), cherries (0.05 ppm), plums
(0.05 ppm), almonds (0.05 ppm), walnuts (0.05 ppm) and sunflower seeds (0.5 ppm).  The
tolerances for methidathion in these commodities do not include the oxygen analog. 
V.B.  ACUTE EXPOSURE
An acute exposure assessment is conducted for each individual label-approved
commodity at the  tolerance.  The DEEM-FCID™ Acute Analysis software program and the
1994-98 USDA CSFII data were used in this assessment.  The acute tolerance assessment does
not routinely address multiple commodities at the tolerance levels since the probability of
consuming multiple commodities at the tolerance decreases as the number of commodities
included in the assessment increases.  The 95th percentile of user-day exposures for all specific
population subgroups was used in evaluating the margins of exposure for the various population
subgroups.
The acute MOEs for the 12 commodities analyzed are summarized in Table 45.  The
consumption of some commodities was sufficiently low in certain population subgroups, such as
infants less than 1 year old and pregnant or nursing females (13 years and older), so that a
calculation of the exposure and MOE was not considered reliable for these population
subgroups.  The exposure and MOE estimates were considered unreliable when there were less
than 25 user-days for any population subgroup.  
The MOEs were less than 100 for most population subgroups for oranges, grapefruit and
tangerines.  The MOEs were also less than 100 for a few infant or children population subgroups
for lemons and apples.  The MOEs were equal to or greater than 100 for all the population
subgroups for pears, stone fruits, nuts and sunflower seeds.  Based on these analyses, the
tolerances for citrus fruit should be reevaluated by U.S. EPA.  The tolerance for apples should
also be reevaluated based on the low MOEs for infants and toddlers.  In order to obtain MOEs of
at least 100 at the 95
th percentile, the tolerances for citrus fruit and apples would need to be
reduced to 0.05 and 0.04 ppm, respectively.
V.C.  CHRONIC EXPOSURE
A chronic exposure assessment using residues equal to the established tolerances for
individual or combinations of commodities has not been conducted because it is highly
improbable that an individual would chronically consume single or multiple commodities with
pesticide residues at the tolerance levels.  This conclusion is supported by data from both PDP
and DPR pesticide monitoring programs which indicate that less than one percent of all sampled
commodities have residue levels at or above the established tolerance (DPR, 1994-2002).Methidathion RCD (Revision 1) February 2007
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Table 45. Margins of Exposure for Acute Dietary Exposure to Tolerance Levels of
Methidathion on Selected Raw Agricultural Commodities
a
Population Subgroup Oranges Grapefruit Tangerines Lemons Apples Plums Pears
U.S. Population 7 23 33 160 270 840    950
Western Region 7 23 33 160 270 750  780
Nursing Infants (<1 yr)   5 LC LC LC  100  LC  170
Non-Nursing Infants (<1 yr)   4   1 43 130 90 300  210
Children (1-2 yrs)   3 21 11 70 90    320  320
Children (3-5 yrs)   4 71 35 70 140 530 510
Children (6-12 yrs)   6 130  110 100 300    550 1,100
Youth (13-19 yrs) 7 20 110 120 470 LC 2,900
Adults (20-49 yrs) 10 19 33 160 730 1,300 1,400
Adults (50+ yrs) 16 21 21 280 880 960 1,400
Females (13-49 yrs) 9 20 25 150 640 970 1,400
Females (13+ yrs/P/NN) 11 LC LC 110 310 LC LC
Females (13+ yrs/N) 10 LC LC 150 610 LC LC
a Based on 95th exposure percentile for all user-day population subgroups.  Values rounded to two significant figures.
LC There were less than 25 user-days for this population subgroup in the 1994-98 USDA Continuing Survey of Food Intakes
by Individuals (CSFII), so the MOE was not considered reliable.
P Pregnant
NN Not nursing
N NursingMethidathion RCD (Revision 1) February 2007
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Table 45 (cont.). Margins of Exposure for Acute Dietary Exposure to Tolerance Levels of
Methidathion on Selected Raw Agricultural Commodities
a
Population Subgroup Peaches Apricots Cherries Almonds Walnuts
Sunflower
 Seeds
U.S. Population 1,700 7,100 12,000 14,000 21,000 38,000
Western Region 1,600  3,700  11,000 12,000 18,000 10,000
Nursing Infants (<1 yr)      260  580     3,600 LC LC 450
Non-Nursing Infants (<1 yr)    260    430  1,800 LC  LC 270
Children (1-2 yrs)    460 1,200  7,200 11,000 6,500 29,000
Children (3-5 yrs) 840 7,600 9,300 8,000 13,000 38,000
Children (6-12 yrs) 1,600 9,800 13,000 16,000 20,000 42,000
Youth (13-19 yrs) 2,300 19,000 20,000 17,000 21,000 85,000
Adults (20-49 yrs) 2,200 10,000 19,000 12,000 25,000 67,000
Adults (50+ yrs) 2,200  5,400 12,000 14,000 26,000 92,000
Females (13-49 yrs) 2,000 14,000 20,000 11,000 24,000 97,000
Females (13+ yrs/P/NN) 1,300 LC 76,000 LC LC 140,000
Females (13+ yrs/N) LC  LC  LC LC LC 66,000
a Based on 95th exposure percentile for all user-day population subgroups.  Values rounded to two significant figures.
LC There were less than 25 user-days for this population subgroup in the 1994-98 USDA Continuing Survey of Food
Intakes by Individuals (CSFII), so the MOE was not considered reliable.
P Pregnant
NN Not nursing
N NursingMethidathion RCD (Revision 1) February 2007
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VI.  REFERENCE DOSES/CONCENTRATIONS
The reference dose (RfD) or reference concentration (RfC) is the dose at which no
adverse effects are expected to occur in humans.  RfDs and RfCs were calculated for
methidathion for acute, seasonal and chronic exposures.   Generally, the RfDs are calculated by
dividing the NOELs by an uncertainty factor of 100 when the NOEL is from an animal study to
account for interspecies and intraspecies variation in sensitivity.  A NOEL of 0.18 mg/kg was
selected for evaluating acute exposure based on depressed ChE activity in the cerebral cortex of
male rats (74% of controls) after 2 weeks of exposure in the 90-day neurotoxicity study.  Using
this NOEL, the acute RfD for methidathion is 0.0018 mg/kg/day or 1.8 μg/kg/day.  This acute
RfD could be used for evaluating dietary exposure without adjustment for oral absorption since
dietary exposure dosages are usually expressed as external dosages.  For evaluating occupational
exposure, the RfD may need to be converted to an absorbed dosage depending on how the
exposure dosages for workers are calculated.  The oral absorption for methidathion was assumed
to be 100% based on the available pharmacokinetics data; therefore, no adjustment is needed. 
The acute RfD would be only protective for systemic effects with occupational exposure,
although local effects such as dermal irritation are not a major concern with methidathion.  An
acute RfC was also calculated for evaluating acute inhalation exposure (ambient air) to
methidathion using the acute oral NOEL.  The oral NOEL was converted to an equivalent human
inhalation NOEL by dividing it by the respiratory rate for humans.
human inhalation NOEL mg m
animal oral NOEL mg kg
respiratory rate m kg human
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The default respiratory rates assumed for infants and adults were 0.59 and 0.28
m
3/kg/day, respectively.  The resulting equivalent acute human inhalation NOELs were 0.31 and
0.64 mg/m
3 for infants and adults, respectively.  After dividing the equivalent human inhalation
NOEL by an uncertainty factor of 100, the resultant acute RfCs (24 hrs) are 3.1 μg/m
3 (0.25 ppb)
and 6.4 μg/m
3 (0.52 ppb)  (Table 46). 
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The 24-hour time weighted average air concentration of methidathion in the first 24 hours with
application site monitoring was 0.88 μg/m
3 (71 ppt).  The 95
th percent upper bound estimate of
the ambient air concentrations at the Jefferson site was 0.66 μg/m
3 (54 ppt).  
To evaluate seasonal exposure, the NOEL of 0.18 mg/kg/day from the oral 90-day
neurotoxicity was selected in which depressed ChE activity in the RBCs of both sexes (56-81%),
in the cerebral cortex of male rats (74% of controls) and in the striatum (63% of controls) and
hippocampus (76'% of controls) of female rats was observed at the LOEL after 90 days.   Since
the NOEL was the same for acute and seasonal exposure, the seasonal RfCs for infants and
adults are the same as for acute RfCs.  The mean air concentration at the Jefferson site during the
one-month monitoring period was estimated to be 86 ng/m
3 (7.0 ppt).  Methidathion RCD (Revision 1) February 2007
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Table 46.  Reference Doses and Concentrations for Methidathion
Exposure
Scenario NOEL Effects on LOEL RfD
RfC
Infants Adults
Acute 0.18
mg/kg
Reduced ChE activity in
cerebral cortex of  male
rats
1.8
μg/kg
3.1 μg/m
3
(0.25 ppb)
6.4 μg/m
3
(0.52 ppb)
Seasonal 0.18
mg/kg/day
Reduced ChE activity in
RBCs, cerebral cortex
(M), striatum (F) and
hippocampus (F) of rats
1.8
μg/kg/day
3.1 μg/m
3
(0.25 ppb)
6.4 μg/m
3
(0.52 ppb)
Chronic 0.15
mg/kg/day
Elevated liver enzymes in
serum and liver
histopathology in dogs
1.5
μg/kg/day
2.5 μg/m
3
(0.21 ppb)
5.4 μg/m
3
(0.43 ppb)
Lifetime Potency
0.53 
(mg/kg/day)
-1
Liver tumors in male mice 1.9 
ng/kg/day -----
6.8 ng/m
3
(0.6 ppt)
To evaluate chronic dietary and occupational exposure to methidathion, the NOEL of
0.15 mg/kg/day from the 1-year dog study was selected in which elevated liver enzymes in the
serum and histological lesions in the liver were seen at the LOEL.  Using this NOEL, the chronic
RfD is 0.0015 mg/kg/day or 1.5 μg/kg/day.  The equivalent chronic human inhalation NOELs
were 0.25 and 0.54 mg/m
3 for infants and adults, respectively.  The resultant chronic RfCs for
methidathion are 2.5 μg/m
3 (0.21 ppb) for infants and 5.4 μg/m
3 (0.43 ppb) .  Assuming the
season for methidathion use lasts 9 months, the annual average air concentration at the Jefferson
site would be 64 ng/m
3 (5.2 ppt).
Generally, RfDs/RfCs are not calculated for carcinogenicity since it is assumed there is
no threshold for this endpoint.  However, it is possible to calculate a dose or air concentration at
which the carcinogenic risk is negligible.  To do this, the negligible risk level (1 x 10
-6) is
divided by the 95% UB estimate of carcinogenic potency (0.53 (mg/kg/day)
-1).  For
methidathion, the exposure dosage or RfD corresponding to a negligible carcinogenic risk is 1.9
ng/kg/day.  The exposure dosage was converted to an air concentration by dividing by the
estimated breathing rate for an adult male (0.28 m
3/kg/day).  The air concentration below which
there would be no regulatory concern for carcinogenic effects is 6.8 ng/m
3 (0.6 ppt).Methidathion RCD (Revision 1) February 2007
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VII.  CONCLUSIONS
The risks for potential adverse human health effects with dietary, drinking water,
occupational and ambient air exposure to methidathion were evaluated using margins of
exposure (MOEs) estimates.   The MOEs for acute, subchronic and chronic exposure were
calculated using no-observed-effect levels (NOELs) from the available guideline and literature
toxicity studies for methidathion.  In selecting the NOELs to evaluate exposure, the greatest
weight was given to guideline studies which met FIFRA guidelines.  Generally, an MOE greater
than 100 is considered sufficiently protective of human health when the NOEL for an adverse
effect is derived from an animal study.  The MOE of 100 allows for humans being 10 times more
sensitive than animals and for a 10-fold variation in sensitivity between the lower distribution of
the overall human population and the sensitive subgroup.  A carcinogenic risk level less than one
in a million or 10
-6 is generally considered negligible.  
The potential health risks from dietary exposure to methidathion appear to be low.  The
MOEs for acute dietary exposure were greater than 200 for all population subgroups in a Tier 3
analysis which included a Monte Carlo analysis for high consumption fruit commodities for
which there were PDP monitoring data.  Percent crop treated was taken into consideration for the
commodities in which the Monte Carlo analysis was performed.  The MOEs for chronic dietary
exposure to methidathion were equal to or greater than 8,000 with a Tier 3 analysis involving
adjustment for percent crop treated for most commodities.  The upper bound estimate of
carcinogenic risk from dietary exposure to methidathion in the U.S. population was slightly
greater than the negligible risk level of 10
-6 even with use of  PDP data and adjustment for
percent crop treated.  The acute dietary MOEs based on the tolerance for methidathion residues
were greater than 100 for all population subgroups on various commodities, except for citrus
fruit and apples.  Based on these estimates, the tolerance levels for these commodities do not
appear to be health protective and DPR recommends that U.S. EPA reevaluate these tolerances.
The potential health risks from methidathion in drinking water also appear to be low. 
The MOEs for acute exposure to methidathion in drinking water were greater than 15,000 for all
population subgroups based on USDA’s PDP drinking water data for California from 2001 to
2003.  The MOEs for chronic drinking water exposure to methidathion were greater than
150,000.  The estimated carcinogenic risk from exposure to methidathion in drinking water was
less than the negligible risk level of 10
-6.  When dietary and drinking water exposures were
combined, the acute and chronic MOEs were still greater than 200 and 7,000, respectively, for
all population subgroups.  Addition of the drinking water exposure to dietary exposure increased
the upper bound estimate for carcinogenic risk only slightly since the contribution from dietary
exposure was so much greater. 
The potential health risks from occupational exposure are of concern.  The MOEs for
acute, seasonal and chronic occupational exposure to methidathion were less than 100 for all
exposure scenarios, except seasonal exposure for thinning artichokes and chronic exposure for
all field worker scenarios.  The MOEs were less than 10 for most handler scenarios and less than
1 for some handler scenarios (aerial handlers and airblast applicators).  In addition, the
carcinogenic risk estimates for occupational exposure to methidathion all exceeded the
negligible risk level.  The estimated carcinogenic risk based on the maximum likelihood estimate
ranged from 2.0 x 10
-5 to 2.3 x 10
-2.  The upper bound estimates of carcinogenic risk wereMethidathion RCD (Revision 1) February 2007
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between and 3.2 x 10
-4 to 3.7 x 10
-2.  Airblast applicators had the highest carcinogenic risk
estimates.
The potential health risks from exposure to methidathion in application site and ambient
air are also of concern.  The MOEs for acute exposure to methidathion in application site air
were less than 100 for both infants and adults, not only meeting the criteria for listing
methidathion as a toxic air contaminant, but suggesting mitigation is needed.  The seasonal and
chronic MOEs for the application site were greater than 100, but less than 1,000 which are still
low enough to meet the criteria for listing.  The MOEs for seasonal and chronic exposure to
methidathion in ambient air were greater than 1,000 for both infants and adults.  The
carcinogenic risk estimates for the application site (2.5 x 10
-5 to 3.9 x 10
-5) and ambient air (7.1 x
10
-6 to 1.1 x 10
-5) were above the negligible risk level not only meeting the listing criteria, but
indicating mitigation may be needed.
The MOEs for most agricultural workers were already significantly less than 100 from
occupational exposure alone, consequently, their aggregate MOEs were not significantly lower
with the addition of dietary, drinking water and ambient air exposure.  Similarly, air exposure
was a major contributor to the aggregate exposure for the general population, so that their
aggregate MOEs were only slightly lower than their MOEs for air exposure alone.
The health risks for methidathion were probably underestimated due to the lack of
toxicity data for the oxygen analog which is the presumed active metabolite.  In the absence of
these toxicity data, the oxon was assumed to have equivalent in toxicity to the parent compound. 
Most likely the NOELs for the oxon would have been lower since the oxon is usually more toxic
than the parent compound for organophosphorothioates, at least for neurological effects.  Health
risks may have also been underestimated from dietary exposure since neither the DPR or PDP
monitoring programs analyzed commodities for the oxon.  Furthermore, the health risk estimates
for methidathion were probably underestimated since they did not take into consideration
cumulative exposure from other organophosphates.  Methidathion RCD (Revision 1) February 2007
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          DATE: 06-22-00                    TIME: 09:18:12
 MULTI-WEIB  (MAR 1985)
 (C) COPYRIGHT CLEMENT ASSOCIATES, INC. 1983-1987
  K.S. CRUMP & COMPANY, INC.
  1201 GAINES STREET
  RUSTON, LA   71270
  (318) 255-4800
     Methidathion, Combined Hepatocellular Adenomas and Carcinomas in Male Mice
          THE  20 OBSERVATIONS AT LEVEL  1 WITH A DOSE OF  .000000    
                           TUMOR                                       TUMOR
  TIME    # OF ANIMALS   INDICATOR            TIME    # OF ANIMALS   INDICATOR
  ----    ------------   ---------            ----    ------------   ---------
   57.0          1           1                 58.0          1           1
   59.0          1           1                 62.0          1           1
   64.0          1           1                 67.0          1           1
   73.0          2           1                 76.0          1           1
   77.0          1           1                 78.0          1           1
   81.0          1           1                 81.0          1           3
   83.0          2           1                 84.0          1           3
   93.0          1           1                 95.0          1           1
   98.0          3           1                 99.0          1           3
  100.0         22           1                100.0          6           2
          THE  20 OBSERVATIONS AT LEVEL  2 WITH A DOSE OF  .600000E-01
                           TUMOR                                       TUMOR
  TIME    # OF ANIMALS   INDICATOR            TIME    # OF ANIMALS   INDICATOR
  ----    ------------   ---------            ----    ------------   ---------
   44.0          2           1                 48.0          1           1
   60.0          1           1                 61.0          1           1
   64.0          1           1                 66.0          1           1
   77.0          1           1                 79.0          1           2
   80.0          1           2                 81.0          1           1
   89.0          1           2                 90.0          1           2
   91.0          1           2                 91.0          1           1
   94.0          1           1                 96.0          1           1
   98.0          3           1                 99.0          1           1
  100.0         19           1                100.0         10           2
          THE  19 OBSERVATIONS AT LEVEL  3 WITH A DOSE OF  .200000    
                           TUMOR                                       TUMOR
  TIME    # OF ANIMALS   INDICATOR            TIME    # OF ANIMALS   INDICATOR
  ----    ------------   ---------            ----    ------------   ---------
    5.0          1           1                 12.0          1           1
   25.0          1           1                 67.0          2           1
   71.0          2           1                 76.0          1           1
   85.0          1           2                 89.0          3           1
   90.0          1           1                 93.0          2           1Methidathion RCD (Revision 1) February 2007
   93.0          1           2                 94.0          1           3
   96.0          1           1                 96.0          1           3
   97.0          1           1                 98.0          1           1
   99.0          3           1                100.0         19           1
  100.0          7           2
          THE  21 OBSERVATIONS AT LEVEL  4 WITH A DOSE OF  .970000    
                           TUMOR                                       TUMOR
  TIME    # OF ANIMALS   INDICATOR            TIME    # OF ANIMALS   INDICATOR
  ----    ------------   ---------            ----    ------------   ---------
   44.0          1           1                 57.0          1           1
   58.0          2           1                 59.0          1           1
   60.0          2           1                 71.0          1           2
   75.0          1           1                 79.0          1           1
   81.0          1           3                 81.0          1           2
   83.0          1           2                 86.0          1           3
   86.0          1           1                 87.0          1           2
   88.0          1           1                 90.0          1           1
   91.0          1           3                 99.0          1           1
   99.0          2           3                100.0         16           1
  100.0         12           2
          THE  32 OBSERVATIONS AT LEVEL  5 WITH A DOSE OF  1.90000    
                           TUMOR                                       TUMOR
  TIME    # OF ANIMALS   INDICATOR            TIME    # OF ANIMALS   INDICATOR
  ----    ------------   ---------            ----    ------------   ---------
   22.0          1           1                 28.0          1           1
   55.0          1           1                 56.0          1           1
   57.0          1           1                 63.0          1           2
   68.0          1           2                 69.0          1           1
   70.0          1           1                 72.0          3           2
   74.0          1           2                 76.0          1           2
   78.0          1           3                 80.0          1           2
   82.0          1           2                 85.0          2           2
   88.0          1           3                 90.0          3           3
   91.0          1           2                 91.0          1           3
   92.0          1           3                 93.0          1           3
   93.0          1           2                 94.0          1           3
   95.0          1           3                 98.0          2           1
   98.0          1           2                 98.0          1           3
   99.0          2           2                 99.0          2           3
  100.0          3           1                100.0          9           2
     FORM OF PROBABILITY FUNCTION: 
          P(DOSE) = 1 - exp( ( -Q0 - Q1 * D - Q2 * D^2 - ... - Q 4 * D^ 4 ) *
(T - T0)^J )
     THE MAXIMUM LIKELIHOOD ESTIMATION OF:
                      PROBABILITY FUNCTION COEFFICIENTS
                          Q( 0)= .476305436831E-12
                          Q( 1)= .864812104460E-13
                          Q( 2)= .375761739529E-12
                          Q( 3)= .104589214976E-12
                          Q( 4)= .000000000000    Methidathion RCD (Revision 1) February 2007
                         TIME FUNCTION COEFFICIENTS
                            T0 =  .000000000000    
                             J =  5.93342862928    
     THE MAXIMUM LIKELIHOOD IS -112.496010523    
                  MAXIMUM LIKELIHOOD ESTIMATES OF EXTRA RISK
*******************************************************************************
             WEIBULL LOWER CONFIDENCE LIMITS ON DOSE FOR FIXED RISK
             ******************************************************
                                                        CONFIDENCE
                             LOWER BOUND   UPPER BOUND    LIMIT
     RISK        MLE DOSE      ON DOSE       ON RISK     INTERVAL       TIME
     ----        --------      -------       -------     --------       ----
 1.000000E-06  1.571056E-05  1.691143E-06  9.289864E-06    95.0%     100.000    
             WEIBULL UPPER CONFIDENCE LIMITS ON RISK FOR FIXED DOSE
             ******************************************************
                                                    CONFIDENCE
                                     UPPER BOUND      LIMIT
         DOSE          MLE RISK        ON RISK       INTERVAL        TIME
         ----          --------        -------       --------        ----
      1.00000         .341090         .529102          95.0%      100.000    
 NORMAL COMPLETION!Methidathion RCD (Revision 1) February 2007
APPENDIX B
Dietary and Drinking Water Exposure Analysis PrintoutsMethidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                        Ver. 2.02
DEEM-FCID Acute analysis for METHIDATHION
Residue file name: H:\MyFiles\DEEM-FCID Files\Methidathion\Methidathionr1acutefood.R98
Analysis Date 10-26-2005             Residue file dated: 10-25-2005/16:02:15/14
Reference dose (NOEL) = 0.3 mg/kg bw/day
--------------------------------------------------------------------------------
RDL indices and parameters for Monte Carlo Analysis:
Index Dist Parameter #1           Param #2    Param #3    Comment
  #   Code 
----- ---- ------------           ----------- ----------- ----------
  1    6   RDF1 APPLES.rdf
  2    6   RDF2 PLUMS.rdf
  3    6   RDF3 APRICOTS.rdf
  4    6   RDF4 ORANGES.rdf
  5    6   RDF5 PEACHES.rdf
  6    6   RDF6 NECTARINES.rdf
  7    6   RDF7 PEARS.rdf
  8    6   RDF8 CHERRIES.rdf
  9    6   RDF9 PRUNES.RDF
  EPA    Crop Food Name                         Def Res     Adj.Factors  RDL  Comment
  Code    Grp                                    (ppm)       #1     #2   Pntr
-------- ---- -------------------------------  ----------  ------ ------ ---  -------
14000030 14   Almond                             0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
14000031 14   Almond-babyfood                    0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
14000040 14   Almond, oil                        0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
14000041 14   Almond, oil-babyfood               0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
11000070 11   Apple, fruit with peel             0.007000   1.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000080 11   Apple, peeled fruit                0.007000   1.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000081 11   Apple, peeled fruit-babyfood       0.007000   1.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000090 11   Apple, dried                       0.007000   8.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000091 11   Apple, dried-babyfood              0.007000   8.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000100 11   Apple, juice                       0.007000   1.300  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000101 11   Apple, juice-babyfood              0.007000   1.300  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000110 11   Apple, sauce                       0.007000   1.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000111 11   Apple, sauce-babyfood              0.007000   1.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
12000120 12   Apricot                            0.050000   1.000  1.000   3  DPR 20
    Full comment: DPR 2002-2004 - RDF, 5% PCT
12000121 12   Apricot-babyfood                   0.050000   1.000  1.000   3  DPR 20
    Full comment: DPR 2002-2004 - RDF, 5% PCT
12000130 12   Apricot, dried                     0.050000   6.000  1.000   3  DPR 20
    Full comment: DPR 2002-2004 - RDF, 5% PCT
12000140 12   Apricot, juice                     0.050000   1.000  1.000   3  DPR 20
    Full comment: DPR 2002-2004 - RDF, 5% PCT
12000141 12   Apricot, juice-babyfood            0.050000   1.000  1.000   3  DPR 20
    Full comment: DPR 2002-2004 - RDF, 5% PCT
95000160 O    Artichoke, globe                   0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LOD
01030170 1CD  Artichoke, Jerusalem               0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LOD
14000590 14   Brazil nut                         0.050000   1.000  1.000      ToleraMethidathion RCD (Revision 1) February 2007
    Full comment: Tolerance
14000680 14   Butternut                          0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
14000810 14   Cashew                             0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
12000900 12   Cherry                             0.004000   1.000  1.000   8  PDP Ch
    Full comment: PDP Cherries 2000 & 2001 CA - RDF, 10% PCT
12000901 12   Cherry-babyfood                    0.004000   1.000  1.000   8  PDP Ch
    Full comment: PDP Cherries 2000 & 2001 CA - RDF, 10% PCT
12000910 12   Cherry, juice                      0.004000   1.500  1.000   8  PDP Ch
    Full comment: PDP Cherries 2000 & 2001 CA - RDF, 10% PCT
12000911 12   Cherry, juice-babyfood             0.004000   1.500  1.000   8  PDP Ch
    Full comment: PDP Cherries 2000 & 2001 CA - RDF, 10% PCT
14000920 14   Chestnut                           0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
10001060 10   Citrus citron                      2.000000   1.000  1.000   4  Tolera
    Full comment: Tolerance
10001070 10   Citrus hybrids                     0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10001080 10   Citrus, oil                        0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
95001280 O    Cottonseed, oil                    0.200000   1.000  1.000      Tolera
    Full comment: Tolerance
95001281 O    Cottonseed, oil-babyfood           0.200000   1.000  1.000      Tolera
    Full comment: Tolerance
11001290 11   Crabapple                          0.007000   1.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California LOD
14001550 14   Filbert                            0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
14001560 14   Filbert, oil                       0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
10001800 10   Grapefruit                         0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10001810 10   Grapefruit, juice                  0.007000   2.100  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
14001850 14   Hickory nut                        0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
95001950 O    Kiwifruit                          0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LOD
10001970 10   Kumquat                            0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10001990 10   Lemon                              0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002000 10   Lemon, juice                       0.007000   2.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002001 10   Lemon, juice-babyfood              0.007000   2.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002010 10   Lemon, peel                        2.000000   1.000  1.000   4  Tolera
    Full comment: Tolerance
10002060 10   Lime                               0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002070 10   Lime, juice                        0.007000   2.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002071 10   Lime, juice-babyfood               0.007000   2.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
14002130 14   Macadamia nut                      0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
95002150 O    Mango                              0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LOD
95002151 O    Mango-babyfood                     0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LOD
95002160 O    Mango, dried                       0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LOD
95002170 O    Mango, juice                       0.050000   1.000  1.000      DPR 20Methidathion RCD (Revision 1) February 2007
    Full comment: DPR 2002-2004 LOD
95002171 O    Mango, juice-babyfood              0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LOD
12002300 12   Nectarine                          0.004000   1.000  1.000   6  PDP Ne
    Full comment: PDP Nectarine 2000 & 2001 CA - RDF, 10% PCT
95002350 O    Olive                              0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
95002360 O    Olive, oil                         0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
10002400 10   Orange                             0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002410 10   Orange, juice                      0.007000   1.800  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002411 10   Orange, juice-babyfood             0.007000   1.800  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002420 10   Orange, peel                       2.000000   1.000  1.000   4  Tolera
    Full comment: Tolerance
12002600 12   Peach                              0.004000   1.000  1.000   5  PDP Pe
    Full comment: PDP Peach 2001 & 2002 CA - RDF, 15% PCT
12002601 12   Peach-babyfood                     0.004000   1.000  1.000   5  PDP Pe
    Full comment: PDP Peach 2001 & 2002 CA - RDF, 15% PCT
12002610 12   Peach, dried                       0.004000   7.000  1.000   5  PDP Pe
    Full comment: PDP Peach 2001 & 2002 CA - RDF, 15% PCT
12002611 12   Peach, dried-babyfood              0.004000   7.000  1.000   5  PDP Pe
    Full comment: PDP Peach 2001 & 2002 CA - RDF, 15% PCT
12002620 12   Peach, juice                       0.004000   1.000  1.000   5  PDP Pe
    Full comment: PDP Peach 2001 & 2002 CA - RDF, 15% PCT
12002621 12   Peach, juice-babyfood              0.004000   1.000  1.000   5  PDP Pe
    Full comment: PDP Peach 2001 & 2002 CA - RDF, 15% PCT
11002660 11   Pear                               0.004000   1.000  1.000   7  PDP Pe
    Full comment: PDP Pear 2003 National - RDF, 10% PCT
11002661 11   Pear-babyfood                      0.004000   1.000  1.000   7  PDP Pe
    Full comment: PDP Pear 2003 National - RDF, 10% PCT
11002670 11   Pear, dried                        0.004000   6.250  1.000   7  PDP Pe
    Full comment: PDP Pear 2003 National - RDF, 10% PCT
11002680 11   Pear, juice                        0.004000   1.000  1.000   7  PDP Pe
    Full comment: PDP Pear 2003 National - RDF, 10% PCT
11002681 11   Pear, juice-babyfood               0.004000   1.000  1.000   7  PDP Pe
    Full comment: PDP Pear 2003 National - RDF, 10% PCT
14002690 14   Pecan                              0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
95002780 O    Pine nut                           0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
14002820 14   Pistachio                          0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
12002850 12   Plum                               0.050000   1.000  1.000   2  DPR 20
    Full comment: DPR 2002-2004 - RDF, 15% PCT
12002851 12   Plum-babyfood                      0.050000   1.000  1.000   2  DPR 20
    Full comment: DPR 2002-2004 - RDF, 15% PCT
12002860 12   Plum, prune, fresh                 0.050000   1.000  1.000   9  DPR Pl
    Full comment: DPR Plum 2002-2004 - RDF, 5% PCT
12002861 12   Plum, prune, fresh-babyfood        0.050000   1.000  1.000   9  DPR Pl
    Full comment: DPR Plum 2002-2004 - RDF, 5% PCT
12002870 12   Plum, prune, dried                 0.050000   5.000  1.000   9  DPR Pl
    Full comment: DPR Plum 2002-2004 - RDF, 5% PCT
12002871 12   Plum, prune, dried-babyfood        0.050000   5.000  1.000   9  DPR Pl
    Full comment: DPR Plum 2002-2004 - RDF, 5% PCT
12002880 12   Plum, prune, juice                 0.050000   1.400  1.000   9  DPR Pl
    Full comment: DPR Plum 2002-2004 - RDF, 5% PCT
12002881 12   Plum, prune, juice-babyfood        0.050000   1.400  1.000   9  DPR Pl
    Full comment: DPR Plum 2002-2004 - RDF, 5% PCT
10003070 10   Pummelo                            0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
11003100 11   Quince                             0.007000   1.000  1.000   1  PDP ApMethidathion RCD (Revision 1) February 2007
    Full comment: PDP Apple 2002 CA - RDF, 15% PCT
20003300 20   Safflower, oil                     0.050000   1.000  1.000      Safflo
    Full comment: Safflower Field Trial High Value
20003301 20   Safflower, oil-babyfood            0.050000   1.000  1.000      Safflo
    Full comment: Safflower Field Trial High Value
15003440 15   Sorghum, grain                     0.200000   1.000  1.000      Tolera
    Full comment: Tolerance
15003450 15   Sorghum, syrup                     0.200000   1.000  1.000      Tolera
    Full comment: Tolerance
95003580 O    Starfruit                          0.100000   1.000  1.000      Tolera
    Full comment: Tolerance
95003610 O    Sugar apple                        0.200000   1.000  1.000      Tolera
    Full comment: Tolerance
20003640 20   Sunflower, seed                    0.220000   1.000  0.500      Sunflo
    Full comment: Sunflower Field Trial High Value, 50% hulls
20003650 20   Sunflower, oil                     0.220000   1.000  0.200      Sunflo
    Full comment: Sunflower Field Trial High Value, 20% Oil
20003651 20   Sunflower, oil-babyfood            0.220000   1.000  0.200      Sunflo
    Full comment: Sunflower Field Trial High Value, 20% Oil
10003690 10   Tangerine                          0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10003700 10   Tangerine, juice                   0.007000   2.300  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
14003910 14   Walnut                             0.050000   1.000  1.000      Tolera
    Full comment: ToleranceMethidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Summary calculations (per capita):
                    95th Percentile      99th Percentile      99.9th Percentile
                   Exposure     MOE     Exposure     MOE     Exposure     MOE  
                  ---------- --------  ---------- --------  ---------- --------
U.S. Population:
                    0.000037     8219    0.000110     2727    0.000324      927 
Western region:
                    0.000042     7216    0.000139     2165    0.000345      868 
Hispanics:
                    0.000048     6202    0.000163     1843    0.000456      657 
Non-hispanic whites:
                    0.000035     8603    0.000098     3076    0.000281     1067 
Non-hispanic blacks:
                    0.000035     8540    0.000108     2765    0.000227     1319 
Non-hisp/non-white/non-black:
                    0.000045     6721    0.000157     1910    0.000439      683 
All infants:
                    0.000126     2372    0.000207     1449    0.000491      611 
Nursing infants (<1 yr old):
                    0.000069     4352    0.000129     2332    0.000244     1227 
Non-nursing infants (<1 yr old):
                    0.000146     2055    0.000227     1322    0.000502      597 
Females 13+ (preg/not nursing):
                    0.000040     7568    0.000216     1386    0.000294     1021 
Females 13+ (nursing):
                    0.000036     8431    0.000284     1057    0.000298     1005 
Children 1-2 yrs:
                    0.000094     3187    0.000281     1067    0.000780      384 
Children 3-5 yrs:
                    0.000079     3806    0.000216     1390    0.000602      498 Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Summary calculations:
                      95th Percentile     99th Percentile     99.9th Percentile
                      Exposure    MOE     Exposure    MOE     Exposure     MOE  
                     ---------- -------  ---------- -------  ---------- --------
Children 6-12 yrs:
                    0.000048     6315    0.000132     2266    0.000474      633 
Youth 13-19 yrs:
                    0.000029    10505    0.000089     3385    0.000333      899 
Adults 20-49 yrs:
                    0.000027    10962    0.000078     3846    0.000214     1403 
Adults 50+ yrs:
                    0.000021    14166    0.000071     4241    0.000174     1723 
Females 13-49 yrs:
                    0.000028    10711    0.000086     3481    0.000215     1395 
Custom demographics 1: Workers, 16+ years:
                    0.000025    11898    0.000077     3906    0.000191     1569 Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
U.S. Population                    Daily Exposure Analysis  /a
---------------                    (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000010     0.000011
            Standard Deviation        0.000025     0.000025
            Margin of Exposure 2/       28,788       28,423
       Percent of Person-Days that are User-Days =  98.73%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    477,361            90.00      0.000022     13,885
    20.00      0.000001    222,005            95.00      0.000037      8,150
    30.00      0.000002    131,758            97.50      0.000061      4,919
    40.00      0.000003     89,808            99.00      0.000111      2,707
    50.00      0.000005     65,467            99.50      0.000154      1,942
    60.00      0.000006     48,612            99.75      0.000203      1,480
    70.00      0.000009     35,231            99.90      0.000329        913
    80.00      0.000012     24,153
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    538,121            90.00      0.000021     14,035
    20.00      0.000001    236,560            95.00      0.000037      8,219
    30.00      0.000002    137,199            97.50      0.000060      4,960
    40.00      0.000003     92,109            99.00      0.000110      2,727
    50.00      0.000004     66,773            99.50      0.000154      1,949
    60.00      0.000006     49,350            99.75      0.000202      1,487
    70.00      0.000008     35,707            99.90      0.000324        927
    80.00      0.000012     24,459
-------------------------------------------------------------------------------
a/ Analysis based on all two-day participant records in CSFII 1994-98 survey.
2/ Margin of Exposure = NOEL/ Dietary Exposure.
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Western region                     Daily Exposure Analysis 
--------------                     (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000012     0.000012
            Standard Deviation        0.000029     0.000029
            Margin of Exposure          25,371       24,943
       Percent of Person-Days that are User-Days =  98.31%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    451,565            90.00      0.000025     11,940
    20.00      0.000001    208,060            95.00      0.000042      7,147
    30.00      0.000002    124,292            97.50      0.000074      4,060
    40.00      0.000003     87,010            99.00      0.000139      2,155
    50.00      0.000005     63,492            99.50      0.000171      1,754
    60.00      0.000007     45,461            99.75      0.000238      1,258
    70.00      0.000009     32,932            99.90      0.000351        854
    80.00      0.000014     21,902
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    529,683            90.00      0.000025     12,069
    20.00      0.000001    227,216            95.00      0.000042      7,216
    30.00      0.000002    130,682            97.50      0.000072      4,162
    40.00      0.000003     89,696            99.00      0.000139      2,165
    50.00      0.000005     65,263            99.50      0.000170      1,762
    60.00      0.000006     46,480            99.75      0.000238      1,260
    70.00      0.000009     33,356            99.90      0.000345        868
    80.00      0.000014     22,177
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Hispanics                          Daily Exposure Analysis 
---------                          (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000013     0.000013
            Standard Deviation        0.000037     0.000037
            Margin of Exposure          23,489       23,056
       Percent of Person-Days that are User-Days =  98.16%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    593,263            90.00      0.000026     11,683
    20.00      0.000001    255,151            95.00      0.000049      6,100
    30.00      0.000002    145,808            97.50      0.000091      3,303
    40.00      0.000003     95,819            99.00      0.000163      1,839
    50.00      0.000004     68,610            99.50      0.000216      1,388
    60.00      0.000006     49,217            99.75      0.000321        935
    70.00      0.000009     34,199            99.90      0.000456        657
    80.00      0.000013     22,573
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000    714,041            90.00      0.000025     11,860
    20.00      0.000001    278,341            95.00      0.000048      6,202
    30.00      0.000002    154,800            97.50      0.000089      3,387
    40.00      0.000003     99,207            99.00      0.000163      1,843
    50.00      0.000004     70,875            99.50      0.000216      1,389
    60.00      0.000006     50,269            99.75      0.000308        975
    70.00      0.000009     34,855            99.90      0.000456        657
    80.00      0.000013     22,983
                                      3 Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Non-hispanic whites                Daily Exposure Analysis 
-------------------                (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000010     0.000010
            Standard Deviation        0.000022     0.000023
            Margin of Exposure          29,907       29,597
       Percent of Person-Days that are User-Days =  98.97%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    432,050            90.00      0.000021     14,161
    20.00      0.000001    207,779            95.00      0.000035      8,533
    30.00      0.000002    126,949            97.50      0.000058      5,215
    40.00      0.000003     88,423            99.00      0.000098      3,058
    50.00      0.000005     65,008            99.50      0.000140      2,135
    60.00      0.000006     48,700            99.75      0.000186      1,610
    70.00      0.000008     35,558            99.90      0.000282      1,065
    80.00      0.000012     24,444
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    472,297            90.00      0.000021     14,251
    20.00      0.000001    218,343            95.00      0.000035      8,603
    30.00      0.000002    131,078            97.50      0.000057      5,252
    40.00      0.000003     90,236            99.00      0.000098      3,076
    50.00      0.000005     66,039            99.50      0.000140      2,142
    60.00      0.000006     49,345            99.75      0.000186      1,611
    70.00      0.000008     35,961            99.90      0.000281      1,067
    80.00      0.000012     24,688
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Non-hispanic blacks                Daily Exposure Analysis 
-------------------                (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000010     0.000010
            Standard Deviation        0.000024     0.000024
            Margin of Exposure          30,518       30,019
       Percent of Person-Days that are User-Days =  98.36%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000    675,350            90.00      0.000020     14,796
    20.00      0.000001    292,872            95.00      0.000036      8,395
    30.00      0.000002    157,746            97.50      0.000059      5,053
    40.00      0.000003     96,807            99.00      0.000109      2,756
    50.00      0.000004     68,788            99.50      0.000150      2,000
    60.00      0.000006     49,984            99.75      0.000180      1,664
    70.00      0.000008     36,216            99.90      0.000227      1,318
    80.00      0.000012     25,402
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000    791,548            90.00      0.000020     14,932
    20.00      0.000001    327,087            95.00      0.000035      8,540
    30.00      0.000002    167,978            97.50      0.000058      5,135
    40.00      0.000003    101,088            99.00      0.000108      2,765
    50.00      0.000004     70,291            99.50      0.000149      2,010
    60.00      0.000006     51,037            99.75      0.000180      1,665
    70.00      0.000008     36,954            99.90      0.000227      1,319
    80.00      0.000012     25,801
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Non-hisp/non-white/non-black       Daily Exposure Analysis 
----------------------------       (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000013     0.000013
            Standard Deviation        0.000034     0.000034
            Margin of Exposure          23,303       22,681
       Percent of Person-Days that are User-Days =  97.33%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000    612,754            90.00      0.000026     11,534
    20.00      0.000001    229,185            95.00      0.000045      6,678
    30.00      0.000002    124,844            97.50      0.000089      3,381
    40.00      0.000004     81,956            99.00      0.000157      1,908
    50.00      0.000005     57,507            99.50      0.000208      1,444
    60.00      0.000007     41,751            99.75      0.000352        852
    70.00      0.000009     31,872            99.90      0.000440        682
    80.00      0.000015     20,627
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000    987,154            90.00      0.000025     12,025
    20.00      0.000001    253,406            95.00      0.000045      6,721
    30.00      0.000002    141,922            97.50      0.000088      3,404
    40.00      0.000003     86,989            99.00      0.000157      1,910
    50.00      0.000005     60,568            99.50      0.000201      1,492
    60.00      0.000007     42,887            99.75      0.000347        864
    70.00      0.000009     32,487            99.90      0.000439        683
    80.00      0.000014     21,091
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
All infants                        Daily Exposure Analysis 
-----------                        (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000039     0.000046
            Standard Deviation        0.000051     0.000052
            Margin of Exposure           7,677        6,573
       Percent of Person-Days that are User-Days =  85.62%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000002    150,568            90.00      0.000103      2,919
    20.00      0.000010     29,901            95.00      0.000138      2,173
    30.00      0.000017     17,208            97.50      0.000178      1,684
    40.00      0.000024     12,371            99.00      0.000218      1,373
    50.00      0.000031      9,704            99.50      0.000284      1,057
    60.00      0.000039      7,638            99.75      0.000357        839
    70.00      0.000052      5,801            99.90      0.000494        607
    80.00      0.000073      4,119
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000098      3,065
    20.00      0.000000 >1,000,000            95.00      0.000126      2,372
    30.00      0.000009     34,472            97.50      0.000166      1,811
    40.00      0.000017     17,258            99.00      0.000207      1,449
    50.00      0.000025     11,898            99.50      0.000269      1,114
    60.00      0.000033      8,997            99.75      0.000347        863
    70.00      0.000045      6,658            99.90      0.000491        611
    80.00      0.000066      4,541
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Nursing infants (<1 yr old)        Daily Exposure Analysis 
---------------------------        (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000013     0.000024
            Standard Deviation        0.000031     0.000038
            Margin of Exposure          22,235       12,617
       Percent of Person-Days that are User-Days =  56.75%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000065      4,645
    20.00      0.000000    604,483            95.00      0.000090      3,327
    30.00      0.000003     99,692            97.50      0.000122      2,465
    40.00      0.000007     40,748            99.00      0.000176      1,702
    50.00      0.000011     27,514            99.50      0.000197      1,526
    60.00      0.000016     19,040            99.75      0.000244      1,231
    70.00      0.000024     12,642            99.90      0.000275      1,091
    80.00      0.000039      7,661
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000045      6,640
    20.00      0.000000 >1,000,000            95.00      0.000069      4,352
    30.00      0.000000 >1,000,000            97.50      0.000099      3,016
    40.00      0.000000 >1,000,000            99.00      0.000129      2,332
    50.00      0.000000 >1,000,000            99.50      0.000195      1,539
    60.00      0.000003    106,875            99.75      0.000206      1,455
    70.00      0.000010     30,313            99.90      0.000244      1,227
    80.00      0.000019     15,594
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Non-nursing infants (<1 yr old)    Daily Exposure Analysis 
-------------------------------    (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000049     0.000051
            Standard Deviation        0.000053     0.000053
            Margin of Exposure           6,149        5,938
       Percent of Person-Days that are User-Days =  96.58%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000006     49,987            90.00      0.000109      2,754
    20.00      0.000015     19,504            95.00      0.000147      2,037
    30.00      0.000022     13,444            97.50      0.000180      1,665
    40.00      0.000028     10,644            99.00      0.000234      1,281
    50.00      0.000035      8,642            99.50      0.000297      1,011
    60.00      0.000044      6,887            99.75      0.000381        788
    70.00      0.000058      5,167            99.90      0.000504        595
    80.00      0.000078      3,847
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000003    108,795            90.00      0.000108      2,789
    20.00      0.000013     23,697            95.00      0.000146      2,055
    30.00      0.000021     14,535            97.50      0.000180      1,667
    40.00      0.000027     11,157            99.00      0.000227      1,322
    50.00      0.000033      9,006            99.50      0.000290      1,034
    60.00      0.000042      7,155            99.75      0.000380        790
    70.00      0.000056      5,346            99.90      0.000502        597
    80.00      0.000076      3,945
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Females 13+ (preg/not nursing)     Daily Exposure Analysis 
------------------------------     (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000015     0.000015
            Standard Deviation        0.000041     0.000041
            Margin of Exposure          19,816       19,816
       Percent of Person-Days that are User-Days = 100.00%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000    645,612            90.00      0.000022     13,803
    20.00      0.000001    218,754            95.00      0.000040      7,568
    30.00      0.000002    136,609            97.50      0.000215      1,396
    40.00      0.000003     87,814            99.00      0.000216      1,386
    50.00      0.000005     66,124            99.50      0.000293      1,025
    60.00      0.000006     50,881            99.75      0.000293      1,022
    70.00      0.000009     34,498            99.90      0.000294      1,021
    80.00      0.000013     23,814
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000    645,612            90.00      0.000022     13,803
    20.00      0.000001    218,754            95.00      0.000040      7,568
    30.00      0.000002    136,609            97.50      0.000215      1,396
    40.00      0.000003     87,814            99.00      0.000216      1,386
    50.00      0.000005     66,124            99.50      0.000293      1,025
    60.00      0.000006     50,881            99.75      0.000293      1,022
    70.00      0.000009     34,498            99.90      0.000294      1,021
    80.00      0.000013     23,814
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Females 13+ (nursing)              Daily Exposure Analysis 
---------------------              (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000014     0.000014
            Standard Deviation        0.000041     0.000041
            Margin of Exposure          21,447       21,447
       Percent of Person-Days that are User-Days = 100.00%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    312,201            90.00      0.000021     14,426
    20.00      0.000002    193,378            95.00      0.000036      8,431
    30.00      0.000002    129,013            97.50      0.000145      2,073
    40.00      0.000003    100,418            99.00      0.000284      1,057
    50.00      0.000004     81,340            99.50      0.000297      1,009
    60.00      0.000005     65,264            99.75      0.000298      1,006
    70.00      0.000006     47,377            99.90      0.000298      1,005
    80.00      0.000009     34,353
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    312,201            90.00      0.000021     14,426
    20.00      0.000002    193,378            95.00      0.000036      8,431
    30.00      0.000002    129,013            97.50      0.000145      2,073
    40.00      0.000003    100,418            99.00      0.000284      1,057
    50.00      0.000004     81,340            99.50      0.000297      1,009
    60.00      0.000005     65,264            99.75      0.000298      1,006
    70.00      0.000006     47,377            99.90      0.000298      1,005
    80.00      0.000009     34,353
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Children 1-2 yrs                   Daily Exposure Analysis 
----------------                   (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000026     0.000026
            Standard Deviation        0.000059     0.000059
            Margin of Exposure          11,506       11,418
       Percent of Person-Days that are User-Days =  99.23%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000002    179,652            90.00      0.000054      5,585
    20.00      0.000004     82,413            95.00      0.000095      3,173
    30.00      0.000006     51,659            97.50      0.000152      1,974
    40.00      0.000008     36,217            99.00      0.000282      1,064
    50.00      0.000011     26,451            99.50      0.000413        726
    60.00      0.000015     19,566            99.75      0.000562        533
    70.00      0.000021     14,248            99.90      0.000780        384
    80.00      0.000030     10,159
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000002    198,055            90.00      0.000053      5,612
    20.00      0.000004     85,547            95.00      0.000094      3,187
    30.00      0.000006     52,751            97.50      0.000151      1,982
    40.00      0.000008     36,714            99.00      0.000281      1,067
    50.00      0.000011     26,700            99.50      0.000412        727
    60.00      0.000015     19,733            99.75      0.000562        533
    70.00      0.000021     14,346            99.90      0.000780        384
    80.00      0.000029     10,227
                                      12 Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Children 3-5 yrs                   Daily Exposure Analysis 
----------------                   (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000024     0.000024
            Standard Deviation        0.000048     0.000048
            Margin of Exposure          12,592       12,540
       Percent of Person-Days that are User-Days =  99.58%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000003    115,277            90.00      0.000048      6,306
    20.00      0.000005     62,963            95.00      0.000079      3,794
    30.00      0.000007     41,945            97.50      0.000125      2,404
    40.00      0.000010     31,106            99.00      0.000216      1,387
    50.00      0.000013     23,729            99.50      0.000297      1,011
    60.00      0.000016     18,412            99.75      0.000414        725
    70.00      0.000021     14,377            99.90      0.000603        497
    80.00      0.000028     10,573
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000003    118,840            90.00      0.000047      6,324
    20.00      0.000005     63,970            95.00      0.000079      3,806
    30.00      0.000007     42,339            97.50      0.000124      2,411
    40.00      0.000010     31,310            99.00      0.000216      1,390
    50.00      0.000013     23,853            99.50      0.000296      1,011
    60.00      0.000016     18,487            99.75      0.000413        727
    70.00      0.000021     14,429            99.90      0.000602        498
    80.00      0.000028     10,601
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Children 6-12 yrs                  Daily Exposure Analysis 
-----------------                  (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000016     0.000016
            Standard Deviation        0.000032     0.000032
            Margin of Exposure          18,844       18,795
       Percent of Person-Days that are User-Days =  99.74%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000002    142,101            90.00      0.000030     10,042
    20.00      0.000004     80,624            95.00      0.000048      6,309
    30.00      0.000005     56,296            97.50      0.000076      3,944
    40.00      0.000007     41,793            99.00      0.000133      2,263
    50.00      0.000009     33,241            99.50      0.000197      1,519
    60.00      0.000011     26,762            99.75      0.000323        928
    70.00      0.000014     20,942            99.90      0.000474        632
    80.00      0.000019     15,496
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000002    144,729            90.00      0.000030     10,060
    20.00      0.000004     81,379            95.00      0.000048      6,315
    30.00      0.000005     56,620            97.50      0.000076      3,947
    40.00      0.000007     41,952            99.00      0.000132      2,266
    50.00      0.000009     33,324            99.50      0.000197      1,519
    60.00      0.000011     26,821            99.75      0.000322        930
    70.00      0.000014     20,983            99.90      0.000474        633
    80.00      0.000019     15,525
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Youth 13-19 yrs                    Daily Exposure Analysis 
---------------                    (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000010     0.000010
            Standard Deviation        0.000020     0.000020
            Margin of Exposure          30,457       29,984
       Percent of Person-Days that are User-Days =  98.45%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    315,827            90.00      0.000019     16,179
    20.00      0.000002    146,144            95.00      0.000029     10,207
    30.00      0.000003     94,705            97.50      0.000047      6,429
    40.00      0.000004     68,526            99.00      0.000091      3,309
    50.00      0.000006     52,013            99.50      0.000128      2,348
    60.00      0.000007     41,192            99.75      0.000189      1,586
    70.00      0.000009     31,867            99.90      0.000334        899
    80.00      0.000013     23,944
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    363,427            90.00      0.000018     16,338
    20.00      0.000002    160,380            95.00      0.000029     10,505
    30.00      0.000003     98,875            97.50      0.000046      6,458
    40.00      0.000004     70,503            99.00      0.000089      3,385
    50.00      0.000006     53,021            99.50      0.000127      2,359
    60.00      0.000007     41,869            99.75      0.000189      1,587
    70.00      0.000009     32,261            99.90      0.000333        899
    80.00      0.000012     24,124
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Adults 20-49 yrs                   Daily Exposure Analysis 
----------------                   (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000008     0.000008
            Standard Deviation        0.000017     0.000017
            Margin of Exposure          36,903       36,454
       Percent of Person-Days that are User-Days =  98.79%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    513,243            90.00      0.000017     18,147
    20.00      0.000001    241,196            95.00      0.000028     10,882
    30.00      0.000002    145,176            97.50      0.000045      6,738
    40.00      0.000003     99,352            99.00      0.000078      3,839
    50.00      0.000004     74,207            99.50      0.000119      2,511
    60.00      0.000005     56,433            99.75      0.000158      1,900
    70.00      0.000007     42,785            99.90      0.000214      1,403
    80.00      0.000010     30,436
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    571,453            90.00      0.000016     18,232
    20.00      0.000001    254,899            95.00      0.000027     10,962
    30.00      0.000002    151,416            97.50      0.000044      6,817
    40.00      0.000003    101,953            99.00      0.000078      3,846
    50.00      0.000004     75,506            99.50      0.000119      2,524
    60.00      0.000005     57,275            99.75      0.000156      1,918
    70.00      0.000007     43,253            99.90      0.000214      1,403
    80.00      0.000010     30,746
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Adults 50+ yrs                     Daily Exposure Analysis 
--------------                     (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000006     0.000006
            Standard Deviation        0.000016     0.000016
            Margin of Exposure          46,822       46,294
       Percent of Person-Days that are User-Days =  98.87%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000    721,921            90.00      0.000013     23,453
    20.00      0.000001    367,768            95.00      0.000021     14,070
    30.00      0.000001    226,220            97.50      0.000038      7,799
    40.00      0.000002    150,752            99.00      0.000071      4,209
    50.00      0.000003    107,448            99.50      0.000109      2,764
    60.00      0.000004     78,434            99.75      0.000146      2,053
    70.00      0.000005     58,091            99.90      0.000175      1,713
    80.00      0.000007     40,296
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000    792,213            90.00      0.000013     23,683
    20.00      0.000001    388,593            95.00      0.000021     14,166
    30.00      0.000001    233,755            97.50      0.000038      7,861
    40.00      0.000002    154,715            99.00      0.000071      4,241
    50.00      0.000003    109,568            99.50      0.000108      2,771
    60.00      0.000004     79,715            99.75      0.000146      2,055
    70.00      0.000005     58,775            99.90      0.000174      1,723
    80.00      0.000007     40,651
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Females 13-49 yrs                  Daily Exposure Analysis 
-----------------                  (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000008     0.000008
            Standard Deviation        0.000018     0.000018
            Margin of Exposure          36,400       35,902
       Percent of Person-Days that are User-Days =  98.63%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    525,504            90.00      0.000016     18,457
    20.00      0.000001    256,860            95.00      0.000028     10,619
    30.00      0.000002    154,167            97.50      0.000048      6,265
    40.00      0.000003    104,744            99.00      0.000087      3,467
    50.00      0.000004     78,160            99.50      0.000144      2,079
    60.00      0.000005     58,536            99.75      0.000168      1,784
    70.00      0.000007     43,738            99.90      0.000215      1,394
    80.00      0.000010     31,087
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    591,723            90.00      0.000016     18,657
    20.00      0.000001    274,213            95.00      0.000028     10,711
    30.00      0.000002    163,066            97.50      0.000047      6,351
    40.00      0.000003    108,045            99.00      0.000086      3,481
    50.00      0.000004     79,658            99.50      0.000144      2,084
    60.00      0.000005     59,517            99.75      0.000168      1,785
    70.00      0.000007     44,348            99.90      0.000215      1,395
    80.00      0.000010     31,295
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutefood.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:38:49    Residue file dated: 10-25-2005/16:02:15/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Custom demographics 1: Workers, 16+ years
All Seasons
All Regions
Sex: M/F-all/
All Races
Age-Low: 16 yrs   High: 99 yrs
-----------------------------------------
                                   Daily Exposure Analysis 
                                   (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000008     0.000008
            Standard Deviation        0.000016     0.000017
            Margin of Exposure          39,458       38,958
       Percent of Person-Days that are User-Days =  98.73%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    578,282            90.00      0.000016     19,208
    20.00      0.000001    276,656            95.00      0.000025     11,772
    30.00      0.000002    167,075            97.50      0.000042      7,194
    40.00      0.000003    111,846            99.00      0.000077      3,884
    50.00      0.000004     81,688            99.50      0.000115      2,610
    60.00      0.000005     61,353            99.75      0.000155      1,941
    70.00      0.000007     45,767            99.90      0.000196      1,529
    80.00      0.000009     32,368
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000    645,253            90.00      0.000016     19,346
    20.00      0.000001    295,444            95.00      0.000025     11,898
    30.00      0.000002    173,762            97.50      0.000041      7,237
    40.00      0.000003    114,509            99.00      0.000077      3,906
    50.00      0.000004     83,245            99.50      0.000115      2,617
    60.00      0.000005     62,172            99.75      0.000154      1,944
    70.00      0.000006     46,382            99.90      0.000191      1,569
    80.00      0.000009     32,698
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California Department of Pesticide Regulation                        Ver. 2.00
DEEM-FCID Chronic analysis for METHIDATHION                       1994-98 data
Residue file: H:\MyFiles\DEEM-FCID Files\Methidathion\Methidathionr1chronicfood.R98
                                                               Adjust. #2 used
Analysis Date 10-26-2005             Residue file dated: 10-25-2005/16:11:37/14
Reference dose (NOEL) = 0.15 mg/kg bw/day
--------------------------------------------------------------------------------
Food Crop                                       Residue       Adj.Factors     
Comment
EPA Code  Grp  Food Name                          (ppm)       
                                                             #1         #2 
-------- ---- -------------------------------   ---------- ------     ------   -------
14000030 14   Almond                             0.001250   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
14000031 14   Almond-babyfood                    0.001250   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
14000040 14   Almond, oil                        0.001250   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
14000041 14   Almond, oil-babyfood               0.001250   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
11000070 11   Apple, fruit with peel             0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000080 11   Apple, peeled fruit                0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000081 11   Apple, peeled fruit-babyfood       0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000090 11   Apple, dried                       0.000350   8.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000091 11   Apple, dried-babyfood              0.000350   8.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000100 11   Apple, juice                       0.000350   1.300      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000101 11   Apple, juice-babyfood              0.000350   1.300      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000110 11   Apple, sauce                       0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000111 11   Apple, sauce-babyfood              0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
12000120 12   Apricot                            0.001300   1.000      1.000   DPR Ap
  Full comment: DPR Apricot 2002-2004 1/2 LOD, 5% CT
12000121 12   Apricot-babyfood                   0.001300   1.000      1.000   DPR Ap
  Full comment: DPR Apricot 2002-2004 1/2 LOD, 5% CT
12000130 12   Apricot, dried                     0.001300   6.000      1.000   DPR Ap
  Full comment: DPR Apricot 2002-2004 1/2 LOD, 5% CT
12000140 12   Apricot, juice                     0.001300   1.000      1.000   DPR Ap
  Full comment: DPR Apricot 2002-2004 1/2 LOD, 5% CT
12000141 12   Apricot, juice-babyfood            0.001300   1.000      1.000   DPR Ap
  Full comment: DPR Apricot 2002-2004 1/2 LOD, 5% CT
95000160 O    Artichoke, globe                   0.025000   1.000      1.000   DPR Ar
  Full comment: DPR Artichoke 2002-2004 1/2 LOD, 100% CT
01030170 1CD  Artichoke, Jerusalem               0.025000   1.000      1.000   DPR Ar
  Full comment: DPR Artichoke 2002-2004 1/2 LOD, 100% CT
14000590 14   Brazil nut                         0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
14000680 14   Butternut                          0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
14000810 14   Cashew                             0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
12000900 12   Cherry                             0.000100   1.000      1.000   PDP Ch
  Full comment: PDP Cherries 2000&2001 CA 1/2 LOD, 5% CT
12000901 12   Cherry-babyfood                    0.000100   1.000      1.000   PDP Ch
  Full comment: PDP Cherries 2000&2001 CA 1/2 LOD, 5% CT
12000910 12   Cherry, juice                      0.000100   1.500      1.000   PDP ChMethidathion RCD (Revision 1) February 2007
  Full comment: PDP Cherries 2000&2001 CA 1/2 LOD, 5% CT
12000911 12   Cherry, juice-babyfood             0.000100   1.500      1.000   PDP Ch
  Full comment: PDP Cherries 2000&2001 CA 1/2 LOD, 5% CT
14000920 14   Chestnut                           0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
10001060 10   Citrus citron                      0.050000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
10001070 10   Citrus hybrids                     0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10001080 10   Citrus, oil                        0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
95001280 O    Cottonseed, oil                    0.001000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 1% CT
95001281 O    Cottonseed, oil-babyfood           0.001000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 1% CT
11001290 11   Crabapple                          0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
14001550 14   Filbert                            0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
14001560 14   Filbert, oil                       0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
10001800 10   Grapefruit                         0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000 & 2001 CA Mean Value
10001810 10   Grapefruit, juice                  0.000168   2.100      1.000   PDP Or
  Full comment: PDP Orange 2000 & 2001 CA Mean Value
14001850 14   Hickory nut                        0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
95001950 O    Kiwifruit                          0.002500   1.000      1.000   DPR Ki
  Full comment: DPR Kiwifruit 2002-2004 1/2 LOD, 10% CT
10001970 10   Kumquat                            0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10001990 10   Lemon                              0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002000 10   Lemon, juice                       0.000168   2.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002001 10   Lemon, juice-babyfood              0.000168   2.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002010 10   Lemon, peel                        0.050000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
10002060 10   Lime                               0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002070 10   Lime, juice                        0.000168   2.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002071 10   Lime, juice-babyfood               0.000168   2.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
11002100 11   Loquat                             0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
14002130 14   Macadamia nut                      0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
95002150 O    Mango                              0.025000   1.000      1.000   DPR Ma
  Full comment: DPR Mango 2002-2004 1/2 LOD, 100% CT
95002151 O    Mango-babyfood                     0.025000   1.000      1.000   DPR Ma
  Full comment: DPR Mango 2002-2004 1/2 LOD, 100% CT
95002160 O    Mango, dried                       0.025000   1.000      1.000   DPR Ma
  Full comment: DPR Mango 2002-2004 1/2 LOD, 100% CT
95002170 O    Mango, juice                       0.025000   1.000      1.000   DPR Ma
  Full comment: DPR Mango 2002-2004 1/2 LOD, 100% CT
95002171 O    Mango, juice-babyfood              0.025000   1.000      1.000   DPR Ma
  Full comment: DPR Mango 2002-2004 1/2 LOD, 100% CT
12002300 12   Nectarine                          0.000100   1.000      1.000   PDP Ne
  Full comment: PDP Nectarine 2000&2001 CA 1/2 LOD, 5% CT
95002350 O    Olive                              0.001250   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
95002360 O    Olive, oil                         0.001250   1.000      1.000   1/2 ToMethidathion RCD (Revision 1) February 2007
  Full comment: 1/2 Tolerance, 5% CT
10002400 10   Orange                             0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002410 10   Orange, juice                      0.000168   1.800      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002411 10   Orange, juice-babyfood             0.000168   1.800      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002420 10   Orange, peel                       0.050000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
12002600 12   Peach                              0.000065   1.000      1.000   PDP Pe
  Full comment: PDP Peach 2001&2002 CA Mean Value, 10% CT
12002601 12   Peach-babyfood                     0.000065   1.000      1.000   PDP Pe
  Full comment: PDP Peach 2001&2002 CA Mean Value, 10% CT
12002610 12   Peach, dried                       0.000065   7.000      1.000   PDP Pe
  Full comment: PDP Peach 2001&2002 CA Mean Value, 10% CT
12002611 12   Peach, dried-babyfood              0.000065   7.000      1.000   PDP Pe
  Full comment: PDP Peach 2001&2002 CA Mean Value, 10% CT
12002620 12   Peach, juice                       0.000065   1.000      1.000   PDP Pe
  Full comment: PDP Peach 2001&2002 CA Mean Value, 10% CT
12002621 12   Peach, juice-babyfood              0.000065   1.000      1.000   PDP Pe
  Full comment: PDP Peach 2001&2002 CA Mean Value, 10% CT
11002660 11   Pear                               0.000100   1.000      1.000   PDP Pe
  Full comment: PDP Pear 2003 NA 1/2 LOD, 5% CT
11002661 11   Pear-babyfood                      0.000100   1.000      1.000   PDP Pe
  Full comment: PDP Pear 2003 NA 1/2 LOD, 5% CT
11002670 11   Pear, dried                        0.000100   6.250      1.000   PDP Pe
  Full comment: PDP Pear 2003 NA 1/2 LOD, 5% CT
11002680 11   Pear, juice                        0.000100   1.000      1.000   PDP Pe
  Full comment: PDP Pear 2003 NA 1/2 LOD, 5% CT
11002681 11   Pear, juice-babyfood               0.000100   1.000      1.000   PDP Pe
  Full comment: PDP Pear 2003 NA 1/2 LOD, 5% CT
14002690 14   Pecan                              0.002500   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 10% CT
95002780 O    Pine nut                           0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance
14002820 14   Pistachio                          0.002500   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 10% CT
12002850 12   Plum                               0.003750   1.000      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 15% CT
12002851 12   Plum-babyfood                      0.003750   1.000      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 15% CT
12002860 12   Plum, prune, fresh                 0.001250   1.000      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 5% CT
12002861 12   Plum, prune, fresh-babyfood        0.001250   1.000      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 5% CT
12002870 12   Plum, prune, dried                 0.001250   5.000      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 5% CT
12002871 12   Plum, prune, dried-babyfood        0.001250   5.000      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 5% CT
12002880 12   Plum, prune, juice                 0.001250   1.400      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 5% CT
12002881 12   Plum, prune, juice-babyfood        0.001250   1.400      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 5% CT
10003070 10   Pummelo                            0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
11003100 11   Quince                             0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
20003300 20   Safflower, oil                     0.005000   1.000      1.000   Safflo
  Full comment: Safflower Field Trial 1/2 LOD, 100% CT
20003301 20   Safflower, oil-babyfood            0.005000   1.000      1.000   Safflo
  Full comment: Safflower Field Trial 1/2 LOD, 100% CT
15003440 15   Sorghum, grain                     0.100000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
15003450 15   Sorghum, syrup                     0.100000   1.000      1.000   1/2 ToMethidathion RCD (Revision 1) February 2007
  Full comment: 1/2 Tolerance, 100% CT
95003580 O    Starfruit                          0.050000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
95003610 O    Sugar apple                        0.100000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
20003640 20   Sunflower, seed                    0.150000   1.000      0.500   Sunflo
  Full comment: Sunflower Field Trial Mean, 100% CT, 50% hulls
20003650 20   Sunflower, oil                     0.150000   1.000      0.200   Sunflo
  Full comment: Sunflower Field Trial Mean, 100% CT, 20% oil
20003651 20   Sunflower, oil-babyfood            0.150000   1.000      0.200   Sunflo
  Full comment: Sunflower Field Trial Mean, 100% CT, 20% oil
10003690 10   Tangerine                          0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10003700 10   Tangerine, juice                   0.000168   2.300      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
14003910 14   Walnut                             0.001250   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CTMethidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                        Ver. 2.00
DEEM-FCID Chronic analysis for METHIDATHION                     (1994-98 data)
Residue file name: H:\MyFiles\DEEM-FCID
Files\Methidathion\Methidathionr1chronicfood.R98
                                                     Adjustment factor #2 used.
Analysis Date 10-26-2005/08:48:23     Residue file dated: 10-25-2005/16:11:37/14
NOEL (Chronic) = .15 mg/kg bw/day
===============================================================================
                    Total exposure by population subgroup
-------------------------------------------------------------------------------
                                                    Total Exposure
                                         -----------------------------------
          Population                         mg/kg       Percent   Margin of
           Subgroup                       body wt/day    of NOEL   Exposr 1/
--------------------------------------   -------------  ---------  ---------
U.S. Population (total)                     0.000002        0.00%      69,278
U.S. Population (spring season)             0.000002        0.00%      64,057
U.S. Population (summer season)             0.000003        0.00%      59,163
U.S. Population (autumn season)             0.000002        0.00%      80,339
U.S. Population (winter season)             0.000002        0.00%      78,172
Northeast region                            0.000002        0.00%      61,129
Midwest region                              0.000002        0.00%      88,554
Southern region                             0.000002        0.00%      80,954
Western region                              0.000003        0.00%      51,627
Hispanics                                   0.000003        0.00%      44,091
Non-hispanic whites                         0.000002        0.00%      77,085
Non-hispanic blacks                         0.000002        0.00%      75,212
Non-hisp/non-white/non-black                0.000003        0.00%      45,620
All infants (< 1 year)                      0.000015        0.01%      10,038
Nursing infants                             0.000005        0.00%      28,984
Non-nursing infants                         0.000019        0.01%       8,043
Children 1-6  yrs                           0.000006        0.00%      26,076
Children 7-12 yrs                           0.000003        0.00%      55,729
Females 13-19 (not preg or nursing)         0.000002        0.00%      91,507
Females 20+ (not preg or nursing)           0.000001        0.00%     108,077
Females 13-50 yrs                           0.000002        0.00%      82,896
Females 13+ (preg/not nursing)              0.000005        0.00%      28,441
Females 13+ (nursing)                       0.000004        0.00%      35,141
Males 13-19 yrs                             0.000002        0.00%      89,150
Males 20+ yrs                               0.000001        0.00%     110,982
Seniors 55+                                 0.000001        0.00%     110,983
Children 1-2 yrs                            0.000007        0.00%      20,203
Children 3-5 yrs                            0.000005        0.00%      29,136
Children 6-12 yrs                           0.000003        0.00%      51,272
Youth 13-19 yrs                             0.000002        0.00%      90,276
Adults 20-49 yrs                            0.000001        0.00%     105,790
Adults 50+ yrs                              0.000001        0.00%     104,219
Females 13-49 yrs                           0.000002        0.00%      98,463
-------------------------------------------------------------------------------Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                        Ver. 2.00
DEEM-FCID Chronic analysis for METHIDATHION                     (1994-98 data)
Residue file name: H:\MyFiles\DEEM-FCID
Files\Methidathion\Methidathionr1chronicfood.R98
                                                     Adjustment factor #2 used.
Analysis Date 10-26-2005/08:49:34     Residue file dated: 10-25-2005/16:11:37/14
Q* = 0.34 
===============================================================================
                    Total exposure by population subgroup
-------------------------------------------------------------------------------
                                                    Total Exposure
                                         -----------------------------------
          Population                         mg/kg         Lifetime risk
           Subgroup                       body wt/day       (Q*= .34)
--------------------------------------   -------------     -------------
U.S. Population (total)                     0.000002         7.36E-07
U.S. Population (spring season)             0.000002         7.96E-07
U.S. Population (summer season)             0.000003         8.62E-07
U.S. Population (autumn season)             0.000002         6.35E-07
U.S. Population (winter season)             0.000002         6.52E-07
Northeast region                            0.000002         8.34E-07
Midwest region                              0.000002         5.76E-07
Southern region                             0.000002         6.30E-07
Western region                              0.000003         9.88E-07
Hispanics                                   0.000003         1.16E-06
Non-hispanic whites                         0.000002         6.62E-07
Non-hispanic blacks                         0.000002         6.78E-07
Non-hisp/non-white/non-black                0.000003         1.12E-06
All infants (< 1 year)                      0.000015         5.08E-06
Nursing infants                             0.000005         1.76E-06
Non-nursing infants                         0.000019         6.34E-06
Children 1-6  yrs                           0.000006         1.96E-06
Children 7-12 yrs                           0.000003         9.15E-07
Females 13-19 (not preg or nursing)         0.000002         5.57E-07
Females 20+ (not preg or nursing)           0.000001         4.72E-07
Females 13-50 yrs                           0.000002         6.15E-07
Females 13+ (preg/not nursing)              0.000005         1.79E-06
Females 13+ (nursing)                       0.000004         1.45E-06
Males 13-19 yrs                             0.000002         5.72E-07
Males 20+ yrs                               0.000001         4.60E-07
Seniors 55+                                 0.000001         4.60E-07
Children 1-2 yrs                            0.000007         2.52E-06
Children 3-5 yrs                            0.000005         1.75E-06
Children 6-12 yrs                           0.000003         9.95E-07
Youth 13-19 yrs                             0.000002         5.65E-07
Adults 20-49 yrs                            0.000001         4.82E-07
Adults 50+ yrs                              0.000001         4.89E-07
Females 13-49 yrs                           0.000002         5.18E-07
-------------------------------------------------------------------------------Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                        Ver. 2.00
DEEM-FCID Chronic analysis for METHIDATHION                     (1994-98 data)
Residue file name: H:\MyFiles\DEEM-FCID
Files\Methidathion\Methidathionr1chronicfood.R98
                                                     Adjustment factor #2 used.
Analysis Date 10-26-2005/08:49:21     Residue file dated: 10-25-2005/16:11:37/14
Q* = 0.53 
===============================================================================
                    Total exposure by population subgroup
-------------------------------------------------------------------------------
                                                    Total Exposure
                                         -----------------------------------
          Population                         mg/kg         Lifetime risk
           Subgroup                       body wt/day       (Q*= .53)
--------------------------------------   -------------     -------------
U.S. Population (total)                     0.000002         1.15E-06
U.S. Population (spring season)             0.000002         1.24E-06
U.S. Population (summer season)             0.000003         1.34E-06
U.S. Population (autumn season)             0.000002         9.90E-07
U.S. Population (winter season)             0.000002         1.02E-06
Northeast region                            0.000002         1.30E-06
Midwest region                              0.000002         8.98E-07
Southern region                             0.000002         9.82E-07
Western region                              0.000003         1.54E-06
Hispanics                                   0.000003         1.80E-06
Non-hispanic whites                         0.000002         1.03E-06
Non-hispanic blacks                         0.000002         1.06E-06
Non-hisp/non-white/non-black                0.000003         1.74E-06
All infants (< 1 year)                      0.000015         7.92E-06
Nursing infants                             0.000005         2.74E-06
Non-nursing infants                         0.000019         9.88E-06
Children 1-6  yrs                           0.000006         3.05E-06
Children 7-12 yrs                           0.000003         1.43E-06
Females 13-19 (not preg or nursing)         0.000002         8.69E-07
Females 20+ (not preg or nursing)           0.000001         7.36E-07
Females 13-50 yrs                           0.000002         9.59E-07
Females 13+ (preg/not nursing)              0.000005         2.80E-06
Females 13+ (nursing)                       0.000004         2.26E-06
Males 13-19 yrs                             0.000002         8.92E-07
Males 20+ yrs                               0.000001         7.16E-07
Seniors 55+                                 0.000001         7.16E-07
Children 1-2 yrs                            0.000007         3.94E-06
Children 3-5 yrs                            0.000005         2.73E-06
Children 6-12 yrs                           0.000003         1.55E-06
Youth 13-19 yrs                             0.000002         8.81E-07
Adults 20-49 yrs                            0.000001         7.51E-07
Adults 50+ yrs                              0.000001         7.63E-07
Females 13-49 yrs                           0.000002         8.07E-07
-------------------------------------------------------------------------------Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                        Ver. 2.02
DEEM-FCID Acute analysis for METHIDATHION
Residue file name: H:\MyFiles\DEEM-FCID
Files\Methidathion\methidathionr1acutewater.R98
Analysis Date 10-26-2005             Residue file dated: 10-12-2005/16:17:59/14
Reference dose (NOEL) = 0.3 mg/kg bw/day
--------------------------------------------------------------------------------
  EPA    Crop                                   Def Res     Adj.Factors   Comment
  Code    Grp  Food Name                         (ppm)       #1    #2   
-------- ---- -------------------------------  ----------  ------ ------  -------
86010000 O    Water, direct, all sources         0.000021   1.000  1.000PDP 20
          Full comment: PDP 2002-2003, Combined CA LOD
86020000 O    Water, indirect, all sources       0.000021   1.000  1.000PDP 20
          Full comment: PDP 2002-2003, Combined CA LODMethidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Summary calculations (per capita):
                    95th Percentile      99th Percentile      99.9th Percentile
                   Exposure     MOE     Exposure     MOE     Exposure     MOE  
                  ---------- --------  ---------- --------  ---------- --------
U.S. Population:
                    0.000001   273469    0.000002   145594    0.000004    72769 
Western region:
                    0.000001   234444    0.000002   124196    0.000005    65492 
Hispanics:
                    0.000001   224430    0.000003   113408    0.000005    65384 
Non-hispanic whites:
                    0.000001   284343    0.000002   163969    0.000004    78613 
Non-hispanic blacks:
                    0.000001   263638    0.000002   132579    0.000005    60655 
Non-hisp/non-white/non-black:
                    0.000001   233949    0.000002   123533    0.000005    65021 
All infants:
                    0.000004    72532    0.000006    50595    0.000011    28244 
Nursing infants (<1 yr old):
                    0.000002   134031    0.000005    61065    0.000008    39404 
Non-nursing infants (<1 yr old):
                    0.000004    68312    0.000006    48940    0.000011    28218 
Females 13+ (preg/not nursing):
                    0.000001   304384    0.000001   251981    0.000002   193796 
Females 13+ (nursing):
                    0.000001   245326    0.000002   173506    0.000002   138304 
Children 1-2 yrs:
                    0.000002   174286    0.000003   104362    0.000004    71758 
Children 3-5 yrs:
                    0.000002   190787    0.000002   121720    0.000004    74577 Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Summary calculations:
                      95th Percentile     99th Percentile     99.9th Percentile
                      Exposure    MOE     Exposure    MOE     Exposure     MOE  
                     ---------- -------  ---------- -------  ---------- --------
Children 6-12 yrs:
                    0.000001   274058    0.000002   164824    0.000002   120691 
Youth 13-19 yrs:
                    0.000001   337091    0.000001   200355    0.000003   111397 
Adults 20-49 yrs:
                    0.000001   295166    0.000002   176256    0.000003    97439 
Adults 50+ yrs:
                    0.000001   326851    0.000001   228555    0.000002   140936 
Females 13-49 yrs:
                    0.000001   293502    0.000002   182361    0.000003   102832 
Custom demographics 1: Workers, 16+ years:
                    0.000001   305915    0.000002   191386    0.000003   102883 Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
U.S. Population                    Daily Exposure Analysis  /a
---------------                    (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000000     0.000000
            Standard Deviation        0.000000     0.000000
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure 2/      677,442      655,569
       Percent of Person-Days that are User-Days =  96.77%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    347,666
    20.00      0.000000 >1,000,000            95.00      0.000001    270,619
    30.00      0.000000 >1,000,000            97.50      0.000001    205,388
    40.00      0.000000    990,463            99.00      0.000002    143,869
    50.00      0.000000    823,917            99.50      0.000003    116,126
    60.00      0.000000    688,714            99.75      0.000003     96,047
    70.00      0.000001    576,625            99.90      0.000004     72,197
    80.00      0.000001    466,747
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    352,002
    20.00      0.000000 >1,000,000            95.00      0.000001    273,469
    30.00      0.000000 >1,000,000            97.50      0.000001    207,759
    40.00      0.000000 >1,000,000            99.00      0.000002    145,594
    50.00      0.000000    845,921            99.50      0.000003    118,089
    60.00      0.000000    704,240            99.75      0.000003     96,417
    70.00      0.000001    588,578            99.90      0.000004     72,769
    80.00      0.000001    474,018
-------------------------------------------------------------------------------
a/ Analysis based on all two-day participant records in CSFII 1994-98
   with 2 days of valid drinking water records.
2/ Margin of Exposure = NOEL/ Dietary Exposure.
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Western region                     Daily Exposure Analysis 
--------------                     (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000001     0.000001
            Standard Deviation        0.000000     0.000000
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         591,316      577,986
       Percent of Person-Days that are User-Days =  97.75%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    308,940
    20.00      0.000000 >1,000,000            95.00      0.000001    231,778
    30.00      0.000000 >1,000,000            97.50      0.000002    176,122
    40.00      0.000000    886,322            99.00      0.000002    122,904
    50.00      0.000000    729,465            99.50      0.000003     96,981
    60.00      0.000000    615,379            99.75      0.000004     76,678
    70.00      0.000001    512,894            99.90      0.000005     65,186
    80.00      0.000001    414,792
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    311,900
    20.00      0.000000 >1,000,000            95.00      0.000001    234,444
    30.00      0.000000 >1,000,000            97.50      0.000002    177,529
    40.00      0.000000    916,623            99.00      0.000002    124,196
    50.00      0.000000    743,135            99.50      0.000003     97,326
    60.00      0.000000    625,112            99.75      0.000004     77,491
    70.00      0.000001    519,825            99.90      0.000005     65,492
    80.00      0.000001    419,711
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Hispanics                          Daily Exposure Analysis 
---------                          (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000001     0.000001
            Standard Deviation        0.000001     0.000001
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         597,191      587,060
       Percent of Person-Days that are User-Days =  98.30%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    304,623
    20.00      0.000000 >1,000,000            95.00      0.000001    223,329
    30.00      0.000000 >1,000,000            97.50      0.000002    162,820
    40.00      0.000000    938,331            99.00      0.000003    112,755
    50.00      0.000000    771,135            99.50      0.000003     96,156
    60.00      0.000000    659,413            99.75      0.000004     78,435
    70.00      0.000001    539,115            99.90      0.000005     65,295
    80.00      0.000001    436,717
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    306,088
    20.00      0.000000 >1,000,000            95.00      0.000001    224,430
    30.00      0.000000 >1,000,000            97.50      0.000002    163,837
    40.00      0.000000    953,717            99.00      0.000003    113,408
    50.00      0.000000    786,909            99.50      0.000003     96,244
    60.00      0.000000    668,726            99.75      0.000004     78,524
    70.00      0.000001    546,044            99.90      0.000005     65,384
    80.00      0.000001    439,438
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Non-hispanic whites                Daily Exposure Analysis 
-------------------                (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000000     0.000000
            Standard Deviation        0.000000     0.000000
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         694,176      671,076
       Percent of Person-Days that are User-Days =  96.67%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    356,122
    20.00      0.000000 >1,000,000            95.00      0.000001    280,873
    30.00      0.000000 >1,000,000            97.50      0.000001    217,459
    40.00      0.000000    994,921            99.00      0.000002    161,082
    50.00      0.000000    827,657            99.50      0.000002    129,148
    60.00      0.000000    691,373            99.75      0.000003    104,283
    70.00      0.000001    579,989            99.90      0.000004     77,759
    80.00      0.000001    471,062
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    361,669
    20.00      0.000000 >1,000,000            95.00      0.000001    284,343
    30.00      0.000000 >1,000,000            97.50      0.000001    221,429
    40.00      0.000000 >1,000,000            99.00      0.000002    163,969
    50.00      0.000000    852,165            99.50      0.000002    129,967
    60.00      0.000000    709,061            99.75      0.000003    105,747
    70.00      0.000001    590,991            99.90      0.000004     78,613
    80.00      0.000001    478,623
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Non-hispanic blacks                Daily Exposure Analysis 
-------------------                (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000000     0.000000
            Standard Deviation        0.000000     0.000000
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         714,020      683,459
       Percent of Person-Days that are User-Days =  95.72%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    356,261
    20.00      0.000000 >1,000,000            95.00      0.000001    257,165
    30.00      0.000000 >1,000,000            97.50      0.000002    184,507
    40.00      0.000000 >1,000,000            99.00      0.000002    131,521
    50.00      0.000000    903,492            99.50      0.000003    110,896
    60.00      0.000000    766,181            99.75      0.000004     84,112
    70.00      0.000000    643,743            99.90      0.000005     60,344
    80.00      0.000001    511,598
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    362,316
    20.00      0.000000 >1,000,000            95.00      0.000001    263,638
    30.00      0.000000 >1,000,000            97.50      0.000002    188,323
    40.00      0.000000 >1,000,000            99.00      0.000002    132,579
    50.00      0.000000    952,911            99.50      0.000003    112,910
    60.00      0.000000    787,988            99.75      0.000004     84,619
    70.00      0.000000    660,967            99.90      0.000005     60,655
    80.00      0.000001    524,337
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Non-hisp/non-white/non-black       Daily Exposure Analysis 
----------------------------       (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000001     0.000001
            Standard Deviation        0.000000     0.000000
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         553,507      541,099
       Percent of Person-Days that are User-Days =  97.76%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    307,541
    20.00      0.000000 >1,000,000            95.00      0.000001    233,144
    30.00      0.000000    957,718            97.50      0.000002    175,657
    40.00      0.000000    778,230            99.00      0.000002    122,477
    50.00      0.000000    654,304            99.50      0.000003     96,271
    60.00      0.000001    556,650            99.75      0.000003     86,707
    70.00      0.000001    479,768            99.90      0.000005     61,183
    80.00      0.000001    389,562
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    310,410
    20.00      0.000000 >1,000,000            95.00      0.000001    233,949
    30.00      0.000000    993,756            97.50      0.000002    179,136
    40.00      0.000000    808,568            99.00      0.000002    123,533
    50.00      0.000000    660,880            99.50      0.000003     96,358
    60.00      0.000001    572,191            99.75      0.000003     87,317
    70.00      0.000001    485,199            99.90      0.000005     65,021
    80.00      0.000001    393,351
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
All infants                        Daily Exposure Analysis 
-----------                        (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000001     0.000002
            Standard Deviation        0.000001     0.000001
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         205,374      166,461
       Percent of Person-Days that are User-Days =  81.05%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000003     86,226
    20.00      0.000001    518,538            95.00      0.000004     68,473
    30.00      0.000001    301,796            97.50      0.000005     58,113
    40.00      0.000001    229,273            99.00      0.000006     48,889
    50.00      0.000002    188,110            99.50      0.000007     42,010
    60.00      0.000002    155,690            99.75      0.000008     36,264
    70.00      0.000002    133,018            99.90      0.000011     28,114
    80.00      0.000003    111,474
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000003     91,986
    20.00      0.000000 >1,000,000            95.00      0.000004     72,532
    30.00      0.000000    775,476            97.50      0.000005     60,718
    40.00      0.000001    364,364            99.00      0.000006     50,595
    50.00      0.000001    238,493            99.50      0.000007     42,962
    60.00      0.000002    186,589            99.75      0.000008     39,544
    70.00      0.000002    149,530            99.90      0.000011     28,244
    80.00      0.000002    121,397
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Nursing infants (<1 yr old)        Daily Exposure Analysis 
---------------------------        (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000001     0.000001
            Standard Deviation        0.000001     0.000001
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         551,040      297,499
       Percent of Person-Days that are User-Days =  53.99%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000002    138,509
    20.00      0.000000 >1,000,000            95.00      0.000003     99,457
    30.00      0.000000 >1,000,000            97.50      0.000004     68,376
    40.00      0.000000    649,680            99.00      0.000006     50,790
    50.00      0.000001    505,742            99.50      0.000007     41,589
    60.00      0.000001    357,347            99.75      0.000008     39,425
    70.00      0.000001    244,449            99.90      0.000008     39,375
    80.00      0.000002    184,008
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000002    175,188
    20.00      0.000000 >1,000,000            95.00      0.000002    134,031
    30.00      0.000000 >1,000,000            97.50      0.000003     94,490
    40.00      0.000000 >1,000,000            99.00      0.000005     61,065
    50.00      0.000000 >1,000,000            99.50      0.000006     50,707
    60.00      0.000000 >1,000,000            99.75      0.000007     41,556
    70.00      0.000001    561,676            99.90      0.000008     39,404
    80.00      0.000001    319,562
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Non-nursing infants (<1 yr old)    Daily Exposure Analysis 
-------------------------------    (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000002     0.000002
            Standard Deviation        0.000001     0.000001
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         166,088      151,568
       Percent of Person-Days that are User-Days =  91.26%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000    707,065            90.00      0.000004     82,107
    20.00      0.000001    337,082            95.00      0.000004     67,084
    30.00      0.000001    241,917            97.50      0.000005     57,503
    40.00      0.000002    199,852            99.00      0.000006     48,613
    50.00      0.000002    170,193            99.50      0.000007     42,500
    60.00      0.000002    143,142            99.75      0.000008     35,990
    70.00      0.000002    124,282            99.90      0.000012     25,506
    80.00      0.000003    105,524
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000004     85,396
    20.00      0.000001    589,547            95.00      0.000004     68,312
    30.00      0.000001    289,945            97.50      0.000005     58,291
    40.00      0.000001    223,741            99.00      0.000006     48,940
    50.00      0.000002    184,503            99.50      0.000007     42,703
    60.00      0.000002    151,473            99.75      0.000008     36,043
    70.00      0.000002    129,615            99.90      0.000011     28,218
    80.00      0.000003    108,485
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Females 13+ (preg/not nursing)     Daily Exposure Analysis 
------------------------------     (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000000     0.000000
            Standard Deviation        0.000000     0.000000
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         697,032      674,332
       Percent of Person-Days that are User-Days =  96.74%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    332,770
    20.00      0.000000 >1,000,000            95.00      0.000001    301,074
    30.00      0.000000 >1,000,000            97.50      0.000001    293,440
    40.00      0.000000 >1,000,000            99.00      0.000001    251,812
    50.00      0.000000    802,948            99.50      0.000001    214,764
    60.00      0.000000    629,495            99.75      0.000002    194,021
    70.00      0.000001    510,135            99.90      0.000002    193,791
    80.00      0.000001    425,574
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    334,804
    20.00      0.000000 >1,000,000            95.00      0.000001    304,384
    30.00      0.000000 >1,000,000            97.50      0.000001    294,050
    40.00      0.000000 >1,000,000            99.00      0.000001    251,981
    50.00      0.000000    812,225            99.50      0.000001    214,907
    60.00      0.000000    645,758            99.75      0.000002    194,034
    70.00      0.000001    514,491            99.90      0.000002    193,796
    80.00      0.000001    435,362
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Females 13+ (nursing)              Daily Exposure Analysis 
---------------------              (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000001     0.000001
            Standard Deviation        0.000000     0.000000
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         490,538      486,794
       Percent of Person-Days that are User-Days =  99.24%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    274,147
    20.00      0.000000 >1,000,000            95.00      0.000001    245,286
    30.00      0.000000    772,985            97.50      0.000001    201,966
    40.00      0.000000    650,062            99.00      0.000002    173,488
    50.00      0.000001    470,169            99.50      0.000002    138,692
    60.00      0.000001    445,621            99.75      0.000002    138,449
    70.00      0.000001    379,856            99.90      0.000002    138,304
    80.00      0.000001    338,288
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    274,320
    20.00      0.000000 >1,000,000            95.00      0.000001    245,326
    30.00      0.000000    778,881            97.50      0.000001    201,989
    40.00      0.000000    651,186            99.00      0.000002    173,506
    50.00      0.000001    470,673            99.50      0.000002    138,696
    60.00      0.000001    446,441            99.75      0.000002    138,451
    70.00      0.000001    380,348            99.90      0.000002    138,304
    80.00      0.000001    338,599
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Children 1-2 yrs                   Daily Exposure Analysis 
----------------                   (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000001     0.000001
            Standard Deviation        0.000001     0.000001
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         455,515      429,881
       Percent of Person-Days that are User-Days =  94.37%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    214,176
    20.00      0.000000 >1,000,000            95.00      0.000002    170,509
    30.00      0.000000    846,910            97.50      0.000002    136,060
    40.00      0.000000    663,182            99.00      0.000003    101,347
    50.00      0.000001    540,108            99.50      0.000003     89,107
    60.00      0.000001    442,835            99.75      0.000004     78,310
    70.00      0.000001    358,620            99.90      0.000004     68,688
    80.00      0.000001    293,357
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    218,738
    20.00      0.000000 >1,000,000            95.00      0.000002    174,286
    30.00      0.000000    959,549            97.50      0.000002    138,286
    40.00      0.000000    711,969            99.00      0.000003    104,362
    50.00      0.000001    576,167            99.50      0.000003     89,808
    60.00      0.000001    469,559            99.75      0.000004     79,674
    70.00      0.000001    374,273            99.90      0.000004     71,758
    80.00      0.000001    299,889
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Children 3-5 yrs                   Daily Exposure Analysis 
----------------                   (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000001     0.000001
            Standard Deviation        0.000001     0.000001
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         487,539      465,201
       Percent of Person-Days that are User-Days =  95.42%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    237,389
    20.00      0.000000 >1,000,000            95.00      0.000002    188,839
    30.00      0.000000    882,964            97.50      0.000002    151,436
    40.00      0.000000    695,245            99.00      0.000002    120,923
    50.00      0.000001    563,285            99.50      0.000003    108,712
    60.00      0.000001    469,103            99.75      0.000003     90,214
    70.00      0.000001    396,041            99.90      0.000004     70,486
    80.00      0.000001    321,727
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    240,740
    20.00      0.000000 >1,000,000            95.00      0.000002    190,787
    30.00      0.000000    958,812            97.50      0.000002    154,023
    40.00      0.000000    744,372            99.00      0.000002    121,720
    50.00      0.000001    589,463            99.50      0.000003    109,123
    60.00      0.000001    484,342            99.75      0.000003     95,679
    70.00      0.000001    404,364            99.90      0.000004     74,577
    80.00      0.000001    330,036
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Children 6-12 yrs                  Daily Exposure Analysis 
-----------------                  (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000000     0.000000
            Standard Deviation        0.000000     0.000000
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         708,950      676,100
       Percent of Person-Days that are User-Days =  95.37%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    342,240
    20.00      0.000000 >1,000,000            95.00      0.000001    271,344
    30.00      0.000000 >1,000,000            97.50      0.000001    212,366
    40.00      0.000000 >1,000,000            99.00      0.000002    163,145
    50.00      0.000000    837,015            99.50      0.000002    147,251
    60.00      0.000000    690,483            99.75      0.000002    130,442
    70.00      0.000001    568,402            99.90      0.000002    120,316
    80.00      0.000001    460,014
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    349,160
    20.00      0.000000 >1,000,000            95.00      0.000001    274,058
    30.00      0.000000 >1,000,000            97.50      0.000001    215,808
    40.00      0.000000 >1,000,000            99.00      0.000002    164,824
    50.00      0.000000    871,824            99.50      0.000002    148,062
    60.00      0.000000    721,891            99.75      0.000002    130,905
    70.00      0.000001    586,481            99.90      0.000002    120,691
    80.00      0.000001    471,723
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Youth 13-19 yrs                    Daily Exposure Analysis 
---------------                    (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000000     0.000000
            Standard Deviation        0.000000     0.000000
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         937,978      880,262
       Percent of Person-Days that are User-Days =  93.85%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    436,104
    20.00      0.000000 >1,000,000            95.00      0.000001    328,642
    30.00      0.000000 >1,000,000            97.50      0.000001    255,506
    40.00      0.000000 >1,000,000            99.00      0.000002    197,033
    50.00      0.000000 >1,000,000            99.50      0.000002    157,419
    60.00      0.000000    924,782            99.75      0.000002    125,214
    70.00      0.000000    760,153            99.90      0.000003    111,280
    80.00      0.000000    604,158
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    444,262
    20.00      0.000000 >1,000,000            95.00      0.000001    337,091
    30.00      0.000000 >1,000,000            97.50      0.000001    261,577
    40.00      0.000000 >1,000,000            99.00      0.000001    200,355
    50.00      0.000000 >1,000,000            99.50      0.000002    158,646
    60.00      0.000000    982,603            99.75      0.000002    125,496
    70.00      0.000000    800,141            99.90      0.000003    111,397
    80.00      0.000000    618,072
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Adults 20-49 yrs                   Daily Exposure Analysis 
----------------                   (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000000     0.000000
            Standard Deviation        0.000000     0.000000
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         725,837      704,533
       Percent of Person-Days that are User-Days =  97.06%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    369,420
    20.00      0.000000 >1,000,000            95.00      0.000001    292,203
    30.00      0.000000 >1,000,000            97.50      0.000001    231,504
    40.00      0.000000 >1,000,000            99.00      0.000002    174,904
    50.00      0.000000    860,300            99.50      0.000002    140,612
    60.00      0.000000    721,738            99.75      0.000003    119,656
    70.00      0.000000    606,635            99.90      0.000003     97,156
    80.00      0.000001    490,022
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    373,820
    20.00      0.000000 >1,000,000            95.00      0.000001    295,166
    30.00      0.000000 >1,000,000            97.50      0.000001    233,655
    40.00      0.000000 >1,000,000            99.00      0.000002    176,256
    50.00      0.000000    880,629            99.50      0.000002    140,857
    60.00      0.000000    739,505            99.75      0.000002    120,285
    70.00      0.000000    616,920            99.90      0.000003     97,439
    80.00      0.000001    497,428
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Adults 50+ yrs                     Daily Exposure Analysis 
--------------                     (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000000     0.000000
            Standard Deviation        0.000000     0.000000
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         689,433      685,142
       Percent of Person-Days that are User-Days =  99.38%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    394,326
    20.00      0.000000 >1,000,000            95.00      0.000001    325,785
    30.00      0.000000 >1,000,000            97.50      0.000001    282,222
    40.00      0.000000    903,088            99.00      0.000001    228,080
    50.00      0.000000    771,845            99.50      0.000002    194,713
    60.00      0.000000    670,030            99.75      0.000002    165,757
    70.00      0.000001    580,856            99.90      0.000002    140,909
    80.00      0.000001    486,420
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    394,883
    20.00      0.000000 >1,000,000            95.00      0.000001    326,851
    30.00      0.000000 >1,000,000            97.50      0.000001    282,569
    40.00      0.000000    907,579            99.00      0.000001    228,555
    50.00      0.000000    775,433            99.50      0.000002    195,072
    60.00      0.000000    672,397            99.75      0.000002    165,827
    70.00      0.000001    582,317            99.90      0.000002    140,936
    80.00      0.000001    487,454
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Females 13-49 yrs                  Daily Exposure Analysis 
-----------------                  (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000000     0.000000
            Standard Deviation        0.000000     0.000000
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         728,702      705,946
       Percent of Person-Days that are User-Days =  96.88%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    362,739
    20.00      0.000000 >1,000,000            95.00      0.000001    291,069
    30.00      0.000000 >1,000,000            97.50      0.000001    231,321
    40.00      0.000000 >1,000,000            99.00      0.000002    177,445
    50.00      0.000000    869,166            99.50      0.000002    141,588
    60.00      0.000000    720,379            99.75      0.000002    125,984
    70.00      0.000001    596,076            99.90      0.000003    102,768
    80.00      0.000001    479,775
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    368,554
    20.00      0.000000 >1,000,000            95.00      0.000001    293,502
    30.00      0.000000 >1,000,000            97.50      0.000001    234,326
    40.00      0.000000 >1,000,000            99.00      0.000002    182,361
    50.00      0.000000    892,161            99.50      0.000002    141,846
    60.00      0.000000    740,105            99.75      0.000002    127,748
    70.00      0.000000    609,661            99.90      0.000003    102,832
    80.00      0.000001    484,310
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: methidathionr1acutewater.R98            Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:41:48    Residue file dated: 10-12-2005/16:17:59/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
Run Comment: ""
===============================================================================
Custom demographics 1: Workers, 16+ years
All Seasons
All Regions
Sex: M/F-all/
All Races
Age-Low: 16 yrs   High: 99 yrs
-----------------------------------------
                                   Daily Exposure Analysis 
                                   (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000000     0.000000
            Standard Deviation        0.000000     0.000000
            Standard Error of mean    0.000000     0.000000
            Margin of Exposure         724,747      706,637
       Percent of Person-Days that are User-Days =  97.50%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    381,179
    20.00      0.000000 >1,000,000            95.00      0.000001    303,766
    30.00      0.000000 >1,000,000            97.50      0.000001    249,619
    40.00      0.000000 >1,000,000            99.00      0.000002    190,092
    50.00      0.000000    841,879            99.50      0.000002    149,300
    60.00      0.000000    709,837            99.75      0.000002    129,154
    70.00      0.000000    601,292            99.90      0.000003    102,764
    80.00      0.000001    492,979
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000001    384,420
    20.00      0.000000 >1,000,000            95.00      0.000001    305,915
    30.00      0.000000 >1,000,000            97.50      0.000001    251,724
    40.00      0.000000 >1,000,000            99.00      0.000002    191,386
    50.00      0.000000    858,882            99.50      0.000002    151,025
    60.00      0.000000    723,598            99.75      0.000002    129,311
    70.00      0.000000    609,915            99.90      0.000003    102,883
    80.00      0.000001    498,432
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California Department of Pesticide Regulation                        Ver. 2.00
DEEM-FCID Chronic analysis for METHIDATHION                       1994-98 data
Residue file: H:\MyFiles\DEEM-FCID Files\Methidathion\methidathionr1chronicwater.R98
                                                               Adjust. #2 used
Analysis Date 10-26-2005             Residue file dated: 10-12-2005/16:19:12/14
Reference dose (NOEL) = 0.15 mg/kg bw/day
--------------------------------------------------------------------------------
Food Crop                                       Residue       Adj.Factors      Comment
EPA Code  Grp  Food Name                          (ppm)       
                                                             #1         #2 
-------- ---- -------------------------------   ---------- ------     ------   -------
86010000 O    Water, direct, all sources         0.000013   1.000      1.000   PDP 20
  Full comment: PDP 2002-2003, 1/2 Combined CA LOD
86020000 O    Water, indirect, all sources       0.000013   1.000      1.000   PDP 20
  Full comment: PDP 2001-2003, 1/2 Combined CA LODMethidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                        Ver. 2.00
DEEM-FCID Chronic analysis for METHIDATHION                     (1994-98 data)
Residue file name: H:\MyFiles\DEEM-FCID
Files\Methidathion\methidathionr1chronicwater.R98
                                                     Adjustment factor #2 used.
Analysis Date 10-26-2005/08:50:06     Residue file dated: 10-12-2005/16:19:12/14
NOEL (Chronic) = .15 mg/kg bw/day
===============================================================================
                    Total exposure by population subgroup
-------------------------------------------------------------------------------
                                                    Total Exposure
                                         -----------------------------------
          Population                         mg/kg       Percent   Margin of
           Subgroup                       body wt/day    of NOEL   Exposr 1/
--------------------------------------   -------------  ---------  ---------
U.S. Population (total)                     0.000000        0.00%     547,429
U.S. Population (spring season)             0.000000        0.00%     552,285
U.S. Population (summer season)             0.000000        0.00%     509,626
U.S. Population (autumn season)             0.000000        0.00%     566,337
U.S. Population (winter season)             0.000000        0.00%     566,244
Northeast region                            0.000000        0.00%     600,096
Midwest region                              0.000000        0.00%     541,483
Southern region                             0.000000        0.00%     575,923
Western region                              0.000000        0.00%     477,793
Hispanics                                   0.000000        0.00%     482,278
Non-hispanic whites                         0.000000        0.00%     561,103
Non-hispanic blacks                         0.000000        0.00%     576,710
Non-hisp/non-white/non-black                0.000000        0.00%     446,548
All infants (< 1 year)                      0.000001        0.00%     166,974
Nursing infants                             0.000000        0.00%     450,205
Non-nursing infants                         0.000001        0.00%     134,797
Children 1-6  yrs                           0.000000        0.00%     391,831
Children 7-12 yrs                           0.000000        0.00%     602,667
Females 13-19 (not preg or nursing)         0.000000        0.00%     777,974
Females 20+ (not preg or nursing)           0.000000        0.00%     548,421
Females 13-50 yrs                           0.000000        0.00%     565,863
Females 13+ (preg/not nursing)              0.000000        0.00%     562,988
Females 13+ (nursing)                       0.000000        0.00%     395,137
Males 13-19 yrs                             0.000000        0.00%     744,021
Males 20+ yrs                               0.000000        0.00%     610,940
Seniors 55+                                 0.000000        0.00%     557,614
Children 1-2 yrs                            0.000000        0.00%     368,642
Children 3-5 yrs                            0.000000        0.00%     393,781
Children 6-12 yrs                           0.000000        0.00%     570,912
Youth 13-19 yrs                             0.000000        0.00%     757,324
Adults 20-49 yrs                            0.000000        0.00%     586,319
Adults 50+ yrs                              0.000000        0.00%     557,285
Females 13-49 yrs                           0.000000        0.00%     588,757
-------------------------------------------------------------------------------Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                        Ver. 2.00
DEEM-FCID Chronic analysis for METHIDATHION                     (1994-98 data)
Residue file name: H:\MyFiles\DEEM-FCID
Files\Methidathion\methidathionr1chronicwater.R98
                                                     Adjustment factor #2 used.
Analysis Date 10-26-2005/08:51:44     Residue file dated: 10-12-2005/16:19:12/14
Q* = 0.34 
===============================================================================
                    Total exposure by population subgroup
-------------------------------------------------------------------------------
                                                    Total Exposure
                                         -----------------------------------
          Population                         mg/kg         Lifetime risk
           Subgroup                       body wt/day       (Q*= .34)
--------------------------------------   -------------     -------------
U.S. Population (total)                     0.000000         9.32E-08
U.S. Population (spring season)             0.000000         9.23E-08
U.S. Population (summer season)             0.000000         1.00E-07
U.S. Population (autumn season)             0.000000         9.01E-08
U.S. Population (winter season)             0.000000         9.01E-08
Northeast region                            0.000000         8.50E-08
Midwest region                              0.000000         9.42E-08
Southern region                             0.000000         8.86E-08
Western region                              0.000000         1.07E-07
Hispanics                                   0.000000         1.06E-07
Non-hispanic whites                         0.000000         9.09E-08
Non-hispanic blacks                         0.000000         8.84E-08
Non-hisp/non-white/non-black                0.000000         1.14E-07
All infants (< 1 year)                      0.000001         3.05E-07
Nursing infants                             0.000000         1.13E-07
Non-nursing infants                         0.000001         3.78E-07
Children 1-6  yrs                           0.000000         1.30E-07
Children 7-12 yrs                           0.000000         8.46E-08
Females 13-19 (not preg or nursing)         0.000000         6.56E-08
Females 20+ (not preg or nursing)           0.000000         9.30E-08
Females 13-50 yrs                           0.000000         9.01E-08
Females 13+ (preg/not nursing)              0.000000         9.06E-08
Females 13+ (nursing)                       0.000000         1.29E-07
Males 13-19 yrs                             0.000000         6.85E-08
Males 20+ yrs                               0.000000         8.35E-08
Seniors 55+                                 0.000000         9.15E-08
Children 1-2 yrs                            0.000000         1.38E-07
Children 3-5 yrs                            0.000000         1.30E-07
Children 6-12 yrs                           0.000000         8.93E-08
Youth 13-19 yrs                             0.000000         6.73E-08
Adults 20-49 yrs                            0.000000         8.70E-08
Adults 50+ yrs                              0.000000         9.15E-08
Females 13-49 yrs                           0.000000         8.66E-08
-------------------------------------------------------------------------------Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                        Ver. 2.00
DEEM-FCID Chronic analysis for METHIDATHION                     (1994-98 data)
Residue file name: H:\MyFiles\DEEM-FCID
Files\Methidathion\methidathionr1chronicwater.R98
                                                     Adjustment factor #2 used.
Analysis Date 10-26-2005/08:51:26     Residue file dated: 10-12-2005/16:19:12/14
Q* = 0.53 
===============================================================================
                    Total exposure by population subgroup
-------------------------------------------------------------------------------
                                                    Total Exposure
                                         -----------------------------------
          Population                         mg/kg         Lifetime risk
           Subgroup                       body wt/day       (Q*= .53)
--------------------------------------   -------------     -------------
U.S. Population (total)                     0.000000         1.45E-07
U.S. Population (spring season)             0.000000         1.44E-07
U.S. Population (summer season)             0.000000         1.56E-07
U.S. Population (autumn season)             0.000000         1.40E-07
U.S. Population (winter season)             0.000000         1.40E-07
Northeast region                            0.000000         1.32E-07
Midwest region                              0.000000         1.47E-07
Southern region                             0.000000         1.38E-07
Western region                              0.000000         1.66E-07
Hispanics                                   0.000000         1.65E-07
Non-hispanic whites                         0.000000         1.42E-07
Non-hispanic blacks                         0.000000         1.38E-07
Non-hisp/non-white/non-black                0.000000         1.78E-07
All infants (< 1 year)                      0.000001         4.76E-07
Nursing infants                             0.000000         1.77E-07
Non-nursing infants                         0.000001         5.90E-07
Children 1-6  yrs                           0.000000         2.03E-07
Children 7-12 yrs                           0.000000         1.32E-07
Females 13-19 (not preg or nursing)         0.000000         1.02E-07
Females 20+ (not preg or nursing)           0.000000         1.45E-07
Females 13-50 yrs                           0.000000         1.40E-07
Females 13+ (preg/not nursing)              0.000000         1.41E-07
Females 13+ (nursing)                       0.000000         2.01E-07
Males 13-19 yrs                             0.000000         1.07E-07
Males 20+ yrs                               0.000000         1.30E-07
Seniors 55+                                 0.000000         1.43E-07
Children 1-2 yrs                            0.000000         2.16E-07
Children 3-5 yrs                            0.000000         2.02E-07
Children 6-12 yrs                           0.000000         1.39E-07
Youth 13-19 yrs                             0.000000         1.05E-07
Adults 20-49 yrs                            0.000000         1.36E-07
Adults 50+ yrs                              0.000000         1.43E-07
Females 13-49 yrs                           0.000000         1.35E-07
-------------------------------------------------------------------------------Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                        Ver. 2.02
DEEM-FCID Acute analysis for METHIDATHION
Residue file name: H:\MyFiles\DEEM-FCID
Files\Methidathion\Methidathionr1acutecomb.R98
Analysis Date 10-26-2005             Residue file dated: 10-25-2005/16:21:22/14
Reference dose (NOEL) = 0.3 mg/kg bw/day
--------------------------------------------------------------------------------
RDL indices and parameters for Monte Carlo Analysis:
Index Dist Parameter #1           Param #2    Param #3    Comment
  #   Code 
----- ---- ------------           ----------- ----------- ----------
  1    6   RDF1 APPLES.rdf
  2    6   RDF2 PLUMS.rdf
  3    6   RDF3 APRICOTS.rdf
  4    6   RDF4 ORANGES.rdf
  5    6   RDF5 PEACHES.rdf
  6    6   RDF6 NECTARINES.rdf
  7    6   RDF7 PEARS.rdf
  8    6   RDF8 CHERRIES.rdf
  9    6   RDF9 PRUNES.RDF
  EPA    Crop Food Name                         Def Res     Adj.Factors  RDL  Comment
  Code    Grp                                    (ppm)       #1     #2   Pntr
-------- ---- -------------------------------  ----------  ------ ------ ---  -------
14000030 14   Almond                             0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
14000031 14   Almond-babyfood                    0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
14000040 14   Almond, oil                        0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
14000041 14   Almond, oil-babyfood               0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
11000070 11   Apple, fruit with peel             0.007000   1.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000080 11   Apple, peeled fruit                0.007000   1.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000081 11   Apple, peeled fruit-babyfood       0.007000   1.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000090 11   Apple, dried                       0.007000   8.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000091 11   Apple, dried-babyfood              0.007000   8.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000100 11   Apple, juice                       0.007000   1.300  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000101 11   Apple, juice-babyfood              0.007000   1.300  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000110 11   Apple, sauce                       0.007000   1.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
11000111 11   Apple, sauce-babyfood              0.007000   1.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California - RDF, 15% PCT
12000120 12   Apricot                            0.050000   1.000  1.000   3  DPR 20
    Full comment: DPR 2002-2004 - RDF, 5% PCT
12000121 12   Apricot-babyfood                   0.050000   1.000  1.000   3  DPR 20
    Full comment: DPR 2002-2004 - RDF, 5% PCT
12000130 12   Apricot, dried                     0.050000   6.000  1.000   3  DPR 20
    Full comment: DPR 2002-2004 - RDF, 5% PCT
12000140 12   Apricot, juice                     0.050000   1.000  1.000   3  DPR 20
    Full comment: DPR 2002-2004 - RDF, 5% PCT
12000141 12   Apricot, juice-babyfood            0.050000   1.000  1.000   3  DPR 20
    Full comment: DPR 2002-2004 - RDF, 5% PCT
95000160 O    Artichoke, globe                   0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LOD
01030170 1CD  Artichoke, Jerusalem               0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LODMethidathion RCD (Revision 1) February 2007
14000590 14   Brazil nut                         0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
14000680 14   Butternut                          0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
14000810 14   Cashew                             0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
12000900 12   Cherry                             0.004000   1.000  1.000   8  PDP Ch
    Full comment: PDP Cherries 2000 & 2001 CA - RDF, 10% PCT
12000901 12   Cherry-babyfood                    0.004000   1.000  1.000   8  PDP Ch
    Full comment: PDP Cherries 2000 & 2001 CA - RDF, 10% PCT
12000910 12   Cherry, juice                      0.004000   1.500  1.000   8  PDP Ch
    Full comment: PDP Cherries 2000 & 2001 CA - RDF, 10% PCT
12000911 12   Cherry, juice-babyfood             0.004000   1.500  1.000   8  PDP Ch
    Full comment: PDP Cherries 2000 & 2001 CA - RDF, 10% PCT
14000920 14   Chestnut                           0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
10001060 10   Citrus citron                      2.000000   1.000  1.000   4  Tolera
    Full comment: Tolerance
10001070 10   Citrus hybrids                     0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10001080 10   Citrus, oil                        0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
95001280 O    Cottonseed, oil                    0.200000   1.000  1.000      Tolera
    Full comment: Tolerance
95001281 O    Cottonseed, oil-babyfood           0.200000   1.000  1.000      Tolera
    Full comment: Tolerance
11001290 11   Crabapple                          0.007000   1.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 California LOD
14001550 14   Filbert                            0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
14001560 14   Filbert, oil                       0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
10001800 10   Grapefruit                         0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10001810 10   Grapefruit, juice                  0.007000   2.100  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
14001850 14   Hickory nut                        0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
95001950 O    Kiwifruit                          0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LOD
10001970 10   Kumquat                            0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10001990 10   Lemon                              0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002000 10   Lemon, juice                       0.007000   2.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002001 10   Lemon, juice-babyfood              0.007000   2.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002010 10   Lemon, peel                        2.000000   1.000  1.000   4  Tolera
    Full comment: Tolerance
10002060 10   Lime                               0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002070 10   Lime, juice                        0.007000   2.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002071 10   Lime, juice-babyfood               0.007000   2.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
14002130 14   Macadamia nut                      0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
95002150 O    Mango                              0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LOD
95002151 O    Mango-babyfood                     0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LOD
95002160 O    Mango, dried                       0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LODMethidathion RCD (Revision 1) February 2007
95002170 O    Mango, juice                       0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LOD
95002171 O    Mango, juice-babyfood              0.050000   1.000  1.000      DPR 20
    Full comment: DPR 2002-2004 LOD
12002300 12   Nectarine                          0.004000   1.000  1.000   6  PDP Ne
    Full comment: PDP Nectarine 2000 & 2001 CA - RDF, 10% PCT
95002350 O    Olive                              0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
95002360 O    Olive, oil                         0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
10002400 10   Orange                             0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002410 10   Orange, juice                      0.007000   1.800  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002411 10   Orange, juice-babyfood             0.007000   1.800  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10002420 10   Orange, peel                       2.000000   1.000  1.000   4  Tolera
    Full comment: Tolerance
12002600 12   Peach                              0.004000   1.000  1.000   5  PDP Pe
    Full comment: PDP Peach 2001 & 2002 CA - RDF, 15% PCT
12002601 12   Peach-babyfood                     0.004000   1.000  1.000   5  PDP Pe
    Full comment: PDP Peach 2001 & 2002 CA - RDF, 15% PCT
12002610 12   Peach, dried                       0.004000   7.000  1.000   5  PDP Pe
    Full comment: PDP Peach 2001 & 2002 CA - RDF, 15% PCT
12002611 12   Peach, dried-babyfood              0.004000   7.000  1.000   5  PDP Pe
    Full comment: PDP Peach 2001 & 2002 CA - RDF, 15% PCT
12002620 12   Peach, juice                       0.004000   1.000  1.000   5  PDP Pe
    Full comment: PDP Peach 2001 & 2002 CA - RDF, 15% PCT
12002621 12   Peach, juice-babyfood              0.004000   1.000  1.000   5  PDP Pe
    Full comment: PDP Peach 2001 & 2002 CA - RDF, 15% PCT
11002660 11   Pear                               0.004000   1.000  1.000   7  PDP Pe
    Full comment: PDP Pear 2003 National - RDF, 10% PCT
11002661 11   Pear-babyfood                      0.004000   1.000  1.000   7  PDP Pe
    Full comment: PDP Pear 2003 National - RDF, 10% PCT
11002670 11   Pear, dried                        0.004000   6.250  1.000   7  PDP Pe
    Full comment: PDP Pear 2003 National - RDF, 10% PCT
11002680 11   Pear, juice                        0.004000   1.000  1.000   7  PDP Pe
    Full comment: PDP Pear 2003 National - RDF, 10% PCT
11002681 11   Pear, juice-babyfood               0.004000   1.000  1.000   7  PDP Pe
    Full comment: PDP Pear 2003 National - RDF, 10% PCT
14002690 14   Pecan                              0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
95002780 O    Pine nut                           0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
14002820 14   Pistachio                          0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
12002850 12   Plum                               0.050000   1.000  1.000   2  DPR 20
    Full comment: DPR 2002-2004 - RDF, 15% PCT
12002851 12   Plum-babyfood                      0.050000   1.000  1.000   2  DPR 20
    Full comment: DPR 2002-2004 - RDF, 15% PCT
12002860 12   Plum, prune, fresh                 0.050000   1.000  1.000   9  DPR Pl
    Full comment: DPR Plum 2002-2004 - RDF, 5% PCT
12002861 12   Plum, prune, fresh-babyfood        0.050000   1.000  1.000   9  DPR Pl
    Full comment: DPR Plum 2002-2004 - RDF, 5% PCT
12002870 12   Plum, prune, dried                 0.050000   5.000  1.000   9  DPR Pl
    Full comment: DPR Plum 2002-2004 - RDF, 5% PCT
12002871 12   Plum, prune, dried-babyfood        0.050000   5.000  1.000   9  DPR Pl
    Full comment: DPR Plum 2002-2004 - RDF, 5% PCT
12002880 12   Plum, prune, juice                 0.050000   1.400  1.000   9  DPR Pl
    Full comment: DPR Plum 2002-2004 - RDF, 5% PCT
12002881 12   Plum, prune, juice-babyfood        0.050000   1.400  1.000   9  DPR Pl
    Full comment: DPR Plum 2002-2004 - RDF, 5% PCT
10003070 10   Pummelo                            0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%Methidathion RCD (Revision 1) February 2007
11003100 11   Quince                             0.007000   1.000  1.000   1  PDP Ap
    Full comment: PDP Apple 2002 CA - RDF, 15% PCT
20003300 20   Safflower, oil                     0.050000   1.000  1.000      Safflo
    Full comment: Safflower Field Trial High Value
20003301 20   Safflower, oil-babyfood            0.050000   1.000  1.000      Safflo
    Full comment: Safflower Field Trial High Value
15003440 15   Sorghum, grain                     0.200000   1.000  1.000      Tolera
    Full comment: Tolerance
15003450 15   Sorghum, syrup                     0.200000   1.000  1.000      Tolera
    Full comment: Tolerance
95003580 O    Starfruit                          0.100000   1.000  1.000      Tolera
    Full comment: Tolerance
95003610 O    Sugar apple                        0.200000   1.000  1.000      Tolera
    Full comment: Tolerance
20003640 20   Sunflower, seed                    0.220000   1.000  0.500      Sunflo
    Full comment: Sunflower Field Trial High Value, 50% hulls
20003650 20   Sunflower, oil                     0.220000   1.000  0.200      Sunflo
    Full comment: Sunflower Field Trial High Value, 20% Oil
20003651 20   Sunflower, oil-babyfood            0.220000   1.000  0.200      Sunflo
    Full comment: Sunflower Field Trial High Value, 20% Oil
10003690 10   Tangerine                          0.007000   1.000  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
10003700 10   Tangerine, juice                   0.007000   2.300  1.000   4  PDP Or
    Full comment: PDP Orange 2000 & 2001 CA - RDF, 10%
14003910 14   Walnut                             0.050000   1.000  1.000      Tolera
    Full comment: Tolerance
86010000 O    Water, direct, all sources         0.000021   1.000  1.000      PDP 20
    Full comment: PDP 2002-2003, Combined CA LOD
86020000 O    Water, indirect, all sources       0.000021   1.000  1.000      PDP 20
    Full comment: PDP 2002-2003, Combined CA LODMethidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Summary calculations (per capita):
                    95th Percentile      99th Percentile      99.9th Percentile
                   Exposure     MOE     Exposure     MOE     Exposure     MOE  
                  ---------- --------  ---------- --------  ---------- --------
U.S. Population:
                    0.000037     8126    0.000110     2732    0.000320      937 
Western region:
                    0.000042     7109    0.000139     2161    0.000338      887 
Hispanics:
                    0.000048     6189    0.000163     1838    0.000451      664 
Non-hispanic whites:
                    0.000035     8490    0.000098     3064    0.000282     1063 
Non-hispanic blacks:
                    0.000035     8558    0.000108     2765    0.000224     1340 
Non-hisp/non-white/non-black:
                    0.000045     6673    0.000157     1908    0.000440      682 
All infants:
                    0.000127     2353    0.000211     1423    0.000492      610 
Nursing infants (<1 yr old):
                    0.000070     4290    0.000128     2348    0.000251     1196 
Non-nursing infants (<1 yr old):
                    0.000145     2067    0.000228     1315    0.000503      596 
Females 13+ (preg/not nursing):
                    0.000039     7618    0.000216     1391    0.000295     1018 
Females 13+ (nursing):
                    0.000037     8117    0.000282     1063    0.000299     1004 
Children 1-2 yrs:
                    0.000094     3187    0.000262     1145    0.000777      386 
Children 3-5 yrs:
                    0.000079     3813    0.000212     1412    0.000589      509 Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Summary calculations:
                      95th Percentile     99th Percentile     99.9th Percentile
                      Exposure    MOE     Exposure    MOE     Exposure     MOE  
                     ---------- -------  ---------- -------  ---------- --------
Children 6-12 yrs:
                    0.000048     6270    0.000133     2252    0.000478      628 
Youth 13-19 yrs:
                    0.000030    10104    0.000091     3312    0.000335      894 
Adults 20-49 yrs:
                    0.000028    10812    0.000079     3819    0.000214     1405 
Adults 50+ yrs:
                    0.000022    13831    0.000071     4252    0.000172     1744 
Females 13-49 yrs:
                    0.000028    10576    0.000086     3478    0.000214     1402 
Custom demographics 1: Workers, 16+ years:
                    0.000026    11654    0.000077     3889    0.000190     1576 Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
U.S. Population                    Daily Exposure Analysis  /a
---------------                    (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000011     0.000011
            Standard Deviation        0.000025     0.000025
            Margin of Exposure 2/       27,750       27,694
       Percent of Person-Days that are User-Days =  99.80%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    307,835            90.00      0.000022     13,782
    20.00      0.000002    174,676            95.00      0.000037      8,111
    30.00      0.000003    113,875            97.50      0.000061      4,937
    40.00      0.000004     81,673            99.00      0.000110      2,729
    50.00      0.000005     60,863            99.50      0.000154      1,949
    60.00      0.000006     46,203            99.75      0.000200      1,498
    70.00      0.000009     33,959            99.90      0.000321        935
    80.00      0.000013     23,602
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    311,680            90.00      0.000022     13,805
    20.00      0.000002    176,022            95.00      0.000037      8,126
    30.00      0.000003    114,449            97.50      0.000061      4,942
    40.00      0.000004     81,973            99.00      0.000110      2,732
    50.00      0.000005     61,031            99.50      0.000154      1,951
    60.00      0.000006     46,323            99.75      0.000200      1,499
    70.00      0.000009     34,030            99.90      0.000320        937
    80.00      0.000013     23,643
-------------------------------------------------------------------------------
a/ Analysis based on all two-day participant records in CSFII 1994-98
   with 2 days of valid drinking water records.
2/ Margin of Exposure = NOEL/ Dietary Exposure.
                                      1 Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Western region                     Daily Exposure Analysis 
--------------                     (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000012     0.000012
            Standard Deviation        0.000029     0.000029
            Margin of Exposure          24,461       24,393
       Percent of Person-Days that are User-Days =  99.72%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    289,619            90.00      0.000025     11,882
    20.00      0.000002    164,789            95.00      0.000042      7,099
    30.00      0.000003    107,441            97.50      0.000072      4,172
    40.00      0.000004     79,052            99.00      0.000139      2,159
    50.00      0.000005     59,027            99.50      0.000171      1,754
    60.00      0.000007     43,013            99.75      0.000237      1,264
    70.00      0.000009     31,629            99.90      0.000339        886
    80.00      0.000014     21,282
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    294,676            90.00      0.000025     11,899
    20.00      0.000002    166,582            95.00      0.000042      7,109
    30.00      0.000003    108,149            97.50      0.000072      4,191
    40.00      0.000004     79,418            99.00      0.000139      2,161
    50.00      0.000005     59,271            99.50      0.000171      1,755
    60.00      0.000007     43,156            99.75      0.000237      1,267
    70.00      0.000009     31,705            99.90      0.000338        887
    80.00      0.000014     21,327
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Hispanics                          Daily Exposure Analysis 
---------                          (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000013     0.000013
            Standard Deviation        0.000035     0.000036
            Margin of Exposure          22,873       22,841
       Percent of Person-Days that are User-Days =  99.86%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    351,039            90.00      0.000026     11,654
    20.00      0.000002    198,977            95.00      0.000049      6,176
    30.00      0.000002    123,081            97.50      0.000087      3,438
    40.00      0.000003     88,189            99.00      0.000163      1,837
    50.00      0.000005     64,328            99.50      0.000214      1,399
    60.00      0.000006     47,087            99.75      0.000298      1,005
    70.00      0.000009     33,183            99.90      0.000451        664
    80.00      0.000013     22,241
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    354,243            90.00      0.000026     11,668
    20.00      0.000002    199,974            95.00      0.000048      6,189
    30.00      0.000002    123,533            97.50      0.000087      3,443
    40.00      0.000003     88,406            99.00      0.000163      1,838
    50.00      0.000005     64,437            99.50      0.000214      1,399
    60.00      0.000006     47,172            99.75      0.000298      1,005
    70.00      0.000009     33,229            99.90      0.000451        664
    80.00      0.000013     22,283
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Non-hispanic whites                Daily Exposure Analysis 
-------------------                (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000010     0.000010
            Standard Deviation        0.000022     0.000022
            Margin of Exposure          28,748       28,689
       Percent of Person-Days that are User-Days =  99.79%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    283,504            90.00      0.000021     13,980
    20.00      0.000002    165,290            95.00      0.000035      8,479
    30.00      0.000003    110,463            97.50      0.000058      5,197
    40.00      0.000004     79,875            99.00      0.000098      3,060
    50.00      0.000005     60,178            99.50      0.000140      2,146
    60.00      0.000007     46,089            99.75      0.000186      1,610
    70.00      0.000009     34,165            99.90      0.000282      1,063
    80.00      0.000013     23,802
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    287,081            90.00      0.000021     13,998
    20.00      0.000002    166,473            95.00      0.000035      8,490
    30.00      0.000003    110,988            97.50      0.000058      5,205
    40.00      0.000004     80,182            99.00      0.000098      3,064
    50.00      0.000005     60,337            99.50      0.000140      2,147
    60.00      0.000006     46,211            99.75      0.000186      1,610
    70.00      0.000009     34,238            99.90      0.000282      1,063
    80.00      0.000013     23,848
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Non-hispanic blacks                Daily Exposure Analysis 
-------------------                (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000010     0.000010
            Standard Deviation        0.000023     0.000024
            Margin of Exposure          29,588       29,524
       Percent of Person-Days that are User-Days =  99.78%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    416,710            90.00      0.000020     14,756
    20.00      0.000001    230,212            95.00      0.000035      8,547
    30.00      0.000002    136,552            97.50      0.000058      5,136
    40.00      0.000003     89,560            99.00      0.000109      2,764
    50.00      0.000005     64,980            99.50      0.000148      2,027
    60.00      0.000006     47,926            99.75      0.000180      1,664
    70.00      0.000009     35,194            99.90      0.000224      1,338
    80.00      0.000012     24,892
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    422,258            90.00      0.000020     14,770
    20.00      0.000001    232,366            95.00      0.000035      8,558
    30.00      0.000002    137,419            97.50      0.000058      5,143
    40.00      0.000003     89,998            99.00      0.000108      2,765
    50.00      0.000005     65,189            99.50      0.000148      2,030
    60.00      0.000006     48,036            99.75      0.000180      1,664
    70.00      0.000008     35,313            99.90      0.000224      1,340
    80.00      0.000012     24,928
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Non-hisp/non-white/non-black       Daily Exposure Analysis 
----------------------------       (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000013     0.000013
            Standard Deviation        0.000034     0.000034
            Margin of Exposure          22,330       22,287
       Percent of Person-Days that are User-Days =  99.81%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    343,750            90.00      0.000026     11,467
    20.00      0.000002    176,718            95.00      0.000045      6,672
    30.00      0.000003    110,895            97.50      0.000089      3,387
    40.00      0.000004     74,118            99.00      0.000157      1,908
    50.00      0.000006     54,178            99.50      0.000203      1,477
    60.00      0.000008     39,883            99.75      0.000323        928
    70.00      0.000010     30,329            99.90      0.000440        682
    80.00      0.000015     20,217
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    348,794            90.00      0.000026     11,485
    20.00      0.000002    178,031            95.00      0.000045      6,673
    30.00      0.000003    111,761            97.50      0.000089      3,388
    40.00      0.000004     74,353            99.00      0.000157      1,908
    50.00      0.000006     54,333            99.50      0.000203      1,477
    60.00      0.000007     40,000            99.75      0.000323        929
    70.00      0.000010     30,363            99.90      0.000440        682
    80.00      0.000015     20,237
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
All infants                        Daily Exposure Analysis 
-----------                        (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000040     0.000045
            Standard Deviation        0.000051     0.000052
            Margin of Exposure           7,428        6,671
       Percent of Person-Days that are User-Days =  89.81%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000002    186,378            90.00      0.000103      2,904
    20.00      0.000008     38,249            95.00      0.000136      2,206
    30.00      0.000016     18,567            97.50      0.000174      1,723
    40.00      0.000024     12,391            99.00      0.000217      1,385
    50.00      0.000031      9,703            99.50      0.000282      1,063
    60.00      0.000039      7,626            99.75      0.000350        858
    70.00      0.000052      5,805            99.90      0.000494        607
    80.00      0.000073      4,107
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000100      3,008
    20.00      0.000002    155,233            95.00      0.000127      2,353
    30.00      0.000010     30,391            97.50      0.000164      1,827
    40.00      0.000019     15,804            99.00      0.000211      1,423
    50.00      0.000027     11,188            99.50      0.000272      1,102
    60.00      0.000035      8,503            99.75      0.000348        863
    70.00      0.000047      6,404            99.90      0.000492        610
    80.00      0.000067      4,452
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Nursing infants (<1 yr old)        Daily Exposure Analysis 
---------------------------        (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000014     0.000022
            Standard Deviation        0.000031     0.000037
            Margin of Exposure          21,319       13,742
       Percent of Person-Days that are User-Days =  64.46%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000060      4,961
    20.00      0.000000    699,460            95.00      0.000090      3,339
    30.00      0.000001    228,629            97.50      0.000118      2,549
    40.00      0.000004     72,562            99.00      0.000163      1,842
    50.00      0.000010     30,686            99.50      0.000204      1,473
    60.00      0.000013     22,998            99.75      0.000250      1,202
    70.00      0.000022     13,897            99.90      0.000253      1,185
    80.00      0.000037      8,021
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000000 >1,000,000            90.00      0.000047      6,449
    20.00      0.000000 >1,000,000            95.00      0.000070      4,290
    30.00      0.000000 >1,000,000            97.50      0.000101      2,966
    40.00      0.000000 >1,000,000            99.00      0.000128      2,348
    50.00      0.000001    595,289            99.50      0.000202      1,484
    60.00      0.000003     89,833            99.75      0.000207      1,446
    70.00      0.000011     27,469            99.90      0.000251      1,196
    80.00      0.000021     14,599
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Non-nursing infants (<1 yr old)    Daily Exposure Analysis 
-------------------------------    (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000050     0.000051
            Standard Deviation        0.000053     0.000053
            Margin of Exposure           5,963        5,925
       Percent of Person-Days that are User-Days =  99.37%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000005     65,424            90.00      0.000109      2,752
    20.00      0.000014     20,709            95.00      0.000145      2,063
    30.00      0.000023     13,321            97.50      0.000180      1,665
    40.00      0.000029     10,435            99.00      0.000230      1,302
    50.00      0.000036      8,440            99.50      0.000289      1,037
    60.00      0.000044      6,799            99.75      0.000383        782
    70.00      0.000058      5,149            99.90      0.000503        596
    80.00      0.000078      3,827
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000004     70,978            90.00      0.000109      2,759
    20.00      0.000014     21,527            95.00      0.000145      2,067
    30.00      0.000022     13,578            97.50      0.000180      1,666
    40.00      0.000028     10,528            99.00      0.000228      1,315
    50.00      0.000035      8,498            99.50      0.000289      1,038
    60.00      0.000044      6,838            99.75      0.000383        783
    70.00      0.000058      5,178            99.90      0.000503        596
    80.00      0.000078      3,837
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Females 13+ (preg/not nursing)     Daily Exposure Analysis 
------------------------------     (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000016     0.000016
            Standard Deviation        0.000041     0.000041
            Margin of Exposure          19,297       19,297
       Percent of Person-Days that are User-Days = 100.00%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    365,255            90.00      0.000022     13,547
    20.00      0.000002    173,257            95.00      0.000039      7,618
    30.00      0.000003    116,703            97.50      0.000214      1,402
    40.00      0.000004     75,651            99.00      0.000216      1,391
    50.00      0.000005     61,042            99.50      0.000294      1,020
    60.00      0.000006     49,452            99.75      0.000294      1,019
    70.00      0.000009     33,215            99.90      0.000295      1,018
    80.00      0.000013     22,226
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    365,255            90.00      0.000022     13,547
    20.00      0.000002    173,257            95.00      0.000039      7,618
    30.00      0.000003    116,703            97.50      0.000214      1,402
    40.00      0.000004     75,651            99.00      0.000216      1,391
    50.00      0.000005     61,042            99.50      0.000294      1,020
    60.00      0.000006     49,452            99.75      0.000294      1,019
    70.00      0.000009     33,215            99.90      0.000295      1,018
    80.00      0.000013     22,226
                                      10 Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Females 13+ (nursing)              Daily Exposure Analysis 
---------------------              (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000015     0.000015
            Standard Deviation        0.000042     0.000042
            Margin of Exposure          20,249       20,249
       Percent of Person-Days that are User-Days = 100.00%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000002    194,459            90.00      0.000019     16,120
    20.00      0.000002    143,108            95.00      0.000037      8,117
    30.00      0.000003    108,902            97.50      0.000161      1,868
    40.00      0.000004     83,096            99.00      0.000282      1,063
    50.00      0.000004     67,313            99.50      0.000298      1,007
    60.00      0.000005     54,715            99.75      0.000298      1,005
    70.00      0.000007     45,323            99.90      0.000299      1,004
    80.00      0.000009     33,193
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000002    194,459            90.00      0.000019     16,120
    20.00      0.000002    143,108            95.00      0.000037      8,117
    30.00      0.000003    108,902            97.50      0.000161      1,868
    40.00      0.000004     83,096            99.00      0.000282      1,063
    50.00      0.000004     67,313            99.50      0.000298      1,007
    60.00      0.000005     54,715            99.75      0.000298      1,005
    70.00      0.000007     45,323            99.90      0.000299      1,004
    80.00      0.000009     33,193
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Children 1-2 yrs                   Daily Exposure Analysis 
----------------                   (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000026     0.000026
            Standard Deviation        0.000058     0.000058
            Margin of Exposure          11,388       11,371
       Percent of Person-Days that are User-Days =  99.85%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000002    142,440            90.00      0.000054      5,590
    20.00      0.000004     72,042            95.00      0.000094      3,185
    30.00      0.000006     47,699            97.50      0.000151      1,992
    40.00      0.000009     33,904            99.00      0.000262      1,144
    50.00      0.000012     25,339            99.50      0.000398        752
    60.00      0.000016     18,914            99.75      0.000564        531
    70.00      0.000021     14,073            99.90      0.000777        385
    80.00      0.000030     10,061
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000002    144,217            90.00      0.000054      5,597
    20.00      0.000004     72,488            95.00      0.000094      3,187
    30.00      0.000006     47,870            97.50      0.000151      1,993
    40.00      0.000009     34,000            99.00      0.000262      1,145
    50.00      0.000012     25,386            99.50      0.000398        753
    60.00      0.000016     18,946            99.75      0.000564        531
    70.00      0.000021     14,090            99.90      0.000777        386
    80.00      0.000030     10,072
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Children 3-5 yrs                   Daily Exposure Analysis 
----------------                   (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000024     0.000024
            Standard Deviation        0.000046     0.000046
            Margin of Exposure          12,387       12,387
       Percent of Person-Days that are User-Days = 100.00%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000003     97,409            90.00      0.000048      6,274
    20.00      0.000005     56,578            95.00      0.000079      3,813
    30.00      0.000008     39,090            97.50      0.000124      2,423
    40.00      0.000010     29,438            99.00      0.000212      1,412
    50.00      0.000013     22,816            99.50      0.000296      1,013
    60.00      0.000017     17,891            99.75      0.000410        731
    70.00      0.000021     14,081            99.90      0.000589        509
    80.00      0.000029     10,381
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000003     97,409            90.00      0.000048      6,274
    20.00      0.000005     56,578            95.00      0.000079      3,813
    30.00      0.000008     39,090            97.50      0.000124      2,423
    40.00      0.000010     29,438            99.00      0.000212      1,412
    50.00      0.000013     22,816            99.50      0.000296      1,013
    60.00      0.000017     17,891            99.75      0.000410        731
    70.00      0.000021     14,081            99.90      0.000589        509
    80.00      0.000029     10,381
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Children 6-12 yrs                  Daily Exposure Analysis 
-----------------                  (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000016     0.000016
            Standard Deviation        0.000032     0.000032
            Margin of Exposure          18,328       18,328
       Percent of Person-Days that are User-Days = 100.00%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000003    117,833            90.00      0.000030      9,951
    20.00      0.000004     72,074            95.00      0.000048      6,270
    30.00      0.000006     52,215            97.50      0.000077      3,912
    40.00      0.000008     39,883            99.00      0.000133      2,252
    50.00      0.000009     31,944            99.50      0.000199      1,508
    60.00      0.000012     25,944            99.75      0.000339        883
    70.00      0.000015     20,472            99.90      0.000478        628
    80.00      0.000020     15,259
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000003    117,833            90.00      0.000030      9,951
    20.00      0.000004     72,074            95.00      0.000048      6,270
    30.00      0.000006     52,215            97.50      0.000077      3,912
    40.00      0.000008     39,883            99.00      0.000133      2,252
    50.00      0.000009     31,944            99.50      0.000199      1,508
    60.00      0.000012     25,944            99.75      0.000339        883
    70.00      0.000015     20,472            99.90      0.000478        628
    80.00      0.000020     15,259
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Youth 13-19 yrs                    Daily Exposure Analysis 
---------------                    (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000010     0.000010
            Standard Deviation        0.000020     0.000020
            Margin of Exposure          29,339       29,285
       Percent of Person-Days that are User-Days =  99.82%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    258,813            90.00      0.000019     15,877
    20.00      0.000002    133,911            95.00      0.000030     10,054
    30.00      0.000003     88,858            97.50      0.000047      6,386
    40.00      0.000005     64,755            99.00      0.000091      3,303
    50.00      0.000006     50,312            99.50      0.000129      2,322
    60.00      0.000008     39,857            99.75      0.000190      1,576
    70.00      0.000010     31,105            99.90      0.000335        894
    80.00      0.000013     23,481
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    262,713            90.00      0.000019     15,910
    20.00      0.000002    135,109            95.00      0.000030     10,104
    30.00      0.000003     89,165            97.50      0.000047      6,389
    40.00      0.000005     64,964            99.00      0.000091      3,312
    50.00      0.000006     50,408            99.50      0.000128      2,335
    60.00      0.000008     39,924            99.75      0.000190      1,576
    70.00      0.000010     31,145            99.90      0.000335        894
    80.00      0.000013     23,511
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Adults 20-49 yrs                   Daily Exposure Analysis 
----------------                   (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000009     0.000009
            Standard Deviation        0.000017     0.000017
            Margin of Exposure          35,099       35,082
       Percent of Person-Days that are User-Days =  99.95%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    322,448            90.00      0.000017     17,796
    20.00      0.000002    186,586            95.00      0.000028     10,809
    30.00      0.000002    122,968            97.50      0.000044      6,755
    40.00      0.000003     89,464            99.00      0.000079      3,819
    50.00      0.000004     68,013            99.50      0.000120      2,502
    60.00      0.000006     53,187            99.75      0.000157      1,908
    70.00      0.000007     40,758            99.90      0.000214      1,404
    80.00      0.000010     29,222
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    323,391            90.00      0.000017     17,799
    20.00      0.000002    186,918            95.00      0.000028     10,812
    30.00      0.000002    123,116            97.50      0.000044      6,757
    40.00      0.000003     89,539            99.00      0.000079      3,819
    50.00      0.000004     68,055            99.50      0.000120      2,503
    60.00      0.000006     53,210            99.75      0.000157      1,909
    70.00      0.000007     40,777            99.90      0.000214      1,405
    80.00      0.000010     29,235
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Adults 50+ yrs                     Daily Exposure Analysis 
--------------                     (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000007     0.000007
            Standard Deviation        0.000015     0.000015
            Margin of Exposure          43,911       43,899
       Percent of Person-Days that are User-Days =  99.97%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    390,144            90.00      0.000013     22,809
    20.00      0.000001    248,593            95.00      0.000022     13,829
    30.00      0.000002    172,505            97.50      0.000038      7,812
    40.00      0.000002    126,193            99.00      0.000071      4,252
    50.00      0.000003     93,893            99.50      0.000108      2,790
    60.00      0.000004     71,177            99.75      0.000147      2,042
    70.00      0.000006     53,597            99.90      0.000172      1,744
    80.00      0.000008     38,133
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    390,644            90.00      0.000013     22,813
    20.00      0.000001    248,793            95.00      0.000022     13,831
    30.00      0.000002    172,614            97.50      0.000038      7,813
    40.00      0.000002    126,253            99.00      0.000071      4,252
    50.00      0.000003     93,928            99.50      0.000108      2,790
    60.00      0.000004     71,197            99.75      0.000147      2,042
    70.00      0.000006     53,608            99.90      0.000172      1,744
    80.00      0.000008     38,142
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Females 13-49 yrs                  Daily Exposure Analysis 
-----------------                  (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000009     0.000009
            Standard Deviation        0.000018     0.000018
            Margin of Exposure          34,691       34,674
       Percent of Person-Days that are User-Days =  99.95%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    329,336            90.00      0.000017     18,138
    20.00      0.000002    196,761            95.00      0.000028     10,573
    30.00      0.000002    127,609            97.50      0.000048      6,223
    40.00      0.000003     93,647            99.00      0.000086      3,477
    50.00      0.000004     71,867            99.50      0.000145      2,073
    60.00      0.000005     55,376            99.75      0.000169      1,778
    70.00      0.000007     41,643            99.90      0.000214      1,402
    80.00      0.000010     30,162
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    330,248            90.00      0.000017     18,147
    20.00      0.000002    197,082            95.00      0.000028     10,576
    30.00      0.000002    127,762            97.50      0.000048      6,225
    40.00      0.000003     93,718            99.00      0.000086      3,478
    50.00      0.000004     71,927            99.50      0.000145      2,074
    60.00      0.000005     55,397            99.75      0.000169      1,778
    70.00      0.000007     41,662            99.90      0.000214      1,402
    80.00      0.000010     30,168
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California Department of Pesticide Regulation                         Ver. 2.02
DEEM-FCID ACUTE Analysis for METHIDATHION                        (1994-98 data)
Residue file: Methidathionr1acutecomb.R98             Adjustment factor #2 used.
Analysis Date: 10-26-2005/08:46:35    Residue file dated: 10-25-2005/16:21:22/14
NOEL (Acute) =   0.300000 mg/kg body-wt/day
Daily totals for food and foodform consumption used.
MC iterations = 500      MC list in residue file     MC seed = 1
Run Comment: ""
===============================================================================
Custom demographics 1: Workers, 16+ years
All Seasons
All Regions
Sex: M/F-all/
All Races
Age-Low: 16 yrs   High: 99 yrs
-----------------------------------------
                                   Daily Exposure Analysis 
                                   (mg/kg body-weight/day) 
                                    per Capita    per User 
                                   -----------  -----------
            Mean                      0.000008     0.000008
            Standard Deviation        0.000016     0.000016
            Margin of Exposure          37,401       37,378
       Percent of Person-Days that are User-Days =  99.94%
  Estimated percentile of user-days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    348,238            90.00      0.000016     18,823
    20.00      0.000001    207,707            95.00      0.000026     11,649
    30.00      0.000002    138,843            97.50      0.000042      7,129
    40.00      0.000003     98,838            99.00      0.000077      3,888
    50.00      0.000004     74,507            99.50      0.000115      2,605
    60.00      0.000005     57,093            99.75      0.000154      1,948
    70.00      0.000007     43,410            99.90      0.000190      1,576
    80.00      0.000010     31,068
  Estimated percentile of per-capita days falling below calculated exposure
    in mg/kg body-wt/day with Margin of Exposure (MOE)
 Percentile   Exposure      MOE            Percentile   Exposure      MOE   
 ----------  ----------  ---------         ----------  ----------  ---------
    10.00      0.000001    349,496            90.00      0.000016     18,829
    20.00      0.000001    208,159            95.00      0.000026     11,654
    30.00      0.000002    139,071            97.50      0.000042      7,133
    40.00      0.000003     98,942            99.00      0.000077      3,889
    50.00      0.000004     74,571            99.50      0.000115      2,606
    60.00      0.000005     57,129            99.75      0.000154      1,948
    70.00      0.000007     43,433            99.90      0.000190      1,576
    80.00      0.000010     31,084
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California Department of Pesticide Regulation                        Ver. 2.00
DEEM-FCID Chronic analysis for METHIDATHION                       1994-98 data
Residue file: H:\MyFiles\DEEM-FCID Files\Methidathion\Methidathionr1chroniccomb.R98
                                                               Adjust. #2 used
Analysis Date 10-26-2005             Residue file dated: 10-25-2005/16:23:35/14
Reference dose (NOEL) = 0.15 mg/kg bw/day
--------------------------------------------------------------------------------
Food Crop                                       Residue       Adj.Factors      Comment
EPA Code  Grp  Food Name                          (ppm)       
                                                             #1         #2 
-------- ---- -------------------------------   ---------- ------     ------   -------
14000030 14   Almond                             0.001250   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
14000031 14   Almond-babyfood                    0.001250   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
14000040 14   Almond, oil                        0.001250   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
14000041 14   Almond, oil-babyfood               0.001250   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
11000070 11   Apple, fruit with peel             0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000080 11   Apple, peeled fruit                0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000081 11   Apple, peeled fruit-babyfood       0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000090 11   Apple, dried                       0.000350   8.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000091 11   Apple, dried-babyfood              0.000350   8.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000100 11   Apple, juice                       0.000350   1.300      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000101 11   Apple, juice-babyfood              0.000350   1.300      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000110 11   Apple, sauce                       0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
11000111 11   Apple, sauce-babyfood              0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
12000120 12   Apricot                            0.001300   1.000      1.000   DPR Ap
  Full comment: DPR Apricot 2002-2004 1/2 LOD, 5% CT
12000121 12   Apricot-babyfood                   0.001300   1.000      1.000   DPR Ap
  Full comment: DPR Apricot 2002-2004 1/2 LOD, 5% CT
12000130 12   Apricot, dried                     0.001300   6.000      1.000   DPR Ap
  Full comment: DPR Apricot 2002-2004 1/2 LOD, 5% CT
12000140 12   Apricot, juice                     0.001300   1.000      1.000   DPR Ap
  Full comment: DPR Apricot 2002-2004 1/2 LOD, 5% CT
12000141 12   Apricot, juice-babyfood            0.001300   1.000      1.000   DPR Ap
  Full comment: DPR Apricot 2002-2004 1/2 LOD, 5% CT
95000160 O    Artichoke, globe                   0.025000   1.000      1.000   DPR Ar
  Full comment: DPR Artichoke 2002-2004 1/2 LOD, 100% CT
01030170 1CD  Artichoke, Jerusalem               0.025000   1.000      1.000   DPR Ar
  Full comment: DPR Artichoke 2002-2004 1/2 LOD, 100% CT
14000590 14   Brazil nut                         0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
14000680 14   Butternut                          0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
14000810 14   Cashew                             0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
12000900 12   Cherry                             0.000100   1.000      1.000   PDP Ch
  Full comment: PDP Cherries 2000&2001 CA 1/2 LOD, 5% CT
12000901 12   Cherry-babyfood                    0.000100   1.000      1.000   PDP Ch
  Full comment: PDP Cherries 2000&2001 CA 1/2 LOD, 5% CT
12000910 12   Cherry, juice                      0.000100   1.500      1.000   PDP Ch
  Full comment: PDP Cherries 2000&2001 CA 1/2 LOD, 5% CTMethidathion RCD (Revision 1) February 2007
12000911 12   Cherry, juice-babyfood             0.000100   1.500      1.000   PDP Ch
  Full comment: PDP Cherries 2000&2001 CA 1/2 LOD, 5% CT
14000920 14   Chestnut                           0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
10001060 10   Citrus citron                      0.050000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
10001070 10   Citrus hybrids                     0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10001080 10   Citrus, oil                        0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
95001280 O    Cottonseed, oil                    0.001000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 1% CT
95001281 O    Cottonseed, oil-babyfood           0.001000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 1% CT
11001290 11   Crabapple                          0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
14001550 14   Filbert                            0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
14001560 14   Filbert, oil                       0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
10001800 10   Grapefruit                         0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000 & 2001 CA Mean Value
10001810 10   Grapefruit, juice                  0.000168   2.100      1.000   PDP Or
  Full comment: PDP Orange 2000 & 2001 CA Mean Value
14001850 14   Hickory nut                        0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
95001950 O    Kiwifruit                          0.002500   1.000      1.000   DPR Ki
  Full comment: DPR Kiwifruit 2002-2004 1/2 LOD, 10% CT
10001970 10   Kumquat                            0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10001990 10   Lemon                              0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002000 10   Lemon, juice                       0.000168   2.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002001 10   Lemon, juice-babyfood              0.000168   2.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002010 10   Lemon, peel                        0.050000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
10002060 10   Lime                               0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002070 10   Lime, juice                        0.000168   2.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002071 10   Lime, juice-babyfood               0.000168   2.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
11002100 11   Loquat                             0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
14002130 14   Macadamia nut                      0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
95002150 O    Mango                              0.025000   1.000      1.000   DPR Ma
  Full comment: DPR Mango 2002-2004 1/2 LOD, 100% CT
95002151 O    Mango-babyfood                     0.025000   1.000      1.000   DPR Ma
  Full comment: DPR Mango 2002-2004 1/2 LOD, 100% CT
95002160 O    Mango, dried                       0.025000   1.000      1.000   DPR Ma
  Full comment: DPR Mango 2002-2004 1/2 LOD, 100% CT
95002170 O    Mango, juice                       0.025000   1.000      1.000   DPR Ma
  Full comment: DPR Mango 2002-2004 1/2 LOD, 100% CT
95002171 O    Mango, juice-babyfood              0.025000   1.000      1.000   DPR Ma
  Full comment: DPR Mango 2002-2004 1/2 LOD, 100% CT
12002300 12   Nectarine                          0.000100   1.000      1.000   PDP Ne
  Full comment: PDP Nectarine 2000&2001 CA 1/2 LOD, 5% CT
95002350 O    Olive                              0.001250   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
95002360 O    Olive, oil                         0.001250   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CTMethidathion RCD (Revision 1) February 2007
10002400 10   Orange                             0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002410 10   Orange, juice                      0.000168   1.800      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002411 10   Orange, juice-babyfood             0.000168   1.800      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10002420 10   Orange, peel                       0.050000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
12002600 12   Peach                              0.000065   1.000      1.000   PDP Pe
  Full comment: PDP Peach 2001&2002 CA Mean Value, 10% CT
12002601 12   Peach-babyfood                     0.000065   1.000      1.000   PDP Pe
  Full comment: PDP Peach 2001&2002 CA Mean Value, 10% CT
12002610 12   Peach, dried                       0.000065   7.000      1.000   PDP Pe
  Full comment: PDP Peach 2001&2002 CA Mean Value, 10% CT
12002611 12   Peach, dried-babyfood              0.000065   7.000      1.000   PDP Pe
  Full comment: PDP Peach 2001&2002 CA Mean Value, 10% CT
12002620 12   Peach, juice                       0.000065   1.000      1.000   PDP Pe
  Full comment: PDP Peach 2001&2002 CA Mean Value, 10% CT
12002621 12   Peach, juice-babyfood              0.000065   1.000      1.000   PDP Pe
  Full comment: PDP Peach 2001&2002 CA Mean Value, 10% CT
11002660 11   Pear                               0.000100   1.000      1.000   PDP Pe
  Full comment: PDP Pear 2003 NA 1/2 LOD, 5% CT
11002661 11   Pear-babyfood                      0.000100   1.000      1.000   PDP Pe
  Full comment: PDP Pear 2003 NA 1/2 LOD, 5% CT
11002670 11   Pear, dried                        0.000100   6.250      1.000   PDP Pe
  Full comment: PDP Pear 2003 NA 1/2 LOD, 5% CT
11002680 11   Pear, juice                        0.000100   1.000      1.000   PDP Pe
  Full comment: PDP Pear 2003 NA 1/2 LOD, 5% CT
11002681 11   Pear, juice-babyfood               0.000100   1.000      1.000   PDP Pe
  Full comment: PDP Pear 2003 NA 1/2 LOD, 5% CT
14002690 14   Pecan                              0.002500   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 10% CT
95002780 O    Pine nut                           0.025000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance
14002820 14   Pistachio                          0.002500   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 10% CT
12002850 12   Plum                               0.003750   1.000      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 15% CT
12002851 12   Plum-babyfood                      0.003750   1.000      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 15% CT
12002860 12   Plum, prune, fresh                 0.001250   1.000      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 5% CT
12002861 12   Plum, prune, fresh-babyfood        0.001250   1.000      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 5% CT
12002870 12   Plum, prune, dried                 0.001250   5.000      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 5% CT
12002871 12   Plum, prune, dried-babyfood        0.001250   5.000      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 5% CT
12002880 12   Plum, prune, juice                 0.001250   1.400      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 5% CT
12002881 12   Plum, prune, juice-babyfood        0.001250   1.400      1.000   DPR Pl
  Full comment: DPR Plum 2002-2004 1/2 LOD, 5% CT
10003070 10   Pummelo                            0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
11003100 11   Quince                             0.000350   1.000      1.000   PDP Ap
  Full comment: PDP Apple 2002 CA 1/2 LOD, 10% CT
20003300 20   Safflower, oil                     0.005000   1.000      1.000   Safflo
  Full comment: Safflower Field Trial 1/2 LOD, 100% CT
20003301 20   Safflower, oil-babyfood            0.005000   1.000      1.000   Safflo
  Full comment: Safflower Field Trial 1/2 LOD, 100% CT
15003440 15   Sorghum, grain                     0.100000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
15003450 15   Sorghum, syrup                     0.100000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CTMethidathion RCD (Revision 1) February 2007
95003580 O    Starfruit                          0.050000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
95003610 O    Sugar apple                        0.100000   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 100% CT
20003640 20   Sunflower, seed                    0.150000   1.000      0.500   Sunflo
  Full comment: Sunflower Field Trial Mean, 100% CT, 50% hulls
20003650 20   Sunflower, oil                     0.150000   1.000      0.200   Sunflo
  Full comment: Sunflower Field Trial Mean, 100% CT, 20% oil
20003651 20   Sunflower, oil-babyfood            0.150000   1.000      0.200   Sunflo
  Full comment: Sunflower Field Trial Mean, 100% CT, 20% oil
10003690 10   Tangerine                          0.000168   1.000      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
10003700 10   Tangerine, juice                   0.000168   2.300      1.000   PDP Or
  Full comment: PDP Orange 2000&2001 CA Mean Value, 5% CT
14003910 14   Walnut                             0.001250   1.000      1.000   1/2 To
  Full comment: 1/2 Tolerance, 5% CT
86010000 O    Water, direct, all sources         0.000013   1.000      1.000   PDP 20
  Full comment: PDP 2002-2003 1/2 Combined CA LOD 
86020000 O    Water, indirect, all sources       0.000013   1.000      1.000   PDP 20
  Full comment: PDP 2002-2003 1/2 Combined CA LOD Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                        Ver. 2.00
DEEM-FCID Chronic analysis for METHIDATHION                     (1994-98 data)
Residue file name: H:\MyFiles\DEEM-FCID
Files\Methidathion\Methidathionr1chroniccomb.R98
                                                     Adjustment factor #2 used.
Analysis Date 10-26-2005/08:53:39     Residue file dated: 10-25-2005/16:23:35/14
NOEL (Chronic) = .15 mg/kg bw/day
===============================================================================
                    Total exposure by population subgroup
-------------------------------------------------------------------------------
                                                    Total Exposure
                                         -----------------------------------
          Population                         mg/kg       Percent   Margin of
           Subgroup                       body wt/day    of NOEL   Exposr 1/
--------------------------------------   -------------  ---------  ---------
U.S. Population (total)                     0.000002        0.00%      61,496
U.S. Population (spring season)             0.000003        0.00%      57,399
U.S. Population (summer season)             0.000003        0.00%      53,009
U.S. Population (autumn season)             0.000002        0.00%      70,358
U.S. Population (winter season)             0.000002        0.00%      68,689
Northeast region                            0.000003        0.00%      55,478
Midwest region                              0.000002        0.00%      76,107
Southern region                             0.000002        0.00%      70,977
Western region                              0.000003        0.00%      46,593
Hispanics                                   0.000004        0.00%      40,397
Non-hispanic whites                         0.000002        0.00%      67,774
Non-hispanic blacks                         0.000002        0.00%      66,535
Non-hisp/non-white/non-black                0.000004        0.00%      41,391
All infants (< 1 year)                      0.000016        0.01%       9,469
Nursing infants                             0.000006        0.00%      27,231
Non-nursing infants                         0.000020        0.01%       7,590
Children 1-6  yrs                           0.000006        0.00%      24,449
Children 7-12 yrs                           0.000003        0.00%      51,012
Females 13-19 (not preg or nursing)         0.000002        0.00%      81,877
Females 20+ (not preg or nursing)           0.000002        0.00%      90,284
Females 13-50 yrs                           0.000002        0.00%      72,304
Females 13+ (preg/not nursing)              0.000006        0.00%      27,074
Females 13+ (nursing)                       0.000005        0.00%      32,271
Males 13-19 yrs                             0.000002        0.00%      79,611
Males 20+ yrs                               0.000002        0.00%      93,920
Seniors 55+                                 0.000002        0.00%      92,561
Children 1-2 yrs                            0.000008        0.01%      19,154
Children 3-5 yrs                            0.000006        0.00%      27,129
Children 6-12 yrs                           0.000003        0.00%      47,047
Youth 13-19 yrs                             0.000002        0.00%      80,661
Adults 20-49 yrs                            0.000002        0.00%      89,620
Adults 50+ yrs                              0.000002        0.00%      87,799
Females 13-49 yrs                           0.000002        0.00%      84,356
-------------------------------------------------------------------------------Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                        Ver. 2.00
DEEM-FCID Chronic analysis for METHIDATHION                     (1994-98 data)
Residue file name: H:\MyFiles\DEEM-FCID
Files\Methidathion\Methidathionr1chroniccomb.R98
                                                     Adjustment factor #2 used.
Analysis Date 10-26-2005/08:54:26     Residue file dated: 10-25-2005/16:23:35/14
Q* = 0.34 
===============================================================================
                    Total exposure by population subgroup
-------------------------------------------------------------------------------
                                                    Total Exposure
                                         -----------------------------------
          Population                         mg/kg         Lifetime risk
           Subgroup                       body wt/day       (Q*= .34)
--------------------------------------   -------------     -------------
U.S. Population (total)                     0.000002         8.29E-07
U.S. Population (spring season)             0.000003         8.89E-07
U.S. Population (summer season)             0.000003         9.62E-07
U.S. Population (autumn season)             0.000002         7.25E-07
U.S. Population (winter season)             0.000002         7.42E-07
Northeast region                            0.000003         9.19E-07
Midwest region                              0.000002         6.70E-07
Southern region                             0.000002         7.19E-07
Western region                              0.000003         1.09E-06
Hispanics                                   0.000004         1.26E-06
Non-hispanic whites                         0.000002         7.52E-07
Non-hispanic blacks                         0.000002         7.67E-07
Non-hisp/non-white/non-black                0.000004         1.23E-06
All infants (< 1 year)                      0.000016         5.39E-06
Nursing infants                             0.000006         1.87E-06
Non-nursing infants                         0.000020         6.72E-06
Children 1-6  yrs                           0.000006         2.09E-06
Children 7-12 yrs                           0.000003         1.00E-06
Females 13-19 (not preg or nursing)         0.000002         6.23E-07
Females 20+ (not preg or nursing)           0.000002         5.65E-07
Females 13-50 yrs                           0.000002         7.05E-07
Females 13+ (preg/not nursing)              0.000006         1.88E-06
Females 13+ (nursing)                       0.000005         1.58E-06
Males 13-19 yrs                             0.000002         6.41E-07
Males 20+ yrs                               0.000002         5.43E-07
Seniors 55+                                 0.000002         5.51E-07
Children 1-2 yrs                            0.000008         2.66E-06
Children 3-5 yrs                            0.000006         1.88E-06
Children 6-12 yrs                           0.000003         1.08E-06
Youth 13-19 yrs                             0.000002         6.32E-07
Adults 20-49 yrs                            0.000002         5.69E-07
Adults 50+ yrs                              0.000002         5.81E-07
Females 13-49 yrs                           0.000002         6.05E-07
-------------------------------------------------------------------------------Methidathion RCD (Revision 1) February 2007
California Department of Pesticide Regulation                        Ver. 2.00
DEEM-FCID Chronic analysis for METHIDATHION                     (1994-98 data)
Residue file name: H:\MyFiles\DEEM-FCID
Files\Methidathion\Methidathionr1chroniccomb.R98
                                                     Adjustment factor #2 used.
Analysis Date 10-26-2005/08:54:09     Residue file dated: 10-25-2005/16:23:35/14
Q* = 0.53 
===============================================================================
                    Total exposure by population subgroup
-------------------------------------------------------------------------------
                                                    Total Exposure
                                         -----------------------------------
          Population                         mg/kg         Lifetime risk
           Subgroup                       body wt/day       (Q*= .53)
--------------------------------------   -------------     -------------
U.S. Population (total)                     0.000002         1.29E-06
U.S. Population (spring season)             0.000003         1.39E-06
U.S. Population (summer season)             0.000003         1.50E-06
U.S. Population (autumn season)             0.000002         1.13E-06
U.S. Population (winter season)             0.000002         1.16E-06
Northeast region                            0.000003         1.43E-06
Midwest region                              0.000002         1.04E-06
Southern region                             0.000002         1.12E-06
Western region                              0.000003         1.71E-06
Hispanics                                   0.000004         1.97E-06
Non-hispanic whites                         0.000002         1.17E-06
Non-hispanic blacks                         0.000002         1.19E-06
Non-hisp/non-white/non-black                0.000004         1.92E-06
All infants (< 1 year)                      0.000016         8.40E-06
Nursing infants                             0.000006         2.92E-06
Non-nursing infants                         0.000020         1.05E-05
Children 1-6  yrs                           0.000006         3.25E-06
Children 7-12 yrs                           0.000003         1.56E-06
Females 13-19 (not preg or nursing)         0.000002         9.71E-07
Females 20+ (not preg or nursing)           0.000002         8.81E-07
Females 13-50 yrs                           0.000002         1.10E-06
Females 13+ (preg/not nursing)              0.000006         2.94E-06
Females 13+ (nursing)                       0.000005         2.46E-06
Males 13-19 yrs                             0.000002         9.99E-07
Males 20+ yrs                               0.000002         8.46E-07
Seniors 55+                                 0.000002         8.59E-07
Children 1-2 yrs                            0.000008         4.15E-06
Children 3-5 yrs                            0.000006         2.93E-06
Children 6-12 yrs                           0.000003         1.69E-06
Youth 13-19 yrs                             0.000002         9.86E-07
Adults 20-49 yrs                            0.000002         8.87E-07
Adults 50+ yrs                              0.000002         9.05E-07
Females 13-49 yrs                           0.000002         9.42E-07
-------------------------------------------------------------------------------